cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
248519,4-Chlorophenyl trifluoromethanesulphonate,810-735-6,29540-84-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248520,"(1R,5S,6r)-3-(tert-Butoxycarbonyl)-3-azabicyclo[3.1.0]hexane-6-carboxylic acid",810-736-1,927679-54-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H302:2;H315:1;H312:1;H332:1;H335:1
248521,1-Hydroxyisoquinoline-7-carboxylic acid,810-737-7,1301214-62-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248522,2-(propan-2-yloxy)acetic acid,810-738-2,33445-07-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H302:1;H314:1
248523,Tris(ethyl)amine pentahydrofluoride,810-739-8,94527-74-9,Skin Corr. 1B,Notified C&L,2,H314:2;H300:1;H310:1;H330:1
248524,meta-Topolin,810-740-3,75737-38-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
248525,5-Chloro-2-methoxynicotinic acid,810-741-9,54916-65-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
248526,Tarenflurbil-acyl-beta-D-glucuronide,810-742-4,162992-67-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
248527,2-Bromo-5-(trifluoromethoxy)pyridine,810-744-5,888327-36-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
248528,2'-Fluoro-5'-iodoacetophenone,810-745-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248529,8-Fluoro-2-methylquinoline-7-boronic acid,810-746-6,957035-06-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
248530,"Pyrrolidine-2,5-diyldimethanol",810-747-1,5626-66-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248531,N-Methyl-N-(oxetan-3-yl)azetidin-3-amine dihydrochloride,810-748-7,1403767-34-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248532,(azetidin-2-yl)methanol,810-749-2,250274-91-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H302:1;H315:2;H312:1;H332:1;H335:2;H318:1;H227:1
248533,[No public or meaningful name is available],810-750-8,63284-72-0,Acute Tox. 4,Notified C&L,1,H302:1
248534,[No public or meaningful name is available],810-751-3,411221-53-9,Acute Tox. 4,Notified C&L,1,H302:1
248535,"Lutetium aluminium oxide, cerium doped, garnet",942-643-8,,Not Classified,REACH registration C&L,1,Not classified:1
248536,Reaction product of alkylaluminum dichloride and magnesium bis(alkylalkanolate) and precipitated synthetic amorphous silica and titanium tetrachloride,,,Flam. Sol. 1;Water-react. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H228:1;H261:1;H315:1;H411:1;H373:1;H318:1;H371:1
248543,Reaction mass of 105-87-3 and 106-22-9 and 106-24-1 and 123-35-3 and 127-91-3 and 5392-40-5 and 5989-27-5 and 78-70-6 and 99-85-4,942-646-4,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H315:1;H304:1;H226:1;H410:1
248544,"10-deacetyl-13-[(4S, 5R)-2-(2,4-dimethoxyphenyl)-3-(2-nitrophenylsulfanyl)-4-phenyl-oxazolidine-5-carboxylic acid]baccatin III)",810-752-9,881844-48-0,Eye Irrit. 2,Notified C&L,1,H319:1
248545,"tert-Butyl 4-({6-[7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl]amino}pyridin-3-yl)piperazine-1-carboxylate",810-753-4,1374639-78-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2,Notified C&L,1,H319:1;H301:1;H373:1;H315:1
248546,[(E)-4-(2-(Aminomethyl)-3-Fluoroalloxy)-N-Tert-butybenzamide HCL],810-755-5,1478364-68-9,Acute Tox. 4;Repr. 2;STOT RE 2,Notified C&L,2,H361:2;H302:2;H373:2
248549,"2-Ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine perchlorate",810-757-6,66729-78-0,Ox. Sol. 3;Acute Tox. 4,Notified C&L,1,H272:1;H302:1
248550,NOOTKATONE,942-649-0,,Eye Irrit. 2,Notified C&L,1,H319:1
248551,"sodium (1R,2R)-2-(2-bromo-5-methoxyphenyl)-1-({3-cyclohexyl-6-[(dimethylsulfamoyl)carbamoyl]-1H-indol-1-yl}methyl)cyclopropanecarboxylate",942-650-6,1542139-01-4,Acute Tox. 4;Eye Dam. 1;STOT RE 2,REACH registration C&L,2,H318:2;H302:2;H373:2
248552,"Reaction Mass of Benzyl (1R,1S) 2,2,4-trimethyl-1-[(2-methylpropanoyl)oxy]pentan-3-yl benzene-1,2-dicarboxylate and Benzyl (3R,3S) 2,2,4-trimethyl-3-[(2-methylpropanoyl)oxy]pentyl benzene-1,2-dicarboxylate",701-008-3,,Not Classified,REACH registration C&L,1,Not classified:1
248554,"1-Penten-4-yn-3-ol, 1-chloro-3-ethyl-",810-759-7,113-18-8,Acute Tox. 3,Notified C&L,1,H301:1
248556,2-propylheptyl methacrylate,810-760-2,149855-64-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,83,H319:83;H335:83;H315:83
248557,Tris(isopropylcyclopentadienyl),810-761-8,130206-63-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H319:22;H335:22;H315:22
248558,Diethylgermane,810-762-3,1631-46-5,Flam. Liq. 2;Water-react. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,22,H319:22;H302:22;H315:22;H225:22;H260:22;H332:22;H335:22
248559,Tert-butylgermane,810-763-9,149540-54-5,Flam. Liq. 2;Water-react. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,22,H319:22;H302:22;H315:22;H225:22;H260:22;H332:22;H335:22
248566,"Reaction mass of N1-benzylpropane-1,2-diamine and N2-benzylpropane-1,2-diamine",942-655-3,1802727-84-9,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,2,H302:2;H314:2;H317:2;H411:2;H318:2
248567,"Reaction products of 2-[(2-methylphenoxy)methyl]oxirane and propane-1,2-diamine",810-766-5,1802886-42-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H400:3;H302:3;H317:3;H315:3;H318:3;H410:3
248568,2-[4-(hydrazinylmethyl)phenyl]pyridine dihydrochloride,810-767-0,1802485-62-6,Acute Tox. 4,REACH registration C&L,2,H302:2
248570,Bis(hexamethylene triamine) diketimine with methyl ethylketone,942-657-4,,Flam. Liq. 2;Asp. Tox. 1;Skin Corr. 1A;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H314:1;H304:1;H412:1;H225:1;H318:1;H336:1
248579,"reaction mass of Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-[bis(2- hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt and Benzenesulfonic acid, 5-[[4-[bis(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[(2-hydroxyethyl)amino]-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-, disodium salt",942-661-6,,Not Classified,REACH registration C&L,2,Not classified:2
248583,Tris(methylphenyl) phosphate,809-930-9,1330-78-5,Repr. 2;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7,H361:7;H400:7;H410:7
248585,"Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',.alpha.''-1,2,3-propanetriyltris[.omega.-[(1-oxo-2-propenyl)oxy]-",942-664-2,,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Aquatic Chronic 3,Notified C&L,83,H331:83;H302:83;H317:83;H412:83;H318:83;H335:83
248586,"Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-, homopolymer, polyethylene glycol mono-Me ether-blocked",942-665-8,,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,83,H413:83;H317:83
248587,((2-decyltetradecyl)oxy)cyclopentane),942-666-3,,Asp. Tox. 1,Notified C&L,1,H304:1
248589,"7-[{4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-2-(carbamoylamino)phenyl}diazenyl]naphthalene-1,3,6-trisulfonic acid, lithium sodium salts",942-667-9,,Skin Sens. 1,Notified C&L,1,H317:1
248590,"(E)-N-((dialkylamino)alkylene)-3,5-bis(polyfluoroalkyl)benzamide",,,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1,Notified C&L,1,H312:1;H332:1;H302:1;H320:1
248591,Copper zirconium oxide,810-773-3,134883-93-5,Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H400:1;H410:1
248592,Cerium manganese zirconium oxide,810-774-9,346701-94-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
248593,Manganese zirconium oxide,810-775-4,145330-11-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
248594,alkyl phenol,942-670-5,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:2;H410:2
248595,long chain alkyl amine,942-671-0,,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H331:1;H302:1;H314:1;H317:1;H400:1;H373:1;H410:1;H311:1
248596,alkyl methacrylate,942-672-6,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H317:1;H315:1;H335:1;H410:1
248597,alkyl alkoxy amine,942-673-1,,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H314:1;H410:1
248598,"2,9-bis[3-(diethylamino)propylsulfamoyl]Quino[2,3-b]acridine-7,14-dione",810-777-5,,Skin Sens. 1,Notified C&L,18,H317:18
248602,Cerium nickel zirconium oxide,810-778-0,440667-11-8,Skin Sens. 1;Carc. 1A;STOT RE 1,Notified C&L,1,H372:1;H350:1;H317:1
248606,"1-(1-hydroxy-5,6,7,8-tetrahydro-2-naphthalenyl)ethanone",810-781-7,95517-07-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,2,H318:2;H302:2;H315:2
248607,"2-chloro-5,5-dimethyl-1,3,2-dioxaphosphorinane 2-sulfide",810-782-2,873-98-3,Acute Tox. 4,Notified C&L,1,H302:1
248611,bis[(4-methoxyphenyl)methyl]amine,810-785-9,17061-62-0,,Notified C&L,2,H314:2
248612,[4-(aminomethyl)phenyl]methanol,810-786-4,39895-56-2,,Notified C&L,2,H312:1;H332:1;H302:2;H314:2
248613,"4-cyano-2,6-difluorobenzoic acid",810-788-5,181073-82-5,,Notified C&L,2,H331:1;H319:1;H315:2;H301:1;H335:2;H311:1;H302:1;H312:1;H332:1;H318:1
248616,Manganese Zirconium Hydroxide,810-791-1,1569259-98-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
248617,Copper Zirconium Hydroxide,810-792-7,116875-80-0,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,1,H400:1;H302:1;H411:1;H332:1;H318:1;H410:1
248620,"(S)-tert.-Butyl-[2-(aminoethoxy)-[1,2]oxaborolan-4-yl]acetate",942-682-0,,Not Classified,Notified C&L,1,Not classified:1
248627,Reaction mass of 2-(2-ethoxyethoxy)ethyl acetate and silver,942-686-2,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H410:1
248628,"1,2-Bis(dichloromethylsilyl)ethene",825-355-6,18142-59-1,Skin Corr. 1;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
248630,"Reaction mass of tetrasodium ethylenediaminetetraacetate and 1,2-benzisothiazol-3(2H)-one and 2-methyl-2H-isothiazol-3-one and water and Quaternary ammonium compounds, benzyl-C8-18-alkyldimethyl, chlorides and Castor oil, hydrogenated, ethoxylated and 1310-73-2 and 24938-91-8 and 63148-62-9",942-688-3,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H318:1;H412:1;H317:1;H315:1
248631,(R)-1-((4-amino-2-bromo-5-fluorophenyl)amino)-3-(benzyloxy)propan-2-ol 4-methylbenzenesulfonate,810-796-9,1294504-64-5,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,2,H317:2;H315:2
248632,Octadecanol ethoxylated (>= 15 EO),942-689-9,,Eye Irrit. 2,Notified C&L,31,H319:31
248633,"Dodecan-1-ol, ethoxylated (>= 15 EO)",942-690-4,,Eye Irrit. 2,Notified C&L,31,H319:31
248637,"Reaction mass of tetrasodium 8,8'-(1E,1'E)-(4,4'-(cyclohexane-1,1-diyl)bis(4,1-phenylene))bis(diazene-2,1-diyl)bis(7-hydroxynaphthalene-1,3-disulfonate) and trisodium 7-hydroxy-8-((E)-(4-(1-(4-((E)-(1-hydroxy-4-sulfonatonaphthalen-2-yl)diazenyl)phenyl)cyclohexyl)phenyl)diazenyl)naphthalene-1,3-disulfonate",942-692-5,,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,8,H319:8;H412:8
248638,2-Cyanoethyl 1-Fluoroethyl carbonate,810-799-5,1537191-46-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H317:1;H315:1
248639,"4-(2,2-Difluoroethoxy) ethylene carbonate",942-693-0,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H317:1;H315:1
248640,1-Fluoroethyl 2-methoxyethyl carbonate,942-694-6,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H317:1;H315:1
248641,meso-1-fluoroethyl-1´-fluoroethyl carbonate,810-800-9,1440539-29-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H317:1;H315:1
248642,"4-(2,2,3,3-Tetrafluoropropoxy) ethylene carbonate",942-695-1,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H317:1;H315:1
248644,"Reaction mass of 1,3'-Bipyridinium, 1'-[3-(dimethylamino)propyl]-6'-hydroxy-4'-methyl-2'-oxo-, inner salt and 1,3'-Bipyridinium, 1'-[3-(dimethylamino)propyl]-1',6'-dihydro-2'-hydroxy-4'-methyl-6'-oxo-, chloride (1:1)",942-697-2,,Not Classified,REACH registration C&L,1,Not classified:1
248648,graphene oxide,942-699-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
248652,"4-methyl-2,6-bis(phenylamino)nicotinonitrile",810-804-0,51566-48-4,Not Classified,Notified C&L,1,Not classified:1
248653,"(±)-6,8-Dimethylnon-7-enal",486-670-9,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H317:2;H315:2
248654,"Reaction mass of glycerol and propane-1,2-diol and l-(+)-lactic acid and dexpanthenol and water and Matricaria recutita, ext.",942-702-8,,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H302:1;H317:1;H315:1;H318:1;H410:1
248657,"Glycerol, ethoxylated (Polymer)",942-704-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248659,"4-(2-{(E)-2-[(1E)-2-chloro-1-{(2E)-2-[1,1-dimethyl-3-(4-sulfobutyl)-1,3-dihydro-2H-benzo[e]indol-2-ylidene]ethylidene}-1H-inden-3-yl]vinyl}-1,1-dimethyl-1H-benzo[e]indolium-3-yl)butane-1-sulfonate",942-705-4,,Skin Sens. 1,Notified C&L,1,H317:1
248662,"Reaction products of 2,7-Naphthalenedisulfonic acid, 4-amino-6-[2-[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-2-sulfophenyl]diazenyl]-3-[2-(2,5-disulfophenyl)diazenyl]-5-hydroxy-, pentasodium salt and lithium chloride",942-709-6,,Skin Sens. 1,Notified C&L,1,H317:1
248663,"2-[{6-[(4-amino-6-chloro-1,3,5-triazin-2-yl)(methyl)amino]-1-hydroxy-3-sulfonaphthalen-2-yl}diazenyl]naphthalene-1,5-disulfonic acid, lithium sodium salts",942-710-1,,Skin Sens. 1,Notified C&L,1,H317:1
248664,Pridopidine free base,810-806-1,346688-38-8,Acute Tox. 3;Repr. 2,Notified C&L,1,H361:1;H301:1
248665,Fater Recycled Cellulose (FRC),942-712-2,,Eye Irrit. 2,Notified C&L,1,H319:1
248666,Emamectin B1A benzoate,810-807-7,138511-97-4,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;STOT SE 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H372:156;H331:156;H400:156;H301:156;H370:156;H318:156;H410:156;H311:156
248667,[4-(2-hydroxyethoxy)phenyl](phenyl)methanone,810-808-2,14814-17-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:2;H335:2;H315:2;Not classified:1
248668,"5-CYCLOPROPYL-1,2,4-OXADIAZOL-3-AMINE",810-809-8,868696-42-8,Acute Tox. 4,Notified C&L,1,H302:1
248669,"Hydrogenated rosin, zinc salt",810-810-3,68425-02-5,Not Classified,Notified C&L,23,Not classified:22;H332:1;H317:1
248672,"1,4-Cyclohexanedicarboxylic acid, 1,4-diisononyl ester",701-012-5,,Not Classified,REACH registration C&L,1,Not classified:1
248674,[No public or meaningful name is available],810-815-0,177149-89-2,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;STOT SE 3;STOT SE 3,Notified C&L,21,H318:21;H335:21;H302:21;H314:21
248675,"Reaction mass of sulfur and 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol",942-713-8,,Skin Irrit. 2;Skin Sens. 1;Repr. 2;Aquatic Chronic 3,Notified C&L,1,H361:1;H412:1;H317:1;H315:1
248676,"2-Propenoic acid, heptadecyl ester, branched",810-816-6,1473386-36-5,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,87,H319:87;H317:87;H315:87;H411:87;H335:87
248677,"2-Propenoic acid, 2-methyl-, heptadecyl ester, branched",810-817-1,1473386-29-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,83,H319:83;H335:83;H315:83
248678,Reaction mass of 111-76-2 and 112-07-2,942-714-3,,Acute Tox. 4,Notified C&L,1,H312:1
248679,(6S)-5-[(tert-butoxy)carbonyl]-5-azaspiro[2.4]heptane-6-carboxylic acid,824-641-8,1129634-44-1,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248681,"5-Azaspiro[2.4]heptane-5,6-dicarboxylic acid, 5-(1,1-dimethylethyl) ester",942-715-9,,Not Classified,Notified C&L,2,Not classified:2
248683,Reaction mass of 141-78-6 and 28805-80-3 and 584-84-9 and 91-08-7,942-716-4,,Flam. Liq. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2,Notified C&L,1,H319:1;H317:1;H351:1;H225:1;H334:1;H332:1;H335:1;H336:1
248685,"Liraglutide (2S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2- [[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl) propanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3- phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]- 3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl) propanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino] 5 oxopentanoyl]amino] propanoyl]amino]propanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)- 5-carbamimidamido-1-[[2-[[(2S)-5-carbamimidamido-1-(carboxymethylamino)-1-oxopentan-2-yl]amino]-2- oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl] amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl] amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-oxohexyl]amino]-2- (hexadecanoylamino)-5-oxopentanoic acid",810-818-7,204656-20-2,Carc. 2;Repr. 2,Notified C&L,3,H361:2;H351:2;Not classified:1
248686,"N-(4-hydroxy-2,6-dimethylphenyl)acetamide",810-819-2,6337-56-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248687,"3,5-Dichloro-4-(prop-2-yn-1-yloxy)benzaldehyde",810-820-8,426229-84-7,Acute Tox. 4;Skin Irrit. 2,Notified C&L,1,H302:1;H315:1
248688,3-Phenylcyclopentane-1-carboxylic acid,810-821-3,91495-75-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H302:2;H315:2;H335:1
248689,4-(2-Methyl-2H-tetrazol-5-yl)phenol,810-822-9,81015-02-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
248690,Methyl 3-(hydroxymethyl)-1H-indole-5-carboxylate,810-823-4,947412-98-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248691,"2-Isobutyl-1,3-dioxo-5-isoindolinecarboxylic acid",810-825-5,346716-89-0,Acute Tox. 3;Skin Sens. 1B;Eye Irrit. 2,Notified C&L,1,H319:1;H301:1;H317:1
248692,[No public or meaningful name is available],810-826-0,26066-88-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H301:1;H315:1
248693,"6,7-Dichloroquinazolin-2-amine",810-827-6,18672-00-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
248694,"1-Methyl-imidazo[1,5-a]pyridine-7-carboxylic acid",810-828-1,1378811-63-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
248695,"7-BROMO-1-METHYLIMIDAZO[1,5-A]PYRIDINE",810-829-7,1379341-62-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
248696,2-(5-Bromo-6-fluoro-1H-indol-3-yl)acetonitrile,810-830-2,1227598-56-2,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H301:1;H315:1
248697,3-Chloro-4-(cyclopropylmethoxy)phenol,810-831-8,1243284-44-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
248698,"3-(3-Methyl-1,2,4-oxadiazol-5-yl)phenol",810-832-3,1082766-16-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
248699,Methyl 3-(cyanomethyl)-1H-indole-5-carboxylate,810-833-9,113438-59-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
248700,1-(1-PYRROLIDINYLCARBONYL)-4-PIPERIDINAMINE HYDROCHLORIDE,810-834-4,889849-93-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
248701,(S)-2-Ethyl-2-mercaptomethyl hexan-1-ol,810-836-5,1193512-93-4,Skin Sens. 1B;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
248703,"Reaction Mass of (3E)-3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one and (1E)-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-1-penten-3-one",942-741-0,,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,4,H411:4;H317:4;H315:4
248710,"Spiroundecenol, tetramethyl-, acetate",810-839-1,678981-31-2,Skin Sens. 1B,Notified C&L,13,H317:13
248713,"1-((4R,5R)-4,5-dihydroxy-N2-(4-(5-(5-(pentyloxy)phenyl)-3-isoxazolyl)benzoyl)-L-ornithine)-4-((4S)-4-hydroxy-4-(4-hydroxy-3-(sulfooxy)phenyl)-L-threonine)-, monosodium salt",810-840-7,208538-73-2,Repr. 2,Notified C&L,6,H361:5;H351:2;H373:1;H372:1;H400:1;H302:2;H332:1;H410:1;H319:1
248715,(2R)-6-fluorochromane-2-carboxylic acid,810-841-2,129101-37-7,,Notified C&L,2,H302:2
248716,sodium cocoyl barley aminoacids,942-725-3,,Eye Dam. 1,REACH registration C&L,2,H318:2
248717,"(2S)-6-fluoro-3,4-dihydro-2H-1-Benzopyran-2-carboxylic acid",810-842-8,129101-36-6,,Notified C&L,2,H302:2
248718,Reaction mass of Pentadecanoic acid and Tridecanoic acid and 2-Methyldodecanoic acid 2-Methyltetradecanoic acid,942-726-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H335:1;H315:1
248719,"(3,3,4,4,5,5,6,6,7,7,8,8,8-Tridecafluorooctyl)phosphonic acid monoethyl ester",825-950-0,1189052-97-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248721,Lithium salt of branched-aliphatic dicarboxylic acid,,,Acute Tox. 4,Notified C&L,1,H302:1
248722,Dialuminium x dysprosium y europium ( 1-x-y ) strontium tetraoxide,810-843-3,201426-52-0,Aquatic Chronic 2,Notified C&L,7,H411:7
248724,sodium 2-[4-(cyclopropylcarbonyl)phenyl]-2-methylpropanoate(1:2),942-731-6,,Not Classified,Notified C&L,1,Not classified:1
248726,"Reaction mass of 2-aminoethanol and 6-[(p-tosyl)amino]hexanoic acid, compound with 2-aminoethanol (1:1)",942-732-1,,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1,H319:1;H317:1
248729,2-[bis(tert-butoxycarbonyl)amino]-5-bromopyridin-3-yl 4-methylbenzenesulfonate,810-844-9,1803573-21-8,Not Classified,REACH registration C&L,2,Not classified:2
248735,"4-(Difluoro-(3,4,5-trifluoro-phenoxy)-methyl)-3,5-difluoro-benzaldehyde",942-738-4,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H319:2;H400:2;H302:2;H315:2;H410:2
248736,"Human Epidermal Growth Factor (HuEGF) (4S)-4-[[(2S)-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2- [[(4R,7S,10S,16S,19S,25S,28S,31R)-31-[[(2S)-4-amino-2- [[(1R,6R,9S,12S,15S,18S,21S,24S,27S,30S,33S,36S,39R,44R,50S,53S,56S,59S,62S,68S,73S,76S,79S,85S)- 15-(4-aminobutyl)-30-[(2S)-butan-2-yl]-44-[[(2S)-4-carboxy-2-[[(2S)-2-[[(2S)-3-carboxy-2-[[(2S)-2-[[(2S)-2,4- diamino-4-oxobutanoyl]amino]-3 hydroxypropanoyl]amino]propanoyl]amino]-3-hydroxypropanoyl]amino] butanoyl]amino]-27-(2-carboxyethyl)-18,62,79-tris(carboxymethyl)-56-(hydroxymethyl)-12,33,68-tris[(4- hydroxyphenyl)methyl]-59,76-bis(1H-imidazol-4-ylmethyl)-9,24-dimethyl-21,53,73-tris(2-methylpropyl)-36- (2-methylsulfanylethyl) 8,11,14,17,20,23,26,29,32,35,38,45,51,54,57,60,63,66,69,71,74,77,80,83,86- pentacosaoxo-85-propan-2-yl-3,4,41,42-tetrathia 7,10,13,16,19,22,25,28,31,34,37,46,52,55,58,61,64,67,70,72,75,78,81,84,87- pentacosazatricyclo[37.31.17.046,50]heptaoctacontane-6-carbonyl]amino]-4 oxobutanoyl]amino]-16-[(2S)- butan-2-yl]-7-(3-carbamimidamidopropyl)-10-(2-carboxyethyl)-19-[(4-hydroxyphenyl)methyl]- 6,9,12,15,18,21,24,27,30-nonaoxo-25,28-di(propan-2-yl)-1,2-dithia-5,8,11,14,17,20,23,26,29- nonazacyclodotriacontane-4-carbonyl]amino]-5-oxopentanoyl]amino]-3-(4 hydroxyphenyl)propanoyl]amino]- 5-carbamimidamidopentanoyl]amino]-3-carboxypropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl] amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-[[(2S)-1-[[(1S)-4- carbamimidamido-1-carboxybutyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid",810-845-4,62253-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
248737,"3-([Pentafluorothio)benzeneboronic acid, pinacol ester",810-847-5,1286278-35-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248738,2-Chloro-L-phenylalanine,810-848-0,103616-89-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248739,3-Chloro-2-methoxybenzeneboronic acid,810-849-6,179898-50-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
248740,"4-Chloro-6,7-dihydro-2-(morpholin-4-yl)-5H-pyrrolo[2,3-d]pyrimidine, N7-BOC protected",810-850-1,1439823-58-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248741,"2-oxo-2,3-dihydro-1H-indole-5-carbonitrile",810-851-7,61394-50-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
248742,N-Methyl-4-methylbenzylamine,810-852-2,699-04-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1;H314:1
248743,4-Ethynyl-2-methylpyridine,810-853-8,30413-56-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
248744,E-Maleimidocaproic acid hydrazine hydrochloride,810-854-3,175290-73-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
248745,5-Bromo-4-methoxy-2-methylbenzoic acid,810-855-9,875245-69-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
248746,"4,4,5,5-Tetramethyl-2-(oxetan-3-yl)-1,3,2-dioxaborolane",810-856-4,1396215-84-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:1;H315:2;H332:1;H335:2
248747,Methyl cis-3-(Boc-amino)cyclobutanecarboxylate,810-858-5,142733-63-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
248748,4-Bromo-2-(difluoromethyl)pyridine,810-859-0,1211580-54-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H227:1
248749,"4-(Bromomethyl)-5-phenyl-1,3-oxazole",810-860-6,368869-94-7,Skin Corr. 1B,Notified C&L,1,H314:1
248750,2-Fluoro-3-nitrobenzyl bromide,810-861-1,946125-65-1,Skin Corr. 1B,Notified C&L,1,H314:1
248751,2-[(Methylamino)methyl]pyridine dihydrochloride,810-862-7,100868-72-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H302:1;H315:1
248752,"1,1,5,5-Tetrafluoro-2,4-pentanedione",810-863-2,70086-62-3,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H318:1;H226:2;H314:1;H319:1;H335:1;H315:1
248753,2-Fluoro-3-nitrobenzyl alcohol,810-864-8,946126-95-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248754,2H-Indazole-3-carbaldehyde,810-865-3,89939-16-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
248755,4-(Piperidin-1-ylmethyl)aniline,810-866-9,29608-05-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,2,H312:2;H332:2;H302:2;H314:2;H335:1
248756,2-Amino-3-methylbenzotrifluoride,810-867-4,88301-98-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
248757,1-Amino-6-bromoisoquinoline,810-869-5,215453-26-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2;H301:1
248758,3-(Cyclopentyloxy)-4-methoxybenzeneboronic acid,810-870-0,159613-21-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248759,4-(Cyclohexylcarbamoyl)-3-fluorobenzeneboronic acid,810-871-6,874289-11-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248760,4-(tert-Butylcarbamoyl)-3-fluorobenzeneboronic acid,810-872-1,874289-18-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248761,3-Chloro-6-hydroxyisoquinoline,810-873-7,1374652-53-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248762,"1,1'-Ethane-1,2-diylbis(2-fluorobenzene)",810-874-2,349-38-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
248763,"2-Bromo-3,6-difluorobenzoic acid",810-875-8,124244-65-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
248764,4-(Bromomethyl)phenyl acetate,810-876-3,52727-95-4,Skin Corr. 1B,Notified C&L,1,H314:1
248765,"2H-Pyrazolo[4,3-c]pyridine",810-877-9,271-50-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
248766,"Furo[2,3-c]pyridine-2-carboxylic acid",810-878-4,112372-15-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248767,2-Fluoro-5-nitrobenzenesulfonyl chloride,810-880-5,713-21-3,Skin Corr. 1B,Notified C&L,2,H314:2
248768,2-Amino-5-bromo-3-(trifluoromethyl)benzoic acid,810-881-0,50419-85-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
248769,5-Bromo-3-fluoro-2-nitroaniline,810-882-6,1193385-18-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
248770,5-Bromo-3-fluoro-2-iodoanisole,810-883-1,1394291-47-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248771,Methyl trans-3-(Boc-amino)cyclobutanecarboxylate,810-884-7,1101173-77-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
248772,4-Bromo-2-iodo-6-nitrophenol,810-885-2,58349-02-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
248773,"2,6-Difluoro-4-(trifluoromethyl)benzaldehyde",810-886-8,134099-34-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
248774,2’-Fluoro-3’-nitroacetophenone,810-887-3,873697-78-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248775,2-Fluoro-3-nitrobenzaldehyde,810-888-9,96516-29-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248776,"4-bromo-3,5-difluorobenzotrifluoride",810-889-4,499238-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
248777,"Hydrocarbons, C10, aromatics, < 1% naphthalene [Solvent naphtha (petroleum), heavy arom.]",942-740-5,,Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H304:1;H411:1;H336:1
248778,[4-methylphenyl-(4-(2-methylpropyl)phenyl)]iodonium hexafluorophosphate,810-891-5,344562-80-7,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H302:1;H317:1;H373:1;H318:1;H410:1
248788,Phenoxy(pyrrolidin-2-yl)phosphinic acid,810-892-0,99305-82-5,Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H314:1
248789,"(1,1-Dioxo-hexahydro-1lambda6-thiopyran-4-yl)-[(R)-2-(4-fluoro-phenyl)-4-(5-trifluoromethyl-pyrimidin-2-yl)-piperazin-1-yl]-methanon",810-893-6,1698871-66-7,STOT RE 1,Notified C&L,1,H372:1
248790,"Alcohols, C2-33, manuf. of, by-products from, overheads",810-894-1,876065-86-0,Repr. 2,Notified C&L,19,H361:19
248797,"N-(3-Chlorophenyl)-1,1,1-trifluoromethanesulfonamide",810-900-2,23384-03-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H311:1
248798,"N-(4-Chlorophenyl)-1,1,1-trifluoromethanesulfonamide",810-901-8,23384-04-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H311:1
248799,"1-Cyclohexyl-2,2,2-trifluoroethanamine",810-902-3,1078726-20-1,Skin Corr. 1B,Notified C&L,1,H314:1
248800,"N-(2-Chlorophenyl)-1,1,1-trifluoromethanesulfonamide",810-903-9,23384-02-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H311:1
248802,"Reaction mass of (3aR*,5aS*,9aS*,9bR*)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan and (3aR*,5aS*,9aS*,9bS*)-3a,6,6,9a-tetramethyldodecahydronaphtho[2,1-b]furan",942-754-1,,Aquatic Chronic 2,REACH registration C&L,6,H411:6
248805,[No public or meaningful name is available],810-904-4,652969-01-2,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,35,H319:35;H302:35;H411:35
248806,[No public or meaningful name is available],810-906-5,160337-95-1,STOT RE 2,Notified C&L,35,H373:35
248807,[No public or meaningful name is available],810-907-0,98530-12-2,Skin Irrit. 2;STOT RE 2,Notified C&L,35,H373:35;H315:35
248810,"fatty alcohol (C9-11), ethoxylated 4EO , phosphated, sodium salt [mono-/diester]",942-755-7,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
248813,[No public or meaningful name is available],810-910-7,151928-23-3,Repr. 2,Notified C&L,1,H361:1
248816,"Aminofunctional polydimethylsiloxane, quaternary",942-757-8,,Skin Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1
248817,(2R)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,942-766-7,,Repr. 2,Notified C&L,1,H361:1
248818,Fatty amines ethoxylated neutralised with lactic acid,942-758-3,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H302:1;H315:1;H410:1
248819,"6,11-dihydro-11-(3-dimethylaminopropylidene)-dibenzo(b,e)thiepin-5-oxide hydrochloride",942-759-9,,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
248820,"6,11-dihydro-11-(3-dimethylaminopropylidene)-dibenzo(b,e)thiepin-5,5-dioxide hydrochloride",942-760-4,,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
248823,"2-propenoic acid salt of N,N-dimethylpropane-1,3-diamine - Poly(oxy-1,2-ethanediyl), .alpha.-(1-oxo-2-propenyl)-.omega.-[(1-oxo- 2-propenyl)oxy]- adduct",942-762-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H412:1;H317:1;H315:1
248826,"Reaction mass of 2-[[[2-[(2-aminoethyl)amino]ethyl]amino]carbonyl]-benzoic acid and 2,2' -[iminobis(2,1-ethanediyliminocarbonyl)]bis-benzoic acid and 7,8,9,10,11,12,20,21,22,23,24,25-dodecahydrodibenzo[i,t] [1,4,7,12,15,18] hexaazacyclodocosine-5,13,18,26(6H,19H)-tetrone",942-764-6,,Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,1,H302:1;H411:1
248827,(2S)-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(2S)-2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide,942-767-2,,Repr. 2,Notified C&L,1,H361:1
248829,Fmoc-D-Ser(tBu)-OH,810-913-3,128107-47-1,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
248831,Dimethylamino(dimethyl)phenylsilane,810-915-4,20180-31-8,Water-react. 1;Skin Corr. 1B,Notified C&L,22,H260:22;H314:22
248832,"1-ethylcyclopenta-1,3-diene; yttrium",810-917-5,476364-59-7,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,23,H228:23;H319:23;H315:23;H261:1
248836,2- (1-naphthylmethyl) benzimidazole,810-918-0,42268-60-0,Acute Tox. 4,Notified C&L,1,H302:1
248837,"3,3,3-trideuterio-2-(trideuteriomethyl)propanoic acid",810-920-1,29054-08-8,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H226:1;H301:1;H311:1
248838,Methyl 5-bromo-3-chloropyridine-2-carboxylate,810-921-7,1214336-41-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H319:91;H335:91;H302:91;H315:91;H312:1;H332:1
248839,1-methoxy-2-(methoxymethyl)-3-methyl-2-(propan-2-yl)hexane,810-922-2,129228-11-1,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,2,H411:2;H315:2
248840,"N1-(tert-Butoxycarbonyl)-4-fluoro-1,2-phenylenediamine",810-923-8,579474-47-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1;H302:1
248841,"2,6-Bis(chloromethyl)-1,4-dimethoxybenzene",810-924-3,1379163-23-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248842,Bis(4-cyanobenzyl)amine Hydrochloride,810-925-9,1802566-49-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H311:1
248843,"(2S,3S,5R,6R)-5,6-Bis(azidomethyl)-2,3-dimethoxy-2,3-dimethyl-1,4-dioxane",810-926-4,1585236-34-5,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H228:1;H319:1;H315:1
248844,"2,2'-Bipyridine-6,6'-diol",810-928-5,103505-54-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248845,"1,2-Benzenedisulfonic Imide",810-929-0,4482-01-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248846,"2-Bromo-9,9-dihexylfluorene",810-930-6,226070-05-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248847,"4,4'-Bis(5-hexyl-2-thienyl)-2,2'-bipyridyl",810-931-1,1047684-56-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248848,"10,10'-Dimethyl-9,9'-biacridinium Bis(monomethyl Terephthalate)",810-932-7,469865-01-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248849,"N,N'-Bis(2-pyridylmethyl)-1,2-ethylenediamine Tetrahydrochloride",810-933-2,1310544-60-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248850,4-Aminophenyl 4-Aminobenzoate,810-934-8,20610-77-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248851,2-Amino-5-fluorobenzothiazole,810-935-3,20358-07-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248852,Tyrphostin AG 494,810-936-9,133550-35-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H301:1;H315:1
248853,5-Amino-2-(hydroxymethyl)phenylboronic Acid Cyclic Monoester,810-937-4,117098-94-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3
248854,4-Aminotriphenylamine,810-939-5,2350-01-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248855,4-Amino-2-methoxyphenol,810-940-0,52200-90-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H302:2;H315:2;H335:1
248856,"(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵] heptadeca-7,13-dien-5-ol",810-941-6,154229-19-3,Repr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H360:3;H373:4;H400:3;H410:3;H361:1
248857,5-Formyl-2-methoxyphenyl Acetate,810-942-1,881-57-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248858,Acetamidine Hydroiodide,810-943-7,1452099-14-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248859,"N-(2-Aminophenyl)-4-[1-[2-(3-thienyl)ethyl]-1H-1,2,3-triazol-4-yl]benzamide",810-944-2,1451042-18-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248860,"1,3-Bis[(di-tert-butylphosphino)oxy]benzene",810-945-8,338800-20-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248861,1-Bromo-4-methoxybutane,810-946-3,4457-67-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H226:2;H319:3;H315:3;H335:1;H302:1
248862,4-(4-Bromophenyl)pyridine,810-947-9,39795-60-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248863,"2-Bromo-4,6-diphenylpyrimidine",810-948-4,56181-49-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248864,10-Bromo-7H-benzo[c]carbazole,810-950-5,1698-16-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248865,"1-(3-Butenyloxy)-2,3,3,4,4,5,5-heptafluorocyclopentene",810-951-0,958032-89-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248866,Benzhydrylphosphonic Acid,810-952-6,92025-81-5,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
248867,BAY 11-7085,810-953-1,196309-76-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
248868,2-Bromo-5-(trimethylsilyl)thiophene,810-954-7,18246-28-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248869,4-Bromo-2-(trimethylsilyl)thiophene,810-955-2,77998-61-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248870,1-Bromo-4-iodonaphthalene,810-956-8,63279-58-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248871,3-(3-Bromophenyl)pyridine,810-957-3,4422-32-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248872,Biphenyl-4-yl- biphenyl-2-yl-amin,810-958-9,1372775-52-4,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H315:1
248873,2-(tert-Butoxycarbonyl)-2-azabicyclo[2.2.1]hept-5-ene,810-959-4,188345-71-3,Eye Dam. 1,Notified C&L,1,H318:1
248874,1-Bromocarbazole,810-961-5,16807-11-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248875,"8-Bromo-5H-pyrido[3,2-b]indole",810-962-0,1236349-67-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248876,4-Bromocarbazole,810-963-6,3652-89-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248877,1-(3-bromo-4-methylphenyl)ethan-1-one,810-964-1,40180-80-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248878,2-Bromophenyl Trifluoromethanesulfonate,810-965-7,129112-25-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248879,"1,4-Bis[2-(9-ethylcarbazol-3-yl)vinyl]benzene",810-966-2,62608-15-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248880,5-Bromoindole-3-carboxylic Acid,810-967-8,10406-06-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248881,"4-Chloro-2,6-pyridinedicarboxylic Acid",810-968-3,4722-94-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248882,"2,6-Bis(di-tert-butylphosphinoxy)phenylchlorohydroiridium(III)",810-969-9,671789-61-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248883,3-Bromo-9-(2-naphthyl)carbazole,810-970-4,934545-80-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248884,5-Bromo-2-methylbenzaldehyde,810-972-5,90050-59-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248885,(4-Bromobutyl)phosphonic Acid,810-973-0,1190-14-3,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
248886,(2-Bromoethyl)phosphonic Acid,810-974-6,999-82-6,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
248887,(4-Bromophenyl)phosphonic Acid,810-975-1,16839-13-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248888,"9-([1,1'-Biphenyl]-4-yl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-9H-carbazole",810-976-7,1391729-66-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248889,"2-[3,5-Bis(trifluoromethyl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",810-977-2,69807-91-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248890,4-(Biphenyl-4-yl)-6-(4-bromophenyl)-2-phenylpyrimidine,810-978-8,1421599-34-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248891,"4-Bromo-2,6-pyridinedicarboxylic Acid",810-979-3,162102-81-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248892,"4-Bromo-2,6-diphenylpyrimidine",810-980-9,40734-24-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248893,"9-Bromo-7,7-dimethyl-7H-benzo[c]fluorene",810-981-4,1198396-46-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248894,"2-(4-Biphenylyl)-4,6-dichloro-1,3,5-triazine",810-983-5,10202-45-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
248895,4-Biphenylyl Trifluoromethanesulfonate,810-984-0,17763-78-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248896,3-Bromo-5-ethoxypyridine,810-985-6,17117-17-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248897,"2-(3-Bromophenyl)-4,6-diphenyl-1,3,5-triazine",810-986-1,864377-31-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
248898,"(2,2'-Bipyridine)bis(2-phenylpyridinato)iridium(III) Hexafluorophosphate",810-987-7,106294-60-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248899,3-[4-(4-Biphenylylamino)phenyl]-9-phenylcarbazole,810-988-2,1160294-96-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248900,"4-(3-Bromophenyl)-2,6-diphenylpyrimidine",810-989-8,864377-28-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248901,"1,3-Bis(dimethylaminomethyl)benzene",810-990-3,19851-44-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
248902,"4,4'-Bis(9H-carbazol-9-yl)-2,2'-dimethylbiphenyl",810-991-9,604785-54-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248903,"4-Bromo-2,6-dichlorobenzoic Acid",810-992-4,232275-51-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248904,2-Chloro-5-iodopyrimidine,810-994-5,32779-38-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H302:1
248905,"3-(Carboxymethyl)-1,2,4-cyclopentanetricarboxylic Acid 1,4:2,3-Dianhydride",810-995-0,6053-46-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248906,1-(Cyclopropylcarbonyl)piperazine Hydrochloride,810-996-6,1021298-67-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:1;H228:1;H302:1;H317:1
248907,2-Chloro-5-fluoro-3-nitropyridine,810-997-1,136888-21-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:1;H312:1;H332:1;H335:1
248908,"3,3'-Carbonylbis(7-diethylaminocoumarin)",810-998-7,63226-13-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248909,Chlorobis(ethylene)iridium(I) Dimer,810-999-2,39722-81-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248910,"4-Chloro-7-(p-toluenesulfonyl)-7H-pyrrolo[2,3-d]pyrimidine",811-000-2,479633-63-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248911,2-Chlorobenzyl Thiocyanate,811-001-8,2082-66-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
248912,"N,N-Dimethyl-1,3-cyclohexanediamine",811-002-3,885280-64-8,Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H318:1;H314:2;H227:1
248913,"3,6-Dibromophthalic Anhydride",811-003-9,25834-16-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248914,"Dimethyl 4-Chloro-2,6-pyridinedicarboxylate",811-004-4,5371-70-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248915,"1,3-Dibromo-5-iodobenzene",811-006-5,19752-57-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248916,"6,7-Dimethoxy-4-hydroxyquinoline",811-007-0,13425-93-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1;H302:1
248917,"1,3-Dibromoazulene",811-008-6,14658-95-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248918,"5,6-Diamino-1,3-diethyluracil Hydrochloride",811-009-1,1785764-26-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248919,"4-(4,5-Diphenyl-1H-imidazol-2-yl)benzonitrile",811-010-7,29898-72-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1
248920,"4,5-Diazafluorene-9-one O-(p-Toluenesulfonyl)oxime",811-011-2,1655490-79-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248921,"9,10-Diphenylanthracene-2-boronic Acid",811-012-8,597553-98-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248922,"1,3-Diiodoazulene",811-013-3,36044-42-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248923,"2,6-Dibromopyrazine",811-014-9,23229-25-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248924,"2,6-Dibromobenzaldehyde",811-015-4,67713-23-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3
248925,"N,N'-Dicyclohexyl-1,2-ethanediamine",811-017-5,4013-98-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
248926,"4,4'-Dimethyl-2,2'-bipyridyl 1-Oxide",811-018-0,81998-03-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248927,"3,3,3',3'-Tetramethyl-1,1'-bis(4-sulfobutyl)benzoindodicarbocyanine Sodium Salt",811-019-6,64285-36-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;Not classified:1
248928,"2,5-Dibromothiophene 1,1-Dioxide",811-020-1,89088-95-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1
248929,"(1S,3R)-(-)-Camphoric Acid",811-021-7,560-09-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248930,Cinnamylphosphonic Acid,811-022-2,146404-58-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248931,"2-(3'-Chlorobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine",811-023-8,1443049-83-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248932,"2-(4'-Chlorobiphenyl-3-yl)-4,6-diphenyl-1,3,5-triazine",811-024-3,1443049-85-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248933,"2-(3'-Chlorobiphenyl-4-yl)-4,6-diphenyl-1,3,5-triazine",811-025-9,1443049-84-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248934,"2-Chloro-4,6-diphenylpyrimidine",811-026-4,2915-16-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
248935,5-Chloro-2-fluoropyridine-3-boronic Acid,811-028-5,937595-70-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248936,trans-Crotononitrile,811-029-0,627-26-9,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H225:1;H315:1
248937,N-(9-Cyclopropyl-1-oxononyl)-N-hydroxy-beta-alanine,811-030-6,1453071-47-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248938,Dibenzofuran-4-carboxaldehyde,811-031-1,96706-46-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248939,"2,4-Dibromo-1-nitrobenzene",811-032-7,51686-78-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248940,9-Ethylcarbazole-3-boronic Acid,811-033-2,669072-93-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248941,6-Fluoro-4-hydroxycoumarin,811-034-8,1994-13-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:2;H302:1
248942,6-Fluorochromone,811-035-3,105300-38-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248943,"5'-Formyl-2,2'-bithiophene-5-boronic Acid",811-036-9,1369328-62-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248944,3-Fluorothiophene,811-037-4,3093-88-7,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H225:1;H315:1
248945,4-Ethoxy-2-methylphenylboronic Acid,811-039-5,313545-31-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248946,Ethyl Pyrimidine-4-carboxylate,811-040-0,62846-82-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248947,"5,6-Diamino-1-methyluracil",811-041-6,6972-82-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248948,"Dimethyl 2,2'-Bipyridine-6,6'-dicarboxylate",811-042-1,142593-07-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248949,Ethyl Coumarin-3-carboxylate,811-043-7,1846-76-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248950,Ethyl 2-Amino-5-methylthiophene-3-carboxylate,811-044-2,4815-32-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248951,Ethyl 1-Methylimidazole-2-carboxylate,811-045-8,30148-21-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248952,2-Ethyl-3-hydroxy-6-methylpyridine Succinate,811-046-3,127464-43-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
248953,"1-tert-butyl 4-ethyl 3-oxopiperidine-1,4-dicarboxylate",811-047-9,71233-25-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:2
248954,Ethyl 3-Aminoisonicotinate,811-048-4,14208-83-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248955,"4-(3,5-Dibromophenyl)-2,6-diphenylpyrimidine",811-050-5,607740-08-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248956,"(4,4'-Di-tert-butyl-2,2'-bipyridine)bis[(2-pyridinyl)phenyl]iridium(III) Hexafluorophosphate",811-051-0,676525-77-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:2;H335:1
248957,"2-(3,5-Dibromophenyl)-4,6-diphenyl-1,3,5-triazine",811-052-6,1073062-59-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248958,"4,4-Difluoro-1,3-dimethyl-4-bora-3a,4a-diaza-s-indacene",811-053-1,154793-49-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248959,"2,4-Dichloro-1,8-naphthyridine",811-054-7,59514-89-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1;H302:1
248960,"3,6-Dibromo-9-(triphenylen-2-yl)carbazole",811-055-2,1351870-16-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248961,"1,4-Dibromo-2,3-difluorobenzene",811-056-8,156682-52-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
248962,"3,6-Dibromo-9-(4-tert-butylphenyl)-9H-carbazole",811-057-3,741293-42-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248963,Dimethyl Dipropargylmalonate,811-058-9,63104-44-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248964,"6,8-Dibromoimidazo[1,2-a]pyrazine",811-059-4,63744-22-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248965,"1,5-Diiodo-2,4-dimethylbenzene",811-061-5,4102-50-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248966,"3,6-Dibromo-9-(p-tolyl)-9H-carbazole",811-062-0,357437-74-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248967,"2,7-Dibromotriphenylene",811-063-6,888041-37-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248968,"11,12-Dihydroindolo[2,3-a]carbazole",811-064-1,60511-85-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248969,"3H-pyrrolo[2,3-d]pyrimidine",811-065-7,271-70-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:1;H312:1;H332:1;H335:1
248970,"2,7-Dibromo-9-phenylcarbazole",811-066-2,444796-09-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
248971,"N,N-Diphenyl-2-naphthylamine",811-067-8,6940-30-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248972,"5,6-Dibromo-1-hexene",811-068-3,4285-48-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248973,"11,12-Dihydro-11-phenylindolo[2,3-a]carbazole",811-069-9,1024598-06-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248974,3-Fluoro-2-methylphenylboronic Acid,811-070-4,163517-61-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248975,"1-Fluoro-3,3-dimethyl-1,2-benziodoxole",811-072-5,1391728-13-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248976,3-Formyl-6-methylchromone,811-073-0,42059-81-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248977,3-{2-[2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)ethoxy]ethoxy}propanoic acid,811-074-6,872679-70-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248978,"Diphenyl(L-lysinate-O,N)borane",811-075-1,118805-56-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248979,Lobenzarit Disodium Salt,811-076-7,64808-48-6,Acute Tox. 4,Notified C&L,1,H302:1
248980,"1,2-thiazole",811-077-2,288-16-4,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H225:3;H315:3;H335:1
248981,1-Iodopyrene,811-078-8,34244-15-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248982,2-Iodotriphenylene,811-079-3,1228778-59-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248983,1-Methyl-4-[1-(4-piperidyl)-4-piperidyl]piperazine,811-080-9,1629218-99-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248984,Lithium Salicylate,811-081-4,75575-50-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248985,Heptylphosphonic Acid,811-083-5,4721-16-8,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
248986,4-Hexylthiophene-2-carbonitrile,811-084-0,1224430-39-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1
248987,"6,6,7,7,8,8,8-Heptafluoro-5,5-bis(trifluoromethyl)-1,3-octadiene",811-085-6,1429188-77-1,Flam. Liq. 3,Notified C&L,1,H226:1
248988,4-Iodotriphenylamine,811-086-1,38257-52-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248989,5-(4-Hydroxypiperidin-1-yl)thiophene-2-carboxaldehyde,811-087-7,207290-72-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248990,3-Hydroxy-1-methacryloyloxyadamantane,811-088-2,115372-36-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248991,1-Hexen-5-yne,811-089-8,14548-31-3,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H304:1;H319:1;H225:1;H315:1
248992,"1,6-Hexylenediphosphonic Acid",811-090-3,4721-22-6,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
248993,3-(Hydroxymethyl)-4-methoxyphenylboronic Acid,811-091-9,908142-03-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248994,"3-Hydroxy-4,4'-dimethyl-2,2'-bipyridyl",811-092-4,81998-07-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248995,Hexylphosphonic Acid,811-094-5,4721-24-8,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
248996,5-Fluororesorcinol,811-095-0,75996-29-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
248997,4-Fluoroindazole,811-096-6,341-23-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
248998,"(2β,3β,5β,22R)-2,3,14,20,22,25-hexahydroxy-cholest-7-en-6-one",811-097-1,5289-74-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,64,H400:64;H410:64
248999,Hexadecylphosphonic Acid,811-098-7,4721-17-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249000,2'-Hydroxy-2-methoxychalcone,811-099-2,42220-77-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249001,Methyl Phosphate,811-100-6,52932-95-3,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
249002,L-Proline Ethyl Ester,811-101-1,5817-26-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1;H227:1
249003,Methoxymethyl Phenyl Sulfone,811-102-7,15251-78-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249004,[NH2Me2][(RuCl((R)-segphos(regR)))2(mu-Cl)3],811-103-2,346457-41-8,Repr. 1A;STOT SE 2;STOT RE 2,Notified C&L,1,H360:1;H373:1;H371:1
249005,[NH2Me2][(RuCl((S)-segphos(regR)))2(mu-Cl)3],811-104-8,488809-34-3,Repr. 1A;STOT SE 2;STOT RE 2,Notified C&L,1,H360:1;H373:1;H371:1
249006,Nonylphosphonic Acid,811-105-3,4730-79-4,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
249007,5-Nitro-o-anisaldehyde,811-106-9,25016-02-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249008,Pergolide,811-107-4,66104-22-1,Acute Tox. 2;Carc. 2;Repr. 2,Notified C&L,1,H361:1;H300:1;H351:1
249009,Phenyl Trifluoromethyl Sulfone,811-109-5,426-58-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H302:1;H312:1;H332:1;H335:1
249010,"19-Maleimido-17-oxo-4,7,10,13-tetraoxa-16-azanonadecanoic Acid",811-110-0,1263045-16-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249011,"Methyl 3,5-Dihydroxy-4-methoxybenzoate",811-111-6,24093-81-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249012,[(4-Methoxyphenyl)ethynyl]trimethylsilane,811-112-1,3989-14-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249013,N-Methoxy-N-methyl-4-(trifluoromethyl)benzamide,811-113-7,116332-61-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249014,"Methyl 2,5-Dichloronicotinate",811-114-2,67754-03-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249015,Methyl 2-Bromo-3-methylbenzoate,811-115-8,131001-86-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
249016,4-Nitrophenyl Isocyanide,811-116-3,1984-23-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249017,Noscapine Hydrochloride,811-117-9,219533-73-0,Acute Tox. 4,Notified C&L,1,H302:1
249018,2-Methoxycarbazole,811-118-4,6933-49-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249019,Methyl 5-Hydroxyanthranilate,811-120-5,1882-72-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
249020,2-[2-(2-Propynyloxy)ethoxy]ethylamine,811-121-0,944561-44-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H318:2;H314:1;H335:1;H315:1
249021,"4'-(4-Pyridyl)-2,2':6',2''-terpyridine",811-122-6,112881-51-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249022,"Tris(1,10-phenanthroline)ruthenium(II) Bis(hexafluorophosphate)",811-123-1,60804-75-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249023,"Tetrabutylammonium Bis(3,4,6-trichloro-1,2-benzenedithiolato)nickelate",811-124-7,87314-12-3,Skin Sens. 1;Resp. Sens. 1;Carc. 1A;STOT RE 1,Notified C&L,1,H372:1;H334:1;H350:1;H317:1
249024,"1,14-Diamino-3,6,9,12-tetraoxatetradecane",811-125-2,68960-97-4,Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H318:1;H314:1;H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249025,"Tris(2,2'-bipyridine)cobalt(III) Tris(hexafluorophosphate)",811-126-8,28277-53-4,Carc. 2,Notified C&L,2,H351:1;H319:1;H335:1;H315:1
249026,"Tris(2,2'-bipyridine)cobalt(II) Bis(hexafluorophosphate)",811-127-3,79151-78-3,Carc. 2,Notified C&L,2,H351:1;H319:1;H335:1;H315:1
249027,"2,2':6',2''-Terpyridine-4'-carboxylic Acid",811-128-9,148332-36-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249028,2-(4-Trifluoromethyl-phenyl)-ethylamine,811-129-4,775-00-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,3,H318:2;H314:3;H335:1
249029,"10-(1,1':3',1''-Terphenyl-5'-yl)anthracene-9-boronic Acid",811-131-5,1415334-59-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249030,Triisopropyl[(trimethylsilyl)ethynyl]silane,811-132-0,107474-02-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249031,"4,4,5,5-Tetramethyl-2-[4-(10-phenylanthracen-9-yl)phenyl]-1,3,2-dioxaborolane",811-133-6,1143576-84-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H413:1;H302:1;H335:1
249032,"4,4,5,5-Tetramethyl-2-[3-(triphenylen-2-yl)phenyl]-1,3,2-dioxaborolane",811-134-1,1115639-92-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249033,"3H,4H-thieno[3,2-d]pyrimidin-4-one",811-135-7,16234-10-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
249034,1-(Trimethoxysilyl)naphthalene,811-136-2,18052-76-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249035,"5-(m-Tolyl)-5H-pyrrolo[3,2-c:4,5-c']dipyridine",811-137-8,1014403-09-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249036,"2-(2,2,2-Trifluoroethoxy)aniline",811-138-3,57946-60-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1;H302:1
249037,N-Succinimidyl Trifluoroacetate,811-139-9,5672-89-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249038,4-Styryltriphenylamine,811-140-4,89114-74-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;Not classified:1
249039,"N,N,N',N'-Tetrapentylmalonamide",811-142-5,1560797-76-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249040,Triisopropanolamine Borate,811-143-0,101-00-8,Eye Irrit. 2,Notified C&L,1,H319:1
249041,Ru-Re(FPh),811-144-6,1471276-06-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249042,(R)-RUCY(regR)-XylBINAP,811-145-1,1384974-38-2,Aquatic Chronic 3,Notified C&L,2,H412:1;H319:1;H335:1;H315:1
249043,Triphenyl(2-thienylmethyl)phosphonium Bromide,811-146-7,23259-98-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249044,"2,2,6,6-Tetramethyl-4-(2-propynyloxy)piperidine 1-Oxyl",811-147-2,147045-24-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249045,(Trifluoroacetyl)benzotriazole,811-148-8,183266-61-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249046,Tris(2-cyanoethyl) Borate,811-149-3,126755-67-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1
249047,"1,5-Pentylenediphosphonic Acid",811-150-9,4672-25-7,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
249048,6-Phenylpyridine-2-carboxylic Acid,811-151-4,39774-28-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249049,4-Phosphonobutyric Acid,811-153-5,4378-43-2,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
249050,5-Phenyl-2-thiophenecarboxylic Acid,811-154-0,19163-24-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
249051,4'-Pentyloxybiphenyl-4-boronic Acid,811-155-6,158937-25-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249052,4-(trans-4-Pentylcyclohexyl)phenylboronic Acid,811-156-1,143651-26-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249053,D-Proline Ethyl Ester,811-157-7,96163-72-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,90,H319:90;H315:90
249054,"2,4,6-Tris(3-bromophenyl)-1,3,5-triazine",811-158-2,890148-78-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
249055,"3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)pyridine",811-159-8,939430-30-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
249056,L-Tetrahydropalmatine,811-160-3,483-14-7,Acute Tox. 4,Notified C&L,2,H302:2
249057,"9-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9H-carbazole",811-161-9,870119-58-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
249058,o-Tolyl Trifluoromethanesulfonate,811-162-4,66107-34-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1
249059,p-Xylylenediphosphonic Acid,811-164-5,4546-06-9,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
249060,[2-(Phosphonomethyl)phenyl]methylphosphonic acid,811-165-0,42104-58-5,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,2,H318:1;H314:2;H290:1
249061,Undecylphosphonic Acid,811-166-6,5137-69-9,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
249062,"2,2'-(2-Vinylanthracene-9,10-diylidene)dimalononitrile",811-167-1,1612793-07-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H311:1
249063,m-Xylylenediphosphonic Acid,811-168-7,144052-40-4,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
249064,"Reaction mass of 1,5-dihydroxy-4-nitro-8-(phenylamino)anthraquinone and 1,8-dihydroxy-4-nitro-5-(phenylamino)anthraquinone",944-623-4,,Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,7,H319:4;H317:7
249066,Reaction products of N-lauroyl-L-glutamic acid with octyldodecanol and behenyl alcohol and beta-sitosterol and campesterol and stigmasterol,942-770-9,,Not Classified,REACH registration C&L,2,Not classified:2
249069,"Amides, C18, branched and linear",942-773-5,,Not Classified,REACH registration C&L,2,Not classified:2
249070,"reaction product of Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy- and hexanedioic acid, polymer with 1,6-hexanediol with diisocyanatomethylbenzene",942-774-0,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
249071,Polyester Acrylate Methacrylate Oligomer,811-170-8,921214-61-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2,Notified C&L,13,H312:13;H302:13;H315:13
249076,"reaction product of 2,2'dimethyl- 4,4'dihydroxy-5,5'ditert-Butyldiphenylsulfido and chloromethyloxyrane",811-173-4,170577-61-4,Skin Irrit. 2,Notified C&L,1,H315:1
249078,"1,2,3-benzothiadiazole-7-carboxylic acid",811-175-5,35272-27-6,Aquatic Chronic 3,Notified C&L,157,H412:157
249079,"benzo[1,2,3]thiadiazole-5-carboxylic acid",811-176-0,192948-09-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,156,H319:156;H335:156;H315:156
249080,"Methyl 2,4-dichlorophenoxyacetate",811-177-6,2176-70-7,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H400:156;H302:156;H317:156;H412:156;H312:156;H332:156;H410:156
249082,Sodium rac-1-hydroxy-3-(quinolin-6-yl)propanesulfonate,811-179-7,1609934-65-7,Acute Tox. 4,Notified C&L,1,H302:1
249083,"6-bromo-1,2,4-triazin-3-amine",811-180-2,69249-22-5,,Notified C&L,5,H312:2;H332:2;H302:2;H228:1;H301:1;H317:1;H319:3;H335:3;H315:3
249087,Reaction mass of 100-42-5 and 271-89-6 and 95-13-6,942-779-8,63393-89-5,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H315:1
249088,"Copper, 3-[(3,4-dicyanophenyl)sulfonyl]-N-(2-hydroxypropyl)-1-propanesulfonamide-lithium 3-[(3,4-dicyanophenyl)sulfonyl]-1-propanesulfonate reaction products complexes",811-181-8,569316-88-7,Eye Dam. 1,Notified C&L,1,H318:1
249089,2-[carbamimidoyl(methyl)amino]acetic acid;hydrochloride,811-182-3,17050-09-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
249090,3-(dimethylaminomethyl)-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide,811-183-9,783355-60-2,Acute Tox. 4;Repr. 2;STOT RE 2,Notified C&L,2,H361:1;H302:2;H373:1;H314:1;H411:1;H318:1;H311:1
249091,Thiooctoyl hyaluronic acid sodium salt,811-184-4,1223313-45-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249092,Methyl 4-formyl-3-nitrobenzoate,811-186-5,153813-69-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249093,1-({4-[(1E)-1-({[4-Cyclohexyl-3-(trifluoromethyl)phenyl]methoxy}imino)ethyl]-2-ethylphenyl}methyl)azetidine-3-carboxylic acid (2E)-but-2-enedioate (2:1),811-187-0,1234627-85-0,Repr. 2;STOT RE 2;Aquatic Chronic 2,Notified C&L,2,H361:2;H411:1;H373:2;H410:1
249094,"2,2-dimethyl-3-oxopropyl acetate",811-188-6,16184-79-5,Eye Irrit. 2,REACH registration C&L,1,H319:1
249098,4-formyl-2-methoxybenzonitrile,811-192-8,21962-49-2,,Notified C&L,2,H331:1;H319:2;H315:2;H301:1;H335:2;H311:1;H302:1
249099,"2,3-dihydro-1,3-oxazol-2-one",811-193-3,27584-70-9,,Notified C&L,2,H226:1;H319:2;H335:2;H315:2
249100,Methyl (chlorosulfonyl)acetate,811-194-9,56146-83-9,Skin Corr. 1B,Notified C&L,3,H314:3
249105,"2,6-dichloro-5-fluoropyridine-3-carbaldehyde",811-201-5,1260758-33-5,,Notified C&L,2,H331:1;H319:2;H315:2;H301:1;H335:2;H311:1;H302:1
249107,"Hydrocarbons, C12-C15, n-alkanes, isoalkanes < 2% aromatics",942-780-3,,Asp. Tox. 1,Notified C&L,1,H304:1
249111,"(S)-(+)-(3,5-Dioxa-4-phospha-cyclohepta[2,1-a;3,4-a']dinaphthalen-4-yl)dimethylamine",811-204-1,185449-80-3,Aquatic Chronic 4,Notified C&L,1,H413:1
249112,"Acid chlorides, coco",942-784-5,,Skin Irrit. 2;Skin Sens. 1B,Notified C&L,1,H317:1;H315:1
249115,2-ethyl-2-phenylbutanoyl chloride,811-205-7,68886-54-4,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,1,H302:1;H314:1;H317:1;H290:1;H332:1;H318:1;H335:1
249118,Phenazonum Coffeinum Citricum,942-787-1,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249121,"5-(hexyloxy)-2,2-dimethyltetrahydrofuran",811-207-8,1497420-94-6,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H317:1;H315:1
249122,"1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxodocosyl)amino]-, ethyl sulfate",811-208-3,68797-65-9,Eye Irrit. 2,Notified C&L,18,H319:18
249123,Palmamidopropyl Trimonium Methosulfate,811-209-9,857026-47-2,Skin Irrit. 2;Eye Dam. 1,Notified C&L,18,H318:18;H315:18
249124,[No public or meaningful name is available],811-210-4,104801-96-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249125,3-METHOXYBENZYLMAGNESIUM CHLORIDE,811-212-5,26905-40-8,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
249127,"(2E)-1,1,1,4,4,4-hexafluoro-2-butene",811-213-0,66711-86-2,Press. Gas (Comp.);Aquatic Chronic 2,REACH registration C&L,3,H280:3;H411:3
249129,Garlic essential oil,942-792-9,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H302:1;H317:1;H315:1;H226:1;H411:1
249131,"4-[(4-chloro-6-{[(3 or 4)-sulfophenyl]amino}-1,3,5-triazin-2-yl)amino]-2-{[1-ethyl-2-hydroxy-4-methyl-6-oxo-5-(sulfonatomethyl)-1,6-dihydropyridin-3-yl]diazenyl}benzenesulfonic acid, lithium sodium salts",942-795-5,,Skin Sens. 1,Notified C&L,1,H317:1
249132,"1-amino-4-({3-[(4-chloro-6-{[(3 or 4)-sulfophenyl]amino}-1,3,5-triazin-2-yl)amino]-2,4,6-trimethyl-5-sulfophenyl}amino)-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid, lithium sodium salts",942-796-0,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
249140,"1,3,5,-Naphtalenetrisulfonic acid, 7-[2-[4-[2-[4-[[4-[[-2-(ethenylsulfonyl)ethyl]amino] 6-fluoro-1,3,5,-triazin-2-yl]amino]phenyl] diazenyl]-phenyl]diazenyl], sodium salt(1:3)",811-216-7,1196707-42-2,Eye Dam. 1,Notified C&L,17,H318:17
249141,"5-({4-chloro-6-[ethyl(phenyl)amino]-1,3,5-triazin-2-yl}amino)-4-hydroxy-3-[(1-sulfo-2-naphthyl)diazenyl]naphthalene-2,7-disulfonic acid, lithium sodium salts",942-803-7,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
249142,"5-({4-chloro-6-[(2-methylphenyl)amino]-1,3,5-triazin-2-yl}amino)-4-hydroxy-3-[(2-sulfophenyl)diazenyl]naphthalene-2,7-disulfonic acid, lithium sodium salts",942-804-2,,Not Classified,Notified C&L,1,Not classified:1
249143,"3-Pyridinemethanesulfonic acid, 5-[2-[5-[[4-[[2-(ethenylsulfonyl)ethyl] amino]-6-fluoro-1,3,5-triazin-2-yl] amino] -2-sulfophenyl]diazenyl] -1-ethyl-1,6-dihydro-2-hydroxy-4- methyl-6-oxo-",811-217-2,1196708-39-0,Skin Sens. 1,Notified C&L,1,H317:1
249144,"2-Anthracenesulfonic acid,1-amino-4-[[3-[[4-[[2-(ethenylsulfonyl)ethyl]amino]-6-fluoro-1,3,5-triazin-2-yl]amino]-2,4,6-5-sulfophenyl] amino]-9,10-dihydro-9,10-dioxo-",811-218-8,1196707-96-6,Skin Sens. 1,Notified C&L,1,H317:1
249145,(S)-5-tert-butoxy-3-(tert-butyldimethylsilyloxy)-5-oxopentylboronic acid (+)-pinanediol ester,811-219-3,1681053-95-1,Aquatic Chronic 4,Notified C&L,1,H413:1
249148,"1,2-Dimethyl-1H-imidazole-5-carboxylic acid",811-220-9,122222-09-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249150,"Pyrido[3,4-d]pyridazin-1,4-dion, 8-Amino-5-chlor-2,3-dihydro-7-phenyl-, Natriumsalz",811-221-4,143556-24-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249152,"Reaction Mass of ethylbenzen, m-xylene, p-xylene and o-xylene",942-808-4,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,17,H312:17;H332:17;H226:17;H315:17
249153,"Reaction products of cuprate(4-), [C-(aminosulfonyl)-C-[[[2-[[4-chloro-6-[(2,5-disulfophenyl)amino]-1,3,5-triazin-2-yl]amino]ethyl]amino]sulfonyl]-29H,31H-phthalocyanine-C,C-disulfonato(6-)-N29,N30,N31,N32]-, tetrasodium and lithium chloride",942-810-5,,Not Classified,Notified C&L,1,Not classified:1
249158,[No public or meaningful name is available],811-223-5,55684-37-2,Flam. Sol. 2;Self-heat. 2,Notified C&L,1,H228:1;H252:1
249159,4-Bromo-1-(ter-Butyl)-1H-Pyrazole,811-224-0,70951-85-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H302:2;H315:2;H318:1
249161,"7-Methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine",811-225-6,71472-58-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H332:1;H302:1;H341:1;H317:1
249162,"(2S)-1-(4-cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-glycinamide",811-226-1,1448347-49-6,,Notified C&L,2,H371:1;H372:1;H361:1
249164,[No public or meaningful name is available],811-227-7,2177-22-2,Flam. Liq. 3;Acute Tox. 4,Notified C&L,1,H226:1;H302:1
249167,EFAPROXIRAL SODIUM,811-228-2,170787-99-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249168,benzo[[]g]chrysene,811-229-8,196-78-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249170,"Reaction mass of allyl (2S,4S)-2-(dimethylcarbamoyl)-4-mercaptopyrrolidine-1-carboxylate and methyl benzoate",942-819-4,,Not Classified,REACH registration C&L,1,Not classified:1
249171,4-Ethyl-5-fluoropyrimidine,811-230-3,137234-88-9,Acute Tox. 3;Carc. 2;Repr. 1B;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H360:1;H351:1;H301:1;H412:1;H373:1
249172,"3,5-Bis(methylsulfonyl)benzenesulfonyl chloride",811-231-9,849035-99-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249173,"Reaction mass of edetic acid and ethylenediamine-N,N'-di(acetic acid)",942-821-5,,Eye Irrit. 2,Notified C&L,1,H319:1
249177,Zinc alpha-glucoheptonate,,12565-63-8,Not Classified,Notified C&L,6,Not classified:6
249178,"Manganese, bis[(2ξ)-D-gluco-heptonato]-",,12565-60-5,Not Classified,Notified C&L,6,Not classified:6
249179,BOLDO AND ARTICHOKE LIQUID HYDROALCOHOLIC EXTRACT,942-825-7,,Flam. Liq. 3;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H317:1
249180,PLANT COMPLEX No.1 HYDROALCOHOLIC EXTRACT,942-826-2,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1
249181,PLANT COMPLEX No.2 HYDROALCOHOLIC EXTRACT,942-827-8,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1
249183,"2,5-Dimethoxy-4-ethylthiophenethylamine",811-235-0,207740-24-7,Acute Tox. 4,Notified C&L,1,H302:1
249185,"pentane-1,5-diaminium sebacate",811-236-6,799768-48-2,Not Classified,Notified C&L,1,Not classified:1
249186,(2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide,811-237-1,698387-09-6,Not Classified,REACH registration C&L,2,Not classified:1;H360:1
249187,"[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-4H-chromen-7-yl]oxy}oxan-2-yl]methyl acetate",811-238-7,,Not Classified,Notified C&L,1,Not classified:1
249190,"1,2,3,4-Tetrahydropyrido[4,3-b][1,8]naphthyridine",811-239-2,387358-41-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249191,rac-Dimethylsilylenebis(2-methylindenyl) zirconium dichloride,811-240-8,143278-86-8,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H317:2;H315:2
249192,epoxi-ingenol-3-angelate,942-833-0,,Acute Tox. 2;Skin Corr. 1A;Acute Tox. 2,Notified C&L,1,H300:1;H314:1;H330:1
249193,[No public or meaningful name is available],811-241-3,4878-36-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249194,"2-(4-benzylpiperazin-1-yl)-6,7-dimethoxyquinazolin-4-amine hydrochloride",942-834-6,,Not Classified,REACH registration C&L,2,Not classified:2
249195,2-Chloro-5-hydroxy-4-methylpyridine,811-242-9,1227502-89-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
249196,2-(Trifluoromethyl)isonicotinonitrile,811-243-4,916210-02-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H302:2;H315:1;H312:2;H332:2;H335:1
249197,3-Amino-6-azaindole dihydrochloride,811-245-5,1257535-55-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249198,2-Formylphenyl acetate,811-246-0,5663-67-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249199,2-Amino-4-bromo-3-fluorobenzoic acid,811-247-6,1416013-62-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:1;H315:2;H312:1;H332:1;H335:2
249200,2-(Difluoromethoxy)-5-fluorobromobenzene,811-248-1,936249-94-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249201,2-Bromo-6-chloroanisole,811-249-7,174913-10-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249202,"5-Bromo-1,3-benzenedicarbonyl dichloride",811-250-2,57863-69-1,Skin Corr. 1B,Notified C&L,1,H314:1
249203,"3,4-Dideoxyglucosone-3-ene",811-251-8,252006-38-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249204,3-Deoxy-D-glucosone,811-252-3,4084-27-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249205,(S)-tert-Butyl 2-(piperidin-4-yl)pyrrolidine-1-carboxylate,811-253-9,1449131-15-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249208,5-Fluoro-2-hydroxy-3-nitropyridine,811-257-0,136888-20-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249209,Methyl 5-bromo-2-methoxyisonicotinate,811-258-6,886365-25-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H332:1;H302:1;H319:1;H335:1;H315:1
249210,3-Chloro-2-iodopyridine,811-259-1,77332-89-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249211,7-Aminoquinoline,811-260-7,580-19-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:1;H315:2;H312:1;H332:1;H335:1
249212,4-(1H-Imidazol-2-yl)aniline,811-261-2,13682-33-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249213,Ethyl 3-(fur-2-yl)-3-oxopropanoate,811-262-8,615-09-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249214,"Reaction mass of trientine and trientine, mono- and di-propoxylated",942-835-1,,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2A;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,3,H319:3;H317:3;H315:3;H411:3;H320:3;H401:3
249232,Di-sec-butylaminodisilane,811-264-9,1497436-56-2,Flam. Liq. 2;Water-react. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,22,H302:22;H314:22;H225:22;H260:22;H312:22;H332:22
249233,2-(4-(trifluoromethyl)phenyl)malonaldehyde,942-837-2,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249234,2-bromo-4-methoxynicotinonitrile,942-838-8,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249235,"2-(3,4-dichlorophenyl)malonaldehyde",811-265-4,849936-29-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249236,"Di[manganese (1+)], 1,2-bis(octahydro-4,7-dimethyl-1H-1,4,7-triazonine-1-yl-kN1, kN4, kN7)ethane-di-μ-oxo-μ-(ethanoato- kO, kO’)-, di[chloride(1-)]",811-267-5,1217890-37-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
249237,4-(1-Bromoethyl)-6-chloro-5-fluoropyrimidine,811-268-0,188416-28-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249238,6-(Trifluoromethyl)nicotinohydrazide,942-839-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249239,3-[6-(Trifluoromethyl)pyridin-3-yl]propanoic acid,942-840-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249241,"1,3-Propanediol, 2-ethyl-2-(hydroxymethyl)-, polymer with 1,3-diisocyanatomethylbenzene, a-hydro-w-hydroxypoly[oxy(methyl-1,2-ethanediyl)] and 1,1'-methylenebis[4-isocyanatobenzene]",942-843-5,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
249242,Acrylic acid-polyethylene glycol monoallyl ether copolymer,942-844-0,,Skin Corr. 1B,Notified C&L,1,H314:1
249243,"1,1,1,3,5,5,5 heptamethyltrisiloxanyl-(3-propyloxy-2-hydroxy-propyl)-dodecyl-{2-[2-(2-hydroxy-ethoxy)-ethoxy]-ethyl}-[2-(2-hydroxy-ethoxy)-ethyl]-ammonium; acetate",942-845-6,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H302:1;H317:1;H315:1;H411:1;H318:1
249244,2-(3-bromophenyl)malonaldehyde,811-269-6,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249245,2-(3-(trifluoromethyl)phenyl)malonaldehyde,942-846-1,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249246,"Silane, triethoxyisooctyl-",811-270-1,127687-56-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249249,2-(4-(trifluoromethoxy)phenyl)malonaldehyde,942-848-2,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249251,"2-([1,1'-biphenyl]-4-yl)malonaldehyde",811-272-2,125507-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249253,2-(4-Methylsulfonyl-2-nitrophenyl)malondialdehyde,811-273-8,197251-71-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249254,2-(3-Chlorophenoxy)malondialdehyde,811-274-3,849021-39-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249257,"Phosphoric acid, (1Z)-2-chloro-1-(2,4-dichlorophenyl)ethenyl dimethyl ester",811-278-5,67628-93-7,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H315:1;H301:1;H411:1;H312:1
249258,(E)-Ferimzone,811-279-0,77359-18-3,Acute Tox. 4,Notified C&L,1,H302:1
249259,(Z)-Fenpyroximate,811-280-6,149054-53-5,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H302:1;H410:1
249264,"(1E,4S)-4-(3,4-dichlorophenyl)-N-methyl-3,4-dihydronaphthalen-1(2H)-imine",811-284-8,312620-93-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,REACH registration C&L,1,H319:1;H400:1;H302:1;H315:1;H335:1
249265,"Reaction mass of [1,1'-bicyclopentyl]-2-ol, cis and 1,1'-bicyclopentyl]-2-ol, trans",942-852-4,,Not Classified,REACH registration C&L,1,Not classified:1
249267,"Reaction mass of disodium 4,4'-bis(2-hydroxynaphthalen-1-ylazo)biphenyl-2,6'-disulphonate and hydrogen 4,4'-bis((E)-(2-hydroxynaphthalen-1-yl)diazenyl)biphenyl-2,2'-disulfonate",942-854-5,,Not Classified,REACH registration C&L,3,Not classified:3
249271,3-(4-isobutyl-2-methylphenyl)propanal,811-285-3,1637294-12-2,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,407,H319:3;H317:407;H315:407;H411:407;H332:393
249272,4-FLUORO-2-METHOXYPYRIDINE,811-286-9,96530-81-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249273,"Reaction mass of 1,3,3-trimethyl-2-[2-(1-methyl-2-phenyl-1H-indol-3-yl)vinyl]-3H-indolium chloride and sodium sulphate",942-856-6,,Aquatic Chronic 2,Notified C&L,1,H411:1
249274,(E)-Pyrifenox,811-287-4,83227-22-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
249282,"3-{3-[(2,4,4-trimethylpentanoyl)oxy]-2,2-bis({[(2,4,4-trimethylpentanoyl)oxy]methyl})propoxy}-2,2-bis({[(2,4,4-trimethylpentanoyl)oxy]methyl})propyl 2,4,4-trimethylpentanoate",,,Not Classified,REACH registration C&L,1,Not classified:1
249283,"Methanesulfonato(2-dicyclohexylphosphino-3,6-dimethoxy-2',4',6'-tri-i-propyl-1,1'-biphenyl)(2'-amino-1,1'-biphenyl-2-yl)palladium(II),",811-291-6,1470372-59-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
249284,[No public or meaningful name is available],811-292-1,503070-57-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249288,4-chloro-2-[(ethoxycarbonyl)amino]-5-sulfamoylbenzoic acid,811-296-3,35442-36-5,,Notified C&L,1,H332:1;H320:1;H315:1
249289,ethyl (5-chloro-2-methyl-4-sulfamoylphenyl)carbamate,811-297-9,35442-35-4,,,0,No data
249294,"3-chloro-2-(3-{2-[1-(chloroacetyl)piperidin-4-yl]-1,3-thiazol-4-yl}-4,5-dihydro-1,2-oxazol-5-yl)phenyl methanesulfonate",811-304-5,1446129-87-8,Eye Irrit. 2,REACH registration C&L,1,H319:1
249295,2-Amino-3-bromo-5-iodopyridine,811-305-0,697300-73-5,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1
249297,2-chloro-N-[2-[1-[(E)-3-(4-chlorophenyl)allyl]-4-piperidyl]-6-(trifluoromethyl)-3-pyridyl]pyridine-4-carboxamide,942-860-8,,Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H300:89;H400:89;H410:89
249298,"2-(tert-butyl)-1H-pyrrolo[2,3-b]pyridine",811-306-6,86847-74-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H320:1;H312:1;H332:1;H335:1
249299,"2,2’-dimethylbibenzyl",811-307-1,952-80-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249300,5-heptyl-2-(4-isothiocyanatophenyl)pyrimidine,942-861-3,,Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H332:1;H302:1
249303,1-bromo-4-n-hexadecylbenzene,811-308-7,126930-72-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249306,1-(2-Hydrazinylethyl)piperidine,942-866-0,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H320:1;H312:1;H332:1;H335:1
249307,"5,5'-Dichloro-6,6'-dimethoxy-2,2'-biphenyldiyl)bis(diphenylphosphine)",811-310-8,185913-98-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249308,"N-[(2S,3S,4S,6S)-6-{[(2S,3S,4S,6R)-6-[(1'R,2S,4'S,5S,6R,8'R,10'E,12'S,13'S,14'E,20'R,21'R,24'S)-6-[(2S)-butan-2-yl]-21',24'-dihydroxy-5,11',13',22'-tetramethyl-5,6-dihydro-3',7',19'-trioxaspiro[pyran-2,6'-tetracyclo[15.6.1.1⁴,⁸.0²⁰,²⁴]pentacosane]-10',14',16',22'-tetraen-2'-oneoxy]-4-methoxy-2-methyloxan-3-yl]oxy}-4-methoxy-2,3-dimethyloxan-3-yl]acetamide",942-867-6,,Aquatic Acute 1,Notified C&L,89,H400:89
249310,"3-(2-hydroxy-5-methylphenyl)-N,N-diisopropyl-3-phenylpropan-1-aminium chloride",811-311-3,124936-75-0,Repr. 2,REACH registration C&L,2,H361:2
249314,"3-ethoxy-4,6-difluoro-7-(pentyloxy)dibenzo[b,d]furan",942-871-8,1799569-89-3,Aquatic Chronic 4,Notified C&L,1,H413:1
249315,"5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole",811-313-4,1086111-17-2,Acute Tox. 3,Notified C&L,1,H301:1
249316,1-tert-Butoxycarbonyl-4-(cyclopropylamino)piperidine,942-872-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H320:1;H335:1;H315:1
249321,oxozirconium; silane,811-319-7,174633-44-4,Not Classified,REACH registration C&L,2,Not classified:2
249324,6-(Hydroxymethyl)picolinic acid,811-322-3,1197-10-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249325,[No public or meaningful name is available],811-323-9,123256-09-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT RE 2,Notified C&L,25,H319:25;H317:25;H315:25;H334:25;H332:25;H373:25;H335:25
249326,[No public or meaningful name is available],811-324-4,68442-25-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,25,H319:25;H317:25
249327,Prepolymer Based on Toluene Diisocyanate (TDI),811-326-5,87257-38-3,Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1,Notified C&L,25,H319:25;H334:25;H317:25
249328,"1,4-Butanediol, polymer with 1,3-diisocyanatomethylbenzene and .alpha.-hydro-.omega.-hydroxypoly(oxy-1,4-butanediyl)",811-327-0,9043-71-4,Skin Sens. 1;Eye Irrit. 2,Notified C&L,26,H319:25;H317:26;H331:1;H334:1;H351:1
249329,Prepolymer Based on Toluene Diisocyanate (TDI),942-873-9,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,25,H319:25;H317:25
249331,N-(2-hydroxyethyl)nicotinamide,811-328-6,6265-73-2,Not Classified,REACH registration C&L,1,Not classified:1
249338,"1,3-dimethyl 2-(4-bromophenyl)propanedioate",811-330-7,149506-35-4,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H302:1;H315:1
249342,[No public or meaningful name is available],811-334-9,25033-65-2,Acute Tox. 4,Notified C&L,156,H302:156
249344,"(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol, (S)-propylene glycol, monohydrate",811-335-4,960404-48-2,Acute Tox. 4;Eye Irrit. 2;Repr. 1B;Lact.;STOT RE 1,Notified C&L,4,H362:3;H360:3;H319:3;H372:4;H302:4
249348,O-(2-tert-butoxyethyl)hydroxylamine,811-338-0,1023742-13-3,Flam. Liq. 3;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H226:2;H400:2;H302:3;H410:2;Not classified:1;H319:1;H335:1;H315:1
249354,"Ethanaminium, N-[4-[bis[4-(diethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-ethyl-, molybdatephosphate",811-341-7,68814-02-8,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H319:83;H400:83;H410:83
249355,"Benzenepropanoic acid, 3-(1,1-dimethylethyl)-4-hydroxy-5-[2-(2-nitrophenyl)diazenyl]-",811-342-2,84267-55-0,STOT RE 2;Aquatic Chronic 4,Notified C&L,83,H413:83;H373:83
249356,"Cyclohexanaminium, N,N,N-trimethyl-, methyl sulfate (1:1)",811-343-8,1377616-75-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,83,H319:83;H302:83;H315:83
249357,FIRASCONE,811-344-3,815580-59-7,Aquatic Chronic 3,Notified C&L,14,H412:14
249358,2-Ethyl-1-octene,811-345-9,51655-64-2,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,25,H304:25;H226:25
249359,2-Butyl-1-hexene,811-346-4,6795-79-5,Flam. Liq. 3;Asp. Tox. 1,Notified C&L,25,H304:25;H226:25
249360,"(2'-Amino-2-biphenylyl)palladium(1+) methanesulfonate - (9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine)",811-348-5,1445085-97-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
249361,"2-(2-methoxy-2-oxoethyl)-6,6-dimethyloxane-2-carboxylic acid methyl ester",942-885-4,,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
249363,"Rhodium › (+)-1,2-Bis((2S,5S)-2,5-diethylphospholano)benzene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate, 98+% (S,S)-Et-DUPHOS-Rh",811-349-0,213343-64-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249365,Tris(2-hydroxyethyl)ammonium salts of tall-oil fatty acids,,,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H319:1;H315:1
249368,Dill essential oil,942-891-7,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H315:1;H304:1;H226:1;H410:1
249369,Anise essential oil,942-892-2,,Skin Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 2,Notified C&L,1,H341:1;H351:1;H411:1;H317:1
249370,"Octadecanoic acid, sulfonated, potassium salt",942-903-0,,Eye Dam. 1;Repr. 1B;Aquatic Chronic 3,REACH registration C&L,4,H360:4;H318:4;H412:4
249381,2-(4-chlorophenyl)malonaldehyde,811-353-2,205676-17-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H320:1;H335:1;H315:1;H302:1;H314:1
249382,2-(4-Methylphenyl)malondialdehyde,811-354-8,27956-35-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H320:1;H335:1;H315:1
249383,Tea tree essential oil,942-904-6,,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H302:1;H317:1;H315:1;H304:1;H226:1;H411:1
249384,Reaction mass of linalool and pin-2(3)-ene and linalyl acetate and pin-2(10)-ene and dipentene,942-905-1,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H317:1;H315:1;H304:1;H226:1;H410:1
249385,"4-((2S,5S)-37-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-2-methyl-4,7,35-trioxo-",942-906-7,,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Notified C&L,1,H331:1;H351:1;H301:1;Not classified:1;H311:1
249388,"1,2-diphenylethanone oxime",811-357-4,952-06-7,Not Classified,REACH registration C&L,1,Not classified:1
249389,{3-(Diphenylphosphino)-2-[(diphenylphosphino)methyl]-2-methylpropyl}(diphenyl)phosphine,811-359-5,22031-12-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249393,TDI Biuret,701-017-2,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Acute Tox. 1;Resp. Sens. 1;STOT SE 3;Carc. 2;Aquatic Chronic 3,REACH registration C&L,1,H317:1;H315:1;H351:1;H412:1;H330:1;H334:1;H318:1;H335:1
249394,CELERY ESSENTIAL OIL,942-909-3,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H315:1;H304:1;H226:1;H410:1
249396,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]-2-oxoethyl]-2-methylaminopropanamide",811-361-6,1005342-46-0,Acute Tox. 4,Notified C&L,1,H302:1
249399,"Reaction mass of Kaolin and 1-(4-chlorophenyl)-4,4-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentan-3-ol and 8061-51-6",942-913-5,,Eye Dam. 1;Repr. 2;Aquatic Chronic 2,Notified C&L,1,H361:1;H318:1;H411:1
249400,"tert-butyl (3S,6S)-3-((tert-butyldimethylsilyl)oxy)-6-chloro-6-((3aS,4S,6S,7aR)-3a,5,5-trimethylhexahydro-4,6-methanobenzo[d][1,3,2]dioxaborol-2-yl)hexanoate",811-363-7,1681053-96-2,Aquatic Chronic 4,REACH registration C&L,1,H413:1
249402,1-(3-Isopropoxyphenyl)methanamine,811-364-2,400771-44-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:1;H335:1;H315:1;H314:2;H318:1
249403,Lavender essentail oil,942-915-6,,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H304:1;H411:1;H317:1;H315:1
249412,"1-(6-nitro-1,3-benzodioxol-5-yl)ethyl carbonochloridate",811-365-8,156876-26-5,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3,Notified C&L,1,H331:1;H314:1;H301:1;H318:1;H311:1
249413,2-oxo-3-(4-phenylphenyl)propanoic acid,811-366-3,91853-46-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:1;H315:2
249414,Digadolinium dizirconium heptaoxide,811-367-9,11073-79-3,Not Classified,REACH registration C&L,2,Not classified:2
249415,"Reaction mass of Refined Alphacedrene, Cedarwood oil distillate, obtained by fractional distillation of the crude oil cupressus funebris wood oil (EC 285-360-9 / CAS 85085-29-6) and Peracetic acid (EC 201-186-8 / CAS 79-21-0) and Sodium carbonate (EC 207-838 / CAS 497-19-8)",942-922-4,,Asp. Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H304:1;H400:1;H410:1
249417,"4-Thia-1-azabicyclo [3.2.0] heptane-2-carboxylic acid,6-[[[[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]amino] phenylacetyl]amino]-3,3-dimethyl-7-oxo-,monohydrate, [2S-[2alpha, 5alpha, 6beta(S*)]]",811-368-4,66258-76-2,Skin Sens. 1B;Resp. Sens. 1B,Notified C&L,2,H334:2;H317:2
249418,5-Methoxy-2-methylbenzoic acid,811-370-5,3168-59-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
249419,"Hydrocarbons, C11-C13 (odd numbered), n-alkanes, <2% aromatics",942-924-5,,Flam. Liq. 4;Asp. Tox. 1,REACH registration C&L,84,H304:84;H227:1
249420,"N, N, N’, N’-tetramethyl-10H-phenothiazine-3, 7-diamine bis(hydrogen mesylate)",811-371-0,1236208-20-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249421,N-Hydroxysulphosuccinimidyl-4-azidobenzoate,811-372-6,199804-22-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249422,4-(3-Fluoroazetidin-1-yl)piperidine dihydrochloride,811-373-1,1403767-21-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249423,"4-Nitro-1,8-naphthalic anhydride",811-374-7,34087-02-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249424,"N,N-Diallyl-4-methylbenzenesulfonamide",811-375-2,50487-72-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249425,Pyrimidine-4-boronic acid,811-376-8,852362-24-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249426,"2,5-Diazaspiro[3.4]octane, N2-BOC protected",811-377-3,1086398-02-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:1;H315:2;H312:1;H332:1;H335:2
249427,2-Bromo-6-methoxypyrazine,811-378-9,91678-76-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249428,"2-Phenyl-1,3-oxazole-4-boronic acid, pinacol ester",811-379-4,885669-16-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249429,Methyl 4-(bromomethyl)phenylacetate,811-381-5,7398-42-7,Skin Corr. 1B,Notified C&L,1,H314:1
249430,"3,4-Dihydro-7-fluoro-4-methyl-1H-1,4-benzodiazepine-2,5-dione",811-382-0,78755-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249431,4-Chloro-6-(trifluoromethyl)nicotinaldehyde,811-383-6,1060807-48-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249432,Ethyl 3-bromo-1H-pyrazole-4-carboxylate,811-384-1,1353100-91-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249433,"2,3-Dichloro-4-hydroxybenzaldehyde",811-385-7,16861-22-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249434,2-Amino-6-methoxypyrazine,811-386-2,6905-47-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249435,5-Ethynyl-2-(trifluoromethyl)pyridine,811-387-8,1196155-24-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249436,Sulphosuccinimidyl acetate,811-388-3,152305-87-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249437,"3-Aminopiperidine hydrochloride, N1-BOC protected",811-389-9,1000796-62-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249438,4-(Aminomethyl)-1-methylpiperidine dihydrochloride,811-390-4,1187582-53-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249439,"2,4-Difluoro-DL-phenylglycine hydrochloride",811-392-5,1374651-47-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249440,3-Bromo-4-phenylpyridine,811-393-0,88345-89-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249441,Ethyl 2-(4-ethylphenyl)thiazole-4-carboxylate,811-394-6,885278-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249442,1-(3-Bromo-5-chloropyridin-2-yl)ethanone,811-395-1,1256823-11-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249443,Ethyl 4-phenylthiazole-5-carboxylate,811-396-7,99822-80-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249444,Ethyl 5-isopropyl-1-methyl-1H-pyrazole-3-carboxylate,811-397-2,1170483-34-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249445,Potassium 3-phenylpropyltrifluoroborate,811-398-8,329976-75-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249446,1-(tert-Butylamino)-3-chloropropan-2-ol hydrochloride,811-399-3,41052-94-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
249447,(cis-1-Amino-indan-2-yl)-methanol,811-400-7,55270-04-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249448,"4-(3,5-Dichlorophenyl)benzylamine hydrochloride",811-401-2,518357-39-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249449,"4-(3,4-Dichlorophenyl)benzylamine hydrochloride",811-402-8,618910-51-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249450,[3-(4-Chlorophenoxy)phenyl]methylamine hydrochloride,811-403-3,1171023-50-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249451,2-Bromo-3-fluoro-4-hydroxypyridine,811-404-9,1211525-92-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
249452,5-(Methoxycarbonyl)thiophene-3-boronic acid,811-405-4,957062-52-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249453,6-Bromo-N-(tetrahydro-2H-pyran-4-yl)-1H-indazol-3-amine,811-407-5,1214900-69-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249454,6-Bromo-3-(methylsulfonyl)-1H-indazole,811-408-0,651780-43-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249455,1H-Indole-6-sulphonamide,811-409-6,145951-26-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249456,"Adamantane-1,3,5-tricarboxylic acid",811-410-1,213274-89-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249457,"5-Bromo-1H-imidazo[4,5-b]pyridine",811-411-7,28279-52-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249458,5-(Propan-2-yl)-1H-indole,811-412-2,97820-51-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249459,"3-(Bromoacetyl)-4-methyl-1,2,5-oxadiazole",811-413-8,165066-97-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249460,4-Bromo-1-(4-fluorophenyl)-1H-pyrazole,811-414-3,957062-56-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249461,N-(methoxycarbonyl)-L-valyl-(5S)-5-methyl-L-proline,811-415-9,1335316-40-9,Not Classified,REACH registration C&L,4,Not classified:4
249462,"zinc, 5,5'-azobis-2,4,6(1H,3H,5H)-pyrimidinetrione complexes and melamine",942-925-0,,Not Classified,Notified C&L,1,Not classified:1
249464,"3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid",811-416-4,936727-05-8,Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Repr. 2,Notified C&L,2,H372:1;H360:1;H301:1;H312:1;H318:1;Not classified:1
249470,3-(1H-imidazol-4-yl)propan-1-ol,811-422-7,49549-75-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249471,"(7R)-2-Chloro-7-ethyl-7,8-dihydro-8-(1-methylethyl)-(5H)-6-pteridinone",811-423-2,889877-77-4,Acute Tox. 4,Notified C&L,1,H302:1
249490,"Reaction products of 4-methyl-2-pentanol and diphosphorus pentasulfide, propoxylated, esterified with diphosphorus pentaoxide, and salted by amines, C12-14- tert-alkyl",952-112-2,,Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H302:1;H314:1;H411:1
249491,"L-Valinamide,N-methyl-L-valyl-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-hydroxy-1- methyl-2-phenylethyl)amino)-1-methoxy-2-methyl-3-oxopropyl)-1pyrrolidinyl)-2- methoxy-1- ((1S)-1-methylpropyl)-4-oxobutyl)-N-methyl-",811-424-8,474645-27-7,Acute Tox. 4,Notified C&L,3,H302:2;H319:1;H335:1;H315:1;H341:1
249492,Reaction mass of 3211-76-5 and 7757-93-9,942-931-3,,Aquatic Chronic 3,Notified C&L,1,H412:1
249493,[No public or meaningful name is available],811-425-3,148553-51-9,Eye Dam. 1;Repr. 2,Notified C&L,1,H361:1;H318:1
249494,"(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol",811-426-9,7488-49-5,Acute Tox. 4,Notified C&L,1,H302:1
249495,Reaction mass of (E)-cyclododec-3-enone and (Z)-cyclododec-3-one,942-937-6,,Not Classified,Notified C&L,1,Not classified:1
249496,"6-(Benzyloxy)-8-(2-bromoacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one",811-427-4,926319-53-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
249497,"6-(4-Methyl-1-piperazinyl)-11H-dibenz[b,e]azepine",811-429-5,1977-11-3,Acute Tox. 4,Notified C&L,1,H302:1
249498,"Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.'-phosphinico-bis-omega.-(decyloxy)-, potassium salt",811-430-0,63887-55-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,6,H318:6;H315:6
249500,"Reaction mass of 4-methylpentane-2,2-diyl dihydroperoxide and 4-methylpentan-2-one and peroxybis-4-methylpentane-2,2-diyl dihydroperoxide",942-932-9,,Flam. Liq. 3;Org. Perox. D;Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,10,H242:10;H302:10;H314:10;H317:10;H304:10;H226:10;H411:10;H332:10;H318:10
249501,2-[(octadecylcarbamoyl)oxy]ethyl acrylate,811-432-1,78433-08-6,Aquatic Chronic 4,Notified C&L,1,H413:1
249503,[No public or meaningful name is available],701-019-3,,Not Classified,REACH registration C&L,1,Not classified:1
249504,5-chloropyrazine-2-carbaldehyde,811-433-7,88625-24-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249505,Tris(sec-butylcyclopentadienyl)yttrium,811-434-2,847153-22-4,Flam. Liq. 3,Notified C&L,23,H226:22;H225:1
249506,"6-bromo-2,7-naphthyridin-1(2H)-one",811-435-8,1260671-39-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249507,"Reaction mass of Refined Alphacedrene, Cedarwood oil distillate, obtained by fractional distillation of the crude oil cupressus funebris wood oil (EC 285-360-9 / CAS 85085-29-6) and Peracetic acid (EC 201-186-8 / CAS 79-21-0) and Sodium carbonate (EC 207-838 / CAS 497-19-8)",942-935-5,,Repr. 2;Aquatic Chronic 2,REACH registration C&L,4,H361:4;H411:4
249508,Enzyme BST dry powder,942-936-0,,Resp. Sens. 1,Notified C&L,1,H334:1
249512,5-iodo-2-(trifluoromethyl)pyridine,811-436-3,873107-98-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249516,"2-propenoic acid salt of N,N-dimethylpropane-1,3-diamine - 2-ethanediyl),.alpha.-(1-oxo-2-propenyl)-.omega.-hydroxy-Poly(oxy-1 adduct",942-942-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249517,[No public or meaningful name is available],811-440-5,1035979-44-2,Repr. 1A,Notified C&L,1,H360:1
249518,"(4S,4aS,5aR,12aR)-4-(dimethylamino)-1,10,11,12a-tetrahydroxy-7-[[methoxy(methyl)amino]methyl]-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide",811-441-0,1035654-66-0,Repr. 1A,REACH registration C&L,1,H360:1
249519,"2-Naftacencarboxamide, 4-(dimethylamin)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-7-iodo-1,11-dioxo-, (4S,4aS,5aR,12aS)-, mono(trifluoroacetate) (salt)",811-442-6,389625-14-3,Repr. 1A,REACH registration C&L,1,H360:1
249520,"2-Naftacencarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-7-methanoyl-1,11-dioxo-, (4S,4aS,5aR,12aS)",811-443-1,1035655-10-7,Repr. 1A,REACH registration C&L,1,H360:1
249526,8-benzyl-8-azabicyclo[3.2.1]octan-3-amine benzoate (1:1),942-946-5,,Acute Tox. 4,REACH registration C&L,1,H302:1
249527,"Siloxanes and Silicones, di-Me, 2-propenoic acid, ester with 2,2'-[oxybis(methylene)]bis[2-ethyl-1,3-propanediol] polymers, esterification product of pentaerythritol and 2-propenoic acid, polymers with 5-isocyanato-1-(isocyanatomethyl)-1,3,3",942-947-0,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249528,2-Propenoic acid polymer with 2-ethyl-2-(hydroxymethyl)-3-propanediol,942-948-6,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
249529,"4,4'-Di-t-butyl-2,2'-bipyridine)bis[3,5-difluoro-2-[5-trifluoromethyl-2-pyridinyl-kN)phenyl-kC]iridium(III) hexafluorophosphate",811-445-2,870987-63-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249530,"(R)-7,7-Bis[(4S)-(phenyl)oxazol-2-yl)]-2,2,3,3-tetrahydro-1,1-spirobiindane",811-446-8,890090-21-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249531,"Palladium - tris[3,5-bis(trifluoromethyl)phenyl]phosphine (1:3)",811-447-3,1130784-80-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249532,"Hexanedioic acid, polymer with 1,2-ethanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-hydroxyethyl acryl, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid",942-949-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249533,"1,3-Dimethoxytetramethyldisiloxane",811-448-9,18187-24-1,Acute Tox. 4,Notified C&L,13,H302:13
249539,"2-isopropyl-2-(3-methylbutyl)propane-1,3-diol",811-449-4,129228-29-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 1B;Repr. 2,REACH registration C&L,1,H341:1;H319:1;H317:1;H315:1;H350:1;H361:1
249541,C9 heavy distillates- Aromatic hydrocarbon,942-957-5,,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Carc. 1B;Aquatic Chronic 2,Notified C&L,1,H319:1;H315:1;H226:1;H411:1;H350:1
249543,"4,8-Bis(Hydroxymethyl)Tricyclo[5.2.1.0(2,6) ]Decane Polymer with 2-Propenoic Acid and 1,4-Butanediol Diglycidyl Ether",942-959-6,,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1
249544,"2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester polymer with polypropylene glycol, 4-methyl-m-phenylene diisocyanate",942-960-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249545,"3-[3-({[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}(methyl)amino)propyl]-7,8-dimethoxy-2,3,4,5-tetrahydro-1H-3-benzazepin-2-one, hydrochloride",942-961-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249547,"Polyphosphoric acids, 2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl esters",811-451-5,1802140-94-8,Skin Sens. 1;Eye Dam. 1,REACH registration C&L,1,H318:1;H317:1
249555,"2-Chloro-6-(trifluoromethyl)nicotinitrile,",811-456-2,386704-06-9,Skin Irrit. 2;Eye Irrit. 2A,Notified C&L,2,H319:2;H335:2;H315:2;H331:1;H301:1;H311:1
249556,"2,4-Pyrimidinediamine, 5-chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-",811-457-8,1032900-25-6,,Notified C&L,3,H360:1;H372:1;H410:2;H400:1;H302:1
249560,Acrylic acid-methacrylic acid-polyethylene glycol monoallyl ether copolymer,942-970-6,,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
249561,"4-(3-amino-1,2,4-triazin-6-yl)-2-fluorobenzonitrile",811-458-3,1197377-47-1,,Notified C&L,2,H312:1;H332:1;H302:1;H303:1;H317:1
249562,"2-propanol, zinc salt",,13282-39-8,,Notified C&L,1,H319:1;H335:1;H315:1
249563,2-methoxy-5-nitrophenyl acetate,811-460-4,53606-41-0,Ox. Sol. 3;Skin Sens. 1,REACH registration C&L,1,H272:1;H317:1
249564,"1-(4-amino-6,7-dimethoxyquinazolin-2-yl)-4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazine-1,4-diium diacetate",942-971-1,,Not Classified,Notified C&L,1,Not classified:1
249565,"1-(4-amino-6,7-dimethoxyquinazolin-2-yl)-4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazine-1,4-diium acetate methanesulfonate (1/1/1)",942-972-7,,Not Classified,Notified C&L,1,Not classified:1
249566,"1-[(1Ξ,2Ξ)-2-Chloro-1-hydroxy-3-(quinolin-6-yl)propyl]pyrrolidine-2,5-dione",811-462-5,1197377-31-3,Skin Sens. 1A;Aquatic Chronic 2,Notified C&L,2,H411:1;H317:1;H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249569,"Reaction mass of Sodium 2-(2 or 3-{[(chloroacetyl)amino]methyl}-4-{[4-(cyclohexylamino)-9,10-dioxo-9,10-dihydroanthracen-1-yl]amino}phenoxy)-5-methylbenzenesulfonate and Sodium 2-(3 or 2-{[(chloroacetyl)amino]methyl}-4-{[4-(cyclohexylamino)-9,10-dioxo-9,10-dihydroanthracen-1-yl]amino}phenoxy)-5-methylbenzenesulfonate",942-981-6,,Aquatic Chronic 2,REACH registration C&L,4,H411:4
249571,"2-(2-chlorophenyl)-4-(3-(dimethylamino)phenyl)-5-methyl-1H-pyrazolo[4,3-c]pyridine-3,6(2H,5H)-dione",942-974-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
249572,"1,3-Butadiene, homopolymer, hydroxy-terminated, polymer with 1,1'-methylenebis[isocyanatobenzene] and 1,1'-methylenebis[4-isocyanatobenzene] homopolymer",942-975-3,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H317:8;H315:8;H351:8;H334:8;H332:8;H373:8;H335:8
249574,"Polysiloxane based surfactant reaction product with methylenediphenyl diisocyanate and 4,4'-methylenediphenyl diisocyanate, oligomers",942-977-4,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H317:8;H315:8;H351:8;H334:8;H332:8;H373:8;H335:8
249575,"1,3-Butanediol, polymer with 1,1'-methylenebis[isocyanatobenzene], 2,2'-oxybis[ethanol], 1,2-propanediol and polypropylene glycol",942-979-5,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H317:8;H315:8;H351:8;H334:8;H332:8;H373:8;H335:8
249577,Tri-n-butylphosphonium tetrafluoroborate,811-463-0,113978-91-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249578,Reaction products of monoethanolamine and boric acid (1:3),701-024-0,,Not Classified,REACH registration C&L,100,Not classified:100
249579,Reaction products of monoethanolamine and boric acid (1:1),701-025-6,,Not Classified,REACH registration C&L,16,Not classified:16
249580,"High temperature calcination products of titanium dioxide, calcium carbonate, calcium fluoride, quartz and antimony oxide containing lewisite and wollastonite",942-982-1,,Not Classified,Notified C&L,1,Not classified:1
249581,"reaction mass of silicon tetrachloride, hexachlorodisilane and pentachlorodisilane",942-983-7,,Water-react. 2;Skin Corr. 1A;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H314:1;H335:1;H261:1
249585,4-(Methylsulfonyl)benzylamine hydrochloride,811-465-1,98593-51-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249589,Reaction mass of phenol and 3-tert-butylphenol and 4-tert-butylphenol,942-988-4,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 3;Muta. 2;Repr. 2;Repr. 2;STOT RE 2;STOT RE 2;Aquatic Chronic 1,Notified C&L,1,H341:1;H331:1;H314:1;H301:1;H361:1;H373:1;H318:1;H410:1;H311:1
249591,tert-Butyl 3-amino-8-azabicyclo[3.2.1]octane-8-carboxylate,942-990-5,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249592,[No public or meaningful name is available],811-466-7,219861-53-7,Acute Tox. 4,Notified C&L,1,H302:1
249593,"(2E)-3-(1,3-benzodioxol-5-yl)-N,N-diphenylacrylamide",811-467-2,1309389-73-8,Not Classified,REACH registration C&L,1,Not classified:1
249599,"Reaction mass of methyl (9E,12E,15Z)-9,12,15-octadecatrienoate and methyl (9E,12Z,15E)-9,12,15-octadecatrienoate and methyl (9Z)-9-octadecenoate and methyl (9Z,12E,15E)-9,12,15-octadecatrienoate and methyl (9Z,12Z)-9,12-octadecadienoate",942-993-1,,Not Classified,REACH registration C&L,1,Not classified:1
249611,"HDI oligomers, oxadiazintrione",942-994-7,,Skin Sens. 1;Acute Tox. 3;STOT SE 3,REACH registration C&L,1,H331:1;H335:1;H317:1
249612,"Fatty acids, C16-18 (even numbered), esters with 1,2-propanediol",943-011-4,,Not Classified,REACH registration C&L,10,Not classified:10
249613,"Siloxanes and Silicones, di-Me, Me vinyl, mono(vinyl group)-terminated",811-469-3,68951-99-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,34,H319:34;H335:34;H315:34
249614,"Fatty acids, C12-18 (even-numbered), 3-methylbutyl esters",943-007-2,,Not Classified,REACH registration C&L,2,Not classified:2
249615,"Formaldehyde, polymeric reaction products with phenol containing under 24% of phenol and under to 1,5 % of formaldehyde",942-995-2,,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 2,Notified C&L,1,H341:1;H331:1;H302:1;H314:1;H317:1;H350:1;H373:1;H318:1;H311:1
249623,"2-(2-Mercaptoethyl)isoindoline-1,3-dione",811-474-0,4490-75-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249625,7-Hydroxy-4-(4-pyridyl)coumarin,811-476-1,92906-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249626,"3-chloro-2-[3-(chloroacetyl)-4,5-dihydro-1,2-oxazol-5-yl]phenyl methanesulfonate",811-477-7,1446134-16-2,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1;H317:1
249630,A-Stage E,,,Not Classified,Notified C&L,2,Not classified:2
249633,Reaction mass of sulfuric acid and aluminium oxide,943-004-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3
249639,polyoxyethylene octyl phenyl ether,943-006-7,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H302:1;H315:1;H410:1
249642,Ammonium 4-isopropylbenzenesulfonate,811-484-5,680972-33-2,Eye Irrit. 2,REACH registration C&L,1,H319:1
249643,"7-chloro-2,4-dioxo-1,4-dihydro-2H-3,1-benzoxazine-6-sulfonamide",811-480-3,23380-53-2,,,0,No data
249644,4-(1H-pyrazol-4-yl)pyridine,943-009-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249648,"25-cyclohexyl-4'-O-de(2,6-dideoxy-3-O-methyl-a-L-arabino-hexopyranosyl)-5-demethoxy-25- de(1-methylpropyl)-22,23-dihydro-5-(hydroxyimino)-Avermectin A1a",811-481-9,165108-07-6,Repr. 2;Aquatic Acute 1,Notified C&L,1,H361:1;H400:1
249649,"N-[2-[(1R)-1-[3-(ethoxy-1,1,2,2,2-d5)-4-(methoxy-d3)-phenyl]-2- (methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-acetamide",811-482-4,1258597-81-7,Acute Tox. 4;Repr. 2;Aquatic Chronic 3,Notified C&L,1,H361:1;H412:1;H302:1
249650,2-amino-5-bromopyridin-3-yl 4-methylbenzenesulfonate,943-013-5,,Not Classified,Notified C&L,1,Not classified:1
249651,3-Hydroxybenzylamine,811-485-0,73804-31-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249655,"HC, C9-C12, n-/iso/cycl./ aromat.(2-25%)",811-486-6,1174921-79-9,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,14,H304:14;H226:14;H411:14;H336:14;H372:1
249658,"2'-(dicyclohexylphosphanyl)-N,N-dimethyl-[1,1'-biphenyl]-2-amine; {2'-amino-[1,1'-biphenyl]-2-yl}palladio methanesulfonate",811-488-7,1445085-87-9,,Notified C&L,2,H319:1;H335:1;H315:1;H351:1
249659,5-(Hydroxymethyl)-2-iodophenol,811-489-2,773869-57-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H312:1;H332:1;H302:1
249661,"Reaction Products of Diphosphorus Pentaoxide with n-Alcohols, C8-10 (even), salted with Amines, C12-14, Tert-alkyl",943-016-1,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,3,H318:3;H411:3;H315:3
249662,"3-chloro-2-(1,1-difluorobut-3-en-1-yl)-6-methoxyquinoxaline",811-491-3,1799733-46-2,Not Classified,REACH registration C&L,2,Not classified:2
249663,"6-{4-[1-propan-2-yl)piperidin-4-yl]-1, 4-diazepan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide",943-017-7,,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H331:1;H400:1;H301:1;H410:1;H311:1
249664,(S)-RUCY(regR)-XylBINAP,811-492-9,1312713-89-5,,Notified C&L,2,H319:2;H335:1;H315:2;H360:1;H340:1;H373:1;H371:1
249669,2-(pyrrolidin-1-yl)acetic acid hydrochloride,811-498-1,6628-74-6,,Notified C&L,2,H312:1;H332:1;H302:1;H319:1;H335:1;H315:1
249672,[No public or meaningful name is available],811-501-6,102293-80-1,Acute Tox. 4,Notified C&L,1,H302:1
249673,Non-graphitic carbon fibre,701-026-1,,Not Classified,REACH registration C&L,16,Not classified:16
249675,4-isobutyl-2-methylbenzaldehyde,811-502-1,73206-60-7,Not Classified,Notified C&L,1,Not classified:1
249676,"Ethyl acetate - (1aR,5S,8S,9S,10R,22aR)-5-tert-butyl-N-[(1R,2R)-2-(difluoromethyl)-1-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}cyclopropyl]-9-ethyl-18,18-difluoro-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiaza-cyclononadecino[11,12-b]quinoxaline-8-carboxamide (1:1)",943-019-8,,STOT RE 2,Notified C&L,1,H373:1
249678,"(1S, 2S, 4R)-2-((2-octyldodecyl)oxy) bicyclo(2.2.1)heptane",943-020-3,,Asp. Tox. 1,Notified C&L,1,H304:1
249680,(2S)-2-(2-chlorophenyl)-2-(methylamino)cyclohexanone,811-504-2,33643-46-8,Acute Tox. 4;Acute Tox. 4,REACH registration C&L,1,H332:1;H302:1
249682,Ammonium (xylenes and 4-ethylbenzene)sulfonates,943-024-5,,Eye Irrit. 2,REACH registration C&L,3,H319:3
249684,[No public or meaningful name is available],811-506-3,12691-60-0,Eye Irrit. 2;STOT SE 3;STOT SE 3;STOT RE 2,Notified C&L,6,H319:6;H335:6;H373:6;H371:6
249692,"Reaction products of diazotised 5-aminonaphthalene-1-sulfonic acid coupled with resorcinol, subsequently coupled with diazotised anthranilic acid and chelated with chromium (3+), potassium salts",943-030-8,,Not Classified,REACH registration C&L,6,Not classified:6
249694,Polyol acrylate,943-031-3,,Eye Irrit. 2,Notified C&L,1,H319:1
249695,2-Cyclohexylidene-2-o-tolylacetonitrile,811-510-5,916887-53-1,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,9,H400:8;H411:9;H317:9
249698,4-Amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide citrate dihydrate,811-513-1,156925-25-6,Eye Dam. 1,Notified C&L,52,H318:52
249699,METHYL FLUFENAMATE,811-514-7,2765-91-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H301:1;H335:1;H410:1
249700,bis(branched-alkyl) 2-{[(1-phenylethyl)amino]methyl}alkanedioate,,,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H410:2;H317:2
249701,"1,1'-(oxydiethane-2,1-diyl)dipyrrolidine",811-515-2,100396-39-2,Met. Corr. 1;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,83,H318:83;H314:83;H301:83;H290:83
249702,N6-Benzoyl-N9-(6-hydroxymethyl-4-triphenylmethylmorpholin-2-yl) Adenine,811-516-8,956139-16-5,Not Classified,REACH registration C&L,2,Not classified:1;H312:1;H332:1;H302:1
249706,(chlorosilyl)disilylamine,811-519-4,57542-86-6,Flam. Liq. 2;Water-react. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,23,H302:23;H314:23;H225:23;H260:22;H312:23;H332:22;H261:1;H330:1;H318:1
249707,Di-sec-butylaminoborane,811-521-5,22093-00-1,Water-react. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Repr. 1B,Notified C&L,22,H360:22;H302:22;H314:22;H261:22;H312:22;H332:22
249708,"sodium 2-methyl-2-({3-[(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)thio]propanoyl}amino)propane-1-sulfonate",811-522-0,62880-93-7,Not Classified,REACH registration C&L,5,Not classified:5
249709,"2-hydroxy-N,N,N-trimethyl-3-[(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)thio]propan-1-aminium chloride",811-523-6,88992-45-4,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H400:5;H302:5;H317:5;H330:4;H318:4;H410:5
249710,[No public or meaningful name is available],811-524-1,1393889-01-4,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
249711,[No public or meaningful name is available],811-525-7,87876-22-0,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
249712,[No public or meaningful name is available],811-526-2,915026-99-2,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
249713,[No public or meaningful name is available],811-527-8,1219444-22-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
249714,[No public or meaningful name is available],811-528-3,88217-10-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
249715,[No public or meaningful name is available],811-529-9,174283-52-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
249716,[No public or meaningful name is available],811-530-4,133551-97-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
249717,[No public or meaningful name is available],811-532-5,151853-67-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
249718,"28-(3-(3-(1-(4-(7-diethylamino-4-methyl-2-oxochromen-3-yl)phenyl)-2,5-dioxopyrrolidin-3-yl)sulfanyl)propanoylamino)-2-hydroxy-2-methylpropyl)-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-12-thia-10,16,22,25,27,30,33,36-octaazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4,6,8-tetraene-15,21,24,26,29,32,35-heptone",943-035-5,,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
249719,"28-(3-(4-(3,6-Bis(dimethylamino)xanthylium-9-yl)-3-carboxybenzoylamino)-2-hydroxy-2-methylpropyl)-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-12-thia-10,16,22,25,27,30,33,36-octaazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4,6,8-tetraene-15,21,24,26,29,32,35-heptone",943-036-0,,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
249720,"28-(3-((4-carboxy-3-(3-dimethylamino-6-dimethylazaniumylidenexanthen-9-yl)-phenyl)aminothiocarbonylamino)-2-hydroxy-2-methylpropyl)-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-12-thia-10,16,22,25,27,30,33,36-octaazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4,6,8-tetraene-15,21,24,26,29,32,35-heptone",943-037-6,,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
249721,Aduct of Ethanolamine and Dipropyleneglycol diacrylate,943-038-1,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H317:1;H315:1
249722,3-Bromo-2-(trifluoromethyl)aniline,811-533-0,244246-71-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249723,Ethyl 3-iodo-1H-pyrazole-4-carboxylate,811-534-6,827316-43-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:3;H315:3;H332:2;H335:3
249726,2-Amino-6-bromobenzaldehyde,811-537-2,135484-74-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249727,3-Chloro-5-fluoropyridine-2-carboxylic acid,811-538-8,128073-01-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249728,"3,4'-Biphthalic Anhydride",811-539-3,36978-41-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
249729,"4-Methoxybenzene-1,2-diol",811-540-9,3934-97-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249730,"5H,6H,7H-pyrrolo[3,4-b]pyridin-5-one",811-541-4,40107-93-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
249731,Methyl 6-chloro-5-fluoronicotinate,811-543-5,78686-78-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:1;H315:2;H312:1;H332:1;H335:2
249732,Methyl 1H-pyrazole-4-carboxylate,811-544-0,51105-90-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249733,Methyl beta-D-maltopyranoside,811-545-6,744-05-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249734,trans-3-Benzylamino-4-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester,811-546-1,138026-89-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249735,"3-Bromobenzene-1,2-diamine",811-547-7,1575-36-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
249736,Sulphosuccinimidyl-3-(4-hydroxyphenyl)propionate sodium salt,811-548-2,106827-57-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249737,"3,3,3-Trichloroprop-1-ene",811-549-8,2233-00-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H226:1;H312:1;H332:1;H335:1
249738,3-(4-Bromophenyl)-5-(trifluoromethyl)isoxazole-4-carboxylic acid,811-550-3,1159978-82-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249739,2-Chloro-4-fluorophenylacetonitrile,811-551-9,,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H335:1;H311:1
249740,1H-Indazole-5-sulphonyl chloride,811-552-4,599183-35-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1;H314:1
249741,4-(Pyrimidin-2-yl)benzenesulphonyl chloride,811-554-5,912569-53-0,Skin Corr. 1B,Notified C&L,1,H314:1
249742,"1,4-Bis(bromodifluoromethyl)benzene",811-555-0,651-12-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249743,4-Chloro-2-hydroxy-5-nitropyridine,811-556-6,850663-54-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
249744,"2-(3,5-Dichlorophenyl)acetic acid",811-557-1,51719-65-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249745,9-Aminocarbazole,811-558-7,17223-85-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249746,5-(Thien-2-yl)nicotinic acid,811-559-2,306934-96-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249751,"(1S, 6S)-1-(2-allyl-3-methoxyphenyl)-6-((tert-butyldimethylsilyl)oxy)undec-2-yn-1-ol",943-041-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
249752,"Essential oil of Cinnamon bark obtained from the bark of Cinnamomum zeylanicum, Lauraceae by distillation",943-043-9,,Asp. Tox. 1;Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Carc. 1B;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H317:2;H315:2;H304:2;H411:2;H350:2;H311:2
249753,"But-2-enedioic acid 2-(2,5-dioxo-pyrrolidin-1-yl)-ethyl ester methyl ester",943-044-4,,Skin Sens. 1,Notified C&L,1,H317:1
249754,"Hydrocarbons, C15-C16, n-alkanes, <2% aromatics",943-046-5,,Asp. Tox. 1,Notified C&L,1,H304:1
249756,Benzyl (2S)-2-amino-3-[3-(methylsulfonyl)phenyl] propanoate hydrochloride salt,811-561-3,1194550-59-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,2,H319:2;H302:2;H315:2;H411:2;H312:2;H332:2;H335:2
249760,"trans-9-[4-(3-Chlor-2-fluor-phenylamino)-7-methoxy-chinazolin-6-yloxy]-1,4-diaza-spiro[5.5]undecan-5-on Dimaleat",811-565-5,1392437-18-1,Repr. 2;STOT RE 2,Notified C&L,1,H361:1;H373:1
249764,"Bis (2,4-di-tert-butylphenyl) hydrogen phosphate",811-566-0,69284-93-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
249765,2-amino-6-bromopyridine-4-carbonitrile,811-567-6,1186194-69-3,,Notified C&L,2,H331:1;H319:2;H315:2;H301:1;H335:2;H311:1;H302:1;H312:1;H332:1
249770,"2H,2H,3H,3H-Perfluorooctanoic acid",811-572-3,914637-49-3,,Notified C&L,2,H314:2
249771,3-fluoropyridine-4-carbonitrile,811-573-9,113770-88-0,,Notified C&L,2,H331:1;H319:2;H315:2;H301:1;H335:2;H311:1;H302:1;H312:1;H332:1
249772,trimethyl-1H-pyrazole-4-sulfonyl chloride,811-574-4,59340-27-1,,Notified C&L,2,H314:2;H335:1
249773,"2,6-dichloro-4-cyanobenzoic acid",811-576-5,1258298-05-3,,Notified C&L,2,H331:1;H319:2;H315:2;H301:1;H335:2;H311:1;H302:1;H312:1;H332:1
249779,"3,3-difluoropropan-1-amine hydrochloride",811-582-8,1010097-89-8,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,Notified C&L,3,H312:2;H332:2;H318:2;H302:2;H314:1
249780,3-bromopyridazine,811-583-3,88491-61-6,,Notified C&L,2,H331:1;H319:2;H315:2;H301:1;H335:2;H311:1;H302:1;H332:1
249782,"{[(2,2-dimethylbut-3-yn-1-yl)oxy]methyl}benzene",811-585-4,1092536-54-3,Skin Sens. 1,REACH registration C&L,1,H317:1
249783,"Benzene, mono-C11-C13-branched alkyl derivatives",810-801-4,,Asp. Tox. 1;Repr. 2;Aquatic Chronic 4,REACH registration C&L,2,H304:2;H361:2;H413:2
249784,isopropyl (2Z)-3-iodoacrylate,943-053-3,,Not Classified,Notified C&L,1,Not classified:1
249792,"Reaction mass of diastereoisomers of 1-chloro-5-(1-((5-chloro-3-methylpentyl)oxy)propoxy)-3-methylpentane and diastereoisomers of 4-((5-chloro-3-methylpentyl)oxy)-2,6-diethyl-5-methyl-1,3-dioxane",943-055-4,,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1,Notified C&L,1,H226:1;H317:1;H315:1
249793,methyl 2-acetyl-4-methylpentanoate,811-590-1,51756-09-3,Not Classified,REACH registration C&L,1,Not classified:1
249814,"(3S,4R,5R)-2-chloro-3,4-bis(phenylmethoxy)-5-(phenylmethoxymethyl)oxolane",811-591-7,4060-34-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249816,Reaction mass of 51596-10-2 and 51596-11-3,943-060-1,,Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H400:1;H302:1;H410:1
249818,Amino-modified organopolysiloxane,811-592-2,670241-70-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,22,H318:22;H315:22
249819,"Hexanoic acid, 2-ethyl-, vanadium(5+) salt (1:?)",,74630-99-2,Not Classified,Notified C&L,22,Not classified:22
249820,Bis(tetrahydroindenyl) zirconium dichloride,811-594-3,12113-38-1,Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,17,H411:17;H314:17
249821,"Aluminum, (cyclohexanaminato)bis(2-methylpropyl)-",811-595-9,1625621-79-5,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,18,H260:18;H250:17;H314:17
249822,"Reaction mass of Cobaltate(1-), bis[6-(amino-κN)-5-[2-[2-(hydroxy-κO)-4-nitrophenyl]diazenyl-κN1]-N-methyl-2-naphthalenesulfonamidato(2-)]-, sodium (1:1) and disodium [6-amino-5-[(2-hydroxy-4-nitrophenyl)azo]-N-methylnaphthalene-2-sulphonamidato(2-)][6-amino-5-[(2-hydroxy-4-nitrophenyl)azo]naphthalene-2-sulphonato(3-)]cobaltate(2-)",943-062-2,,Aquatic Chronic 2,REACH registration C&L,2,H411:2
249823,"Fatty acids, C18-unsatd., compd. with 2-propanol, 1,1’-iminobis-, N-C12-18-(even numbered) alkyl derivs.",943-381-7,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H400:1;H410:1;H315:1
249826,polymeric photoinitiator,811-598-5,478549-43-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,2121,H319:2121;H317:2121
249830,"Reaction mass of trisodium4-[[4-chloro-6-[(4-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-[[1-(2,5-dichloro-4-sulphonatophenyl)-4,5-dihydro-3-methyl-5-oxo-1Hpyrazol-4-yl]azo]benzenesulphonate and trisodium4-[[4-chloro-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-[[1-(2,5-dichloro-4-sulphonatophenyl)-4,5-dihydro-3-methyl-5-oxo-1Hpyrazol-4-yl]azo]benzenesulphonate",943-063-8,,Skin Sens. 1,REACH registration C&L,2,H317:2
249832,5-FORMYL-2-METHYLPHENYLBORONIC ACID,811-600-4,1186398-35-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249833,3-Amino-4-ethoxybenzoic acid,811-602-5,875256-49-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249834,Reaction mass of 2-methoxy-2-methylbutane and 4-methoxypent-2-ene,701-027-7,,Flam. Liq. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H225:1;H336:1
249835,"Sodium 3-{[(2S,4R)-1-{[1,1'-biphenyl]-4-yl}-5-ethoxy-4-methyl-5-oxopentan-2-yl]carbamoyl}propanoate",811-603-0,149690-05-1,Not Classified,Notified C&L,2,Not classified:1;H413:1;H319:1
249836,Reaction product of: stearyl-diethanol-amine with C16-C18 saturated fatty acids,943-080-0,,Not Classified,REACH registration C&L,2,Not classified:2
249839,"Boron doped barium europium strontium silicate, orthorombic",943-065-9,,Eye Dam. 1,REACH registration C&L,2,H318:2
249841,"5-({4-chloro-6-[ethyl(phenyl)amino]-1,3,5-triazin-2-yl}amino)-4-hydroxy-3-[(2-sulfophenyl)diazenyl]naphthalene-2,7-disulfonic acid, lithium sodium salts",943-066-4,,Not Classified,Notified C&L,1,Not classified:1
249845,"Dodecanoic acid, ester with 1,2,3-propanetriol",811-605-1,37318-95-9,Aquatic Chronic 2,REACH registration C&L,3,H411:3
249846,methyl (2E)-3-(4-formylphenyl)prop-2-enoate,811-606-7,58045-41-3,Aquatic Chronic 2,Notified C&L,2,H411:1;H319:1;H302:1;H315:1;H412:1;H312:1;H332:1;H335:1
249852,"2-Propenoic acid polymer with alcohol a-aminoethylique and 2,2'-[1,4-Butanediylbis(oxymethylene)]bis[oxirane]",943-073-2,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H317:1;H315:1
249853,"7-({[3-({4-[(2-hydroxy-1-naphthyl)diazenyl]phenyl}diazenyl)phenyl]sulfonyl}amino)naphthalene-1,3-disulfonic acid, lithium sodium salts",943-074-8,,Aquatic Chronic 3,Notified C&L,1,H412:1
249854,"2-propenoic acid, 2-methyl-, methyl ester, polymer with butyl 2-propenoate and oxiranylmethyl 2-methyl-2-propenoate, 2-propenoate",943-075-3,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
249856,"Prop-2-enoic acid, polymer with 2-(hydroxymethyl)-2-ethylpropane-1,3-diol and 2-benzofuran-1,3-dione and 2-methylaminoethanol",943-077-4,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
249857,"Poly(oxy-1,2-ethanediyl), .alpha.-(1-oxo-2- propenyl)-.omega.-methoxy- reaction products with N,N-Dimethyl-N-(3-aminopropyl)amine",943-079-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249859,(R)-2-Methylpiperidine,811-610-9,1722-95-8,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H302:1;H315:1;H225:1;H318:1;H335:1
249861,2-cyclopropylbenzoic acid,811-613-5,3158-74-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,4,H319:3;H335:3;H315:3;Not classified:1
249863,"Essential oil of Mentha Spicata L., Erospicata (Labiatae) obtained from aerial parts by steam distillation",811-616-1,1563063-07-9,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,4,H319:4;H302:4;H317:4;H315:4;H304:4
249866,"2-{[4-chloro-6-({8-hydroxy-3,6-disulfo-7-[(1-sulfo-2-naphthyl)diazenyl]-1-naphthyl}amino)-1,3,5-triazin-2-yl]amino}-5-sulfobenzoic acid, lithium sodium salts",943-083-7,118578-12-4,Skin Sens. 1,Notified C&L,1,H317:1
249867,"(6α,11β,16α)-2-chloro-6,9-difluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione",811-617-7,1310709-74-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249868,"Salt of 4-azidobutan-1-amine and (7,7-dimethyl-2-oxobicyclo[2.2.1]hept-1-yl)methanesulfonic acid",943-084-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249869,DIETHYL 1-BOC-AZETIDINE-3-DICARBOXYLATE,811-618-2,1011479-75-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
249870,(3-endo)-8-benzyl-8-azabicyclo[3.2.1]octan-3-amine (2E)-but-2-enedioate (1:1),943-085-8,,Not Classified,Notified C&L,1,Not classified:1
249871,3-Adamantyl-4-Methoxyphenyl Boronic Acid,811-619-8,459423-32-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H302:1;H315:1;H332:1;H335:1
249872,11-((2-methylbutoxy)methyl)tricosane,943-086-3,,Asp. Tox. 1,Notified C&L,3,H304:3
249873,"N,N'-bis{3-[di-(branched and cyclic) alkylamino]alkyl}alkanediamide",,,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1,H319:1;H317:1
249874,"(9R,10AR)-9-((2,2-DIETHOXYETHYLTHIO)METHYL)-7-METHYL-4,6,6A,7,8,9,10,10AOCTAHYDROINDOLO[",943-088-4,,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;STOT RE 2;STOT RE 2,Notified C&L,1,H373:1;H300:1;H310:1;H330:1
249875,"5-[(1R)-2-[6-(2,2-difluoro-2-phenyl-ethoxy)hexylamino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one; naphthalene-1,5-disulfonic acid (2:1)",811-620-3,1044516-17-7,Acute Tox. 3;Acute Tox. 3,Notified C&L,1,Not classified:1;H331:1;H301:1
249877,"1-[(phenylmethyl)sulfinyl]-N,N-dipropyl-formamide",811-622-4,51954-81-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H400:156;H410:156
249878,[No public or meaningful name is available],811-624-5,1780451-32-2,Skin Sens. 1;Acute Tox. 4;STOT SE 3,Notified C&L,25,H332:25;H335:25;H317:25
249879,aliphatic polyisocyanate,811-625-0,1809331-98-3,Skin Sens. 1B;Acute Tox. 4;STOT SE 3;Aquatic Chronic 2,Notified C&L,25,H332:25;H335:25;H411:25;H317:25
249881,BALSAM PERU ESSENTIAL OIL,943-091-0,,Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H318:1;H411:1;H317:1;H373:1
249883,LEMON ESSENTIAL OIL,943-092-6,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H315:1;H304:1;H226:1;H410:1
249884,"1,1'-Methylenebis(4-isocyanato-3,5-bis(1-methylethyl))benzene",811-627-1,2162-69-8,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 1;Resp. Sens. 1;STOT SE 3,Notified C&L,35,H302:33;H314:33;H330:33;H334:33;H335:33;H413:2;H319:2;H317:2;H315:2
249885,7-[4-(4-(benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one,811-628-7,913611-97-9,Acute Tox. 4;Carc. 2;Repr. 1A;Lact.;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,4,H362:4;H360:4;H372:4;H302:4;H400:4;H351:4;H410:4
249886,"28-(3-(5-((3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl)-2-hydroxy-2-methylpropyl)-18-hydroxy-34-(1-hydroxyethyl)-23,31-dimethyl-12-thia-10,16,22,25,27,30,33,36-octaazapentacyclo[12.11.11.03,11.04,9.016,20]hexatriaconta-3(11),4,6,8-tetraene-15,21,24,26,29,32,35-heptone",943-093-1,,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
249887,"(3,5-Bis(methylsulfonyl)phenyl)methanol",811-629-2,849924-86-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249888,"tris(4-nonylphenyl, branched) phosphite",701-028-2,,Aquatic Chronic 4,REACH registration C&L,40,H413:32;H400:16;H410:24;H317:16;H361:8;H302:8;H314:8
249895,rac-Dimethylsilylbis(1-indenyl)zirconium dichloride,811-636-0,121009-93-6,,Notified C&L,2,H319:2;H315:2;H335:1;H317:1
249896,"2-Amino-9H-pyrido[2,3-b]indole",811-637-6,26148-68-5,Muta. 2;Carc. 2,Notified C&L,2,H341:2;H351:2
249897,5-Amino-3-bromo-2-methylpyridine,811-638-1,186593-43-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H335:1;H302:1;H315:2
249898,"(8S)-5,6,7,8-Tetrahydroquinolin-8-amine dihydrochloride",811-639-7,865303-57-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249899,2-Amino-5-chlorobenzhydrol,811-640-2,7039-50-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249900,TP-5,811-641-8,69558-55-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249901,N-Methylbiphenyl-2-amine,811-642-3,14925-09-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249902,"2-Chloro-L-phenylalanine, N-BOC protected",811-643-9,114873-02-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249903,2-Hydroxy-6-methoxy-4-methylquinoline,811-644-4,5342-23-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249904,"2-Chloro-L-phenylalanine, N-FMOC protected",811-646-5,198560-41-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
249905,4-Acetyl-2-chlorobenzoic acid,811-647-0,115382-35-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249906,2-NBDG,811-648-6,186689-07-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249907,3-(trifluoromethyl)-1H-pyrazol-5-amine,811-649-1,852443-61-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:3;H315:3;H312:2;H332:2;H335:3
249908,(5-bromo-2-nitro-phenyl)methanol,811-650-7,1241894-37-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,90,H318:89;H314:90
249909,"3-Bromo-4-fluorobenzene-1,2-diamine",811-651-2,1257535-06-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
249910,"L-Gulofuranuronic acid, gamma-lactone",811-652-8,14474-04-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249911,1-O-Galloyl beta-D-glucopyranoside,811-653-3,13405-60-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249912,2-Bromo-6-(trifluoromethyl)nicotinic acid,811-654-9,749875-07-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249913,"6-Bromo-2,3-dihydro-1H-indole",811-655-4,63839-24-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H335:2;H302:3;H315:2;H312:2;H332:2
249914,3-(Hydroxymethyl)isoxazole,811-657-5,89102-73-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249915,"1-Chloro-2,4-dinitro-5-fluorobenzene",811-658-0,327-91-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249916,Mal-PEG2-acid,811-659-6,1374666-32-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
249917,"2-Bromo-5-chloro-1,3-dimethylbenzene",811-660-1,103724-99-8,Skin Sens. 1B,Notified C&L,90,H317:89;H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
249918,"2-Amino-3,5-difluorobenzoic acid",811-661-7,126674-78-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
249919,5-Methoxyoxindole,811-662-2,7699-18-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H335:2;H302:1;H315:2
249920,"1-Amino-6-azido-1,6-dideoxy-beta-D-glucopyranoside",811-663-8,187100-24-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249921,"6-Deoxy-6-iodo-1,2:3,4-di-O-isopropylidene-alpha-D-galactopyranose",811-664-3,4026-28-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249922,2-Bromo-6-chlorophenol,811-665-9,2040-88-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
249923,2-Boc-6-hydroxy-2-azaspiro[3.4]octane,811-666-4,1363381-95-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
249924,3-Methyl-1H-pyridazin-6-one,811-668-5,302964-01-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,90,H319:90;H302:90;H315:90;H312:90;H332:90;H335:90
249925,"4-Bromo-N,N-dimethylbenzamide",811-669-0,18469-37-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249926,2-Amino-6-chlorophenol,811-670-6,38191-33-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:2;H335:2
249928,6-(Morpholin-4-yl)nicotinic acid,811-672-7,120800-52-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
249929,"2-Bromo-3,4-difluorobenzoic acid",811-673-2,170108-05-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H319:1;H302:1;H315:1;H411:1;H335:1
249930,5-(tert-Butyldimethylsilyloxy)-1H-indole,811-674-8,106792-38-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249935,"(2R,3R)-(-)-Bis(diphenylphosphino)bicyclo[2.2.1]hept-5-ene(1,5-cyclooctadiene)rhodium(I) tetrafluoroborate",811-679-5,521272-85-5,,Notified C&L,2,H319:2;H335:1;H315:2;H413:1;H302:1;H312:1;H332:1
249936,"1,2-Bis((2R,5R)-2,5-diethylphospholano)benzene(cyclooctadiene)rhodium(I) tetrafluoroborate",811-680-0,228121-39-9,,Notified C&L,2,H319:2;H335:2;H315:2
249939,"1-isocyanato-2(or 4)-(4-isocyanatobenzyl)benzene and their reaction products with [(methylethylene)bis(oxy)]dipropanol and butane-1,3-diol and propylene glycol",701-029-8,,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,REACH registration C&L,8,H319:8;H317:8;H315:8;H351:8;H334:8;H332:8;H373:8;H335:8
249941,"2-{[4-({4-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-5-sulfo-1-naphthyl}diazenyl)-(6 or 7)-sulfo-1-naphthyl]diazenyl}benzene-1,4-disulfonic acid, lithium sodium salts",943-097-3,,Skin Sens. 1,Notified C&L,1,H317:1
249942,"4,4'-(1-phenylethane-1,1-diyl)bis(heptyloxybenzene)",811-683-7,1799707-26-8,Aquatic Chronic 4,Notified C&L,1,H413:1
249943,3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carbonyl fluoride,811-684-2,1255735-07-9,Acute Tox. 4;Skin Corr. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H302:1;H314:1
249945,Single Wall Carbon Nanotubes (SWCNT),943-098-9,,Eye Irrit. 2,REACH registration C&L,3,H319:3
249958,XPhos Pd G4,811-696-8,1599466-81-5,,Notified C&L,2,H319:2;H335:2;H315:2;H412:1
249969,2-fluoro-6-nitro-N-phenylbenzamide,811-702-9,870281-83-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249970,tert-butyl N-[(1S)-1-(5-fluoro-4-oxo-3-phenylquinazolin-2-yl)propyl]carbamate,811-703-4,870281-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249972,3-(1H-Imidazol-5-yl)pyridine,943-107-6,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
249973,N-((R)-1-(5-Chloro-1H-benzoimidazol-2-yl)-2-methoxy-ethyl)-3-methyl-4-(3-oxo-morpholin-4-yl)-benzamide Sodium Salt,811-706-0,1622159-00-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H302:1;H314:1
249975,trisodium bis[3-[1-(3-chlorophenyl)-5-(hydroxykO)-3-methyl-1H-pyrazol-4-yl]diazenyl}-4-(hydroxy-kO)5-nitrobenzenesulfonato(3-)]chromate(3-),943-109-7,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H411:2;H317:2
249978,"Fatty acids, C18-unsatd., dimers, polymers with bisphenol A, epichlorohydrin, glycidyl Ph ether, tall-oil fatty acids and tetraethylenepentamine",811-707-6,73891-94-8,Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,22,H319:22;H335:22;H411:22;H317:22
249979,(3-Methyl-butylamino)-3-pyridinyl methyl phosphinic acid,943-112-3,,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H302:1;H314:1
249980,"2-[2-(3,4-dimethoxyphenyl)-6-methyl-3-oxo-pyridazine-4-carbonyl]cyclohexane-1,3-dione",943-130-1,,Muta. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H341:89;H400:89;H410:89
249981,"Propane, 2-chloro-1,1,1,2-tetrafluoro-",,421-73-8,Press. Gas (Liq.),Notified C&L,6,H280:6
249982,"Propane, 2,3-dichloro-1,1,1-trifluoro-",811-709-7,338-75-0,STOT SE 3;Ozone 1,Notified C&L,6,H420:6;H335:6;H336:6
249983,Fluoropolymer~,863-119-4,1793072-86-2,Acute Tox. 3,Notified C&L,13,H331:13
249984,Cinnamon essential oil; coumarin free,943-113-9,,Skin Sens. 1;Eye Irrit. 2;Muta. 2;Carc. 1B;Aquatic Chronic 3,Notified C&L,1,H341:1;H319:1;H317:1;H412:1;H350:1
249985,Angelica Root essential oil,943-114-4,,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H304:1;H226:1;H411:1;H317:1
249992,Reaction mass of palladium and carbon,943-121-2,,Flam. Sol. 2,Notified C&L,1,H228:1
249993,(E)-methyl non-2-enoate,811-711-8,14952-06-8,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2,H400:2;H411:2
249994,4-CYCLOHEXYLBUTAN-2-ONE,811-712-3,2316-85-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H301:1;H315:3;H302:2;H227:2
249996,3-(3-carbamoyl-6-hydroxy-4-methyl-2-oxopyridin-1(2H)-yl)propanoic acid,811-713-9,78057-29-1,Not Classified,REACH registration C&L,1,Not classified:1
249997,Indazolpyrrolopyrimdine derivative,,,Repr. 1B;STOT SE 1,Notified C&L,35,H360:35;H370:35
250001,"1,3-Benzodioxol-4-amine",811-716-5,1668-84-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 2,Notified C&L,1,H341:1;H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250002,3-(3-cyano-6-hydroxy-4-methyl-2-oxopyridin-1(2H)-yl)propanoic acid,811-717-0,78057-27-9,Not Classified,REACH registration C&L,1,Not classified:1
250003,"Reaction mass of butan-1-ol and Tetra-n-butyl titanate, polymer with water",943-125-4,,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H226:1;H336:1;H315:1
250004,"Reaction mass of propan-2-ol and butan-1-ol and Titanium, Bu alc. iso-Pr alc. complexes",943-127-5,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1
250005,Reaction mass of 2-ethylhexan-1-ol and titanium tetraisopropanolate and titanium tetrakis(2-ethylhexanolate),943-128-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250006,"(RS)-4-[1-(2,3-dimethylphenyl)ethyl]-1H-imidazole;medetomidine",811-718-6,86347-14-0,Acute Tox. 2;Acute Tox. 2;STOT SE 3;STOT SE 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H372:0;H300:0;H400:0;H330:0;H370:0;H410:0;H336:0
250007,3-(2-((4-Carbamimidoylphenyl)carbamoyl)-4-ethenyl-5-methoxyphenyl)-6-((cyclopropylmethyl)carbamoyl)pyridine-2-carboxylic acid,811-719-1,918407-35-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250008,N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide dihydrochloride,811-720-7,1380317-28-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2,Notified C&L,1,H319:1;H315:1;H373:1;H361:1;H335:1
250010,Reaction mass of 141-78-6 and 1421259-21-3,943-129-6,,Flam. Liq. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,1,H319:1;H317:1;H315:1;H225:1;H361:1;H336:1
250018,Octylchlorohydrin,811-729-6,18371-71-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,22,H318:22;H319:22;H315:22
250019,2-(aminooxy)ethan-1-ol,811-730-1,3279-95-6,Not Classified,Notified C&L,2,Not classified:1;H302:1;H227:1;H315:1;H318:1;H335:1
250024,"Reaction mass of Amines, C10-14-branched and linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-) (1:1) and Amines, C10-14-branched and linear alkyl, bis[2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-) and Amines, C10-14-branched and linear alkyl, [2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]benzoato(2-)]chromate(1-)",943-133-8,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H317:2
250026,"Methyl 3-[(4S)-8-bromo-1-methyl-6-pyridin-2-yl-4H-imidazol[1,2-a][1,4]benzodiazepin-4-yl] propanoate",811-733-8,1001415-66-2,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,Notified C&L,2,H312:2;H332:2;H302:2;H317:2
250027,"4-[(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl)thio]butane-1-thiol",811-734-3,36097-07-1,Aquatic Chronic 4,Notified C&L,1,H413:1
250033,"Reaction mass of 2-{[(2-{3-[2-({[2-(methacryloyloxy)ethoxy]carbonyl}amino)propan-2-yl]phenyl}propan-2-yl)carbamoyl]oxy}propyl methacrylate and 1,3-phenylenebis(propane-2,2-diylcarbamoyloxyethane-2,1-diyl) bis(2-methylacrylate) and 1,3-phenylenebis(propane-2,2-diylcarbamoyloxypropane-2,1-diyl) bis(2-methylacrylate)",943-136-4,,Skin Sens. 1,REACH registration C&L,1,H317:1
250034,"N,N'-Bis(poly(oxyethylene))stearylamine",943-138-5,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,12,H400:6;H302:12;H315:6;H318:12;H410:6;H411:6
250035,"2-Propenoic acid, polymer with 2- propenoic acid, sodium salt and sodium 2-methyl-2-propene-1-sulfonate",811-738-5,1233879-59-8,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:1;H315:1;H314:1;Not classified:1
250041,"2-Chloro-1,3-bis(2,6-diisopropylphenyl)-1H-imidazolium Chloride",811-743-2,1228185-09-8,,Notified C&L,2,H320:1;H335:1;H315:2;H319:1
250042,"2-[(Tetrahydro-2-furanyl)methyl]-propanedioic acid, 1,3-dimethyl ester",811-744-8,1134802-45-1,Not Classified,REACH registration C&L,2,Not classified:2
250045,1-(5-(Aminomethyl)-2-nitrophenyl)ethanone hydrochloride,943-140-6,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250046,"1-(1-Naphthalenyl)-3-(tetrahydro-2-furanyl)-propanoic acid, sodium salt (1:2)",811-747-4,130209-69-7,Not Classified,REACH registration C&L,2,Not classified:2
250049,"5-bromo-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione",811-750-0,830346-48-0,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
250052,"4‘-Ethoxy-3,2‘,3‘-trifluoro-4-pentyloxy-biphenyl-2-ol",943-142-7,,Not Classified,REACH registration C&L,2,Not classified:2
250053,2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanenitrile,811-752-1,169032-19-3,Aquatic Chronic 3,REACH registration C&L,2,H412:2
250054,"Reaction mass of diphosphorus pentasulphide and lithium sulphide, anhydrous",943-143-2,,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H301:1;H315:1
250056,5-Chloro-2-(methylsulfonamido)benzoic acid,811-754-2,89979-12-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250057,4-[4-tert-butylsulfanyl-3-(trifluoromethyl)phenyl]-1-methyl-pyrazole,811-755-8,1434818-00-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250058,"Di-tert-butyl(2',4',6'-triisopropyl-3,6-dimethoxy-[1,1'-biphenyl]-2-yl)phosphine",811-756-3,1160861-53-9,,Notified C&L,4,H319:4;H335:3;H315:4
250059,"Reaction mass of Amines, C10-14-branched and linear alkyl, [2,4-dihydro-4-[(2-hydroxy- 4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)][2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-); Amines, C10-14-branched and linearalkyl, bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-) (1:1) and Amines, C10-14-branchedand linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)] chromate(1-)",943-144-8,,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,85,H400:85;H302:85;H410:85
250060,"Reaction mass of Amines, C10-14-branched and linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-) (1:1) and Amines, C10-14-branched and linear alkyl, bis[2,4-dihydro-4-[(2-hydroxy-4-nitrophenyl)azo]-5-methyl-2-phenyl-3H-pyrazol-3-onato(2-)]chromate(1-)",943-145-3,,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,85,H412:85;H317:85
250064,"1,3-(Bis-(2-chloroethyl)urea",811-761-0,2214-72-4,Acute Tox. 3;Muta. 2;Carc. 2;Repr. 2,Notified C&L,2,H341:2;H361:2;H351:2;H301:2
250065,Pyrifluquinazon Metabolite B,811-762-6,337457-78-0,Acute Tox. 4;Acute Tox. 4;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H302:1;H332:1;H373:1;H410:1
250066,(RS)-{O-Ethyl S-propyl (E)-[2-(cyanoimino)-3-ethylimidazolidin-1-yl]phosphonothioate},811-763-1,140163-89-9,Acute Tox. 3;Acute Tox. 4,Notified C&L,17,H332:16;H301:17;H331:1;H400:1
250067,Synthetic Paraffinic Kerosine derived from a feedstock of alcohol,943-146-9,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H315:1;H304:1;H226:1;H332:1
250070,4-(trifluoromethyl)-2(3H)-thiazolone,811-764-7,1153291-65-6,Acute Tox. 3,Notified C&L,1,H301:1
250071,"Sucrose, glycerol and propane-1,2-diol, reaction products with C16-18(even numbered) fatty acids",943-149-5,,Not Classified,REACH registration C&L,1,Not classified:1
250072,Lead-Iron-Titanium-Bismuth-Potassium Oxide,943-147-4,,Acute Tox. 4;Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,Notified C&L,1,H360:1;H302:1;H332:1;H373:1;H410:1
250090,sodium [2-(sulfanyl-kS)-1H-benzimidazole-6-sulfonato(2-)]argentate(1-),811-765-2,1639466-17-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250091,6-Aminopyridine-2-sulfonamide,811-766-8,75903-58-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250092,"Reaction mass of acetic acid and water and 5-(diisopropylamino)-2-[[4-(dimethylamino)phenyl]azo]-3-methyl-1,3,4-thiadiazolium acetate",943-150-0,,Skin Corr. 1A;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
250093,"Reaction mass of acetic acid and 2-[2-[4-(diethylamino)phenyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate",943-151-6,,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H302:1;H314:1;H226:1;H410:1
250094,"Benzene, C20-22 (even numbered) alkyl derivs.",943-152-1,,Asp. Tox. 1,REACH registration C&L,1,H304:1
250097,3-(3-(4-(Pyridin-2-yloxymethyl)--benzyl)-isoxazol-5-yl)-pyridin-2-ylamine,811-768-9,936339-60-5,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,90,H302:90;H411:90
250099,"[2-(2-aminophenyl)phenyl]palladio methanesulfonate; di-tert-butyl({2-[2,4,6-tris(propan-2-yl)phenyl]phenyl})phosphane",811-771-5,1447963-75-8,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H412:1
250100,"Reaction products of triglycerides, C18 (unsaturated) alkyl with 2-(2-aminoethylamino)ethanol and sodium chloroacetate",943-154-2,,Eye Dam. 1,REACH registration C&L,1,H318:1
250102,4-Azaphthalide,811-772-0,5657-51-2,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2,H319:2;H302:2
250103,Ethyl (E)-4-methylpent-2-enoate,811-774-1,15790-86-0,Flam. Liq. 3,REACH registration C&L,2,H226:2
250104,"Oxirane, methyl-, polymer with oxirane, 2-aminopropyl methylether",943-156-3,,Skin Corr. 1B;Eye Dam. 1,Notified C&L,83,H318:83;H314:83
250105,1-(4-TETRAHYDROPYRANYL)-1H-PYRAZOLE-4-BORONIC ACID PINACOL ESTER,811-775-7,1040377-03-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H302:1;H315:2
250106,1-Allylisatin,811-776-2,830-74-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250107,2-chloro-3-nitropyridin-4-amine,811-777-8,2789-25-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H302:2;H312:1;H332:1;H335:2
250108,9-Aminoanthracene,811-778-3,779-03-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250109,"[1-[(3,5-Dimethyl-1H-pyrrol-2-yl)(3,5-dimethyl-2H-pyrrol-2-ylidene)methyl]-4-iodobenzene](difluoroborane)",811-779-9,250734-47-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250110,5-Diethylamino-1-pentanol,811-780-4,2683-57-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250111,4-Cyano-4''-propyl-p-terphenyl,811-782-5,54296-25-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1
250112,Cesium(I) Bis(trifluoromethanesulfonyl)imide,811-783-0,91742-16-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
250113,4-Chloro-5-methoxy-3(2H)-pyridazinone,811-784-6,63910-43-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250114,Butylamine Hydrobromide,811-785-1,15567-09-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250115,Benzylamine Hydrobromide,811-786-7,37488-40-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250116,9-(4-Biphenylyl)carbazole,811-787-2,6299-16-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250117,3-Bromo-9-(p-tolyl)-9H-carbazole,811-788-8,731016-44-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250118,"2-(4-Bromophenyl)-4,6-diphenyl-1,3,5-triazine",811-789-3,23449-08-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
250119,"4-(4-Bromophenyl)-2,6-diphenylpyrimidine",811-790-9,58536-46-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250120,"(2,2'-Bipyridine)bis[2-(2,4-difluorophenyl)pyridine]iridium(III) Hexafluorophosphate",811-791-4,864163-80-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250121,5-Bromo-2-(5-bromo-2-thienyl)pyridine,811-793-5,136902-53-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250122,4-Benzyl-2-hydroxymorpholin-3-one,811-794-0,287930-73-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250123,5-Bromo-1-methylisatin,811-795-6,2058-72-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250124,"3,9'-Bicarbazole",811-796-1,18628-07-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250125,"1-Bromo-2,4,5-trimethoxybenzene",811-797-7,20129-11-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250126,Benzyl 2-Hydroxyphenyl Ketone,811-798-2,2491-31-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250127,"3-Bromo-2,6-dimethoxytoluene",811-799-8,22794-95-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250128,"{2,8-bis[[](2-octyldodecyl)oxy]-11-(trimethylstannyl)-4,10-dithiatricyclo[[]7.3.0.0^{3,7}]dodeca-1(9),2,5,7,11-pentaen-5-yl}trimethylstannane",811-800-1,1320201-22-6,Acute Tox. 2;Acute Tox. 1;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H300:1;H400:1;H330:1;H310:1;H410:1
250129,"2,4-Bis(benzyloxy)-6-chloro-1,3,5-triazine",811-801-7,851030-18-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250130,"1,8-Bis(diphenylphosphino)naphthalene",811-802-2,153725-04-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
250131,"4-(Bromomethyl)-4'-methyl-2,2'-bipyridyl",811-803-8,81998-05-2,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
250132,"3-Amino-2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine",811-804-3,893440-50-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250133,7-(Diethylamino)-3-(2-thienyl)coumarin,811-805-9,117850-52-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;H302:1
250134,7-(Diethylamino)-3-phenyl-2H-chromen-2-one,811-806-4,84865-19-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;Not classified:1
250135,"1,1'-Dibutyl-3,3,3',3'-tetramethylindotricarbocyanine Hexafluorophosphate",811-808-5,134339-08-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H315:1;Not classified:1
250136,"2,7-Dibromo-9-hexylcarbazole",811-809-0,654676-12-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250137,"3,9-Diphenyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)carbazole",811-810-6,1359833-28-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250138,"1,3-Diaminopropane Dihydrobromide",811-811-1,18773-03-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250139,"1,3-Diaminopropane Dihydroiodide",811-812-7,120675-53-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250140,Diethyl (Ethoxymethyl)phosphonate,811-813-2,10419-80-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250141,"2,6-Diethynylpyridine",811-814-8,75867-46-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250142,"Ethyl 4,6-Dihydroxynicotinate",811-815-3,6975-44-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250143,Ethyl 2-Iodo-2-methylpropionate,811-816-9,7425-55-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250144,Ethyl 2-Iodopropionate,811-817-4,31253-08-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250145,"2,5-Furandicarbonyl Dichloride",811-819-5,10375-34-5,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
250146,5-Fluoro-3-methylindole,811-820-0,392-13-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250147,[8-(Glycidyloxy)-n-octyl]trimethoxysilane,811-821-6,1239602-38-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250148,BD140,811-822-1,1201643-08-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250149,"2,6-Di(2H-1,2,3-triazol-4-yl)pyridine",811-823-7,1542234-40-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250150,"2,2'-(2,2,3,3,4,4,5,5,6,6,7,7-Dodecafluorooctane-1,8-diyl)bis(oxirane)",811-824-2,74328-56-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250151,"Dithieno[3,2-c:2',3'-e]oxepine-4,6-dione",811-825-8,1043023-52-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250152,Methyl 4-Bromo-3-chlorobenzoate,811-826-3,117738-74-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250153,(1-methyl-1H-pyrazol-5-yl)methanol,811-827-9,84547-61-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:1
250154,Methyl 4-Aminopyridine-2-carboxylate,811-828-4,71469-93-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250155,Methyl 3-amino-5-bromo-2-methylbenzoate,811-830-5,1000342-11-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250156,2-Methoxyphenyl Trifluoromethanesulfonate,811-831-0,59099-58-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250157,Propargyl Sulfide,811-832-6,13702-09-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H315:1
250158,1-(2-Propynyl)piperazine,811-833-1,52070-67-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250159,(R)-1-(3-Pyridylthiocarbamoyl)pyrrolidine-2-carboxylic Acid,811-834-7,1443438-29-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250160,Isobutylamine Hydrobromide,811-835-2,74098-36-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250161,8-Iodoquinoline,811-836-8,1006-47-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250162,Indometacin Farnesil,811-837-3,85801-02-1,Acute Tox. 4,Notified C&L,1,H302:1
250163,[2-[(Methylthio)(2H-pyrrol-2-ylidene)methyl]-1H-pyrrole](difluoroborane),811-838-9,892505-41-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250164,Lanthanum(III) Bis(trifluoromethanesulfonyl)imide,811-839-4,168106-26-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
250165,"Methyl 2,6-Difluoro-3-nitrobenzoate",811-841-5,84832-01-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250166,4-(Propargyloxy)benzaldehyde,811-842-0,5651-86-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H315:2;H312:1;H332:1;H302:1
250167,2-Phenylethylamine Hydrobromide,811-843-6,53916-94-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250168,"[[(3,4,5-Trimethyl-1H-pyrrol-2-yl)(3,4,5-trimethyl-2H-pyrrol-2-ylidene)methyl]carbonitrile](difluoroborane)",811-844-1,157410-23-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1
250169,4-(Trifluoromethyl)benzamidine Hydrochloride,811-845-7,38980-96-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
250170,"Triethoxy[5,5,6,6,7,7,7-heptafluoro-4,4-bis(trifluoromethyl)heptyl]silane",811-846-2,130676-81-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250171,"2,3-Thiophenedicarboxylic Anhydride",811-847-8,6007-83-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250172,Tris Borate EDTA buffer,811-848-3,610769-35-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250174,Cardamom Essential Oil,943-157-9,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H317:1;H315:1;H304:1;H226:1;H411:1
250176,CUMIN ESSENTIAL OIL,943-160-5,,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H304:1;H226:1;H411:1;H317:1
250177,CARAWAY ESSENTIAL OILCAS: 8000-42-8 / 85940-31-4,943-161-0,,Flam. Liq. 3;Asp. Tox. 1;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H315:1;H304:1;H226:1;H312:1;H410:1
250178,Parsley Essential Oil,943-162-6,,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H304:1;H226:1;H410:1
250181,1-(4-(3-Aminopropyl)piperazin-1-yl)ethanone,811-850-4,141516-24-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250182,(5-Methyl-6-morpholin-4-ylpyridin-3-yl)boronic acid hydrochloride,943-165-2,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250183,"N-(biphenyl-4-yl)-N-[2-(9,9-diphenyl-9H-fluoren-4-yl)phenyl]-9,9-dimethyl-9H-fluoren-2-amine",811-852-5,1792219-00-1,Not Classified,REACH registration C&L,1,Not classified:1
250189,N-[4-(2-(2-[4-(methanesulfonamido)phenoxy]ethyl)amino)phenyl]methanesulfonamide,811-856-7,176447-94-2,Acute Tox. 4;Repr. 1B,Notified C&L,1,H360:1;H302:1
250190,"2(1H)-Quinolinone, 5-[(1R)-2-amino-1-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-8-hydroxy-, acetate (1:2)",811-857-2,1640894-09-2,Eye Dam. 1,Notified C&L,3,H318:3
250191,"pentasodium 4-amino-3-[(2,4-disulfonatophenyl)diazenyl]-5-hydroxy-6-[(4-nitro-2-sulfonatophenyl)diazenyl]naphthalene-1,7-disulfonate",811-858-8,1422649-48-6,Skin Sens. 1,REACH registration C&L,1,H317:1
250193,1-cyclohexylethyl (E)-but-2-enoate,944-449-9,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H317:1
250198,"Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-, ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1)",811-861-4,117223-63-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,33,H319:33;H315:32
250199,2-Methyl-2-(pyridin-4-yl)propan-1-amine,943-169-4,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250200,Salts of alkyl hydroxybenzoic acids,811-863-5,220795-13-1,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;Not classified:1;H317:1;H315:1
250201,"Reaction mass of C18 (unsatd.) fatty acid amides/esters of diethanolamine, C16-18 (even-numbered) fatty amine ethoxylates, castor oil ethoxylates and sulfosuccinates of C18 (unsatd.) fatty acid diethanolamide, sodium salt",943-172-0,,Skin Sens. 1,REACH registration C&L,1,H317:1
250206,"1-[3,5-bis(trifluoromethyl)phenyl]-3-[(1R,2R)-2-(dimethylamino)cyclohexyl]thiourea",811-865-6,620960-26-1,,Notified C&L,2,H319:2;H335:2;H315:2
250209,"(2S,3S)-3-Methylpyrrolidine-2-carboxylic acid",811-868-2,10512-89-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250211,(4-Hydroxyphenyl)methyl(2-methylbenzyl)sulfonium Hexafluoroantimonate,811-870-3,141651-31-2,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H332:1;H302:1;H411:1
250212,Benzyl(4-hydroxyphenyl)methylsulfonium Hexafluoroantimonate,811-871-9,125662-42-2,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H332:1;H302:1;H411:1
250216,"2-Bromo-4,5-dimethylthiazole",811-876-6,29947-24-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H332:2;H335:2
250221,"1-[1,3]Dioxolan-2-ylmethyl-1H-pyrazole-4-boronic acid, pinacol ester",811-881-3,864754-17-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250222,3-AMINO-4-IODOBENZONITRILE,811-882-9,665033-21-6,Acute Tox. 4,Notified C&L,1,H302:1
250223,4-(3-METHYLOXETAN-3-YL)BENZOIC ACID,811-883-4,1315567-78-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250224,5-Bromo-3-chloropicolinaldehyde,811-885-5,885168-04-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
250225,"5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboxamide",811-886-0,1361232-73-6,Not Classified,Notified C&L,1,Not classified:1
250228,"5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile",811-889-7,1350653-26-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
250230,"4-Bromo-4'-chloro-1,1'-biphenyl",811-890-2,23055-77-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H319:2;H400:1;H302:2;H315:2;H335:2;H410:1
250231,(2-chloro-6-fluorophenyl)boronic acid,811-891-8,313545-32-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:3;H315:4;H302:1
250232,2-Bromo-3-(bromomethyl)pyridine,811-892-3,94446-97-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:2;H302:2;H315:3;H312:2;H332:2;H335:3;H318:1
250233,"4,4'-Oxydibenzeneboronic acid",811-893-9,19014-29-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250234,2-Methoxybenzoylacetonitrile,811-894-4,35276-83-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250235,"15-(3,4-Dichlorophenyl)pentadecanoic acid",811-896-5,116409-73-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250236,1-(1-methyl-1H-pyrazol-3-yl)ethan-1-amine,811-897-0,911788-35-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,2,H312:2;H332:2;H302:2;H314:2
250237,2-Fluoro-4-formylbenzeneboronic acid,811-898-6,871126-22-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
250238,"1,4-Dihydro-6-fluoro-4-oxoquinoline-3-carboxylic acid",811-899-1,117685-48-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250239,Tetramethylsuccinic acid,811-900-5,630-51-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H315:1;H312:1;H332:1;H318:1;H335:1
250240,"(R)-3,3'-Bis(3,5-dichlorophenyl)-1,1'-binapthyl-2,2'-diyl hydrogenphosphate",811-901-0,1191451-24-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
250241,"(R)-3,3'-Bis(3,5-difluorophenyl)-1,1'-binapthyl-2,2'-diyl hydrogenphosphate",811-902-6,1191451-23-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
250242,"(R)-3,3'-Bis(4-nitrophenyl)-1,1'-binapthyl-2,2'-diyl hydrogenphosphate",811-903-1,695162-89-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
250243,"(R)-3,3'-Bis(3,5-di-tert-butylphenyl)-1,1'-binapthyl-2,2'-diyl hydrogenphosphate",811-904-7,861909-39-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
250244,(6-Aminopyridin-3-yl)acetic acid,811-905-2,39658-45-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
250245,"1,1,1,2,2,3,3-heptafluoropropane",811-906-8,2252-84-8,Press. Gas (Comp.);Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H280:2;H315:2
250246,3-Chloro-7-bromo-4-hydroxyquinoline,811-907-3,1203579-13-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250247,tert-Butyl (2R)-2-formylmorpholine-4-carboxylate,811-908-9,913642-85-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:1;H335:2;H302:1;H315:2;H318:1
250248,"1-Phenylvinylboronic acid, pinacol ester",811-909-4,143825-84-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250249,3-Bromo-2-(trifluoromethyl)benzoic acid,811-911-5,1227605-02-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250250,1-(Tetrahydro-2H-pyran-2-yl)-1H-indazole-4-carboxylic acid,811-912-0,1000576-23-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250251,2-(Pyrrolidin-3-yl)ethanol hydrochloride,811-913-6,664364-46-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
250252,4-(Phenylaminocarbonyl)benzeneboronic acid,811-914-1,330793-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250253,(Bicyclo[1.1.1]pent-1-yl)methanol,811-915-7,22287-32-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:1;H315:2;H227:1
250254,"tert-Butyl [(1R,2S)-2-(aminomethyl)cyclohexyl]carbamate",811-916-2,1259277-49-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250255,"2,6-difluoropyridin-4-amine",811-917-8,63489-58-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H319:91;H335:91;H302:91;H315:91;H312:1;H332:1
250256,4-[(tert-Butyl)sulphanyl]benzaldehyde,811-918-3,88357-16-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250257,3-(Aminomethyl)cyclobutanol hydrochloride,811-919-9,1427386-91-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250258,"3-Bromo-2,6-difluorophenol",811-920-4,221220-99-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250259,Bromo-PEG5-alcohol,811-922-5,957205-14-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250260,Borrelidin,811-923-0,7184-60-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250261,"1,3-Dichloroisoquinoline-6-carboxylic acid",811-924-6,1416712-68-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250262,6-Fluoro-5-nitro-1H-indazole,811-925-1,633327-51-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
250263,1H-Pyrrole-3-carboxaldehyde,811-926-7,7126-39-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:1;H315:3;H312:1;H332:1;H335:2
250264,Sulphosuccinimido biotin,811-927-2,194041-65-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250270,Rhamnolipids: fermentation products of glucose with Pseudomonas bacteria,943-175-7,,Eye Dam. 1,Notified C&L,1,H318:1
250272,"4,6-bis(diphenylphosphanyl)-10H-phenoxazine; {2'-amino-[1,1'-biphenyl]-2-yl}palladio methanesulfonate",811-929-3,1602922-03-1,,Notified C&L,2,H319:2;H335:2;H315:2
250273,"2-Amino-4,6-dimethoxybenzamide",811-930-9,63920-73-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
250275,"ethyl 3-[(3R)-3-{[(1S)-1-phenylethyl]amino}-2,3,4,9-tetrahydro-1H-carbazol-9-yl]propanoate",811-937-7,1638586-33-0,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H319:1;H400:1;H410:1
250290,"5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamidium chloride",811-931-4,1426309-48-9,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1
250291,"2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-[(E)-phenyldiazenyl]pyrimidine-4,6-diamine",811-933-5,1350653-29-0,Not Classified,Notified C&L,1,Not classified:1
250293,"2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidine-4,5,6-triamine",811-934-0,1350653-30-3,Not Classified,Notified C&L,1,Not classified:1
250297,(S)-5-fluoro-3-methylisobenzofuran-1(3H)-one,943-180-4,1803573-19-4,Not Classified,REACH registration C&L,2,Not classified:2
250299,3-ethyl-4-hydroxyproline methyl ester p-toluenesulfonate salt isomer mixture,943-183-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
250300,"C16-18-(even numbered, C18-unsaturated)-alkylamines acetates",817-198-7,1273322-47-6,Acute Tox. 4;Skin Corr. 1B;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H400:3;H302:3;H314:3;H373:3;H410:3
250301,3-(Benzyl(tert-butoxycarbonyl)amino)propanoic acid,811-938-2,289889-03-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250302,bromotrichlorosilane,811-939-8,13465-74-2,Skin Corr. 1B;STOT SE 3,Notified C&L,22,H335:22;H314:22
250303,Tris(iso-propylcyclopentadienyl) lutetium,811-940-3,952518-15-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H319:22;H335:22;H315:22
250305,[No public or meaningful name is available],811-941-9,686-54-4,,Notified C&L,3,H319:3;H335:3;H315:3;H226:1
250306,"Poly(oxy-1,2-ethanediyl),a-phosphono-w-(octyloxy)- (3EO)",943-185-1,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,4,H318:4;H412:4;H315:4
250307,"Decyl alcohol ethoxylated, phosphate (9EO)",943-186-7,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,4,H318:4;H315:4
250308,"C9-11 alcohol, ethoxylated,phosphated (3-20EO) (136504-88-6)",811-942-4,136504-88-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:8;H315:8
250315,[No public or meaningful name is available],811-949-2,1516887-33-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
250316,[No public or meaningful name is available],811-950-8,530112-57-3,Repr. 2,Notified C&L,1,H361:1
250317,"Ethyl 3-(3,4-bis(benzyloxy)phenyl)-2-formamido-3-hydroxypropanoate",811-951-3,173597-35-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250318,"(S)-1-hidroxy-1,1-diphenylpropan-2-amonium(2S,3R)-2-(((benzyloxy)carbonyl)amino)-3-(-(3,4-bis(benzyloxy)phenyl)-3-hydroxypropanoate",811-952-9,78603-92-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250320,"Allyl (2R,3S)-2-(3-bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylate",811-953-4,117348-70-6,Not Classified,REACH registration C&L,1,Not classified:1
250322,"Alcohols, C11-14 linear and branched, C13 rich, 5-15 EO",943-189-3,,Aquatic Chronic 3,Notified C&L,1,H412:1
250324,"3-bromo-1lambda6-thiolane-1,1-dione",811-957-6,14008-53-8,,Notified C&L,2,H301:1;H319:1;H335:1;H302:1;H315:1
250327,[No public or meaningful name is available],811-963-9,198840-68-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,9,H319:9;H315:9
250330,"2,2-dimethylcyclopropane-1-carboxylic acid",811-960-2,75885-59-5,,Notified C&L,3,H314:1;H302:2;H317:1;H315:2;H318:1;H335:2;H319:1
250337,3-ethoxyazetidine hydrochloride,811-966-5,535924-73-3,,Notified C&L,2,H319:2;H335:2;H315:2
250341,1-bromo-3-methylbutan-2-one,811-970-7,19967-55-6,Flam. Liq. 3,Notified C&L,7,H226:7;H319:1;H335:1;H315:1
250344,(5-methylthiophen-2-yl)methanol,811-973-3,63826-59-5,,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
250345,"2,6-dichloro-9-methyl-9H-purine",811-974-9,2382-10-7,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H412:1
250360,"2,5-Furandione, polymer with ethenylbenzene, 2-methoxy-1-methylethyl",811-979-6,156475-83-1,Skin Sens. 1;Eye Irrit. 2,Notified C&L,57,H319:57;H317:57
250362,"Tricyclodecanedimethanol, polymer with 1,6-diisocyanatohexane, 2-hydroxyethyl methacrylate-blocked",811-980-1,1660137-54-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,57,H319:57;H315:57
250372,Polymethylenepolyphenylene isocyanate polymer with dehydrated castor oil and propoxylated glycerol,943-205-9,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H317:8;H315:8;H351:8;H334:8;H332:8;H373:8;H335:8
250374,"1,3-Butanediol, polymer with MDI, 4,4’MDI homopolymer, tripropylene glycol, 1,2-propanediol and hydroxylated polybutadiene",943-208-5,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H317:8;H315:8;H351:8;H334:8;H332:8;H373:8;H335:8
250375,4-Bromo-1H-pyrazole-5-carbaldehyde,811-983-8,1007346-33-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250377,"Reaction product of disodium 4,4'-dinitrostilbene-2,2'-disulphonate, p-[(4-amino-2,5-xylyl)azo]benzenesulphonic acid, 3-[(4-amino-2-methoxyphenyl)azo]-4-hydroxybenzenesulphonic acid, copper (II) sulfate",943-210-6,,Aquatic Chronic 3,REACH registration C&L,3,H412:3
250386,POPPY HYDROALCOHOLIC EXTRACT,943-216-9,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1
250395,1-Methyl-5-((methylamino)methyl)-1H-pyrazole-3-carbonitrile hydrochloride,943-223-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250396,[No public or meaningful name is available],811-988-5,,Aquatic Chronic 3,Notified C&L,1,H412:1
250397,Hydromagnesite,,12072-90-1,Not Classified,Notified C&L,1,Not classified:1
250399,[No public or meaningful name is available],811-991-1,210920-40-4,Skin Sens. 1,Notified C&L,2,H317:2;H319:1;H315:1;H411:1;H373:1
250403,"Formaldehyde, polymer with 2-methylbenzenamine, sulfate",811-995-3,1879947-32-6,Eye Dam. 1,Notified C&L,13,H318:13
250406,2-chloro-6-hydrazinylpyrazine,811-999-5,63286-29-3,,Notified C&L,2,H318:1;H335:2;H302:2;H315:2;H319:1;H312:1;H332:1
250408,3-amino-2-(4-fluorophenyl)propanoic acid hydrochloride,812-001-0,1455095-34-7,,Notified C&L,2,H319:2;H335:2;H315:2
250411,6-chloro-1-benzothiophene-2-carboxylic acid,812-004-7,26018-73-5,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H312:1;H332:1
250414,1-hydroxycyclobutane-1-carboxylic acid,812-007-3,41248-13-9,,Notified C&L,2,H319:1;H335:1;H315:1;H314:1
250416,"(R)-(+)-2-(BOC-Amino)-1,4-butanediol",812-009-4,397246-14-9,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
250422,"(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3,3-dimethylbutanoic acid",812-016-2,132684-60-7,Not Classified,Notified C&L,3,Not classified:1;H335:2;H315:2;H319:1;H302:1
250427,"5-chloropyrazolo[1,5-a]pyrimidine",812-022-5,29274-24-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:3;H315:3;H312:2;H332:2;H335:3
250429,"(3R)-N-[(1S)-phenylethyl]-2,3,4,9-tetrahydro-1H-carbazol-3-amine hydrochloride",812-024-6,1638534-24-3,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1,H318:1;H411:1
250430,Reaction Mass of Dialuminium Titanium Pentoxide and Strontium Calcium Aluminosilicate,943-224-2,,Not Classified,Notified C&L,1,Not classified:1
250431,2-(Methylsulfonyl)-5-(trifluoromethyl)aniline,812-025-1,402-19-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250432,tert-Butyl piperidine-3-carboxylate,812-026-7,301180-05-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
250433,16-HIDROXY PREDNISOLONE ACETATE,812-027-2,86401-80-1,Repr. 2,Notified C&L,1,H361:1
250437,"4''-Butoxy-4-ethyl-2',2'',3''-trifluoro-[1,1':4',1'']-terphenyl",812-028-8,612543-60-9,Not Classified,REACH registration C&L,1,Not classified:1
250438,4-Ethyl-2’-fluoro-4’-bromobiphenyl,812-029-3,116713-40-7,Not Classified,REACH registration C&L,2,Not classified:2
250448,(2-fluorobenzyl)hydrazine,812-035-6,51859-98-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,REACH registration C&L,4,H331:4;H319:4;H315:4;H301:4;H311:4
250450,"Reaction products of diazotized 4-amino-6-[(4-aminophenyl)diazenyl]-3-[(4-aminophenyl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid, coupled with benzene-1,3-diamine, sodium salts",812-037-7,1793011-72-9,Not Classified,REACH registration C&L,1,Not classified:1
250451,"N,N,N-tributylbutan-1-aminium ({[(2S,5R)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]oct-6-yl]oxy}sulfonyl)oxidanide",812-038-2,1192651-80-1,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H302:1
250453,"1H,1H-Perfluorotetradecan-1-ol",812-039-8,15622-57-8,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H314:1;H412:1;H301:1;H312:1;H332:1
250454,Fumonisin B3,812-040-3,136379-59-4,Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 2,Notified C&L,1,H319:1;H300:1;H315:1;H351:1;H330:1;H335:1;H310:1
250460,"Isocyanic acid, polymethylenepolyphenylene ester, polymer with 1,4-butanediol and 2-oxepanone",943-234-7,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H317:8;H315:8;H351:8;H334:8;H332:8;H373:8;H335:8
250461,"1,3-Butadiene, homopolymer, hydroxy-terminated, polymer with 1,1'-methylenebis[isocyanatobenzene]",943-235-2,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H317:8;H315:8;H351:8;H334:8;H332:8;H373:8;H335:8
250462,Ethyl methanephosphinate,812-047-1,16391-07-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2;H226:1;H412:1;H312:1;H332:1
250470,"Reaction mass of Cyclohexanol, 2-methylene-5-(1-methylethenyl)-, (1S,5R)- and (1S-trans)-2-methyl-5-(1-methylvinyl)cyclohex-2-en-1-ol and Cyclohexanol, 2-methylene-5-(1-methylethenyl)-, (1R,5R)- and (1R-cis)-2-methyl-5-(1-methylvinyl)cyclohex-2-en-1-ol",943-238-9,,Not Classified,REACH registration C&L,1,Not classified:1
250472,"6-chloro-3-methyl-[1,2,4]triazolo[4,3-b]pyridazine",812-052-9,7197-01-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H302:3;H315:3
250473,1-tert-Butylimidazole,812-053-4,45676-04-8,,Notified C&L,2,H318:1;H335:1;H302:1;H315:2;H319:1
250474,"4-(2-chlorophenyl)-9,9-diphenyl-9H-fluorene",812-055-5,713127-22-1,Not Classified,REACH registration C&L,1,Not classified:1
250477,"5-Amino-1,3-benzoxazol-2(3H)-one",812-058-1,14733-77-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
250478,3-(Dimethylcarbamoyl)-5-fluorobenzeneboronic acid,812-059-7,874219-39-3,,Notified C&L,2,H319:2;H335:2;H315:2
250479,"5-(2-methylpropyl)-1,3,4-thiadiazol-2-amine",812-060-2,52057-89-3,,Notified C&L,2,H332:1;H302:2;H319:1;H335:1;H315:1
250484,"(E)-4,4'-(ethene-1,2-diyl)bis(2-methoxyphenol)",943-241-5,,Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H315:1
250492,"Reaction products from the esterification of neopentylglycol with fatty acids, C16-18 (even numbered) and C18-unsatd. and fatty acids, C18-unsaturated, dimers",943-242-0,,Not Classified,REACH registration C&L,1,Not classified:1
250494,"1H-pyrrolo[3,2-b]pyridine-5-carboxylic acid",812-073-3,872355-64-1,,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
250495,2-(2-bromoethyl)pyridine hydrobromide,812-074-9,72996-65-7,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
250497,"Reaction product of Campholenaldehyde and Propionaldehyde, hydrogenated",943-243-6,,Aquatic Chronic 3,REACH registration C&L,3,H412:3
250504,(2S)-3-(4-hydroxyphenyl)-2-[(methoxycarbonyl)amino]propanoic acid,812-079-6,338386-45-1,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H302:1;H315:1
250509,"DNA, d(3'-amino-3'-deoxy-P-thio)(T-A-G-G-G-T-T-A-G-A-C-A-A), 5'-[O-[2-hydroxy-3-[(1-oxohexadecyl)amino]propyl] hydro-gen phosphorothioate], sodium salt (1:13)",812-080-1,1007380-31-5,Repr. 2,Notified C&L,1,H361:1
250510,[No public or meaningful name is available],812-081-7,65072-03-9,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 4,Notified C&L,13,H304:13;H226:13;H413:13
250514,[2-hydroxy-4-(trifluoromethyl)phenyl]boronic acid,812-084-3,1072951-50-8,,Notified C&L,2,H319:2;H335:2;H315:2
250515,4-amino-2-bromobenzonitrile,812-085-9,53312-82-6,,Notified C&L,2,H312:2;H332:2;H302:2;H317:1;H319:1;H315:1;H335:1
250517,"2-(2-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",812-088-5,876062-39-4,,Notified C&L,2,H319:2;H335:2;H315:2
250518,(6-Bromopyridin-3-yl)methanamine,812-089-0,120740-10-5,,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
250530,"5-(tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-indol-2-one",812-101-4,837392-64-0,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
250533,hept-6-yn-1-ol,812-105-6,63478-76-2,,Notified C&L,2,H226:1;H319:1;H335:1;H227:1;H315:1
250540,"Hexanedioic acid, polymer with 1,2-ethanediol and 1,2-propanediol, benzene, 1,3-diisocyanatomethyl-, 2-propenoic acid, 2-hydroxyethyl ester and ethanol, 2,2'-oxybis-",943-256-7,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250542,"Reaction products of Propylidynetrimethanol, ethoxylated, esters with acrylic acid and 3-aminopropyldimethylamine",943-258-8,,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
250543,"2-hydroxyethylacrylate, polypropyleneglycol monoacrylate, polymers with hexamethylene 1,6-diisocyanate,homopolymer",943-259-3,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
250544,"Carbonic acid, dimethyl ester, polymer with 1,6-hexanediol, polymer with Isophorone diisocyanate and 2-hydroxyethyl acrylate",943-260-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250549,acetylxylan esterase,812-111-9,188959-24-2,Resp. Sens. 1,REACH registration C&L,4,H334:4
250550,"Reaction mass of 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate (1:1)",943-265-6,,Eye Irrit. 2A;STOT SE 3;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,3,H360:3;H319:3;H373:3;H335:3;H410:3
250551,"(2-(4-(2-Hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4 (3H)-one)",812-112-4,1044870-39-4,STOT SE 2,Notified C&L,91,H371:91
250552,2-[4-(diphenylmethyl)piperazin-1-yl]ethanol,812-114-5,10527-64-7,Acute Tox. 3,REACH registration C&L,3,H301:3;H315:1;H304:1;H225:1;H373:1;H361:1;H336:1
250555,"Alcohols C9-11-iso-, C10-rich, ethxylated 5-15 EO",943-268-2,,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H318:1;H302:1
250556,Direct Orange 102,943-269-8,,Not Classified,REACH registration C&L,3,Not classified:3
250559,N-XantPhos,812-116-6,261733-18-0,,Notified C&L,2,H319:2;H335:2;H315:2
250566,"1-Iodo-3,5-bis(methylsulfonyl)benzene",812-120-8,849035-96-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250567,2-[4-(cyclopropylcarbonyl)phenyl]-2-methylpropanenitrile,812-121-3,169280-06-2,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H302:2
250569,1H-indol-3-ylmethanamine,812-123-4,22259-53-6,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,3,H318:2;H335:2;H302:2;H315:2;H314:1
250576,6-chloro-3-(trifluoromethyl)pyridine-2-carbonitrile,812-131-8,401590-41-8,,Notified C&L,2,H331:1;H319:2;H315:2;H301:1;H335:2;H311:1;H302:1;H312:1;H332:1
250584,"6-O-[(9Z,12Z)-octadeca-9,12-dienoyl]-a-D-glucopyranose",943-274-5,,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1
250586,"Fatty acids, C18-unsatd., dimers, polymers with ethylenediamine and polyethylene glycol",812-136-5,68552-04-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250587,"(1R,4S)-6-tert-butoxy-4-(tert-butyldimethylsilyloxy)-6-oxo-1-(2-(thiophen-2-yl)acetamido)hexylboronic acid, (+)-pinanediol ester",812-137-0,1681053-97-3,Aquatic Chronic 4,REACH registration C&L,1,H413:1
250588,"2,6-Dichloro-4-(methylsulfonyl)phenol",812-138-6,20951-05-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250589,"8-Bromo-5-chloro-1,6-naphthyridine",812-139-1,909649-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250590,"(2S,3R,4S,5S,6R)-2-(4-CHLORO-3-(4-(((S)-TETRAHYDROFURAN-3-YL)OXY)BENZYL)PHENYL)-6-(HYDROXYMETHYL)-2-METHOXYTETRAHYDRO-2H-PYRAN-3,4,5-TRIOL",812-140-7,915095-96-4,Acute Tox. 4,Notified C&L,1,H302:1
250591,"8-Bromo-1,6-naphthyridin-5(6H)-one",812-141-2,155057-97-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250593,Epoxy Diacrylate Oligomer,943-277-1,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H319:1;H317:1;H315:1;H412:1;H335:1
250594,Urethane Diacrylate Oligomer,943-278-7,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
250595,"(E)-2-(2-((4-(2,2-dichlorovinyl)phenoxy)methylphenyl)-2-methoxyimino-N-methylacetamide",812-142-8,1159341-93-1,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H400:1;H410:1
250596,methyl {2-chloro-5-[[](1E)-1-(6-methyl-2-pyridylmethoxyimino)ethyl]benzyl}carbamate,812-143-3,799247-52-2,Acute Tox. 4;STOT SE 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,90,H400:90;H370:90;H332:90;H373:90;H410:90
250598,methyl 2-(4-hydroxybenzoyl)benzoate,812-145-4,21147-23-9,Eye Irrit. 2,Notified C&L,2,H319:1;H302:1;H317:1
250599,"(5S,8S)-8-(((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro[4.5]dec-1-en-2-ol",812-147-5,552292-08-7,Repr. 2,Notified C&L,2,H361:2
250600,[No public or meaningful name is available],812-148-0,1214741-14-6,Eye Irrit. 2,Notified C&L,1,H319:1
250603,"Reaction mass of bis(2-methylpropyl) (1R,2R,3R,6S)-3,6-dimethylcyclohexane-1,2-dicarboxylate and bis(2-methylpropyl) (1S,2S,3R,6S)-3,6-dimethylcyclohexane-1,2-dicarboxylate",943-279-2,,Aquatic Chronic 2,Notified C&L,1,H411:1
250605,"1-Pyrrolidinecarboxylic acid, 2-[[[(3-chloro-2-pyrazinyl)methyl]amino]carbonyl]-, phenylmethyl ester, (2S)-",812-149-6,1418307-17-1,Not Classified,Notified C&L,2,Not classified:1;H412:1
250610,methyl dithiocarbazinate,812-150-1,5397-03-5,,Notified C&L,3,H319:2;H300:1;H310:1;H330:1;H335:1;H315:1
250611,Polyamine Adduct,943-281-3,,Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;STOT SE 3;Repr. 2;STOT RE 1,Notified C&L,1,H372:1;H314:1;H317:1;H361:1;H334:1;H318:1;H335:1
250614,"Ethyl 2-(chloromethyl)-1,3-thiazole-4-carboxylate",812-152-2,842130-48-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H302:1;H315:2;H312:1;H332:1;H335:2;H318:1
250615,4-Chloro-6-(isopropylamino)pyrimidine,812-153-8,945896-32-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250616,"1-Bromo-6-chloroimidazo[1,5-a]pyrazine",812-154-3,1214875-29-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H317:1;H315:1
250617,"8-Benzyl-1,3,8-triaza-spiro[4.5]decan-4-one",812-155-9,170921-48-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250618,Ethyl 6-bromo-4-chloroquinazoline-2-carboxylate,812-156-4,1159976-38-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250620,4-(Benzyloxy)-3-nitrobenzaldehyde,812-159-0,22955-07-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250621,"2,6-Difluoro-3-hydroxybenzeneboronic acid",812-160-6,957065-86-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250622,"4-Bromo-3-fluorobenzene-1,2-diamine",812-161-1,886762-86-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
250623,"Methyl 8-oxo-1,4-dioxaspiro[4.5]decane-7-carboxylate",812-162-7,52506-21-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
250624,3-Phenylpyrrolidine,812-163-2,936-44-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
250625,3-Cyanophenylhydrazine Hydrochloride,812-164-8,2881-99-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
250626,Iridium(III) chloride trihydrate,812-165-3,13569-57-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
250627,1-(2-Methoxypyridin-3-yl)ethanol,812-166-9,112197-02-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250628,2-Methyl-1H-indole-5-carboxylic acid,812-167-4,496946-80-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250629,Ethyl 3-bromo-4-fluorobenzoate,812-169-5,23233-33-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250630,trans-4-(Dimethylamino)cyclohexanol,812-170-0,103023-51-4,STOT SE 3,Notified C&L,2,H318:1;H335:2;H315:2;H319:1
250631,PX-866,812-171-6,502632-66-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:1
250632,tert-Butyl 3-(iodomethyl)azetidine-1-carboxylate,812-172-1,253176-94-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H315:2;H318:1
250633,4-Pyrazin-2-ylbenzoic acid,812-173-7,216060-23-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250634,"2,3,4-Tri-O-isobutyryl-1-O-trichloroacetimidoyl-alpha-D-glucopyranuronic acid methyl ester",812-174-2,150607-96-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250635,"2-Azidoethyl 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranoside",812-175-8,140428-81-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250636,Methyl 3-amino-2-bromo-5-fluorobenzoate,812-176-3,1342063-52-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250637,t-Boc-N-amido-PEG3-acid,812-177-9,1347750-75-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250638,"3,5-Diamino-6-chloro-N-(N-{4-[4-(2,3-dihydroxypropoxy)phenyl]butyl}carbamimidoyl)pyrazine-2-carboxamide methanesulfonate",812-178-4,587879-54-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250639,Biotin-PEG12-Acid,812-180-5,1621423-14-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250640,3-Aminotetrahydrofuran hydrochloride,812-181-0,204512-94-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H335:2;H302:1;H315:2
250641,2-Cyclopropylbenzeneboronic acid,812-182-6,1373393-41-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250642,Pyrrolidin-3-one hydrochloride,812-183-1,3760-52-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,2,H319:2;H302:2;H315:2;H412:1;H335:2
250643,3-(Naphth-2-yl)quinoxaline-5-carboxylic acid,812-184-7,688801-18-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250644,"4,6-Dichloro-1H-pyrrolo[3,2-c]pyridine",812-185-2,67139-79-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H335:3;H302:3;H315:3
250645,Pyrrolidin-3-one,812-186-8,96-42-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250646,8-Bromo-3-chloroisoquinoline,812-187-3,1029720-63-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250647,"(1R,2S)-2-(tert-Butoxycarbonylamino)cyclopentanecarboxylic acid",812-188-9,130981-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250648,"(1S,2R)-2-(tert-Butoxycarbonylamino)cyclopentanecarboxylic acid",812-189-4,137170-89-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250649,(4-Formyl-1-naphthalene)boronic acid,812-191-5,332398-52-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250650,2-(Benzyloxy)ethanamine,812-192-0,38336-04-8,Skin Corr. 1B,Notified C&L,3,H314:3;H318:1
250651,2-Isobutylpyrrolidine hydrochloride,812-193-6,1184994-37-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250652,Ethyl (E)-3-ethoxy-2-methylacrylate,812-194-1,1085699-23-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250653,3-(Chloromethyl)benzeneboronic acid,812-195-7,957035-15-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250654,4-(Propan-2-yl)-1H-pyrazol-3-amine,812-196-2,151521-49-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:2;H302:2;H315:1;H332:2;H335:2;H314:1
250655,4-Bromo-3-fluoro-2-hydroxybenzaldehyde,812-197-8,1427373-29-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250656,4-Iodo-5-methyl-1H-imidazole,812-198-3,15813-07-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250657,6-Bromo-4-(trifluoromethyl)-1H-benzimidazole,812-199-9,914637-51-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250658,"Imidazo[1,2-a]pyridin-6-amine",812-200-2,235106-53-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H335:2;H302:3;H315:2
250659,"2-(3,4-difluoro-2-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",812-201-8,1025707-97-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
250660,Ethyl (2R)-2-fluoropropanoate,812-202-3,72959-94-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
250661,2-Phenylmorpholine hydrochloride,812-203-9,23972-42-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
250662,3-Bromo-4-azaindole,812-204-4,23688-47-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:3;H315:3;H312:1;H332:1;H335:3
250663,Methyl 4-chloro-6-(trifluoromethyl)nicotinate,812-206-5,1211539-36-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250664,"Hexakis(1H,1H,5H-perfluoropentoxy)phosphazene",812-207-0,16059-16-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250665,5-Fluoro-1H-indazole-6-boronic acid,812-208-6,1253911-22-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250666,Reaction mass of trimethyl(octadecyloxy)silane and octadecanol,943-282-9,,Not Classified,REACH registration C&L,2,Not classified:2
250671,"4-(4-cyclopropyl-1-naphthyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione",943-285-5,1533519-84-4,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1
250678,"Reaction mass of disodium 3-[(5-chloro-2-phenoxyphenyl)azo]-4-hydroxy-5-[[(p-tolyl)sulphonyl]amino]naphthalene-2,7-disulphonate and 3-[(5-chloro-2-phenoxyphenyl)azo]-4-hydroxy-5-[[(ptolyl)sulphonyl]amino]naphthalene-2,7-disulphonic acid",943-290-2,,Not Classified,REACH registration C&L,2,Not classified:2
250680,2-(4-ethyl-3-iodophenyl)-2-methylpropanoic acid,812-218-0,1256584-73-2,Not Classified,Notified C&L,2,Not classified:2
250682,"Reaction mass of mono(4-(((E)-((E)-4-((4-(4-ethoxyphenylamino)phenyl)(4-(ethyl(4-sulfonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dienylidene)(ethyl)ammonio)methyl)benzenesulfonate)sodium salt and hydrogen [4-[4-(p-ethoxyanilino)-4'-[ethyl(m-sulphonatobenzyl)amino]benzhydrylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(m-sulphonatobenzyl)ammonium, monosodium salt",943-287-6,,Not Classified,REACH registration C&L,5,Not classified:5
250687,"1-(4-tert-butylphenyl)-3-(4-methoxyphenyl)propane-1,3-diol",943-286-0,955359-35-0,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1
250689,"Reaction mass of tetrasodium [μ-[[4,4'-[(3,3'-dihydroxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxynaphthalene-2,7-disulphonato]](8-)]]dicuprate(4-) and hydrogen [[4,4'-[(3,3'-dihydroxy[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[3-hydroxynaphthalene-2,7-disulphonato]](8-)]]dicuprate(4-)",943-289-7,,Not Classified,REACH registration C&L,3,Not classified:3
250691,"Condensation products of 4-dodecylphenol and formaldehyde, acetic derivs., reaction products with calcium hydroxide (PROPOSED)",943-288-1,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H315:1
250693,"Homopolymer of 4,4'-methylenedicyclohexyl diisocyanate",943-291-8,,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
250695,4-Chloro-2-(methylsulfonyl)benzoic acid,812-221-7,142994-03-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250696,"2-(1,3-dioxoisoindolin-2-yl)ethane-1-sulfonamide",812-222-2,4443-23-6,Not Classified,REACH registration C&L,2,Not classified:2
250697,5'-Fluoro-2'-iodoacetophenone,812-223-8,914225-70-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
250698,"Poly(oxy-1,2-ethanediyl), .alpha.-(1-oxo-2- propenyl)-.omega.-methoxy- reaction products with N,N-Diethyl-1,3-propanediamine",943-293-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
250699,"D-Glucitol, 1,4:3,6-dianhydro-, 2,5-bis(2-methyl-2-propenoate)",812-224-3,108646-62-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
250700,L-Citrulline DL-Malate,812-225-9,54940-97-5,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
250706,"di-tert-butyl[3,6-dimethoxy-2',4',6'-tris(propan-2-yl)-[1,1'-biphenyl]-2-yl]phosphane; {2'-amino-[1,1'-biphenyl]-2-yl}palladio methanesulfonate",812-231-1,1536473-72-9,,Notified C&L,2,H319:2;H335:2;H315:2
250708,"calcium 2-((3-fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl)carbamoyl)cyclopent-1-ene-1-carboxylate",812-232-7,1354012-90-0,Acute Tox. 4;Repr. 1A;Aquatic Chronic 4,Notified C&L,1,H413:1;H360:1;H302:1
250709,1-(7-Amino-5-bromoindolin-1-yl)ethanone,812-233-2,133433-62-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250710,"(T-4)-Bis[N,N'-1,2-ethanediylidenebis[2-methyl-2-propanamine]]cobalt",812-234-8,177099-51-3,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 1,Notified C&L,24,H341:23;H319:23;H317:23;H315:23;H351:23;H301:23;H334:23;H410:23;H228:1
250711,"Propanenitrile, 3-[bis[3-(dimethylamino)propyl]amino]-",812-235-3,64971-37-5,Acute Tox. 4;Acute Tox. 2;Skin Corr. 1B;Aquatic Chronic 2,Notified C&L,22,H302:22;H314:22;H310:22;H411:22
250716,"2'-Deoxy-2',2'-difluro-d-cytidine-5'-o-[phenyl(benzoxy-l-alaninyl)] phosphate (S-isomer)",812-237-4,1562406-27-2,Muta. 2;Repr. 2,Notified C&L,1,H341:1;H361:1
250718,"hexasodium 5-({4-chloro-6-[{2-[(4-{[4-chloro-6-({8-hydroxy-3,6-disulfonato-7-[(4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]-1-naphthyl}amino)-1,3,5-triazin-2-yl]amino}phenyl)sulfonyl]ethyl}(2-hydroxyethyl)amino]-1,3,5-triazin-2-yl}amino)-4-hydroxy-3-[(4-{[2-(sulfonatooxy)ethyl]sulfonyl}phenyl)diazenyl]naphthalene-2,7-disulfonate",943-299-1,,Not Classified,Notified C&L,1,Not classified:1
250721,"Alcohols, C9-11-branched, ethoxylated",943-302-6,,Acute Tox. 4;Eye Dam. 1,Notified C&L,83,H318:83;H302:83
250722,2-(Methylsulfonyl)-1-pyridin-3-ylethanone,812-239-5,27302-94-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250723,1-(4-Chlorophenyl)-2-(methylsulfonyl)ethanone,812-240-0,24437-48-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250724,Reaction products of diphenyl ether and 9-methylene nonadecane,943-303-1,,Not Classified,REACH registration C&L,2,Not classified:2
250725,"Enzymatic hydrolysis products of Ophiopogon japonicus, Liliaceae, root",812-241-6,,Not Classified,REACH registration C&L,3,Not classified:3
250726,"2-hydroxyethyl [(1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyl] carbonate",701-039-2,156324-78-6,Eye Irrit. 2,REACH registration C&L,4,H319:4
250729,Mixed Hexenes T-149OH,943-306-8,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 1B;Carc. 1A;Repr. 2;STOT RE 2,Notified C&L,1,H319:1;H315:1;H304:1;H225:1;H340:1;H350:1;H373:1;H361:1;H335:1
250730,Fullerenes C60/C70,943-307-3,131159-39-2,Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1
250731,"tetrahydro-2H-1,4-oxazine polymer with 3-methyl-1,5-pentanediyl diacrylate and N'-(3-aminopropyl)-N,N-dimethylpropane-1,3-diamine",943-308-9,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H317:1;H315:1
250733,1-chloro-3-iodo-5-(trifluoromethyl)benzene,812-243-7,1189352-83-7,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2,H318:2;H315:2
250734,"2,3,3,4,4-pentafluoro-2,5-bis(1,1,1,2,3,3,3-heptafluoropropan-2-yl)-5-methoxytetrahydrofuran",812-244-2,957209-18-6,Not Classified,Notified C&L,2,Not classified:2
250736,Cyclopropylacetic acid,812-246-3,5239-87-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H302:1;H315:1
250737,6-Cyclopropylnicotinic acid,812-247-9,75893-75-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
250738,"(4AS,7AS)-TERT-BUTYL OCTAHYDRO-1H-PYRROLO[3,4-B]PYRIDINE-1-CARBOXYLATE",812-248-4,181141-40-2,Acute Tox. 4;Skin Sens. 1B,Notified C&L,1,H302:1;H317:1
250739,5-Chloro-3-fluoropyridine-2-carbaldehyde,812-250-5,214055-11-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250740,4-Trifluoromethyl-thiazole-2-carbaldehyde,812-251-0,354587-75-0,Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:1
250741,"4H,5H,6H-pyrrolo[1,2-b]pyrazole-2-carboxylic acid",812-252-6,796729-03-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
250742,"Pyrazolo[1,5-a]pyridine-2-carbaldehyde",812-253-1,885275-10-5,Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:1
250743,1-METHYL-1H-INDAZOLE-6-CARBOXYLIC ACID,812-254-7,1031417-77-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250744,2-METHYL-2H-INDAZOLE-5-CARBOXYLIC ACID,812-255-2,1197943-94-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
250745,(2S)-2-(3-BROMOPHENYL)PYRROLIDINE HCL,812-256-8,1391452-66-6,Acute Tox. 4;Skin Sens. 1B,Notified C&L,1,H302:1;H317:1
250746,(2R)-2-(3-BROMOPHENYL)PYRROLIDINE HCL,812-257-3,1391550-13-2,Acute Tox. 4;Skin Sens. 1B,Notified C&L,1,H302:1;H317:1
250747,"[4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidin-1-yl](5-methylpyridin-3-yl)methanone",943-309-4,156523-04-5,Not Classified,REACH registration C&L,2,Not classified:2
250749,"Reaction mass of 5,5'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[3-methylsalicylic] acid, potassium salt, compound with 2,2',2''-nitrilotriethanol and 2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4-[2-[4-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-2-sulfophenyl]ethenyl]-3-sulfophenyl]azo]-4-hydroxy-, potassium salt, compd. with 2,2',2''-nitrilotris[ethanol] and 3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[6-amino-4-hydroxynaphthalene-2-sulphonic] acid, potassium salt, compound with 2,2',2''-nitrilotriethanol and 3,3'-[vinylenebis[(3-sulpho-p-phenylene)azo]]bis[5-amino-4-hydroxynaphthalene-2,7-disulphonic] acid, potassium salt, compound with 2,2',2''-nitrilotriethanol",,,Not Classified,REACH registration C&L,1,Not classified:1
250754,1-tert-butyl-4-[1-(4-ethoxyphenyl)-2-nitro-propyl]benzene,943-314-1,,Acute Tox. 3;STOT RE 2,Notified C&L,89,H373:89;H301:89
250756,(NE)-N-[1-[(6-chloro-1-oxido-pyridin-1-ium-3-yl)methyl]imidazolidin-2-ylidene]nitramide,943-316-2,,STOT RE 2;Aquatic Chronic 2,Notified C&L,89,H373:89;H411:89
250759,"(2S,5R)-5-[(benzyloxy)amino]piperidine-2-carboxamide",812-263-6,1416134-49-0,Not Classified,Notified C&L,1,Not classified:1
250760,"(S)-N-((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide",943-317-8,,STOT SE 2,Notified C&L,1,H371:1
250761,Reaction mass of 1330-20-7 and 25036-25-3,943-318-3,,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;STOT RE 2,Notified C&L,1,H319:1;H317:1;H315:1;H226:1;H373:1;H335:1
250762,Reaction mass of 26265-08-7 and 67-64-1,943-319-9,,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H317:1;H315:1;H226:1;H336:1
250763,Reaction mass of 25068-38-6 and 68609-97-2 and 9003-36-5,943-320-4,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H317:1;H315:1
250764,2-Amino-1-pyrroline Hydrochloride,812-264-1,7544-75-4,,Notified C&L,3,H315:3;H319:2;H335:1
250768,ONION HYDROALCOHOLIC EXTRACT,943-324-6,,Flam. Liq. 3;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H317:1
250770,"tert-Butyl 5-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate",812-267-8,216064-48-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
250771,4-(BENZYLOXY)CYCLOHEXANONE,812-268-3,2987-06-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250772,"2,2',2''-nitrilotriethanol and sodium salts of 3,3'- {ethane-1,2-diylbis[(2-sulfo-4,1-phenylene)diazene-2,1-diyl]}bis(5-amino-4- hydroxynaphthalene-2,7-disulfonic acid)",943-325-1,,Skin Sens. 1B,REACH registration C&L,15,H317:14;Not classified:1
250773,"1,3-dipyridin-4-ylurea",812-269-9,39642-87-0,Acute Tox. 2;Acute Tox. 3,Notified C&L,1,H300:1;H311:1
250774,"(4,6-dimethoxy-pyrimidin-2-yl)-[3-(2,2,2-trifluoro-ethoxy)-pyridin-2-yl]-amine",943-326-7,,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,89,H412:89;H302:89
250779,"Reaction Mass of 4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-one and 4-(2,6,6-trimethylcyclohex-2-en-1-yl)butan-2-one and 4-[(1RS,6RS)-2,2,6-trimethylcyclohexyl]butan-2-one and (2RS,4aRS)-2,5,5-trimethyl-1,2,3,4,4a,5,6,7-octahydronaphthalen-2-ol and 2,5,5-trimethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-ol",943-328-8,,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H315:1
250788,Precipitate from tellurium containing acid solutions by copper metal cementation,943-528-5,,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;Muta. 2;Carc. 1A;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H341:4;H360:4;H319:4;H372:4;H400:4;H317:4;H315:4;H301:4;H334:4;H350:4;H332:4;H410:4
250789,"Platinum, carbonyl(eta4-2,4,6,8-tetraethenyl-2,4,6,8-tetramethylcyclotetrasiloxane)- (9CI)",812-272-5,226921-57-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1
250790,Tris[(trimethylsilyl)methylene]aluminium(III),812-273-0,41924-27-0,Pyr. Liq. 1;Water-react. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H260:1;H318:1;H250:1;H314:1
250791,Bis(mesityloxide)ruthenium(II),812-274-6,857678-47-8,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H228:1;H319:1;H302:1;H315:1;H312:1;H332:1
250792,Rhodium(III) hydroxide hydrate,812-275-1,120824-04-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H302:1;H315:1;H312:1;H332:1
250793,"Bis(trifluoroacetato)[(S)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl]ruthenium(II)",812-276-7,106681-16-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H302:1;H315:1;H312:1;H332:1
250794,"Chloro[1,3-bis(2,6-diisopropylphenyl)imidazole-2-ylidene]gold(I)",812-277-2,852445-81-9,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H228:1;H319:1;H302:1;H315:1;H312:1;H332:1
250795,Tetrakis(1-methyl-1-propanolato)tungsten(VI) oxide,812-278-8,1676078-32-2,Flam. Liq. 3;Water-react. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H302:1;H315:1;H226:1;H260:1;H312:1;H332:1
250796,Dihydrogen bisoxalatoplatinate(II),812-279-3,83771-84-0,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Acute Tox. 4,Notified C&L,2,H302:2;H314:2;H290:2;H312:2;H332:2;H318:2
250797,"[(r)-(-)-1-[(s)-2-(diphenylphosphino)-ferrocenyl]-ethyldi-tert.butylphosphine-(1,5-cyclooctadiene)-rhodium(I)]-tetrafluoroborate",812-280-9,673458-86-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H302:1;H315:1;H312:1;H332:1;H318:1
250798,Dirhodium(II) tetrakisacetate hydrate,812-281-4,29998-99-0,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H228:1;H319:1;H302:1;H315:1;H312:1;H332:1
250799,Rhodium(III) oxide hydrate,812-283-5,39373-27-8,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
250800,"Chlorophenylallyl[1,3-bis[2,6-bis(diphenylmethyl)-4-methylphenyl-imidazol-2-ylidene]palladium(II)",812-284-0,1380314-24-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,2,H413:1;H319:2;H302:1;H315:2;H312:1;H332:1
250801,"chloro[(S)-2,2´-bis(bis(3,5-dimethylphenyl)phosphino)-1,1´-binaphthyl](p-cymene)ruthenium(II) chloride",812-285-6,1345887-44-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H302:1;H315:1;H312:1;H332:1
250802,"[N-[(1R,2R)-2-(amino-κN)-1,2-diphenylethyl]-4-methylbenzenesulfonamidato-κN]chloro[(1,2,3,4,5-η)-1,2,3,4,5-pentamethyl-2,4-cyclopentadien-1-yl]-rhodium Stereoisomer",812-286-1,223392-99-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H302:1;H315:1;H312:1;H332:1
250804,"Reaction mass of bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl]adipate and 2-[2-(2-butoxyethoxy)ethoxy]ethyl (3,6,9,12-tetraoxahexadecyl)adipate",943-330-9,,Not Classified,REACH registration C&L,2,Not classified:2
250805,"(2S,5R)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamide",812-287-7,1192651-49-2,Not Classified,Notified C&L,1,Not classified:1
250806,"2-[2-[2-Chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, sodium salt",812-288-2,115970-66-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250810,H-Cys(1)-Cys(2)-Glu-Tyr-Cys(3)-Cys(1)-Asn-Pro-Ala-Cys(2)-Thr-Gly-Cys(3)-Tyr-OH,812-291-9,851199-59-2,Acute Tox. 4,Notified C&L,44,H302:44;H373:1;H312:1;H332:1
250816,1-Bromo-2-phenoxy-benzene,812-295-0,7025-06-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
250819,"reaction mass of 1,1,1,2,2,3,3,4,4,5,5,6,6,6-tetradecafluoro-hexane and 1,1,1,2,2,3,3,4,5,5,5-undecafluoro-4-(trifluoromethyl)pentane",943-336-1,,Not Classified,Notified C&L,1,Not classified:1
250823,sodium ethanesulfinate,812-301-1,20035-08-9,,Notified C&L,2,H319:1;H335:1;H315:1;H312:1;H332:1;H302:1
250825,3-bromo-2-methylphenol,812-303-2,7766-23-6,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
250830,4-pyrazol-1-yl-pyridine HCl,943-337-7,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250831,Reaction products resulting from the esterification of C18 unsaturated fatty acid with glycerol oligomers,943-350-8,,Not Classified,REACH registration C&L,1,Not classified:1
250834,"methyl 2-[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetate",812-311-6,956229-86-0,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
250835,"tert-butyl 1,7-diazaspiro[4.4]nonane-1-carboxylate",812-312-1,885268-47-3,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
250838,3-fluoro-1H-pyrazole,812-315-8,14521-81-4,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H312:1;H332:1
250839,"Reaction mass of 4-methylene-2-phenyltetrahydro-2H-pyran and 4-methyl-2-phenyl-3,6-dihydro-2H-pyran",943-338-2,,Aquatic Chronic 3,REACH registration C&L,3,H412:3
250841,1-methyl-1H-pyrazol-4-amine monohydrochloride,812-317-9,127107-23-7,,Notified C&L,3,H319:3;H335:3;H315:3;H302:1
250852,2-(3-amino-5-methoxy-phenoxy)ethanol,812-329-4,725237-16-1,Muta. 2,Notified C&L,1,H341:1
250853,IR 775 Chloride,812-331-5,199444-11-6,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
250856,Reaction products of Nitrilotri(methylphosphonic acid) and hydrogen peroxide,943-339-8,,Eye Irrit. 2,REACH registration C&L,1,H319:1
250857,2-(4-((4-chlorophenyl)(phenyl)methyl)piperazin-1-yl)acetic acid,812-334-1,942132-30-1,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Repr. 2;Aquatic Acute 1,Notified C&L,1,H319:1;H302:1;H400:1;H312:1;H361:1;H335:1
250858,2-(2-(4-((2-chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid,812-335-7,83881-59-8,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Repr. 2;Aquatic Acute 1,Notified C&L,2,H319:1;H302:2;H400:2;H312:1;H361:1;H335:1
250860,C18unsatd. fatty acids reaction products with N-(2-hydroxy)propylamine,943-345-0,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1,H318:1;H411:1;H315:1
250864,"dibenzylbenzene, ar-methyl derivative, hydrogenated",943-342-4,,Aquatic Chronic 4,REACH registration C&L,2,H413:2
250866,Mixed octenes T-149OH,943-344-5,,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 1B;Carc. 1A;Aquatic Chronic 2,Notified C&L,1,H319:1;H302:1;H315:1;H411:1;H225:1;H340:1;H350:1;H332:1;H335:1
250880,"2,2,2-Trifluoro-1-(4-isocyanatopiperidin-1-yl)ethanone",812-354-0,493036-44-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
250884,"Phosphorotetrathioic acid, trilithium salt",812-358-2,82857-67-8,Flam. Sol. 1;Water-react. 1;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H228:1;H400:1;H314:1;H301:1;H260:1;H332:1;H318:1
250885,Lithium Phosphorous Sulfide Iodide (7:2:8:1),943-346-6,,Flam. Sol. 1;Water-react. 1;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H228:1;H400:1;H314:1;H301:1;H260:1;H332:1;H318:1
250901,2-(2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethoxy)acetic Acid,812-370-8,682323-77-9,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Repr. 2;Aquatic Acute 1,Notified C&L,2,H319:1;H302:2;H400:2;H312:1;H361:1;H335:1
250902,2-(2-(4-benzhydrylpiperazin-1-yl)ethoxy) acetic acid,812-371-3,83881-53-2,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;STOT SE 3;Repr. 2;Aquatic Acute 1,Notified C&L,1,H319:1;H302:1;H400:1;H312:1;H361:1;H335:1
250908,1-[dimethoxy(methyl)silyl]methanamine,812-377-6,343926-26-1,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,3,H318:3;H226:3;H314:3
250910,"bis(N-decyl-N,N-dimethyldecan-1-aminium) adipate",812-378-1,210420-85-2,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H302:1;H314:1;H318:1;H410:1
250913,4-(1H-pyrazol-1-yl)aniline hydrochloride,812-381-8,913848-94-9,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
250916,3-(methylsulfonyl)propanoic acid,812-384-4,645-83-0,,Notified C&L,3,H319:3;H335:3;H315:3;H302:1
250918,Chlorodihydrido[bis[(2-diisopropylphosphino)ethyl]amine]iridium,812-387-0,791629-96-4,,Notified C&L,2,H319:2;H335:2;H315:2
250919,"1,3-dimethyl-4-phenyl-1H-pyrazol-5-amine",812-388-6,3654-22-6,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
250928,adamantane-1-carbohydrazide,812-397-5,17846-15-0,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H312:1;H332:1
250930,4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide;methanesulfonic acid,812-398-0,857890-39-2,Repr. 2,Notified C&L,2,H361:2;H362:1;H302:1;H372:1
250935,"methyl({[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl})amine",812-403-6,1150271-47-8,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
250938,"2-fluoro-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzonitrile",812-406-2,1029714-87-1,Acute Tox. 5;Skin Sens. 1A,Notified C&L,1,H303:1;H317:1
250950,[No public or meaningful name is available],812-418-8,457957-14-1,Skin Irrit. 2,Notified C&L,32,H315:32
250954,2-[2-(4-benzoylphenoxy)ethoxy]ethyl methacrylate,943-359-7,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H317:2
250955,"(2Z)-2,4,4,4-Tetrafluorobut-2-en-1-ol",812-421-4,91600-37-2,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H226:1;H335:1
250956,(2S)-2-[(tert-Butoxycarbonyl)amino]-3-phenylpropanohydrazide,812-423-5,30189-48-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250957,3-Nitropyridine-2-carboxylic acid,812-424-0,59290-85-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250958,4-(Pyrrolidin-3-yl)pyridine,812-425-6,150281-47-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250959,Methyl 3-fluoro-5-methylisonicotinate,812-426-1,1803821-90-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250960,"trans-2,6-Dimethylpiperidin-4-one, N-BOC protected",812-427-7,184368-70-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
250961,Methyl 3-amino-5-methylisonicotinate,812-428-2,1805106-63-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250962,2-Methylpyridine-3-boronic acid,812-429-8,899436-71-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:2;H335:3;H302:1;H315:3;H318:1
250963,"tert-Butylboronic acid, pinacol ester",812-430-3,99810-76-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250964,3-Hydroxymethyl-3-methylcyclobutanone,812-431-9,1523617-87-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250965,(Isoquinolin-4-yl)methanamine,812-432-4,58123-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250966,"3-Bromo-2,6-difluoronitrobenzene",812-434-5,1420800-30-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
250967,"1H-Perfluorohexane-1,1-diol",812-435-0,754-79-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
250969,"Reaction mass of acetic acid and water and 3,7-bis(diethylamino)phenoxazin-5-ium acetate",943-361-8,,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
250970,Reaction mass of acetic acid and water and 2-[[4-[ethyl(2-hydroxyethyl)amino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium acetate,943-362-3,,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
250971,"Reaction mass of acetic acid and water and 1,4-dimethyl-5-[[4-[methylbenzylamino]phenyl]azo]-1H-1,2,4-triazolium acetate",943-363-9,,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
250972,"1-acetyl-3-(3-pyridylmethylamino)-6-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-4H-quinazolin-2-one",812-436-6,337458-27-2,Acute Tox. 4;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,90,H400:90;H302:90;H410:90;H330:90
250974,7-azaspiro[3.5]nonane hydrochloride,812-438-7,1414885-16-7,,Notified C&L,2,H319:2;H335:2;H315:2
250979,2-oxa-8-azaspiro[4.5]decane hydrochloride,812-443-4,479195-19-2,,Notified C&L,2,H319:2;H335:2;H315:2
250982,reaction products of acetic anhydride and adipic acid,943-366-5,,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;STOT SE 3,REACH registration C&L,1,H302:1;H314:1;H226:1;H332:1;H335:1
250984,"[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid",812-447-6,933708-92-0,,Notified C&L,3,H319:3;H335:3;H302:2;H315:3
250988,(2E)-3-(4-cyanophenyl)prop-2-enoic acid,812-449-7,16642-94-7,Acute Tox. 4,Notified C&L,2,H302:2;H319:1;H335:1;H315:1
250989,methyl (E)-3-(4-cyanophenyl)prop-2-enoate,812-450-2,67472-79-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H331:1;H319:1;H302:1;H315:1;H312:1;H335:1
250990,"5-methyl-1,2-oxazole-4-sulfonyl chloride",812-451-8,321309-26-6,Skin Corr. 1B,Notified C&L,2,H314:2;H335:1
250991,"methyl 2-(5-methyl-1,2-oxazol-3-yl)acetate",812-452-3,934172-40-4,Acute Tox. 4,Notified C&L,1,H302:1
250992,7-Hydroxyquinoline-(1H)-2-one,812-453-9,70500-72-0,,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
250993,1-(1-Benzothiophen-4-yl)piperazine hydrochloride,812-454-4,913614-18-3,Acute Tox. 4,Notified C&L,3,H302:3
250994,Reaction mass of 2-phenylethanol and (4-methylphenoxy)acetaldehyde,943-369-1,,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H317:1;H315:1
251010,Bis(4-methoxybenzoyl)diethylgermanium,812-467-5,1207515-90-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251011,"1,3-disilacyclobutane",812-468-0,287-55-8,Flam. Liq. 2;Water-react. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H319:22;H315:22;H225:22;H260:22;H335:22
251012,"1,2-Benzoquinone",812-469-6,583-63-1,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Carc. 2,Notified C&L,22,H341:22;H319:22;H315:22;H351:22;H301:22;H311:22
251014,"Hexanoic acid, 2-ethyl-, compd. with N,N-dimethylcyclohexanamine (1:1)",812-471-7,80004-13-3,Acute Tox. 4;Skin Corr. 1B,Notified C&L,22,H302:22;H314:22
251015,"2-Propenoic acid, 2-methyl-, 3-[3-(5-chloro-2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphen",812-472-2,275371-71-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
251017,[No public or meaningful name is available],812-474-3,68910-64-5,Skin Sens. 1,Notified C&L,3,H317:3
251018,[No public or meaningful name is available],812-475-9,59633-97-5,Skin Sens. 1,Notified C&L,3,H317:3
251019,[No public or meaningful name is available],812-476-4,84732-35-4,Skin Sens. 1,Notified C&L,3,H317:3
251020,"N,N'-(10,17,-dioxo-3,6,21,24-tetraoxa-9,11,16,18-tetraazahexacosane-1,26-diyl)bis([(4S)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinolin-4-yl]benzenesulfonamide)",812-478-5,1234423-95-0,STOT SE 2,Notified C&L,1,H371:1
251021,"8,8-bis(3,7-dimethyloctyl)-3,12-dithiatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),4,10-tetraen-7-one",943-373-3,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
251022,"4,11-dibromo-8,8-bis(3,7-dimethyloctyl)-3,12-dithiatricyclo[7.3.0.0²,⁶]dodeca-1(9),2(6),4,10-tetraen-7-one",943-374-9,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
251023,1-Benzyl-N-cyclopropylpiperidin-4-amine,812-479-0,387358-47-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H320:1;H335:1;H315:1
251024,Reaction mass of Calcium Hydroxide and Calcium Sulphate and Calcium Carbonate and Ettringite,943-377-5,,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
251025,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with 1,1'-methylenebis[4-isocyanatocyclohexane] and 2-oxepanone",943-378-0,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,140,H319:140;H315:140
251028,"4-Isoxazolecarboxylic acid, 3,5-diethyl-, (1aR,2S,5R,5aS,6S,8aS,9R,10aR)-1a,2,5,5a,6,9,10,10a-octahydro-5,5a-dihydroxy-4-(hydroxymethyl)-1,1,7,9-tetramethyl-11-oxo-1H-2,8a-methanocyclopenta[a]cyclopropa[e]cyclodecen-6-yl ester",812-481-1,1383547-60-1,Acute Tox. 2;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 2;Repr. 2,Notified C&L,2,H300:2;H315:1;H330:2;H318:1;H361:1;H314:1
251029,"Reaction products of diazotized 2-amino-4-nitrophenol, coupled with resorcinol and subsequently coupled with diazotized 5-amino-4-hydroxynaphthalene-2,7-disulfonic acid and diazotiazed paranitroaniline",943-382-2,,Eye Irrit. 2,REACH registration C&L,3,H319:3
251030,Galangal Oil,943-383-8,,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H317:1;H315:1;H304:1;H411:1;H318:1
251032,(4S)-1-(tert-butoxycarbonyl)-4-(hydroxymethyl)-L-proline,812-482-7,1643468-66-9,Not Classified,Notified C&L,1,Not classified:1
251033,"Ethyl 4,6-dimethoxypyrimidine-2-carboxylate",812-483-2,128276-49-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251035,[(2-Ethyl-6-methyl-phenyl)-(2-methoxy-1-methyl-ethyl)-carbamoyl]-methanesulfonic acid sodium salt,812-484-8,171118-09-5,Aquatic Chronic 2,Notified C&L,156,H411:156
251037,"Formaldehyde, polymeric reaction products with phenol containing less than 10% of phenol and less than 1% of formaldehyde",943-388-5,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 4;Muta. 2;Carc. 1B,Notified C&L,1,H341:1;H302:1;H314:1;H317:1;H350:1;H312:1;H332:1;H318:1
251040,Sodium-6-[(3-carboxylatopropanoyl)amino]-2-[(3carboxypropanoyl)amino]hexanoic acid,943-389-0,,Not Classified,REACH registration C&L,2,Not classified:2
251041,"2,5-Bis{[bis(2-hydroxyethyl)amino]methyl}-1,4-benzenediol",943-390-6,,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H301:1;H315:1
251044,"6-(5-Chloropyrid-2-yl)-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5,7-dione",943-393-2,,Acute Tox. 4;STOT SE 3;Repr. 2;Lact.;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H362:1;H302:1;H411:1;H373:1;H361:1;H336:1
251045,"6-(5-Chloropyrid-2-yl)-7-hydroxy-6,7- dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one",943-394-8,,Acute Tox. 4;STOT SE 3;Repr. 2;Lact.;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H362:1;H302:1;H411:1;H373:1;H361:1;H336:1
251046,Brettphos,812-485-3,1070663-78-3,,Notified C&L,5,H319:5;H335:4;H315:5;H302:1;H412:1
251047,"6-(5-Chloropyrid-2-yl)-7-phenoxycarbonyloxy-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazin-5-one",943-395-3,,Acute Tox. 4;STOT SE 3;Repr. 2;Lact.;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H362:1;H302:1;H411:1;H373:1;H361:1;H336:1
251051,"(R)-2-((2R,3R,4S)-3,4-Dihydroxytetrahydrofuran-2-yl)-2-hydroxyethyl 2-(3-benzoylphenyl)propanoate",943-397-4,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251052,(2-chlorophenyl) acetate,812-487-4,4525-75-1,Not Classified,REACH registration C&L,1,Not classified:1
251053,"1,6-Naphthyridine-3-carboxylic acid",812-489-5,1017793-59-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251054,4-(Triphenylmethyl) Piperazine Succinate,943-399-5,,Skin Sens. 1;Eye Irrit. 2;Repr. 2,Notified C&L,1,H361:1;H319:1;H317:1
251055,"Carbamic acid, N-[(1S)-3-methyl-1-[[(2S)-2-methyl-2-oxiranyl]carbonyl]butyl]-, 1,1-dimethylethyl ester",812-494-2,247068-83-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H315:1
251056,"4-Morpholineethanamine, N-(1,1-dimethylethyl)-",812-495-8,22687-32-7,Acute Tox. 4;Skin Corr. 1A;Eye Dam. 1,Notified C&L,83,H318:83;H302:83;H314:83
251060,"Phosphoric acid, C14-15 branched and linear alkyl esters, potassium salts",812-497-9,1893414-79-3,Aquatic Chronic 3,Notified C&L,1,H412:1
251061,"reaction products of diazotised 4-nitrobenzenamine, coupled with 6-amino-4-hydroxynaphthalene-2-sulfonic acid, subsequently diazotised and coupled with the reaction product of diazotized 3-amino-4-hydroxy-5-nitrobenzenesulfonic acid and resorcinol, sodium salt.",943-403-5,,Eye Irrit. 2,REACH registration C&L,5,H319:5
251064,"C8-18 (even numbered) and C18 (unsaturated) sarcosinates, 2-hydroxypropylammonium salt",943-406-1,,Skin Corr. 1B;Eye Irrit. 2,Notified C&L,1,H319:1;H314:1
251071,(R)-3-cyclohexyl-2-hydroxypropionic acid,812-501-9,156469-00-0,Not Classified,REACH registration C&L,2,Not classified:2
251074,Zinc bis[4-Methyl-5-imidazolecarboxaldehyde],943-411-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H315:1;H335:1;H410:1
251075,"Iron(III) 1,3,5-benzenetricarboxylate hydrate",943-412-4,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251080,"2,5-Furandione, telomer with ethylbenzene and (1-methylethyl)benzene, 2-methoxy-1-methylethyl 2-((2-methyl-1-oxo-2-propen-1-yl)oxy)ethyl ester",812-505-0,1889200-41-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,57,H319:57;H315:57
251081,"Waste plastics, poly(ethylene terephtalate), polymers with acrylic acid, adipic acid, dipropylene glycol and trimethylolpropane",812-506-6,1892578-66-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,57,H319:57;H315:57
251082,tert-Butyl 4-hydrazinylpiperidine-1-carboxylate hydrochloride,812-507-1,1258001-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251084,reaction product of alumina and sulfuric acid,812-508-7,1093112-19-6,Not Classified,REACH registration C&L,1,Not classified:1
251085,[No public or meaningful name is available],812-509-2,3520-43-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 1,Notified C&L,1,H319:1;H302:1;H315:1;H335:1;H410:1
251096,"Essential oil of Litsea, Litsea cubeba (Lauraceae) obtained from the fruits by distillation",943-438-6,,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,26,H319:26;H317:26;H315:26;H304:26;H411:26
251098,"5-fluoro-1-[(4-methylphenyl)sulfonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine",812-520-2,1259279-57-6,Muta. 2;Aquatic Chronic 2,REACH registration C&L,2,H341:2;H411:2
251110,"3-amino-N,N,N-trimethylanilinium trichlorozincate(1-)",812-526-5,53831-80-4,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3;Carc. 1B;Aquatic Chronic 1,Notified C&L,1,H331:1;H319:1;H317:1;H301:1;H350:1;H410:1
251111,4-chloro-2-nitropyridine,812-527-0,65370-42-5,,Notified C&L,3,H319:3;H302:3;H315:3;H332:3;H335:3;H312:2
251112,(2-bromophenyl)methanesulfonyl chloride,812-528-6,24974-74-1,,Notified C&L,3,H319:2;H314:3;H315:2;H200:1;H335:2;H318:1
251113,"1-Butyl-2-(5-(1-butyl-3,3-dimethyl-1,3-dihydro-indol-2-ylide ne)penta-1,3-dienyl)-3,3-dimethyl-3H-indolium perchlorate",812-529-1,131443-20-4,,Notified C&L,2,H228:2;H318:1;H302:1
251123,methyl 5-methoxy-2-methylbenzoate,812-540-1,73502-03-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251126,"1-[4-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]phenyl]-N-ethoxy-2-methoxy-ethanimine",943-421-3,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
251127,BASIC RED 18:1 (LIQUID),943-422-9,,Flam. Liq. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H226:1;H314:1
251128,"Formaldehyde, polymer with tar acids, xylenol fraction, Bu ether",943-423-4,,Skin Sens. 1,Notified C&L,3,H317:3
251130,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H319:1;H315:1
251131,"methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate",812-543-8,198904-31-3,Eye Dam. 1;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,2,H372:2;H318:2;H411:2
251134,Doshion CSA-9 L Na+,943-427-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
251135,"Sorbitan C16-18 (even numbered) fatty acid esters, ethoxylated (1-6.5 moles ethoxylated)",943-428-1,,Not Classified,REACH registration C&L,2,Not classified:2
251136,"(1S)-1-phenylethanaminium (2S)-2-[({[(1R,2R)-2-allylcyclopropyl]oxy}carbonyl)amino]-3,3-dimethylbutanoate",943-429-7,1799733-54-2,Not Classified,REACH registration C&L,6,Not classified:6
251137,1-methyl-3-((methyl-λ2-azanyl)methyl)-1H-pyrazole-5-carbonitrile hydrochloride,943-430-2,1643141-20-1,Acute Tox. 4,REACH registration C&L,2,H302:1;Not classified:1
251138,"5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one monohydrochloride",812-545-9,93173-05-8,Not Classified,REACH registration C&L,2,Not classified:2
251140,Aluminium magnesium carbonate hydroxide,943-434-4,,Not Classified,REACH registration C&L,26,Not classified:26
251145,"Reaction mass of [(1R,2S)-2-cyclopentylcyclopentyl] (E)-but-2-enoate and [(1S,2R)-2-cyclopentylcyclopentyl] (E)-but-2-enoate and [(1S,2S)-2-cyclopentylcyclopentyl] (E)-but-2-enoate and [(1R,2R)-2-cyclopentylcyclopentyl] (E)-but-2-enoate",943-447-5,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H400:1;H410:1;H315:1
251152,"2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylic anhydride",812-546-4,14297-82-6,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H314:1;H317:1;H318:1;H410:1
251154,"methyl (1R)-2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropane-1-carboxylate",943-436-5,,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1
251157,"N,N'-[1,4-phenylenebis(methylene)]bis{N,N-dimethyl-3-[(prop-2-enoyl)amino]propan-1-aminium} dichloride",812-548-5,1621424-03-0,Skin Sens. 1;Eye Dam. 1,REACH registration C&L,2,H318:2;H317:2
251158,"disodium 4,4'-bis[(prop-2-enoyl)amino][1,1'-biphenyl]-2,2'-disulfonate",812-549-0,881539-89-5,Eye Dam. 1,REACH registration C&L,2,H318:2
251159,[No public or meaningful name is available],812-550-6,60644-92-0,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,6,H312:6;H332:6;H226:6;H302:6
251160,[No public or meaningful name is available],812-551-1,1765-26-0,Flam. Liq. 3;Repr. 2,Notified C&L,6,H361:6;H226:6
251161,[No public or meaningful name is available],812-552-7,211931-77-0,Acute Tox. 3;STOT SE 3,Notified C&L,6,H331:6;H335:6
251162,Bis(1-methyl-3-butylcyclopentadienyl)zirconium dimethyl,812-553-2,173772-79-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H317:3;H315:3
251163,"Benzenamine, 3-methyl-4-[2-[4-(trifluoromethyl)phenyl]diazenyl]-",812-554-8,1352059-88-1,Acute Tox. 3;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H400:83;H301:83;H312:83;H332:83;H410:83
251164,"1H-Imidazolium, 3-ethyl-1-methyl-, O,O-bis(2-ethylhexyl) phosphorodithioate (1:1)",812-555-3,1209005-89-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H400:83;H410:83
251169,"Phenol, butenylated, aminated",812-556-9,78330-13-9,Aquatic Chronic 2,Notified C&L,1,H411:1
251170,2-bromo-N-methyl-N-(4-nitrophenyl)acetamide,812-557-4,23543-31-9,Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H301:1;H314:1
251180,Reaction mass of 141-78-6 and 53317-61-6 and 584-84-9,943-441-2,,Flam. Liq. 3;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H317:1;H226:1;H332:1;H336:1
251186,"Benzenemethanol, lithium salt",943-617-9,15082-42-5,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,REACH registration C&L,1,H319:1;H335:1;H351:1;H225:1
251188,[No public or meaningful name is available],812-563-7,607732-61-6,Acute Tox. 4,Notified C&L,1,H302:1
251190,2-Chloro-4-phenylpyrimidine,812-564-2,13036-50-5,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,2,H318:1;H335:2;H301:1;H315:2;H319:1;H302:1
251191,"2-Propenoic acid polymer with 1,3-isobenzofurandione, 2,2'-(ethylenedioxy)diethanol and 1,3,5-tris(2-hydroxyethyl)cyanuric acid",943-445-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
251192,"alpha-hydroxy-omega-hydroxypoly(oxy-1,4-butanediyle) polymer with 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate and 2-hydroxyethyl methacrylate",943-448-0,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
251196,"Cyclohexane, 5-isocyanto-1-(isocyanatomethyl)-1,3,3-trimethyl-, polymers with (2-hydroxyethyl)-terminated hydrogenated polybutadiene",943-452-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
251199,Thorium(IV) nitrate hydrate,812-565-8,61443-54-7,Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H319:1;H335:1;H315:1
251200,"Reaction mass of aluminium oxide and silicon dioxide and water and Alcohols, C10-16, ethoxylated",943-455-9,,Eye Dam. 1,Notified C&L,1,H318:1
251204,"1-(4-chloro-phenyl)-4,4-dimethyl-2-[1,2,4]triazol-1-yl-pentan-3-one",812-566-3,63190-87-4,Aquatic Chronic 2,Notified C&L,156,H411:156
251206,"(1R,2R)-1-amino-2-difluoromethyl)-N- (1-methylcyclopropylsulfonyl)cyclo propanecarboxyamide hydrochloride",943-460-6,,Eye Dam. 1,REACH registration C&L,6,H318:6
251207,2-Methyl-2-(tetrahydro-pyran-4-sulfonyl)-propionic acid,812-568-4,1017539-95-5,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
251208,[No public or meaningful name is available],812-570-5,191175-18-5,Eye Irrit. 2,Notified C&L,33,H319:33
251212,1-methylcyclopropane-1-sulfonamide,812-573-1,669008-26-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251213,"1-Naphthalenesulfonic acid, 6-diazo-5,6-dihydro-5-oxo-, ester with 4,4',4''-ethylidynetris[phenol]",812-574-7,138636-85-8,Self-react. D;Skin Irrit. 2;STOT SE 3;Carc. 2;STOT SE 1;STOT RE 1,Notified C&L,1,H372:1;H242:1;H315:1;H351:1;H370:1;H335:1
251218,Reaction mass of isododecyl 3-mercaptopropionate and isotridecyl 3-mercaptopropionate,943-463-2,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H302:1;H317:1
251222,4-(Benzyloxycarbonylamino)phenylboronic Acid (contains varying amounts of Anhydride),812-577-3,192804-36-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
251223,4-Methylcyclohexen-1-ylboronic acid,812-578-9,850567-92-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251224,N-Boc-(R)-2-amino-3-methoxy-1-propanol,812-579-4,183793-49-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251225,"Methyl 2-chloro-1,3-thiazole-5-carboxylate",812-581-5,72605-86-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251226,4'-Hydroxy-2'-(trifluoromethyl)acetophenone,812-582-0,220227-53-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251227,2-Acetylbenzonitrile,812-583-6,91054-33-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
251228,tert-Butyl 3-aminopropanoate,812-584-1,15231-41-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251229,1-(Chlorodifluoromethoxy)-4-nitrobenzene,812-585-7,40750-71-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H301:1;H411:1
251230,2-((tert-Butoxycarbonyl)amino)-2-(oxetan-3-yl)acetic acid,812-586-2,1408074-43-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251231,3-Amino-5-bromophenol,812-587-8,100367-38-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251232,5-Bromo-3-chloroisoquinoline,812-588-3,1029720-67-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
251233,Methyl 3-bromo-5-fluoropyridine-2-carboxylate,812-589-9,1214337-00-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251234,4-Bromo-6-methylisoquinoline,812-590-4,1204298-52-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251235,"Benzyl 2,3,4-tri-O-benzyl-D-glucopyranosyluronate",812-592-5,4539-78-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251236,"2-Methyl-2H-1,4-benzoxazin-3(4H)-one",812-593-0,21744-83-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251237,Ethyl 3-oxocyclobutanecarboxylate,812-594-6,87121-89-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251238,6-Azido-6-deoxy-L-galactose,812-595-1,70932-63-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251239,Recombinant Lysostaphin,812-596-7,9011-93-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251240,Piperlongumine,812-597-2,20069-09-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251241,"5,7-Dichloro-8-hydroxyquinoline beta-D-glucuronide",812-598-8,40951-47-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251242,5-Chloro-8-hydroxyquinoline beta-D-glucuronide,812-599-3,65851-39-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251243,Bromo-PEG2-CH2CO2tBu,812-600-7,1807518-63-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251244,Proparyl-PEG4-methane,812-601-2,89635-82-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251245,(2-Naphthyl)methanol,812-602-8,1592-38-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251246,"2,4,5-Triiodo-1H-imidazole",812-603-3,1746-25-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2;H301:1
251247,tert-Butyl 3-(2-hydroxyethyl)azetidine-1-carboxylate,812-604-9,152537-03-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
251248,2-Methyl-7-azaindole,812-605-4,23612-48-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
251249,Azido-PEG2-Amine,812-607-5,166388-57-4,Skin Corr. 1B,Notified C&L,1,H314:1
251251,"(1-Benzylazetidine-2,4-diyl)dimethanol",812-609-6,127310-66-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251252,3-Chloro-5-(dimethylcarbamoyl)benzeneboronic acid,812-610-1,957120-57-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251253,5-Bromo-2-methoxybenzenesulphonamide,812-611-7,23095-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251254,3-Fluoro-4-(oxetan-3-yloxy)aniline,812-612-2,1349716-61-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251255,"1,5-dimethyl-1H-pyrazol-3-amine",812-613-8,35100-92-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H315:2;H318:1
251256,5-Bromo-2-(piperazin-1-yl)pyridine,812-614-3,73406-97-0,Acute Tox. 3,Notified C&L,1,H301:1
251257,2-Vinylfuran,812-615-9,31093-57-9,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1;H225:1
251258,"6-Bromo-3,4-dihydro-1,8-naphthyridin-2(1H)-one",812-616-4,129686-16-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
251259,"3'-Bromo-4',2,2,2-tetrafluoroacetophenone",812-618-5,150698-74-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251260,"(2S,3S)-3-(ethoxycarbonyl)bicyclo[2.2.2]octan-2-aminium chloride",812-619-0,1626394-43-1,Skin Corr. 1;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H318:2;H412:2;H314:2;H317:2
251261,[No public or meaningful name is available],812-620-6,1051375-19-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
251262,Solvate of di-tert-butyl {5-bromo-3-[(1R)-1-(2-{[(5-cyano-1-methyl-1H-pyrazol-3-yl)methyl](methyl)carbamoyl}-5-fluorophenyl)ethoxy]pyridin-2-yl}-2-imidodicarbonate with 2-methylbutan-2-ol (1:1),812-621-1,1910113-99-3,Not Classified,REACH registration C&L,1,Not classified:1
251263,PF-06668559 acetonitrile solvate,,,Not Classified,REACH registration C&L,1,Not classified:1
251264,"5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3H-2-benzofuran-1-one",812-623-2,862081-37-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251265,4-bromo-5-fluoro-1H-pyrazole,812-624-8,1346555-56-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251268,"2-oxepanone, homopolymer, ester with 3-hydroxy-2,2-dimethylpropanoic acid, 2-propenoate",812-625-3,96915-49-0,Skin Sens. 1,Notified C&L,5,H317:5
251269,"Dimethyl-[2-(5-[1,2,4]triazol-1-ylmethyl-1H-indol-3-yl)-ethyl]-amine",812-626-9,144034-80-0,Eye Irrit. 2,Notified C&L,1,H319:1
251271,"Alcohols, C12-15, ethoxylated, phosphated (3-20EO)",943-470-0,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,3,H318:3;H411:3;H315:3
251272,"Alcohols, C20-22, ethoxylated, phosphated (3-20EO)",943-471-6,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:3;H315:3
251273,"Fatty alcohol, C20-*22, ethoxylated (>7 - < 15 EO)",943-472-1,,Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,3,H412:3;H400:3;H302:3
251274,"Nonylphenol, ethoxylated, phosphated, sodium salt (7EO)",943-473-7,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,3,H318:3;H315:3
251275,"Rape-oil alkyl amines, ethoxylated (>25EO)",943-474-2,,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H319:3;H400:3;H302:3;H410:3
251276,"Reaction mass of oleic acid and magnetite and Distillates (petroleum), hydrotreated light",943-475-8,,Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H304:1;H319:1;H315:1
251278,"Reaction mass of Methyl N-octadecylterephthalamate and N,N'-dioctadecylterephthalamid",943-498-3,,Not Classified,REACH registration C&L,3,Not classified:3
251282,"Dodecanaminium, N,N-dimethyl-N-(3-(barley-protein-hydrolysate) propyl)-, chloride",943-480-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
251283,[No public or meaningful name is available],812-629-5,1777-89-5,Acute Tox. 4,Notified C&L,1,H302:1
251287,"Reaction mass of 5-[(2,4-dinitrophenyl)amino]-2-anilinobenzenesulphonic acid and sodium 2-anilino-5-(2,4-dinitroanilino)benzenesulphonate",943-483-1,,Not Classified,REACH registration C&L,6,Not classified:6
251288,Barium Europium Strontium Chloride Phosphate,812-631-6,1273005-45-0,Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:3;H302:3
251289,"1,1'-Methylenebis(4-isocyanatobenzene) and oligomeric reaction products of 1,1'-methylenebis(4-isocyanatobenzene) and oxydipropanol",701-040-8,,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,REACH registration C&L,24,H319:24;H317:24;H315:24;H351:24;H334:24;H332:24;H373:24;H335:24
251290,"1,1'-Methylenebis(4-isocyanatobenzene) and oligomeric reaction products of 1,1'-methylenebis(4-isocyanatobenzene) and oxydipropanol and oligomerization reaction products of oxydipropanol",701-041-3,,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,REACH registration C&L,8,H319:8;H317:8;H315:8;H351:8;H334:8;H332:8;H373:8;H335:8
251297,"2,3-dihydro-1H-inden-2-yl-methanesulfonate",812-638-4,777-72-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
251302,"Reaction mass of tetrasodium [mono(4,4'-(1Z,1'Z)-(4,4'-dioxidobiphenyl-3,3'-diyl)bis(diazene-2,1-diyl)bis(5-amino-3-oxidonaphthalene-2,7-disulfonate(3-)) cuprate (4-)] and tetraammonium [mono(4,4'-(1Z,1'Z)-(4,4'-dioxidobiphenyl-3,3'-diyl)bis(diazene-2,1-diyl)bis(5-amino-3-oxidonaphthalene-2,7-disulfonate(3-)) cuprate (4-)]",943-486-8,,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,3,H302:3;H317:3
251304,2-Bromo-1-cyclopropyl-2-(2-fluorophenyl)ethanone,812-641-0,204205-33-4,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H319:1;H315:1
251305,A-Stage F,,,Not Classified,Notified C&L,1,Not classified:1
251314,"1,4 -bis(methylenephosphonate) piperazine aluminium hydroxide complex",943-488-9,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Repr. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H317:1;H315:1;H412:1;H334:1;H361:1
251315,"N-(3-Fluoro-4-(2-(5-((2-methoxyethylamino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-(4-fluorophenyl)acetamide monoglycolate",812-647-3,875337-44-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251320,[No public or meaningful name is available],812-657-8,1797905-62-4,Aquatic Chronic 3,Notified C&L,1,H412:1
251324,"2,2'-(perfluoronaphthalene-2,6-diylidene)dimalononitrile",812-659-9,912482-15-6,Acute Tox. 4,Notified C&L,2,H302:1;H331:1;H301:1;H311:1
251332,4-methyl-6-phenyl-2-hexanol,943-493-6,72681-01-7,Skin Irrit. 2;STOT SE 3,REACH registration C&L,1,H336:1;H315:1
251333,"3-(3-Bromophenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine",812-666-7,916423-55-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251334,2-{(2S)-1-[(1-Phenyl-1H-tetrazol-5-yl)sulfonyl]propan-2-yl} pyridine,943-494-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;Not classified:1;H302:1
251337,"5,9-dimethyldec-4-enal",943-495-7,689-65-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2,H400:2;H302:2;H317:2;H315:2;H412:2;H332:2
251338,Addition reaction products of conjugated sunflower-oil fatty acids and tall-oil fatty acids with maleic anhydride,701-043-4,,Skin Irrit. 2;Skin Sens. 1,REACH registration C&L,3,H317:3;H315:3
251339,Georgywood,812-667-2,59056-93-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,13,H400:13;H410:13
251340,phenyl pent-4-enoate,812-668-8,51231-09-5,Acute Tox. 4;Skin Sens. 1B;Acute Tox. 4,REACH registration C&L,2,H332:2;H302:2;H317:2
251341,Dimethylpyrrolidone,812-669-3,60544-40-3,Skin Irrit. 2;Eye Dam. 1,Notified C&L,159,H318:83;H315:159;H360:76;H319:76;H335:76
251348,"Reaction mass of 3,5-diethyl-2,5-dimethyl-cyclohex-2-en-1-one and 3,5-diethyl-5,6-dimethylcyclohex-2-en-1-one",943-554-7,,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,26,H412:26;H315:26
251349,Epoxide compound~,812-670-9,63832-41-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,13,H319:13;H317:13;H315:13
251364,"2,6-dihydroxybenzaldehyde",812-673-5,387-46-2,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,REACH registration C&L,4,H318:4;H335:4;H315:4
251365,"1,3-Thiazole-2-carbonitrile",812-674-0,1452-16-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,3,H319:3;H302:3;H315:3;H312:2;H332:3;H371:2;H373:1;H335:1;H311:1
251366,"methyl 3-{[(2,6-difluorophenyl)sulfonyl]amino}-2-fluorobenzoate",812-675-6,1195768-19-4,Not Classified,Notified C&L,1,Not classified:1
251367,3-Bromo-N-{[4-methanesulfonyl-2-(trifluoromethyl)phenyl]methyl}pyridin-2-amine,812-676-1,1638892-78-0,Muta. 2,Notified C&L,2,H341:1;Not classified:1
251369,Organosilane,943-500-2,,Flam. Liq. 2;Skin Sens. 1,Notified C&L,1,H225:1;H317:1
251370,"Sulfuric acid, mono-C14-16 (even numbered)-alkyl esters, sodium salts",943-502-3,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,4,H318:4;H400:4;H411:4;H315:4;H228:2;H335:2
251371,tert-butyl 6-cyano-2-[2-(4-ethyl-3-iodophenyl)propan-2-yl]-1H-indole-3-carboxylate,812-677-7,1256584-75-4,Not Classified,Notified C&L,1,Not classified:1
251380,"2,6-bis({[bis(2-hydroxyethyl)amino]methyl})-4-[2-(3-{[bis(2-hydroxyethyl)amino]methyl}-4-hydroxyphenyl)propan-2-yl]phenol; 2,6-bis({[bis(2-hydroxyethyl)amino]methyl})-4-[2-(4-hydroxyphenyl)propan-2-yl]phenol; 2-[(2-hydroxyethyl)amino]ethan-1-ol; 2-{[bis(2-hydroxyethyl)amino]methyl}-4-[2-(3-{[bis(2-hydroxyethyl)amino]methyl}-4-hydroxyphenyl)propan-2-yl]phenol; 2-{[bis(2-hydroxyethyl)amino]methyl}-4-[2-(4-hydroxyphenyl)propan-2-yl]phenol; 4-[2-(4-hydroxyphenyl)propan-2-yl]phenol",943-503-9,,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Repr. 1B;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,1,H360:1;H315:1;H412:1;H373:1;H318:1;H335:1
251381,4-(methylsulfonyl)-2-(trifluoromethyl)benzaldehyde,812-681-9,1215310-75-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2;H402:1
251382,"Amines, di-C12-C14-alkylmethyl",943-504-4,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,REACH registration C&L,2,H318:2;H400:2;H315:2
251383,[No public or meaningful name is available],812-682-4,757218-51-2,Skin Sens. 1B,Notified C&L,156,H317:156
251385,3-chloro-5-trichloromethyl-cyclopentene,812-685-0,72685-38-2,Acute Tox. 4;Skin Sens. 1A;Acute Tox. 4;Aquatic Acute 1,Notified C&L,156,H400:156;H302:156;H317:156;H332:156;H410:156
251386,2-(2-chloro-phenyl)-bicyclopropyl,812-686-6,1006691-50-4,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,156,H302:156;H411:156;H317:156
251389,"1,3-Benzenedicarboxylic acid, polymer with 2,2-dimethyl-1,3-propanediol, 1,2-ethanediol, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, hexanedioic acid, 1,6-hexanediol and 1,3-isobenzofurandione reaction products with 3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate and",943-507-0,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
251393,"Rosin, fumarated, polymer with glycerol, ammonium salt",812-691-3,68554-18-7,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,3,H413:3;H319:3;H317:3
251401,"Mixture of 2,2,5-Trimethylhex-4-enal and Toluene",943-511-2,,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;Repr. 2;STOT RE 2,Notified C&L,1,H319:1;H302:1;H315:1;H304:1;H225:1;H373:1;H361:1;H335:1;H336:1
251405,"1-Hexen-3-one, 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-",943-512-8,,Not Classified,REACH registration C&L,2,Not classified:2
251406,2-(4-Biphenylyloxy)ethyl Methacrylate,812-698-1,121711-42-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,32,H319:32;H302:32
251419,[3-methoxycarbonyl-4-[6-(4-prop-2-enoyloxybutoxycarbonyloxy)naphthalene-2-carbonyl]oxy-phenyl] 6-(4-prop-2-enoyloxybutoxycarbonyloxy)naphthalene-2-carboxylate,812-702-1,914918-26-6,Not Classified,REACH registration C&L,2,Not classified:2
251424,"Zeolite, phosphor and titanium containing, crystalline, synthetic, non fibrous",943-514-9,,STOT RE 2,REACH registration C&L,1,H373:1
251426,"(4{[11S,14S)-14-[3-(Carbamoylamino)propyl]-1-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-9,12,15-trioxo-11-(propan-2-yl)-3,6-dioxa-10,13-diazapentadecan-15-yl]amino}phenyl)methyl {(2S)-2-hydroxy-3-[(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-21-methoxy-14-methyl-8,15-dimethylidene-24-oxo-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35] hentetracontan-20-yl]propyl}carbamate",943-515-4,,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;Not classified:1;H312:1;H332:1
251427,"2,2'-{octahydro-1H-4,7-methanoindene-2,5-diylbis[(2,1-phenylene)oxymethylene]}bis(oxirane)",943-519-6,,Skin Sens. 1B;Muta. 2;Aquatic Chronic 4,REACH registration C&L,1,H341:1;H413:1;H317:1
251428,"Reaction product of 2,4-Dinitrotoluene and 2,6-Dinitrotoluene and hydrogen, deaminated",943-517-5,,Flam. Liq. 3;Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,83,H318:83;H226:83;H301:83;H314:83
251447,"N-(3-aminopropyl)-N- (C12-18 even numbered) alkyl-propane-1,3-diamine",812-713-1,1219458-12-4,Acute Tox. 3;Skin Corr. 1C;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H400:1;H314:1;H301:1;H411:1;H373:1;H410:1
251452,"Acetic acid, C8-10-branched alkyl esters, C9-rich",943-525-9,,Not Classified,REACH registration C&L,1,Not classified:1
251453,4-(Pyrrolidin-1-ylmethyl)benzylamine,812-712-6,91271-79-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H318:2;H314:1;H335:1;H302:1;H315:1
251463,"Reaction mass of trisodium bis[4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzene-1-sulphonato(3-)]ferrate(3-) and hydrogen bis[4-[4,5-dihydro-4-[(2-hydroxy-5-nitrophenyl)azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzene-1-sulphonato(3-)]ferrate(3-)",943-520-1,,Not Classified,REACH registration C&L,6,Not classified:6
251464,Strontium neodecanoate,812-724-1,106705-37-7,Acute Tox. 4;Eye Dam. 1,REACH registration C&L,5,H318:3;H302:3;Not classified:2
251466,Propan-2-yl (3S)-3-{[(S)-({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl){[2-methyl-1-oxo-1-(propan-2-yloxy)propan-2-yl]amino}phosphoryl]amino}-4-methylpentanoate—(2E)-but-2-enedioic acid (2/3),943-522-2,,STOT RE 1,Notified C&L,35,H372:35
251467,Gravimetric concentrate,943-523-8,,Carc. 2;Repr. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,1,H372:1;H360:1;H400:1;H351:1;H411:1
251468,"Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-[(2-methyl-1-oxo-2-propen-1-yl)oxy]-, ether with 2,2'-[oxybis",812-725-7,1203603-19-3,Eye Irrit. 2,Notified C&L,1,H319:1
251470,"Reaction mass of sodium 4-(4-acetamidophenylamino)-1-amino-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate and hydrogen 4-(4-acetamidophenylamino)-1-amino-9,10-dioxo-9,10-dihydroanthracene-2-sulfonate",943-524-3,,Aquatic Chronic 4,REACH registration C&L,4,H413:4
251471,"Reaction mass of sodium 7-hydroxy-8-((E)-(4-(1-(4-((E)-(4-hydroxyphenyl)diazenyl)phenyl)cyclohexyl)phenyl)diazenyl)naphthalene-1,3-disulfonate and sodium 8,8'-(1E,1'E)-(4,4'-(cyclohexane-1,1-diyl)bis(4,1-phenylene))bis(diazene-2,1-diyl)bis(7-hydroxynaphthalene-1,3-disulfonate)",943-526-4,,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,6,H319:6;H412:6
251472,Tall-oil fatty acids salts of condensation products of tall-oil fatty acids with diethanolamine and triethanolamine,,,Not Classified,REACH registration C&L,1,Not classified:1
251473,"Reaction mass of sodium thiosulphate, sodium sulphite, sodium polysulfide and sodium sulfide",943-531-1,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H400:1;H301:1;H314:1;H311:1
251474,3-[2-({[4-methanesulfonyl-2-(trifluoromethyl)phenyl]methyl}amino)pyridin-3-yl]prop-2-yn-1-ol,943-529-0,,Skin Sens. 1B;Aquatic Acute 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H401:1;H317:1
251475,"Fatty acids, C18 (even numbered) and C18 unsatd., reaction products with triethanolamine, di-Me sulfate quaternized",943-532-7,,Not Classified,REACH registration C&L,1,Not classified:1
251482,Reaction mass of 6-ethyl-3-methyloct-5-en-1-ol and 6-ethyl-3-methyloct-6-en-1-ol,943-533-2,,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,1,H319:1;H317:1
251487,"Reaction product of C16-22, even, C18-rich, unsaturated and saturated triglycerides with, N-(2-hydroxypropylamine)",943-537-4,,Not Classified,REACH registration C&L,1,Not classified:1
251488,"Succinic anhydride, alkylation products with C12-rich branched olefins from propene oligomerisation, hydrolyzed, esterification products with propylene oxide",943-535-3,,Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,4,H319:4;H317:4
251489,[No public or meaningful name is available],812-732-5,15873-42-4,Acute Tox. 3;Eye Dam. 1,Notified C&L,4,H318:4;H301:4
251491,"Isopropyl (1R,3S,4R,5R)-3-azido-5-hydroxy-4-[(2,3,4-tri-O-benzyl-6deoxy-α-L-galactopyranosyl)oxy]cyclohexanecarboxylate",812-733-0,1620677-97-5,Not Classified,REACH registration C&L,2,Not classified:2
251506,"Reaction Products of Diphosphorus Pentaoxide with Alcohols, C14-18 even, salted with Amines, C12-14, Tert-alkyl",943-540-0,,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,3,H400:3;H411:3;H317:3
251520,"Reaction mass of 2,4-dimethyl-6-phenyl-3,6-dihydro-2H-pyran and 2-methyl-4-methylene-6-phenyltetrahydro-2H-pyran and 4,6-dimethyl-2-phenyl-3,6-dihydro-2H-pyran",943-553-1,,Eye Irrit. 2B;Aquatic Chronic 3,REACH registration C&L,1,H319:1;H412:1
251524,cis-2- Pentylcyclopentanol,812-739-3,157357-30-7,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H319:1;H315:1
251525,"Essential oil obtained from the leaves of Cymbopogon flexuosus, gramineae by distillation",943-552-6,,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,21,H317:21;H315:21;H304:21;H411:21;H318:21
251527,Alkylolammonium salt,812-737-2,398475-96-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,118,H319:118;H400:73;H410:73;H315:73;H411:45
251532,Reaction mass of disodium [N-(2-chlorophenyl)-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-) and hydrogen[N-(2-chlorophenyl)-2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxobutyramidato(2-)][3-hydroxy-4-[(2-hydroxy-1-naphthyl)azo]-7-nitronaphthalene-1-sulphonato(3-)]chromate(2-),943-548-4,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,6,H411:6;H317:6
251533,"Poly(oxy-1,2-ethanediyl), a-sulfo-w-hydroxy-,C9-11-branched alkyl ethers, sodium salts",943-550-5,,Eye Irrit. 2,Notified C&L,1,H319:1
251534,"(1aR,5S,8S,10R,22aR)·5 tert·butyl-14·methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a tetradecahydro-8H-7,10·methanocyclopropa(18,19)(1,10,3,6)dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid",943-551-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,1,H413:1;H319:1;H335:1;H315:1
251567,"Reaction mass of Trisodium 4-({4-chloro-6-[(4-sulfonatophenyl)amino]-1,3,5-triazin-2-yl}amino)-2-{[1-ethyl-2-hydroxy-4-methyl-6-oxo-5-(sulfonatomethyl)-1,6-dihydropyridin-3-yl]diazenyl}benzenesulfonate and Trisodium 4-({4-chloro-6-[(3-sulfonatophenyl)amino]-1,3,5-triazin-2-yl}amino)-2-{[1-ethyl-2-hydroxy-4-methyl-6-oxo-5-(sulfonatomethyl)-1,6-dihydropyridin-3-yl]diazenyl}benzenesulfonate",944-218-2,,Resp. Sens. 1,REACH registration C&L,6,H334:6
251575,Yellow LF 6911,,,Not Classified,REACH registration C&L,1,Not classified:1
251579,"N1,N3-diallylpropane-1,3-diamine dihydrochloride",812-745-6,205041-15-2,Not Classified,REACH registration C&L,2,Not classified:2
251580,Sodium 3-fluoro-4-methylbenzoate,812-746-1,1805805-74-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251581,Sodium 2-fluoro-4-methylbenzoate,812-747-7,1708942-19-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251582,Sodium 2-chloro-5-methylbenzoate,812-748-2,118537-88-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251583,Sodium 4-chloro-2-methylbenzoate,812-749-8,203261-42-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251584,Sodium 2-fluoro-3-methylbenzoate,812-750-3,1708942-18-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251585,Sodium 2-fluoro-3-(trifluoromethyl)benzoate,812-751-9,1701446-41-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251586,Sodium 2-fluoro-4-(trifluoromethyl)benzoate,812-752-4,1708942-20-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251587,"4-Chloro-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile",812-754-5,24391-41-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
251588,"2,2,3,3,3-Pentafluoropropylamine hydrochloride",812-755-0,374-14-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:2;H315:3;H312:2;H332:2;H335:3
251589,"4-Bromo-1,1-difluoro-cyclohexane",812-756-6,1196156-51-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;H314:1;H227:1
251590,2-Amino-4-iodophenol,812-757-1,99969-17-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
251592,"2-Propen-1-aminium, N,N-dimethyl-N-2-propen-1-yl-, chloride (1:1), polymer with 2-hydroxypropyl 2-propenoate and 2-propenoic acid",812-758-7,67990-40-3,Skin Irrit. 2,Notified C&L,1,H315:1
251595,2-[3-(4-propylheptyl)morpholin-4-yl]ethanol,943-564-1,79874-76-3,Not Classified,REACH registration C&L,4,Not classified:4
251596,3-Chloro-2-hydroxybenzonitrile,812-759-2,13073-27-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251597,4-[(Trimethylsilyl)ethynyl]benzoic acid,812-760-8,16116-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90,H319:90;H335:90;H315:90
251598,Methyl 3-fluoro-5-nitrobenzoate,812-761-3,883987-72-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251599,4-(Difluoromethoxy)-2-fluorobenzaldehyde,812-762-9,1214358-05-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
251600,2-Amino-3-bromo-5-fluorophenol,812-763-4,1805027-31-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251601,2-Bromo-4-fluoro-6-methoxyaniline,812-765-5,354574-32-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251602,5-Bromo-2-nitrobenzenesulphonyl chloride,812-766-0,1193388-84-9,Skin Corr. 1B,Notified C&L,2,H314:2
251603,4-Bromo-2-nitrobenzenesulphonyl chloride,812-767-6,89465-98-5,Skin Corr. 1B,Notified C&L,2,H314:2
251604,2-Bromo-6-nitrobenzenesulphonyl chloride,812-768-1,1261675-40-4,Skin Corr. 1B,Notified C&L,1,H314:1
251605,3-Fluoro-5-nitrobenzyl alcohol,812-769-7,883987-74-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251611,"4-(2-Aminoethyl)aniline, 4-BOC protected",812-770-2,94838-59-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251612,Methyl diacetate,812-771-8,628-51-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251613,Perfluoro(tert-butyl) iodide,812-772-3,4459-18-1,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1;H330:1
251614,Hydroxy-PEG1-CH2CO2tBu,812-773-9,287174-32-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251615,2-Chloro-5-fluorophenylhydrazine hydrochloride,812-774-4,502496-25-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251616,"(5S)-N-tert-Butyloxycarbonyl-3,4,5,6-tetrahydro-5-phenyl-4(H)-1,4-oxazin-2-one",812-776-5,220077-24-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251617,Methyl 3-oxetaneacetate,812-777-0,1217800-69-5,Acute Tox. 4,Notified C&L,1,H302:1
251618,Azetidine-3-carboxamide hydrochloride,812-778-6,124668-45-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251619,"Pyrrolo[1,2-a]pyrimidine-6-carboxylic acid",812-779-1,1083196-26-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
251620,"1,3-Diiodotetrafluorobenzene",812-780-7,67815-57-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251621,BIIB021,812-781-2,848695-25-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251622,2-Fluoro-5-nitrobenzoyl chloride,812-782-8,709-46-6,Skin Corr. 1B,Notified C&L,1,H314:1
251623,(4-Cyanophenyl)phosphonic acid,812-783-3,16672-78-9,Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H332:1;H302:1;H314:1
251624,3-Hydroxymethyl-azetidine-1-carboxylic acid benzyl ester,812-784-9,618446-42-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
251625,"3-Bromo-5-chloroimidazo[1,2-a]pyrazine",812-785-4,1243389-43-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251626,"(3R)-3-(Bromomethyl)pyrrolidine, N-BOC protected",812-787-5,1067230-65-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
251627,exo-BCN-PEG4-acid,812-788-0,1421932-54-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251628,2-Bromo-2-methylpropanal,812-789-6,13206-46-7,Flam. Liq. 3,Notified C&L,2,H226:2
251629,2-Bromo-5-fluoro-3-nitropyridine,812-790-1,652160-72-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251631,"4-Chloro-1,2-dihydro-2-oxoquinoline-3-carbonitrile",812-792-2,680210-85-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251632,2-Bromo-3-iodobenzoic acid,812-793-8,855198-37-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251633,2-Bromo-6-iodobenzoic acid,812-794-3,1022128-96-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251636,"3-Cyano-6,7-dihydro-4-trifluoromethyl-1,5H-cyclopenta-[b]-pyrid-2-one",812-795-9,371967-27-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H335:1;H311:1
251637,5-Cyclopropyl-1-methyl-pyrazol-3-amine,812-796-4,1170238-67-1,Skin Corr. 1B,Notified C&L,1,H314:1
251638,4-(methoxycarbonyl)pyridine-3-carboxylic acid,812-798-5,24202-74-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H302:2;H315:3
251639,4-n-Butylbenzotrifluoride,943-573-0,,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
251641,"2,3,5,5-Tetrafluoro-4-(trifluoromethyl)",812-799-0,15895-68-8,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H331:2;H319:2;H315:2;H301:2;H335:2;H311:2
251642,[3-(1-piperidyl)phenyl]methanamine,812-800-4,175696-71-6,Skin Corr. 1B,Notified C&L,1,H314:1
251643,[(3S)-1-Benzylpyrrolidin-3-yl]methanamine hydrochloride,812-802-5,131852-54-5,Skin Corr. 1B,Notified C&L,1,H314:1
251644,"(15,16)β-Met",812-803-0,67372-68-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,1,H312:1;H332:1;H361:1;H302:1
251645,"13α-ethyl-11-methyliden-18,19-dinor-17α-hydroxy-17α-pregn-4-en-20-yn-3,3-ethylene oxoketal",943-574-6,,Aquatic Chronic 4,Notified C&L,1,H413:1
251646,Ethyl pentafluoroethyl ethyl ketone,812-804-6,378-72-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
251647,"Ethanedioic acid, monolithium salt",812-805-1,58567-85-4,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H302:1
251648,"4,4-Dimethyl-N-[2-[1-[2-[5-methyl-3-(trifluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]thiazol-4-yl]-2,6-dioxo-cyclohexanecarboxamide",943-575-1,,Aquatic Chronic 2,Notified C&L,89,H411:89
251649,(2R)-2-(tert-Butoxymethyl)oxirane,812-806-7,130232-98-3,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
251650,"3,3-Diisopropoxypropyl(triphenyl)phosphonium bromide",812-807-2,72931-54-5,Skin Corr. 1B,Notified C&L,1,H314:1
251651,Isobutyl Methanesulfonate,812-808-8,16156-53-9,Skin Corr. 1B,Notified C&L,2,H314:1;H319:1;H315:1
251652,3-(Biphenyl-4-ylamino)-2-cyano-acrylic acid ethyl ester,812-809-3,904815-00-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H335:1;H311:1
251654,"2,3-Difluoro-4-(trifluoromethyl)pyridine",812-811-4,1215034-77-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H226:1;H312:1;H332:1;H335:1
251656,3-(bromomethyl)-5-methylpyridine hydrobromide,812-813-5,1235342-53-6,,Notified C&L,2,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1;H314:1
251657,3-Fluoro-4-iodo-2-methylaniline,812-814-0,329927-16-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251658,4-Bromo-3-fluoro-2-methylaniline,812-815-6,127408-03-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251659,2-Fluoro-4-methyl-5-nitrophenol,812-816-1,110298-75-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251660,2-Fluoro-4-methyl-5-nitroanisole,812-817-7,3108-02-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251661,3'-Chloro-5'-methoxyacetophenone,812-818-2,214760-34-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251662,5-Chloro-2-nitro-4-(trifluoromethoxy)aniline,812-819-8,914637-23-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251663,4-Chloro-3-(trifluoromethoxy)aniline,812-820-3,97608-50-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1
251665,2-Bromo-6-methoxybenzotrifluoride,812-822-4,1214345-25-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251666,4-Chloro-3-(trifluoromethoxy)nitrobenzene,812-824-5,113421-97-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251667,2'-Fluoro-3'-methylacetophenone,812-825-0,865664-05-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251668,5-Fluoro-1-naphthaldehyde,812-826-6,110931-86-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251670,"1-tert-butyl 2-methyl 4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrole-1,2-dicarboxylate",812-828-7,942070-38-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
251671,2-Chloro-6-isopropoxypyridine,812-829-2,89481-98-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
251672,2-(Difluoromethyl)pyridin-4-ol,812-830-8,501125-75-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251673,3-Chloro-4-hydroxypyridine,812-831-3,89284-20-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
251674,4-Iodo-2-nitrophenol,812-832-9,21784-73-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
251675,"5-Acetyl-2,2-difluoro-1,3-benzodioxole",812-833-4,136593-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251676,4-Bromo-2-fluoro-3-methylbenzonitrile,812-835-5,1114546-30-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251677,4’-Bromo-5’-chloro-2’-fluoroacetophenone,812-836-0,1594605-40-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
251678,4-Bromo-5-chloro-2-fluorobenzoic acid,812-837-6,1349708-91-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
251679,4-Amino-2-fluoro-3-methylbenzonitrile,812-838-1,757247-93-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251680,3'-Bromo-5'-chloroacetophenone,812-839-7,154257-85-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251684,3-Bromo-5-nitrophenol,812-840-2,116632-23-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251685,2-Amino-3-fluorophenol,812-841-8,53981-23-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251686,4-Amino-3-hydroxybenzonitrile,812-842-3,55586-26-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251692,3-Fluoro-4-iodobenzotrifluoride,812-847-0,132554-73-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251693,3-Fluorophenylsulphur pentafluoride,812-848-6,1422-41-9,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H226:1;H312:1;H332:1;H335:1
251694,"2,3-Diamino-6-fluorobenzotrifluoride",812-849-1,1440535-07-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251695,(3-bromo-5-methoxyphenyl)methanol,812-850-7,262450-64-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
251696,1-bromo-3-(bromomethyl)-5-methoxybenzene,812-851-2,59297-29-9,Acute Tox. 4;Skin Corr. 1B,Notified C&L,2,H302:2;H314:2;H335:1
251699,"trans-4-((2-Amino-3,5-dibromobenzyl)amino)cyclohexanol Hydrobromide",812-853-3,1185314-26-4,Aquatic Chronic 2,Notified C&L,1,H411:1
251702,(2S)-2-aminopent-4-ynoic acid,812-854-9,23235-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
251703,"2-Chloro-1,3-benzothiazole-6-carboxylic acid",812-855-4,3855-95-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251707,Methyl 2-bromo-3-nitrobenzoate,812-859-6,5337-09-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
251710,4-Fluoro-2-methyl-6-nitroaniline,812-862-2,147285-87-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251711,3-(3-nitrophenyl)-3-oxopropanenitrile,812-863-8,21667-64-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
251712,5-Amino-2-(trifluoromethoxy)benzotrifluoride,812-864-3,104678-68-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251713,4-(Perfluorobutyl)anisole,812-865-9,153910-98-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251714,2-Amino-5-bromo-3-fluorobenzoic acid,812-866-4,874784-14-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251715,3-[(Trifluoromethyl)sulphanyl]benzonitrile,812-868-5,660-44-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251716,3-(Trifluoromethylthio)benzyl alcohol,812-869-0,82174-08-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251717,"(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile",812-870-6,128196-01-0,Acute Tox. 4;Skin Sens. 1,Notified C&L,1,H302:1;H317:1
251718,3'-(Trifluoromethylthio)acetophenone,812-871-1,56773-33-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251719,Methyl 2-amino-6-fluoro-3-nitrobenzoate,812-872-7,346691-23-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
251720,"Methyl 2,3-diamino-6-fluorobenzoate",812-873-2,403712-67-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT SE 3,Notified C&L,1,H312:1;H332:1;H335:1;H302:1
251730,"4-Amino-4-methylpiperidine, 4-BOC protected",812-875-3,163271-08-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
251731,"4-(2,2,2-Trifluoroethoxy)phenylhydrazine hydrochloride",812-876-9,115171-04-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
251732,methyl 8-(6-hexyl-2-undecyltetrahydro-2H-pyran-3-yl)octanoate,943-596-6,,Asp. Tox. 1,Notified C&L,2,H304:2
251733,"4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluorononyl methacrylate",812-877-4,1228350-17-1,STOT RE 2,REACH registration C&L,1,H373:1
251735,8-hexyl-10-methyl-7methylenehexadecane,943-598-7,,Asp. Tox. 1,Notified C&L,1,H304:1
251736,12-methyl-9-methylene-10-octylicosane,943-599-2,,Asp. Tox. 1,Notified C&L,1,H304:1
251737,Undistilled 12-methyl-9-methylene-10-octylicosane,943-600-6,,Asp. Tox. 1,Notified C&L,1,H304:1
251738,"9, 12-dimethyl-10-octylicosane",943-601-1,,Asp. Tox. 1,Notified C&L,1,H304:1
251739,Methyl 3-amino-5-bromo-2-methoxybenzoate,812-879-5,926069-76-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251740,5-Bromo-2-iodoaniline,812-880-0,64085-52-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H302:3;H315:2;H312:1;H332:1
251741,3-Amino-5-bromo-2-methoxybenzoic acid,812-881-6,60541-85-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251742,"1,3-Benzodioxole-5,6-diamine",812-882-1,38608-07-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251743,3-Chloro-5-methoxybenzaldehyde,812-883-7,164650-68-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251744,3-Chloro-5-methoxybenzyl bromide,812-884-2,885270-32-6,Skin Corr. 1B,Notified C&L,1,H314:1
251745,Methyl 3-bromo-4-(trifluoromethyl)benzoate,812-885-8,455941-82-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251749,"Methyl-4,5-dichloro-3-(chlorosulfonyl)thiophene-2-carboxylate",943-603-2,,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H318:1;H412:1;H317:1
251750,Reaction mass of ammonium 4-amino-3-nitrobenzenesulfonate and sodium 4-amino-3-nitrobenzenesulfonate,943-604-8,,Eye Irrit. 2,Notified C&L,31,H319:31
251751,"flutianil (ISO); (2Z)-{[2-fluoro-5-(trifluoro­methyl)phenyl]thio}[3-(2-methoxyphenyl)-1,3-thiazolidin-2-ylidene]acetonitrile",812-888-4,958647-10-4,Aquatic Chronic 1,Harmonised C&L,0,H410:0
251752,"Benzenepropanamine, gamma-ethyl-3-methoxy-N,N,beta-trimethyl-, trifluoroacetate , (betaR,gammaR)-",812-890-5,1071929-06-0,Acute Tox. 3,Notified C&L,1,H301:1
251753,2-chloro-5-methylpyridine 1-oxide,812-891-0,20173-49-3,Expl. 1.1,REACH registration C&L,2,H201:2
251754,"6- Fluoro-3-[(2S)-2-methyl-1-piperidinyl]-[1,2,4]-[triazolo]4,3-alpha]pyridine hydrochloride",943-605-3,,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
251755,5-Chloro-3-[(methylamino)sulfonyl]-2-thiophene carboxylic acid,812-892-6,70374-36-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H332:1;H302:1;H319:1;H335:1;H315:1
251756,5-Chloro-3-sulfo-2-thiophene carboxylic acid mono sodium salt,812-893-1,187746-94-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251757,5-Chloro-3-sulfino-N-[tris(hydroxymethyl)methyl]thiophene-2- carboxamide potassium salt,943-606-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251760,N-[1-(4-bromoisoxazol-3-yl)-1-methyl-ethyl]-2-[(3-ethynyl-6-quinolyl)oxy]-2-methylsulfanyl-acetamide,943-610-0,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
251761,"1-chloro-2,2,5,5-tetramethylimidazolidin-4-one",812-894-7,38951-85-8,Flam. Sol. 1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H228:1;H319:1;H302:1;H315:1
251765,sulfurised olefin,,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H315:1
251766,"2-butanone , reaction products",812-895-2,1627113-88-5,Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H314:1;H317:1
251767,benzylated DETA-KETA-MEK ketamine,812-896-8,1635370-77-2,Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H314:1;H317:1
251769,(2-Ethylhexyl) (hydrogenated tallow alkyl) methylamine,943-612-1,,Asp. Tox. 1;Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,5,H400:5;H315:5;H304:5;H373:5;H318:5;H410:5
251771,"N-(6-methylpyridin-2-yl)-6-chloro-4-hydroxy-2-methyl-2H-thieno-[2,3-e]- 1,2-thiazine-3-carboxamide 1,1-dioxide",943-613-7,,Acute Tox. 2;Acute Tox. 2,Notified C&L,1,H300:1;H310:1
251774,"Reaction mass of Disodium [1-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl-kN1}naphthalen-2-olato(2-)-kO][3-(hydroxy-kO)-4-{[2-(hydroxy-kO)naphthalen-1-yl]diazenyl-kN1}-7-nitronaphthalene-1-sulfonato(3-)]chromate(2-) and Disodium [1-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl-kN2}naphthalen-2-olato(2-)-kO][3-(hydroxy-kO)-4-{[2-(hydroxy-kO)naphthalen-1-yl]diazenyl-kN1}-7-nitronaphthalene-1-sulfonato(3-)]chromate(2-)",944-038-4,,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7,H400:7;H410:7
251775,"1-Methoxy-3,3,3-trifluoropropene",812-897-3,26885-71-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H226:2;H319:1;H335:1;H315:1
251776,"Phenol, 2-(2H-benzotriazol-2-yl)-6-dodecyl-4-methyl-, branched and linear",943-614-2,,Aquatic Chronic 2,Notified C&L,25,H411:25
251777,"[5aR-(5aα,8aβ,9α)]-5a,6,8a,9-Tetrahydro-9-(3,4,5-trimethoxyphenyl)-furo[3’,4’:6,7]naphtho[2,3-d]-1,3-dioxole-5,8-dione",812-898-9,477-49-6,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H315:1;H301:1;H312:1;H332:1;H335:1
251778,[1-(tert-Butoxycarbonyl)-4-(4-fluorophenyl)piperidin-4-yl]acetic acid,812-899-4,644981-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251779,"(15S,17S,2R)-17-hydroxy-2,15-dimethyl-14-[(4R)-4-methyl-1,3- dioxan-2-ylcarbonyl]tetracyclo[8.7.0.02,7.011,15]heptadeca-3,6- dien-5-one",943-615-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251780,"(15S,17S,2R)-17-hydroxy-2,15-dimethyl-14- [(4S)-4-methyl-1,3-dioxan-2- ylcarbonyl]tetracyclo[8.7.0.02,7.011,15]he ptadeca-3,6-dien-5-one",943-616-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251781,4-(2-Methoxycarbonylethyl)benzeneboronic acid,812-900-8,850568-44-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251782,"2-(6-Aminohexylamino)-1-(3,4-dihydroxybenzene)ethanol sulfate",943-618-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251784,"2,4-Dichlorobenzo[4,5]thieno[3,2-d]pyrimidine",812-901-3,160199-05-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251786,"3,3-Bis(trifluoromethyl)-4,4,4-trifluorobutan-1-ol",812-902-9,14115-49-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251787,"3-bromo-3',4',5'-triphenyl-1,1':2',1''-terphenyl",812-903-4,872118-06-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251788,"4,4,5,5-tetramethyl-2-(10-(naphthalen-2-yl)anthracen-9-yl)-1,3,2-dioxaborolane",812-905-5,922518-84-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251789,"Ethyl 2,6-difluorobenzoate",943-621-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251790,"Ethyl 3,4,5-trifluorobenzoate",812-906-0,495405-09-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251791,"3-methyl-1,2-benzothiazole 1,1-dioxide",812-907-6,34989-82-7,Not Classified,REACH registration C&L,1,Not classified:1
251792,2-(Trifluoromethyl)morpholine hydrochloride,812-908-1,1196152-51-8,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:1;H312:1;H332:1;H335:2;H315:1
251793,4-Chloro-5-fluoropyrimidine,812-909-7,347418-42-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:2;H315:3;H312:1;H332:1;H335:3
251794,"Imidazo[1,2-a]pyridine-5-carboxylic acid",812-910-2,479028-72-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251795,(Perfluorohexyl)trifluorooxirane,812-911-8,87375-53-9,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H225:1;H315:1
251796,[No public or meaningful name is available],,,Self-heat. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H302:1;H332:1;H252:1
251797,(4-Bromopyridin-2-yl)methanol,812-912-3,131747-45-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
251798,TCBD-1,,,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H228:1;H319:1;H335:1;H315:1
251799,"2,2,4,4-tetramethylcyclobutane-1,3-diol",812-914-4,2694-23-7,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H228:2;H319:2;H335:2;H315:2
251800,"Amides, C8-18 (even-numbered), C18unsatd, N-[3-(dimethylamino)propyl]",944-209-3,,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2,H400:2;H302:2;H314:2;H317:2;H411:2;H318:2
251801,3-(Difluoromethoxy)phenol,812-916-5,88798-13-4,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,Notified C&L,3,H315:3;H301:1;H412:1;H318:1;H335:2;H319:1;H302:1;H312:1;H332:1
251802,Piperidine-2-carbonitrile hemioxalate,812-917-0,1523571-93-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251803,Ethyl 4-chloropicolinate,812-918-6,64064-56-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251807,"Reaction mass of rel-(2R,3aR,6R,7aR)-2,6-dimethyl-3a-(propan-2-yl)octahydro-1-benzofuran and rel-(2R,3aR,6S,7aR)-2,6-dimethyl-3a-(propan-2-yl)octahydro-1-benzofuran and rel-(2R,3aS,6S,7aS)-2,6-dimethyl-3a-(propan-2-yl)octahydro-1-benzofuran",943-623-1,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H317:1
251808,"(5S)-3,4,5,6-Tetrahydro-5-phenyl-N-(benzyloxycarbonyl)-4(H)-1,4-oxazin-2-one",812-919-1,147700-91-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251809,"O-trityl-L-threonine, N-FMOC protected",812-920-7,133180-01-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251812,"Reaction mass of (7R,13S,17S)-13-methyl-3-oxo-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-2,3,6,7,8,9,10,11,12,13,14,15,16, 17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate and (7S,13S,17S)-13-methyl-3-oxo-7-(9-((4,4,5,5,5-pentafluoropentyl)thio)nonyl)-2,3,6, 7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate",943-624-7,,Not Classified,REACH registration C&L,2,Not classified:2
251813,Cresol novolak epoxy anhydride,812-922-8,168750-21-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
251815,"6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purine-2-thione",812-923-3,43157-50-2,Acute Tox. 4,Notified C&L,1,H302:1
251816,"N,N''-(methyl-m-phenylene)bis[N',N'-dimethylurea]",943-625-2,,Not Classified,REACH registration C&L,1,Not classified:1
251817,Polycarbonate polyol,812-924-9,700359-17-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H301:1;H315:1
251822,4-[fluoro(dimethyl)silyl]butanenitrile,812-925-4,1639345-42-8,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Acute Tox. 2;STOT RE 2;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,3,H319:2;H302:1;H317:1;H412:1;H330:1;H402:1;H373:1;H314:1;H300:1;H315:1;H332:1;H310:1
251823,"Reaction products of N6,N6'-hexane-1,6-diylbis[N2,N4-dibutyl-N2,N4,N6-tris(2,2,6,6-tetramethylpiperidin-4-yl)-1,3,5-triazine-2,4,6-triamine] and allylbromide, subsequently reacted with ethaneperoxoic acid, hydrogenated",812-927-5,1902936-62-2,Not Classified,REACH registration C&L,84,Not classified:84
251825,[No public or meaningful name is available],,,Aquatic Chronic 3,Notified C&L,1,H410:1
251827,5-formylpyridine-3-carbonitrile,812-930-1,70416-53-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251829,"tert-butyl (4aS,7aS)-2,3,4,4a,5,6,7,7a-octahydropyrrolo[3,4-b]pyridine-1-carboxylate",812-932-2,159991-07-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2;H312:1;H332:1
251830,"ert-butyl (4aR,7aR)-2,3,4,4a,5,6,7,7a-octahydropyrrolo[3,4-b]pyridine-1-carboxylate",812-933-8,186201-89-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251831,"tert-butyl (3aR,6aR)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[2,3-c]pyrrole-5-carboxylate",812-934-3,370882-39-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251832,5-bromo-2-fluoro-3-methylbenzonitrile,812-935-9,1110502-49-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2;H312:1;H332:1
251833,1-(METHYL-D3)-4-NITRO-1H-PYRAZOLE,812-936-4,1447606-92-9,Acute Tox. 4,Notified C&L,1,H302:1
251834,tert-butyl N-(5-hydroxypiperidin-3-yl)carbamate,812-938-5,1502766-14-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
251835,2-Fluoro-4-(methoxycarbonyl)benzoic acid,812-939-0,314241-04-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H302:2;H315:3
251836,"(1-(TERT-BUTOXYCARBONYL)-1,4,5,6-TETRAHYDROPYRIDIN-3-YL) BORONIC ACID PINACOL ESTER",812-940-6,1121057-77-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251837,"2-(2,5-difluorophenyl)ethanol",812-941-1,862255-56-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
251839,Sodium 4-(4-substitutedanilino)-4-substituedbut-2-enoate,,,Skin Sens. 1B,REACH registration C&L,1,H317:1
251840,"(2R,3S,4R,5R)-2-(hydroxyMethyl)-5-(6-((2-(Methylthio)ethyl)aMino)-2-((3,3,3-trifluoropropyl)thio)-9H-purin-9-yl)tetrahydrofuran-3,4-diol",812-944-8,163706-58-9,Skin Irrit. 2,Notified C&L,1,H315:1
251841,4-CHLORO-3-(4-METHYLPIPERAZIN-1-YL)PHENOL,812-945-3,177489-11-1,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H302:1;H314:1
251843,DIMETHYL (CYANOMETHYL)PHOSPHONATE,812-946-9,21658-92-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H311:1
251844,"(S)-2,2,4-trimethylpyrrolidine hydrochloride",943-629-4,1897428-40-8,Not Classified,REACH registration C&L,3,Not classified:3
251845,"(2S)-2-aminobutanedioic acid;(1S,3R,4E,6E,8E,10Z,12Z,14E,16E,23R,27R,29R,31S,33S,35R,37S,38R)-3-[(2R,3S,4S,5S,6R)-4-[[2-(dimethylamino)acetyl]amino]-3,5-dihydroxy-6-methyloxan-2-yl]oxy-N-(2-dimethylaminoethyl)-23,27,29,31,33,35,37-heptahydroxy-19-[(2S)-5-hydroxy-7-[4-(methylamino)phenyl]-7-oxoheptan-2-yl]-18-methyl-21,25-dioxo-20,39-dioxabicyclo[33.3.1]nonatriaconta-4,6,8,10,12,14,16-heptaene-38-carboxamide",812-947-4,143563-20-6,Acute Tox. 3,Notified C&L,1,H301:1
251846,"A mixture of: isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-dodecylphenol; isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-(n)-tetracosylphenol; isomers of 2-(2H-benzotriazol-2-yl)-4-methyl-5,6-didodecyl-phenol. n=5 or",943-631-5,,Aquatic Chronic 2,Notified C&L,1,H411:1
251850,"3-Hydroxy-N,N,N-trimethylanilinum methylsulfate",943-633-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251851,2-[4-(2-piperidin-1-ylethoxy)benzoyl]benzoic acid,812-949-5,130566-58-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251853,"Reaction mass of methyl 6-chloro-4-hydroxy-2-methyl-2H-thieno [2,3-e][1,2] thiazine-3- carboxylate 1,1-dioxide and methyl 6-chloro-4-hydroxy-2H-thieno (2,3-e)(1,2)thiazine-3-carboxylate 1,1-dioxide",943-634-1,,Acute Tox. 3;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H301:1;H317:1
251854,"6,7-Dichloro-4-hydroxy-2H-thieno- [2,3-e]-1,2-thiazine-3-carboxylic acid methylester 1,1-dioxide",943-650-9,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
251855,"Reaction mass of Methyl 4-hydroxy-2H-thieno[2,3- e][1,2]thiazine-3-carboxylate 1,1- dioxide and 6,7-Dichloro-4-hydroxy-2H-thieno- [2,3-e]-1,2-thiazine-3-carboxylic acid methylester 1,1-dioxide and 5-Chloro-3[[(methoxycarbonyl) methylamino]sulfonyl]-2- thiophenecarboxylic acid methylester and methyl 6-chloro-4-hydroxy-2H-thieno (2,3-e)(1,2)thiazine-3-carboxylate 1,1-dioxide",943-635-7,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
251856,"4,5-Dichloro-3- [[(methoxycarbonyl)methylamino]sulfony l]-2-thiophene carboxylic acid methylester",943-658-2,,Aquatic Chronic 3,Notified C&L,1,H412:1
251857,"Reaction mass of 5-Chloro-3[[(methoxycarbonyl) methylamino]sulfonyl]-2- thiophenecarboxylic acid methylester and 3-[[(Methoxycarbonyl )methylamino]sulfonyl]-2- thiophene carboxylic acid methyl ester and Methyl 5-chloro-3- (chlorosulfonyl)thiophene-2- carboxylate and 4,5-Dichloro-3- [[(methoxycarbonyl)methylamino]sulfony l]-2-thiophene carboxylic acid methylester",943-636-2,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H317:1
251858,7-Chloroethyl-8-benzyltheophyllin,943-637-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251859,"3,4-Dimethoxy-1,2,5-thiadiazole",812-951-6,55904-37-5,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H373:1;H412:1;H301:1;H317:1
251860,tert-Butyl 3-amino-4-fluoropyrrolidine-1-carboxylate,943-638-3,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251862,"Reaction Mass of disodium [(E)-7-nitro-3-oxido-4-((2-oxidonaphthalen-1-yl)diazenyl)naphthalene-1-sulfonate) (E)-1-((3,5-dinitro-2-oxidophenyl)diazenyl)naphthalen-2-olate) chromate(2-)] and Hydrogen [(E)-7-nitro-3-oxido-4-((2-oxidonaphthalen-1-yl)diazenyl)naphthalene-1-sulfonate)(E)-1-((3,5-dinitro-2-oxidophenyl)diazenyl)naphthalen-2-olate) chromate(2-)]",943-640-4,,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,7,H400:7;H410:7
251863,"(R,R)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride",943-642-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251864,"(S,S)-N,N′-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminochromium(III) chloride",943-643-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251867,"N-(6-aminopyridin-2-yl)-6-chloro-4-hydroxy-2-methyl-2H-thieno-[2,3-e]-1,2-thiazine-3-carboxamide 1,1-dioxide",943-646-7,,Acute Tox. 1;Acute Tox. 1,Notified C&L,1,H300:1;H310:1
251868,"4-Methoxy-1,2,5-thiadiazole-3-carbonitrile",943-647-2,,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H373:1;H412:1;H301:1;H317:1
251869,"6,7-Dichloro-4-hydroxy-2-methyl-N-(2-pyridinyl)-2H-thieno-[2,3-e]-1,2- thiazine-3-carboxamide 1,1-dioxide",943-648-8,,Acute Tox. 1;Acute Tox. 1,Notified C&L,1,H300:1;H310:1
251870,"6,7-Dichloro-4-hydroxy-2-methyl-2H-thieno-[2,3-e]-1,2-thiazine-3- carboxylic acid methylester 1,1-dioxide",943-649-3,,Acute Tox. 3;Aquatic Chronic 3,Notified C&L,1,H412:1;H301:1
251871,"3,4,5-Trimethoxybenzoic acid, 3-[[2-[3- (hydroxypropyl)methylamino]ethyl]methylamino]propylester",812-952-1,63257-33-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251872,(2-Pyridyl)-oxamic acid potassium salt,943-651-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251873,5-Chloro-3-sulfinothiophene-2-carboxylic acid,812-953-7,187746-97-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251874,"tert-Butyl N-[(1R*,2S*,5S*)-7-oxo-6-oxabicyclo[3.2.1]oct-3-en-2-yl]carbamate",812-954-2,1228186-88-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
251875,"Reaction mass of (E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one and (E) -1-(2,6,6-trimethylcyclohex-2-en-1-yl)pent-1-en-3-one and (E) -1-(2,6,6-trimethylcyclohex-1-en-1-yl)pent-1-en-3-one",943-653-5,,Skin Irrit. 2;Eye Irrit. 2B;Aquatic Chronic 2,REACH registration C&L,3,H319:3;H411:3;H315:3
251876,N-[3-(Aminomethyl)phenyl]-N-methylacetamide hydrochloride,812-955-8,849020-90-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251879,4-methoxy-N-methyl-3-nitrobenzamide,812-957-9,333350-60-0,Acute Tox. 4,Notified C&L,1,H302:1
251881,Zinc(dihydroxyterephthalate),943-656-1,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H315:1;H335:1;H410:1
251883,"Amines, (2-ethylhexyl)(hydrogenated tallow alkyl)methyl",812-958-4,1078712-76-1,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H319:1;H400:1;H410:1;H315:2;H317:1;H412:1;H402:1;H318:1
251884,"2-Propenoic acid, 2-methyl-, polymer with butyl 2-propenoate, ethenylbenzene and methyl 2-methyl-2-propenoate, zinc salt",,62180-77-2,Not Classified,Notified C&L,1,Not classified:1
251891,2-(2-Nitrophenyl)malondialdehyde,812-961-0,386715-37-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251892,"Ceramide (Octadecanamide, N-[(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl])",812-962-6,34354-88-6,Not Classified,REACH registration C&L,9,Not classified:9
251893,"9-Octadecenamide, N-[(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-, (9Z)-",812-963-1,178436-06-1,Not Classified,REACH registration C&L,9,Not classified:9
251895,chlorid acid,943-664-5,,Met. Corr. 1;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H314:1;H335:1;H290:1
251896,"Reaction mass of nonane-1,3-diyl diacetate and tetrahydro-3-pentyl-2H-pyran-4-yl acetate",943-794-2,,Aquatic Chronic 3,REACH registration C&L,2,H412:2
251897,RD 14153,943-665-0,,Not Classified,REACH registration C&L,2,Not classified:2
251898,(2-Chloro-5-methyl-4-(methylsulfonyl)phenyl)hydrazine,943-666-6,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
251899,tert-Butyl ethyl(piperidin-4-yl)carbamate,812-964-7,313977-45-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
251905,[4-[2-[2-(dimethylamino)-2-oxoethoxy]-2-oxoethyl]phenyl]4-(diaminomethylideneamino)benzoate; carbonate,814-267-3,916043-52-2,Not Classified,REACH registration C&L,2,Not classified:2
251907,"[(2R,6R,10S,11R,13R,15R,17R)-13-Benzyl-6-hydroxy-15-isopropenyl-4,17-dimethyl-5-oxo-12,14,18-trioxapentacyclo[11.4.1.01,10.02,6.011,15]octadeca-3,8-dien-8-yl]methyl (4-acetoxy-3-methoxyphenyl)acetate",943-667-1,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1;Acute Tox. 3;Muta. 1B,Notified C&L,1,H331:1;H314:1;H301:1;H340:1;H311:1
251910,"2-[(E)-(6-Methyl-2,3,4,9-tetrahydro-1H-carbazol-1-ylidene)amino] ethanol",814-577-9,110951-48-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,2,H413:2;H319:2;H335:2;H315:2
251911,"6-Methyl-1-(2-chloroethylimino)-1,2,3,4-tetrahydrocarbazole hydrochloride",814-575-8,110951-51-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,REACH registration C&L,2,H413:2;H319:2;H335:2;H315:2
251912,N-[4-(4-Azidosalicylamido)butyl]3-(2'-pyridyldithio)propionamide,812-965-2,147492-84-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251913,2-Bromo-5-(trifluoromethyl)benzeneboronic acid 96%,812-966-8,957034-38-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H335:1
251914,tert-Butyl azetidin-3-yl(methyl)carbamate hydrochloride,812-967-3,943060-59-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H302:1;H315:3
251917,"Reaction mass of 1,5-diamino-4,8-dihydroxy(4-hydroxyphenyl)anthraquinone and 1,5-diamino-4,8-dihydroxy-2-(4-methoxyphenyl)anthraquinone",943-670-8,,Skin Sens. 1A,REACH registration C&L,10,H317:10
251919,"2-Fluoro-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzoic acid—hydrogen chloride (1/2)",812-968-9,1197377-34-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
251920,Conotoxin Ac1.1b,812-969-4,1174710-25-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
251922,"1-Bromo-3,3,4,4,5,5,6,6,6-nonafluorohexane",812-971-5,38436-14-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
251923,"Conotoxin ArIB [V11L,V16A]",812-972-0,1003196-23-3,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
251924,"Reaction mass of chloride and 1,4-dioxane",943-672-9,,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1;Eye Dam. 1;STOT SE 3;Carc. 2,Notified C&L,1,H314:1;H351:1;H225:1;H312:1;H318:1;H335:1
251925,"Reaction mass of ammonia and 1,4-dioxane",943-673-4,,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Carc. 2,Notified C&L,1,H319:1;H302:1;H315:1;H351:1;H225:1;H332:1
251926,"Reaction mass of Diazomethyl(trimethyl)silane and 1,1'-oxydiethane",943-675-5,,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 1;STOT SE 3;Carc. 1B,Notified C&L,1,H302:1;H225:1;H330:1;H350:1;H336:1
251927,Reaction mass of magnesium ethyne bromide and tetrahydrofuran,943-676-0,,Flam. Liq. 2;Water-react. 1;Asp. Tox. 1;Skin Corr. 1A;Carc. 2;Repr. 2,Notified C&L,1,H314:1;H304:1;H351:1;H225:1;H260:1;H373:1;H361:1
251928,Conotoxin MII [E11A],812-973-6,223416-51-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
251929,"[5-Methanesulfonyl-2-((R)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-[(1R,5R)-1-(5-trifluoromethyl-isoxazol-3-yl)-3-aza-bicyclo[3.1.0]",812-974-1,1421936-85-7,Acute Tox. 2;STOT RE 1,Notified C&L,1,H372:1;H300:1
251930,"Reaction mass of Magnesium;heptane;bromide and 1,1'-oxydiethane",943-677-6,,Flam. Liq. 1;Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H224:1;H302:1;H314:1;H335:1
251931,Reaction mass of titanium tetrachloride and dichloromethane,943-678-1,,Skin Corr. 1C;Carc. 1B,Notified C&L,1,H350:1;H314:1
251932,2-(2-bromoethyl)oxirane,812-975-7,13287-42-8,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H226:2;H319:1;H335:2;H315:2;H302:1;H318:1
251933,"6-Amino-2-ethyl-1,3-benzothiazole",812-976-2,17142-81-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251934,"1,2-thiazole-3-carbonitrile",812-977-8,1452-17-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
251935,"2,4-Dihydro-5-[2,4-dihydroxy-5-isopropylphenyl]-4-(1-methyl-1H-indol-5-yl)-3H-1,2,4-triazol-3-one",812-978-3,888216-25-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251936,3-Chloro-4-fluoro-6-nitro-toluene,812-979-9,1352457-29-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
251937,"3,4,5-TRICHLOROPHENYLBORONIC ACID",812-980-4,862248-93-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
251938,2-Chloro-5-(trifluoromethoxy)pyridine,812-982-5,1206972-45-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2;H332:1
251939,"N-[2-(4-cyclopropylphenyl)-1,1-dimethyl-2-oxo-ethyl]-2,6-difluoro-benzamide",943-679-7,,Aquatic Chronic 1,Notified C&L,89,H410:89
251940,Conotoxin PeIA,812-983-0,866876-88-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
251941,Reaction mass of propan-2-ol and butan-1-ol and O-isopropyl ethylthiocarbamate,943-680-2,,Flam. Liq. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H302:2;H227:2;H315:2;H411:2
251943,"Benzamide, N-[(cyclohexylamino)thioxomethyl]-",812-984-6,4921-92-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,13,H400:13;H410:13
251945,(2-Pyrrolidin-1-ylphenyl)methanamine,812-985-1,72752-53-5,Skin Corr. 1B,Notified C&L,3,H314:3;H335:1;H302:2;H312:1;H332:1
251947,methyl 6-fluoro-1H-indole-4-carboxylate,812-987-2,1082040-43-4,Not Classified,Notified C&L,2,Not classified:1;H301:1
251948,2IP,812-988-8,2365-40-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;Not classified:1
251949,(Arg8)-Vasotocin,812-989-3,113-80-4,Repr. 2,Notified C&L,1,H361:1
251951,1-(4-BROMOPHENYL)NAPHTHALENE,812-991-4,204530-94-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
251952,"3,4-DIFLUOROSTYRENE",812-993-5,405-03-8,Flam. Liq. 3,Notified C&L,1,H226:1
251957,Amide and Derivatives,,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
251961,"5-bromo-1H-1,2,3-benzotriazole",813-000-8,32046-62-1,,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
251962,"5-chloro-1H-pyrazolo[4,3-d]pyrimidine",813-001-3,633328-98-0,,Notified C&L,3,H319:3;H335:3;H302:3;H315:3
251966,"(1R,3E,6R,7E,9S,11E,14S,16R,17S,18R,19S)-6-hydroxy-19-(1H-indol-3-ylmethyl)-7,9,16,17-tetramethyl-15-oxa-20-azatetracyclo[11.8.0.01,18.014,16]henicosa-3,7,11-triene-2,5,21-trione",813-006-0,50335-03-0,,Notified C&L,2,H319:2;H335:1;H315:1;H312:1;H302:1
251968,2-bromothiophene-3-carbaldehyde,813-009-7,1860-99-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2;H312:1;H332:1
251969,"6-Chloro-1H-pyrazolo[3,4-b]pyrazine",813-010-2,1260664-81-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H312:1;H319:1
251971,"tert-butyl 5-amino-2,3-dihydro-1H-indole-1-carboxylate",813-012-3,129487-92-9,,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
251972,4-methoxy-3-nitrophenol,813-013-9,15174-02-4,,Notified C&L,2,H319:2;H302:2;H312:2;H332:2;H335:2;H315:1
251973,[No public or meaningful name is available],,,Skin Corr. 1B,Notified C&L,1,H314:1
251975,(2R)-2-methylmorpholine hydrochloride,813-017-0,168038-14-0,,Notified C&L,3,H319:3;H302:3;H315:3;H312:1;H332:1;H335:3
251996,"Lignin, sodium salt",813-021-2,37203-80-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
251998,1-Ethylpyrazole-3-carbonyl chloride,813-023-3,1006471-16-4,Skin Corr. 1B,Notified C&L,2,H314:2
251999,"Copolymer of vinyl pyrrolidone, dimethylaminoethylmethacrylate, stearyl acrylate and PPG-3 acrylate monomers",813-024-9,160364-67-0,Aquatic Chronic 3,Notified C&L,1,H412:1
252000,"Ethyl 2-((6-amino-2,3-dichlorobenzyl)amino)acetate",813-025-4,70406-92-7,Skin Sens. 1;Muta. 2;Carc. 2,Notified C&L,2,H341:2;H351:2;H317:2
252001,Barium Europium Strontium Silicate,813-027-5,1273018-30-6,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
252004,"Reaction mass of 1,3,5-tris(5-isocyanatopentyl)-1,3,5-triazinane-2,4,6-trione and 1-{5-[3,5-bis(5-isocyanatopentyl)-2,4,6-trioxo-1,3,5-triazinan-1-yl]pentyl}-3,5-bis(5-isocyanatopentyl)-1,3,5-triazinane-2,4,6-trione",943-686-5,,Skin Sens. 1,REACH registration C&L,2,H317:2
252006,"Reaction mass of 1,3,5-tris(5-isocyanatopentyl)-1,3,5-triazinane-2,4,6-trione and 2-methylpropyl N-(5-isocyanatopentyl)-N-(5-isocyanatopentylcarbamoyl)carbamate",943-687-0,,Skin Mild Irrit. 3;Skin Sens. 1,REACH registration C&L,2,H316:2;H317:2
252007,(R)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid,813-028-0,118488-18-9,Skin Sens. 1;Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1
252009,"Reaction mass of 3,7-bis(diethylamino)phenoxazin-5-ium chloride and 3,7-bis(diethylamino)phenoxazin-5-ium trichlorozincate",943-688-6,,Acute Tox. 3;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H400:5;H317:5;H301:5;H318:5;H410:5
252010,"[D-gluco-heptonato-κO1,κO2,κO3,κO6,κO7]calcium(II) nitrate",943-689-1,,Not Classified,REACH registration C&L,2,Not classified:2
252011,"6-(1,3-Dioxopropan-2-yl)picolinic acid",813-030-1,212755-80-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252012,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252014,"Reaction products of diazotised 2-amino-4,6-dinitrophenol coupled with 4-Naphthalenesulfonic acid, 2-hydroxy-6-[(sulfomethyl)amino]-, monosodium salt, chelated with chromium (3+), sodium salts",943-692-8,,Not Classified,REACH registration C&L,8,Not classified:8
252015,tert-Butyl 4-hydroxybenzylcarbamate,813-031-7,149505-94-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
252016,"1,2,3,4-tetrachloroisoindolo[2,3-a]benzimidazol-11-one",813-032-2,40382-92-1,Eye Irrit. 2,Notified C&L,1,H319:1
252018,"Reaction mass of diammonium (2R,3R)-2,3-dihydroxybutanedioate and diammonium bis[(2R,3R)-2,3-dioxidobutanedioato]diantimonate(2-)",943-693-3,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1,Notified C&L,1,H302:1;H317:1;H315:1
252021,"Reaction products of diazotised 5,5’-methylenedianthranilic acid, coupled with resorcinol, subsequently coupled with diazotised 4-aminobenzene-1,3-disulfonic acid, chelated with copper sulphate, sodium potassium salt.",943-695-4,,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,3,H319:3;H411:3;H317:3
252022,"Reaction products of diazotised 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid coupled with resorcinol, subsequently coupled with diazotized 2-amino-4,6-dinitrophenol and diazotized 4-nitrobenzenamine, chelated with iron (3+), sodium potassium salts",943-697-5,,Aquatic Chronic 2,REACH registration C&L,6,H411:6
252027,n-Octylmethyldiethoxysilane,813-033-8,2652-38-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252029,3-amino-4-methoxy-N-methylbenzamide,813-034-3,878160-14-6,Acute Tox. 4,Notified C&L,1,H302:1
252030,"(2-Bromo-2,2-difluoro-acetyl) 2-bromo-2,2-difluoro-acetate",813-035-9,7601-98-1,Skin Corr. 1B,Notified C&L,1,H314:1
252031,"3-(10-carboxydecyle)-1,1,1,3,5,5,5-heptamethyltrisiloxane",813-036-4,63672-06-0,Aquatic Chronic 3,Notified C&L,1,H412:1
252032,"methyl (2R,3S)-3-amino-2-hydroxy-3-phenylpropanoate, hydrochloride",943-702-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252034,Dimethoxy(methoxymethyl)silane,813-039-0,1353001-41-8,Flam. Liq. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H335:1;H302:1;H225:1
252037,4-(3-Chloropropyl) morpholine,943-703-6,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252050,"Pyridinium, 1-[4-[[4-[(4-amino-9,10-dihydro-9,10-dioxo-3-sulfo-1-anthracenyl)amino]cyclohexyl]amino]-6-[(2,5-disulfophenyl)amino]-1,3,5-triazin-2-yl]-3-carboxy-, inner salt, sodium salt (1:3)",813-042-7,1918149-24-2,Not Classified,Notified C&L,1,Not classified:1
252052,"Reaction mass of 3,3'-(1E,1'E)-(4,4'-(6-(bis(2-hydroxyethyl)amino)-1,3,5-triazine-2,4-diyl)bis(azanediyl)bis(3-methoxy-4,1-phenylene))bis(diazene-2,1-diyl)dibenzenesulfonic acid and disodium 3,3'-[[6-[bis(2-hydroxyethyl)amino]-1,3,5-triazine-2,4-diyl]bis[imino(3-methoxy-4,1-phenylene)azo]]bis[benzenesulphonate]",943-704-1,,Not Classified,REACH registration C&L,6,Not classified:6
252055,"Reaction mass of (2R*,4R*,4aR*,9bS*)-2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine and (2R*,4R*,4aS*,9bR*)-2,4-dimethyl-4,4a,5,9b-tetrahydroindeno[1,2-d][1,3]dioxine",944-528-8,,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,3,H412:3;H302:3
252058,"Reaction mass of 2,4,6-trimethyl-4-phenyl-1,3-dioxane isomer 1 and 2,4,6-trimethyl-4-phenyl-1,3-dioxane isomer 2",945-924-3,,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,4,H412:4;H302:4
252059,"Reaction mass of 3',5-diallyl[biphenyl]-2,4'-diol and 5,5'-diallyl[biphenyl]-2,2'-diol",943-705-7,947686-05-7,Acute Tox. 5;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,REACH registration C&L,1,H319:1;H317:1;H315:1;H303:1;H411:1;H335:1
252060,2-chloro-5-methyl-4-nitropyridine 1-oxide,813-043-2,60323-96-8,Expl. 1.1;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H319:1;H302:1;H315:1;H201:1;H335:1
252061,(2-Cyclopropylphenyl)methanamine,943-706-2,,Skin Corr. 1B,Notified C&L,1,H314:1
252062,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252063,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252064,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252065,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252066,"(2S)-2-[[2-(1-benzofuran-6-carbonyl)-5,7-dichloro-3,4-dihydro-1H-isoquinoline-6-carbonyl]amino]-3-(3-methylsulfonylphenyl)propanoic acid",813-044-8,1025967-78-5,Repr. 2,Notified C&L,3,H361:3
252068,"Reaction mass of pin-2(10)-ene and (-)-pin-2-ene-10-ol and 4-(hydroperoxymethyl)-6,6-dimethyl-bicyclo[3.1.1]hept-3-ene and pin-2-ene-1-carbaldehyde",943-712-5,,Flam. Liq. 2;Org. Perox. B;Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,2,H319:2;H317:2;H225:2;H241:2
252069,"(5E)-3-Allyl-5-(3-ethyl-4-methyl-1,3-thiazol-2(3H)-ylidene)-2-thioxo-1,3-thiazolidin-4-one",813-045-3,203785-75-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252077,3-METHYLBENZYLMAGNESIUM CHLORIDE,813-052-1,29875-06-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
252078,5-Amino-1-methyl-4-nitroimidazole,813-053-7,4531-54-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 1A;Carc. 1A;Repr. 1A,Notified C&L,1,H360:1;H319:1;H302:1;H315:1;H340:1;H350:1;H335:1
252079,4-Chloro-3-formylpyrazole,813-054-2,623570-54-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252082,"1,2,3,4-tetrahydroisoquinolin-7-ol",813-057-9,30798-64-2,,Notified C&L,2,H319:2;H302:2;H315:2;H412:2;H335:2
252083,tert-butyl N-methylcarbamate,813-058-4,16066-84-5,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H312:1;H332:1
252084,"4-Amino-2,6-difluorophenol",813-060-5,126058-97-7,,Notified C&L,2,H319:1;H335:1;H315:1;H314:1
252091,"Hydrocarbons, C13-C16, n-alkanes, isoalkanes, cyclics, < 0.03% aromatics",813-066-8,1174522-45-2,Asp. Tox. 1,Notified C&L,1,H304:1
252092,4-(Hydrazinocarbonyl)benzoic acid,813-067-3,46206-74-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H335:1;H311:1
252093,Cesium Tungsten Suboxide,813-068-9,189619-69-0,Not Classified,Notified C&L,1,Not classified:1
252105,"Reaction mass of 3,5-dimethylcyclohex-3-ene-1-carbaldehyde and 2,4-dimethylcyclohex-3-ene-1-carbaldehyde",943-728-2,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,9,H411:9;H317:9;H315:9
252107,Monopentaerythritol tetraesters and dipentaerythritol hexaesters of 2-ethylhexanoic and n-valeric acids,943-730-3,,Not Classified,REACH registration C&L,2,Not classified:2
252108,"Poly[oxy(methyl-1,2-ethanediyl)], a,a',a''-1,2,3-propanetriyltris[w-hydroxy-, polymer with 1,3-diisocyanatomethylbenzene, 2-hydroxyethyl acrylate-blocked",943-731-9,,Eye Irrit. 2,Notified C&L,1,H319:1
252109,2-(3-Hydroxycarbonyl-6-pyridyl)malondialdehyde,813-071-5,212755-81-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252112,"(1S)-1-(1H-1,3-benzodiazol-2-yl)ethan-1-amine dihydrochloride",813-073-6,925689-54-9,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
252113,"4-(2,5-dioxo-1-pyrrolidinyl)-benzenesulfonyl azide",813-074-1,40686-15-5,Self-react. C;Skin Sens. 1,Notified C&L,1,H242:1;H317:1
252114,"4-(2,5-dihydro-3-methyl-2,5-dioxo-1H-pyrrol-1-yl)-benzenesulfonyl azide",813-075-7,1715005-50-7,Self-react. C;Skin Sens. 1,Notified C&L,1,H242:1;H317:1
252115,tert-butyl (4-(benzyloxy)-8-methylnaphthalen-2-yl)carbamate,813-076-2,1662687-76-4,STOT RE 2,Notified C&L,1,H373:1
252117,"Phenol, C14-18-alkyl derivs",813-078-3,1190625-94-5,Skin Irrit. 2;Aquatic Chronic 4,Notified C&L,2,H413:2;H315:2
252121,"6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazolin-4-amine",813-083-0,937265-83-3,Acute Tox. 4;Repr. 2;STOT SE 2;STOT RE 2,Notified C&L,1,H361:1;H302:1;H373:1;H371:1
252124,"(2R,3S,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol",813-086-7,141206-42-0,Repr. 2,Notified C&L,3,H361:2;H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252125,"2,4-difluoro-3-nitropyridine",813-087-2,60186-14-3,,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
252130,"Sodium 3,5-bis(trifluoromethyl)benzoate",813-093-5,87441-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252131,4-AMINO-2-CHLORO-3-FLUOROPYRIDINE,813-094-0,1227577-03-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252133,"2-(2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethoxy)ethyl (4-nitrophenyl) carbonate",813-096-1,1345681-74-4,Skin Sens. 1B;Muta. 2;Carc. 2;STOT RE 2,Notified C&L,1,H341:1;H373:1;H351:1;H317:1
252134,Monoclonal Antibody Derivative,,,Repr. 2,Notified C&L,35,H361:35
252135,Oxadiazol benzenesulfonamide Derivative,,,Acute Tox. 4;STOT RE 2,Notified C&L,1,H373:1;H302:1
252136,Fluropyranothiazole derivative,,,STOT RE 2,Notified C&L,35,H373:35
252138,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with 1,3-diisocyanatomethylbenzene and a-hydro-w-hydroxypoly[oxy(methyl-1,2-ethanediyl)]",943-737-1,,Eye Irrit. 2,Notified C&L,1,H319:1
252139,"Poly(oxy-1,2-ethanediyl), .alpha.-(1-oxo-2-propen-1-yl)-.omega.-phenoxy-",813-097-7,56441-05-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
252140,reaction mass of: dicalcium (bis(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)dihydroxide tri-calcium (tris(2-hydroxy-5-tetra-propenylphenylmethyl)methylamine)tri-hydroxide poly[calcium ((2-hydroxy-5-tetrapropenyl-phenylmethyl)methylamine)hydroxide],813-098-2,220795-04-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,2,H319:2;H317:2;H315:2
252141,5-(Trifluoromethoxy)pyridin-2-amine,813-099-8,1221171-88-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
252142,Fmoc-Val-Cit-PAB-PNP,813-100-1,863971-53-3,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H319:1;H302:1
252143,5-Bromo-4-methyl-1H-indazole,813-101-7,1082041-34-6,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,Notified C&L,3,H312:1;H332:1;H318:1;H302:1;H331:1;H319:1;H315:1;H301:2;H335:1;H311:1
252144,"1,3,2-Dioxaborolane-4,4-diacetic acid,2-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-5-oxo",813-102-2,1239908-20-3,Repr. 1B;Lact.,Notified C&L,1,H362:1;H360:1
252145,Noneth-4,813-103-8,39587-22-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H318:1;H302:1
252146,Mal-PEG2-NHS ester,813-104-3,1433997-01-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252147,N-(1-hydroxy-2-(hydroxymethyl)-4-(4-octylphenyl)butan-2-yl)acetamide,813-105-9,249289-10-9,Acute Tox. 4;Repr. 2,Notified C&L,1,H361:1;H302:1
252148,"(2R,3R,3aS,7R,8aS,9S,10aR,11S,12R,13aR,13bS,15S,18S,21S,24S,26R,28R,29aS)-2-[(2S)-3-amino-2-hydroxypropyl]-3-methoxy-26-methyl-20,27-dimethylidenehexacosahydro-11,15:18,21:24,28-triepoxy-7,9-ethano-12,15-methano-9H,15H-furo[3,2-i]furo[2',3':5,6]pyrano[4,3-b][1,4]dioxacyclopentacosin-5(4H)-one methanesulfonate",813-106-4,441045-17-6,Muta. 2;Repr. 2;Aquatic Chronic 1,Notified C&L,1,H341:1;H361:1;H410:1
252149,"2,3,5,6-Tetrafluoro-4-(trifluoromethyl)phenylacetic acid",813-108-5,32304-29-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252151,"4,4'-BIPIPERIDINE, 1-BOC PROTECTED",813-109-0,171049-35-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
252152,(S)-(+)-2-PHENYLGLYCINE AMIDE,813-110-6,6485-52-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H317:1;H315:1;H312:1;H332:1;H335:1
252153,N-(3-chlorophenyl)-4-[2-[(2-methoxy-1-methyl-ethyl)amino]-4-pyridyl]pyrimidin-2-amine,943-738-7,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
252154,"1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with 1, 6-diisocyanatohexane, 2-methyloxirane and oxirane, 2-propenoate",943-739-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252155,3-Bromo-4-formylbenzonitrile,813-111-1,89891-69-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252156,"Hexane, 1,6-diisocyanato-, homopolymer, 2-hydroxyethyl methacrylate- and 2-oxepanone homopolymer 2-[(1-oxo-2-propen-1-yl)oxy]ethyl ester-blocked",943-740-8,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252157,"2-Oxepanone, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3- trimethylcyclohexane, propylene glycol monoacrylate-blocked",943-741-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252158,Methylthiomercaptopropionic acid,943-742-9,,Skin Corr. 1A,Notified C&L,1,H314:1
252159,"Hexanedioic acid, polymer with 2,2-dimethyl-l,3-propanediol, 5-isocyanato-l-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 1,1'-methylenebis[4-isocyanatocyclohexane], 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[ethanol] and 2-methyl-l,5-pentanediamine, 2-hydroxyethyl acrylate-blocked",943-743-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252160,"Propenoic acid, monoester with 1,2-propaneiol, polymer with .alpha.-hydro-.omega.-hydroxypoly(oxy-1,4-butanediyl), .alpha.-hydro-.omega.-hydroxypoly[oxy(methyl-1,2-ethanediyl)] ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1), and 1,1`-methylenebis[4-isocyanatocyclohexane",943-745-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,26,H319:26;H315:26
252161,SP200-5,,,Acute Tox. 3;Skin Corr. 1B;Muta. 1B;Carc. 1B;Repr. 1B;STOT SE 1,Notified C&L,1,H360:1;H314:1;H340:1;H370:1;H350:1;H311:1
252162,"2-Propenoic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",943-747-6,,Eye Irrit. 2,Notified C&L,1,H319:1
252164,"2-Oxepanone, polymer with 1,6-diisocyanatohexane and 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 2-hydroxyethyl acrylate- and 2-oxepanone homopolymer 2-[(1-oxo-2-propen-1-yl)oxy]ethyl ester-blocked",943-748-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252165,"hexanedioic acid, polymer with 2,2-dimethyl-1,3-propanediol, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 2-hydroxyethyl 2-propenoate and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",943-749-7,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252166,"2-Propenoic acid, 1,1'-[oxybis(methyl-2,1-ethanediyl)] ester, polymers with ethanolamine and 2-hydroxyethyl acrylate-blocked polypropylene glycol-TDI polymer",943-750-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252167,"1,4-Cyclohexanedimethanol, polymer with 1,6-diisocyanatohexane, 2-hydroxy-3-[(1-oxo-2-propen-1-yl)oxy]propyl methacrylate-blocked",943-751-8,,Skin Sens. 1,Notified C&L,1,H317:1
252168,"Hexane, 1,6-diisocyanato-, homopolymer, 2-oxepanone homopolymer 2-[(1-oxo-2-propen-1-yl)oxy]ethyl ester- and propylene glycol monoacrylate-blocked",943-752-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252169,"Cyclohexane, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethyl-, polymers with reduced Me esters of reduced polymd. oxidized tetrafluoroethylene, polylactic acid 2-[(1-oxo-2-propen-1-yl)oxy]ethyl ester-blocked",943-753-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252170,"2-Propenoic acid, 2-methyl-, monoester with 1,2-propanediol, polymer with 2-hydroxyethyl 2-propenoate, 1,1'-methylenebis[4-isocyanatocyclohexane] and a,a',a''-1,2,3-propanetriyltris[w-hydroxypoly[oxy(methyl-1,2-ethanediyl)]]",943-754-4,,Eye Irrit. 2,Notified C&L,1,H319:1
252172,"Hexane, 1,6-diisocyanato-, homopolymer, acrylic acid-polyethylene glycol ether with trimethylolpropane (3:1) reaction products-blocked",943-757-0,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
252173,"Oxirane, 2-methyl-, polymer with oxirane, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediaol (3:1), 2-propenoate, polymer with 1,6-diisocyanatohexane, 2-hydroxyethyl acrylate-blocked",943-758-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252174,"Carbonic acid, dimethyl ester, polymer with 1,6-diisocyanatohexane, 1,6-hexanediol and 2-oxepanone, 2-hydroxyethyl acrylate-blocked",943-759-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252175,"2-Propenoic acid, 2-hydroxyethyl ester, reaction products with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and polyethylene-polypropylene glycol ether with trimethylolpropane (3:1) acrylate",943-760-7,,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1
252176,"Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1), 2-propenoate, reaction products with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",943-761-2,,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1;H317:1
252177,"2-Propenoic acid, 2-hydroxyethyl ester, reaction products with 1,6-diisocyanatohexane, dipropylene glycol, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and polyethylene-polypropylene glycol ether with trimethylolpropane (3:1)",943-762-8,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252178,"sulfurized alkylphenol, calcium salts",,,Aquatic Chronic 4,Notified C&L,2,H413:2
252179,"1,3-Benzenedicarboxylic acid, 5-sulfo-, sodium salt (1:1), polymer with 1,3-diisocyanatomethylbenzene, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, hexanedioic acid, a-hydro- w-hydroxypoly(oxy-1,2-ethanediyl) and 2,2'-oxybis[ethanol], 2-oxepanone homopolymer 2-[(1-oxo-2-propen-1-yl)oxy]ethyl ester-blocked",943-763-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252180,"1,3-Hexanediol, 2-ethyl-, polymer with 1,6-diisocyanatohexane, 2-hydroxyethyl acrylate- and propylene glycol monoacrylate-blocked",943-764-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252181,"2-Propenoic acid, 2,2-bis(hydroxymethyl)-1,3-propanediyl ester, polymer with 2-(hydroxymethyl)-2-[[(1-oxo-2-propenyl) oxy] methyl]-1,3-propanediyl di-2-propenoate and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",943-765-4,,Eye Irrit. 2,Notified C&L,26,H319:26
252183,"Hexanedioic acid, polymer with 1,4-cyclohexanedimethanol, 2,2-dimethyl-1,3-propanediol, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid and 1,1'-methylenebis[4-isocyanatocyclohexane], pentaerythritol triacrylate-blocked, compds. with triethylamine",943-767-5,,Eye Dam. 1,Notified C&L,1,H318:1
252184,"2-PROPENOIC ACID, 2-HYDROXYETHYL ESTER, POLYMER WITH 1,3-DIISOCYANATOMETHYLBENZENE AND A-HYDRO-W-HYDROXY- POLY[OXY(METHYL-1,2-ETHANEDIYL)]",943-768-0,,Eye Irrit. 2,Notified C&L,1,H319:1
252185,"2-Oxepanone, polymer with 1,6-diisocyanatohexane and 1,6-hexanediol, propylene glycol monoacrylate-blocked",943-769-6,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
252186,"2-oxepanone, homopolymer, 2-[(1-oxo-2-propenyl)oxy]ethyl ester, reaction products with 1,6-diisocyanatohexane homopolymer and tricyclodecanedimethanol",943-770-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252187,"siloxanes and silicones, di-Me, hydroxyethyl Me, ethoxylated, polymers with hydroxyethyl acrylate and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",943-771-7,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252189,"hexanedioic acid, polymer with 1,2-ethanediol and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-hydroxyethyl acrylate blocked",943-773-8,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252190,"2-propenoic acid, 2-hydroxyethyl ester, polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-oxepanone and 2,2''-oxybis[ethanol]",943-774-3,,Eye Irrit. 2,Notified C&L,1,H319:1
252191,N-DEBOC DOCETAXEL,813-115-3,133524-69-3,Repr. 2,Notified C&L,1,H361:1
252192,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and a,a',a''-1,2,3-propanetriyltris[w-hydroxypoly[oxy(methyl-1,2-ethanediyl)]]",943-775-9,,Eye Irrit. 2,Notified C&L,1,H319:1
252193,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with 1,1'-methylenebis[4-isocyanatocyclohexane] and a,a',a''-1,2,3-propanetriyltris[w-hydroxypoly[oxy(methyl-1,2-ethanediyl)]]",943-776-4,,Eye Irrit. 2,Notified C&L,1,H319:1
252194,SP200-7,,,Acute Tox. 1;Skin Corr. 1B;Muta. 1B;Carc. 1B;Repr. 1B;STOT SE 1,Notified C&L,1,H360:1;H314:1;H340:1;H370:1;H350:1;H310:1
252200,"5-hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyl polycyclic {[(4methylphenyl)sulfonyl]oxy}acetate",,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252202,"Reaction product of Fatty acids, C18 alkyl with amines, polyethylenepoly-tetraethylenepentamine fraction",701-046-0,,Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,3,H318:3;H411:3;H317:3;H315:3
252203,"2-Oxepanone, polymer with 1,4-butanediol and 1,3-diisocyanatomethylbenzene, 2-hydroxyethyl acrylate-blocked",943-780-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252204,"for CAS 82339-13-7, Hexanedioic acid, polymer with 1,3-diisocyanatomethylbenzene and 2,2-dimethyl-1,3-propanediol, 2-hydroxyethyl acrylate-blocked",943-781-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252205,"poly(oxy-1,4-butanediyl), .alpha.-hydro-.omega.-hydroxy-, polymer with 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-hydroxyethyl acrylate-blocked",943-782-7,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252206,"Hexanedioic acid, polymer with 1,4-butanediol, 1,6-diisocyanatohexane, 1,2-ethanediol and 2,2'-oxybis[ethanol], propylene glycol monoacrylate-blocked",943-783-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252207,"1,3-Benzenedicarboxylic acid, polymer with 2-(chloromethyl)oxirane, 2,2-dimethyl-1,3-propanediol, hexanedioic acid, 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoic acid, 1,1'-methylenebis[4-isocyanatocyclohexane], 4,4'-(1-methylethylidene)bis[phenol], 2,2'-[oxybis(methylene)]bis[2-(hydroxymethyl)-1,3-propanediol] tetra-2-propenoate and 2-propenoic acid, dipentaerythritol pentaacrylate-blocked, compds. with triethylamineyl",943-784-8,,Eye Dam. 1,Notified C&L,1,H318:1
252208,"hexanedioic acid, polymer with 1,4-butanediol, 2-hydroxyethyl 2-propenoate and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane",943-785-3,,Eye Irrit. 2,Notified C&L,1,H319:1
252209,"Hexanedioic acid, polymer with 1,4-butanediol, 1,3-diisocyanatomethylbenzene and 2-hydroxyethyl 2-propenoate",943-786-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252210,"1,3-Benzenedicarboxylic acid, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, hexanedioic acid, 1,6-hexanediol, 1,3-isobenzofurandione and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane, 2-hydroxyethyl acrylate-blocked",943-787-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252211,5-[4-(Propan-2-yl)piperazin-1-yl]pyridin-2-amine,813-117-4,866620-36-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252212,1-Boc-3-hydroxy-3-(aminomethyl)azetidine,813-119-5,1008526-71-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:3;H315:3;H312:1;H332:1;H335:3
252213,"Reaction product of 3,5,5-trimethyl-hexanoic acid and 2-methylpropanoic acid and pentaerythritol",813-120-0,1262967-45-2,STOT RE 2,REACH registration C&L,3,H373:3
252216,"Condensation products of triethanolamine with addition products of fatty acids, C18 (unsaturated) alkyl with maleic anhydride",,,Skin Sens. 1B,REACH registration C&L,2,H317:2
252217,IPDA-BADGE-BUMGE,,,Acute Tox. 4;Skin Corr. 1C;Skin Sens. 1,REACH registration C&L,2,H302:2;H314:2;H317:2
252219,"Poly(oxy-1,2-ethanediyl), a-hydro-w-hydroxy-, ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1), polymer with 1,3-diisocyanatomethylbenzene, 2-propenoate (ester)",943-792-1,,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H319:1;H412:1
252222,"1,7-dichloro-4-methoxy-isoquinoline",813-121-6,630423-36-8,Skin Sens. 1A;Eye Irrit. 2,REACH registration C&L,3,H319:3;H317:2;H315:1
252225,"Amides, C8-18 (even numbered) and C18 (unsaturated) alkyl, N-[3-(dimethylamino)propyl]",701-052-3,,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,13,H400:13;H302:13;H314:13;H317:13;H411:13;H318:13
252226,"(3aR,4R,5R,7S,8S,9R,9aS,12R)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(((1R,2R,4R)-4-amino-2-hydroxycyclohexyl)thio)acetate",813-124-2,1061337-51-6,STOT SE 2,Notified C&L,1,H371:1
252228,"Reaction products of diazotised 4-amino-3-hydroxy-7-nitronaphthalene-1-sulfonic acid coupled with 2-naphthol and 2-amino-4 (or 5)-nitrophenol, chelated with chromium (3+), sodium salt",943-797-9,,Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,1,H400:1;H411:1
252229,N-Benzyl-2-chloroacetamide,813-125-8,2564-06-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
252230,Methyl 4-chloro-2-methoxybenzoate,813-126-3,78955-90-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252234,3-Fluoro-2-nitrotoluene,813-128-4,3013-27-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252235,"Siloxanes and silicones, dimethyl, 3-hydroxypropyl terminated, diethers with polyethylene glycol monoacrylate",943-800-3,,Eye Irrit. 2,Notified C&L,1,H319:1
252236,"9,12-Octadecadienoic acid, (Z,Z)-, dimer, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol and 2-propenoic acid",943-801-9,,Eye Irrit. 2,Notified C&L,26,H319:26
252237,"Fatty acids, C18-unsatd., dimers, polymers with acrylic acid, pentaerythritol and phtalic anhydride",943-802-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252238,1-chloro-4-[(prop-2-yn-1-yloxy)methyl]benzene,813-130-5,4039-86-5,Acute Tox. 4;Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,83,H302:83;H411:83;H315:83
252239,"2-Oxepanone, homopolymer, N,N'-(1,3-phenylenebis(1-methylethylidene))bis(carbamate)(2:1), bis(2-((1-oxo-2-propen-1-yl)oxy)ethyl)ester",943-804-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252240,"1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with 2-methyloxirane and oxirane, 2-propenoate, reaction products with diethylamine",943-805-0,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252241,"1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with 2-methyloxirane and oxirane, acrylate 2-([1,1'-biphenyl]-4-ylcarbonyl)benzoate, reaction products with diethylamine",943-806-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252242,"1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with 2-methyloxirane and oxirane, 2-([1,1'-biphenyl]-4-ylcarbonyl) benzoate 2-propanoate 1418831-86-3",943-807-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252243,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with 2-oxiranylmethyl 2-methyl-2-propenoate, 2-propenoate, tert-Bu 2-ethylhexaneperoxoate-initiated",943-808-7,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252244,"1,3-Propanediol, 2,2-bis(hydroxymethyl)-, polymer with 2-methyloxirane and oxirane, 2-([1,1-biphenyl]-4-ylcarbonyl)benzoate 2-propenoate, reaction products with N-butyl-1-butanamine",943-809-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252245,"1,2,4-Benzenetricarboxylic acid, ester with 1,2-ethanediol, polymer with butyl 2-methyl-2-propenoate, 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid, 1,2-ethanediol, methyl 2-propenoate and 2-oxiranylmethyl 2-methyl-2-propenoate, 2-propenoate, 1,1-dimethylpropyl 2-ethylhexaneperoxoate-initiated",943-810-8,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252246,"2-Propenoic acid, 2-methyl-, butyl ester, polymer with methyl 2-propenoate and oxiranylmethyl 2-methyl-2-propenoate, 2-propenoate",943-811-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252247,"1,3-Benzenedicarboxylic acid, polymer with 1,2-ethanediol, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 4,5,6,7,8,8-hexachloro-3a,4,7,7a-tetrahydro-4,7-methanoisobenzofuran-1,3-dione and 1,3-isobenzofurandione",943-812-9,,Eye Irrit. 2,Notified C&L,1,H319:1
252248,"Fatty acids, C18-unsatd., dimers, polymers with acrylic acid, ethylene oxide, pentaerythritol and propylene oxide",943-813-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252249,"2-Propenoic acid, polymer with ethenylbenzene, 1-(4-morpholinyl)-2-propen-1-one and octadecyl 2-propenoate, 2-hydroxy-3-[(1-oxoneodecyl)oxy]propyl ester, bis(1,1-dimethylpropyl) peroxide-initiated",943-815-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252250,"Hexanedioic acid, polymer with 2-(chloromethyl)oxirane, α-hydro-ω-hydroxypoly(oxy-1,2-ethanediyl) ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1) and 4,4'-(1-methylethylidene)bis[phenol], 2-propenoate",943-816-0,,Eye Irrit. 2,Notified C&L,1,H319:1
252251,tert-Butyl 4-(4-aminobenzyl)piperidine-1-carboxylate,813-131-0,221532-96-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252252,"2,5-Furandione, telomer with ethylbenzene and (1-methylethyl)benzene, 2-methoxy-1-methylethyl 2-((2-methyl-1-oxo-2-propen-1-yl)oxy)ethyl ester",943-817-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252256,"2S,3S,4S,5R,6R)-6-[(2R,3R,4R,5R,6R)-3-acetamido-2,5-dihydroxy-6-sulfooxyoxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid",701-054-4,,Not Classified,REACH registration C&L,2,Not classified:2
252257,"Waste plastics, poly(ethylene terephtalate), polymers with acrylic acid, adipic acid, dipropylene glycol and trimethylolpropane",943-818-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252258,"Siloxanes and Silicones, di-Me, 3-hydroxypropyl group-terminated, ethoxylated propoxylated, reaction products with acrylic acid, maleic anhydride and pentaerythritol",943-819-7,,Eye Irrit. 2,Notified C&L,26,H319:26
252259,"1,3-isobenzofurandione, polymer with (chloromethyl)oxirane and 4,4''-(1-methylethylidene)bis[phenol], ester with .alpha.-[2-[(1-oxo-2-propenyl)oxy]ethyl]-.omega.-hydroxypoly[oxy(1-oxo-1,6-hexanediyl)]",943-820-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,26,H319:26;H315:26
252260,"Fatty acids, C18-unsatd., dimers, mixed diesters with 2,2''-[oxybis(methylene)] bis[2-ethyl-1,3-propanediol], pentaetythritol and phthalic acid, hexaacrylates",943-821-8,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252261,"Hexanedioic acid, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, 1,6-hexanediol,-hydro--hydroxypoly(oxy-1,2-ethanediyl) and 2,2'-oxybis[ethanol], [[1,3,3-trimethyl-5-[[[2-[(1-oxo-2-propenyl)oxy]ethoxy]carbo nyl]amino]cyclohexyl]methyl]carbamate",943-822-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252262,"2,5-Furandione, polymer with 2-(chloromethyl)oxirane, a-hydro-w-hydroxypoly(oxy-1,2-ethanediyl) ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1), and 4,4'-(1-methylethylidene)bis[phenol], 2-propenoate, reaction products with diethanolamine",943-823-9,,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1
252263,"1,4-Dioxane-2,5-dione, 3,6-dimethyl-, (3S, 6S)-, homopolymer, (2-((1-oxo-2-propen-1-yl)oxy)ethyl) ester",943-824-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252264,"Carbonic acid, dimethyl ester, polymer with 1,6-hexanediol, diester with {3-[(carboxyamino)methyl]-3,5,5-trimethylcyclohexyl]carbamic acid mono[2-[(1-oxo-2-propenyl)oxy]ethyl} ester",943-826-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252265,"Siloxanes and silicones, dimethyl, 3-hydroxypropyl terminated, diethers with polyethylene glycol monoacrylate",943-827-0,,Eye Irrit. 2,Notified C&L,1,H319:1
252266,4-Thiobenzonitrile,813-133-1,36801-01-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2;H312:1;H332:1
252268,"hexanedioic acid, polymer with 1,6-hexanediol and methylenebutanedioic acid, di-2-propenoate, reaction products with 6H-dibenz[c,e][1,2]oxaphosphorin 6-oxide",943-829-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252269,"Hexane, 1,6-diisocyanato-, homopolymer, 2-oxepanone homopolymer 2-[(1-oxo-2-propen-1-yl)oxy]ethyl ester-blocked",943-830-7,,Aquatic Chronic 3,Notified C&L,1,H412:1
252270,"Poly(oxy-1,2-ethanediyl), a,a''-[(1-methylethylidene)di-4,1-phenylene]bis[w-[(1-oxo-2-propenyl)oxy]-",943-831-2,,Aquatic Chronic 2,Notified C&L,1,H411:1
252271,"hexanedioic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, 2,2-dimethyl-1,3-propanediol, 1,3-isobenzofurandione and 2-propenoic acid",943-832-8,,Eye Irrit. 2,Notified C&L,1,H319:1
252272,"bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid, 1,4,5,6,7,7-hexachloro-, polymer with 1,3-isobenzofurandione, 4,4''-(1-methylethylidene)bis[cyclohexanol] and 2,2''-oxybis[ethanol] 73287-36-2",943-833-3,,Eye Irrit. 2,Notified C&L,1,H319:1
252273,"Hexanedioic acid, polymer with 1,2-ethanediol, 2-ethyl-2-(hydroxymethyl)-1,3-propanediol and 1,3-isbenzofurandione, 2-propenoate",943-835-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252274,"Poly[oxy(methyl-1,2-ethanediyl)], w-[3-(diethylamino)-1-oxopropoxy]-w',w''-bis[(1-oxo-2-propen-1-yl)oxy]-a,a',a''-1,2,3-propanetriyltris-",943-837-5,,Eye Irrit. 2,Notified C&L,57,H319:57
252275,"Fatty acids, C18-unsatd., dimers, polymers with acrylic acid, ethylene oxide and trimethylolpropane",943-838-0,,Eye Irrit. 2,Notified C&L,1,H319:1
252277,"2-Propenoic acid, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol, methyloxirane and oxirane, reaction products with N-propyl-1-propanamine",943-840-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252278,"Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with 2,2-bis(hydroxymethyl)-1,3-propanediol and oxirane, 2-propenoate (9CI)",943-841-7,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252279,"Hexanedioic acid, polymer with 2-(chloromethyl)oxirane, 2,2''-dimethyl-1,3-propanediol and 4,4''-(1-methylethylidene)bis[phenol], 2-propenoate",943-842-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252280,Skin Irrit. 2 (H315) ;par Eye Irrit. 2 (H319),943-843-8,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252281,AKOR074,,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
252282,Post-transition metal Zinc Halide Pnictide Selenide Sulfide,,,Aquatic Chronic 2,Notified C&L,1,H411:1
252283,Post-transition metal Zinc Halide Pnictide Sulfide,,,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1
252284,Calcium Alkylated Naphthalene Sulphonate,,,Eye Irrit. 2,Notified C&L,1,H319:1
252290,Essential oil Girofle Clou,943-850-6,,Asp. Tox. 1;Skin Sens. 1A;Eye Irrit. 2,Notified C&L,1,H304:1;H319:1;H317:1
252292,Hydrogenated rosin alcohols,701-057-0,,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,1,H413:1;H317:1
252295,Alkylated Naphthalene Sulphonic Acid,,,Eye Irrit. 2,Notified C&L,1,H319:1
252298,"Phenol, 4,4''-(1-methylethylidene)bis-, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine, 1,3-benzenedimethanamine, (chloromethyl)oxirane and a-hydro-w-hydroxypoly(oxy-1,2-ethanediyl)",943-855-3,,Aquatic Chronic 2,Notified C&L,1,H411:1
252299,"Phenol, 4,4`-(1-methylethylidene)bis-, polymer with (chloromethyl)oxirane and methyloxirane polymer with oxirane 2-aminopropyl methyl ether, 5-amino-1,3,3-trimethylcyclohexanemethanamine- and 1,3-benzenedimethanamine-terminate",943-856-9,,Aquatic Chronic 2,Notified C&L,1,H411:1
252300,"Neodecanoic acid, oxiranylmethyl ester, reaction products with bisphenol A-diethylenetriamine- epichlorohydrin-polyethylene glycol-polypropylene glycol diglycidyl ether polymer, acetates (salts)",943-857-4,,Aquatic Chronic 2,Notified C&L,1,H411:1
252301,"Phenol, 4,4'-(1-methylethylidene)bis-, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine, 1,3-benzenedimethanamine, 2-(chloromethyl)oxirane and a-hydro-w-hydroxypoly(oxy-1,2-ethanediyl), N-(2-cyanoethyl) derivs",943-859-5,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252302,"Hexanedioic acid, polymer with N,N.-bis(2-aminoethyl)-1,2-ethanediamine, (chloromethyl)oxirane, a-hydro-w-hydroxypoly(oxy-1,2-ethanediyl) and 4,4.-(1-methylethylidene)bis[phenol], reaction products with Bu glycidyl ether, acetates (salts)",943-860-0,,Aquatic Chronic 2,Notified C&L,1,H411:1
252303,"Phenol, 4,4'-(1-methylethylidene)bis-, polymers with 5-amino-1,3,3 trimethylcyclohexanemethanamine, epichlorohydrin, formaldehyde-phenol polymer glycidyl ether and polyethylene glycol, reaction products with Bu glycidyl ether",943-861-6,,Aquatic Chronic 2,Notified C&L,1,H411:1
252304,"Phenol, 4,4'-(1-methylethylidene)bis-, polymers with epichlorohydrin, ethylenediamine and formaldehyde-phenol polymer glycidyl ether",943-862-1,,Aquatic Chronic 2,Notified C&L,1,H411:1
252305,"3,6-dimethyl-4-(2-naphthyl)-5-(2,4,6-trifluorophenyl)pyridazine",943-863-7,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
252306,"3-Difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid methoxy-[2-methoxy-1-methyl-2-(2,4,5-trichloro-thiophen-3-yl)-ethyl]-amide",943-864-2,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
252307,2-(4-nitro-3-oxo-3H-isobenzofuran-1-ylidene)-malonic acid dimethylester,943-865-8,,Skin Sens. 1B,Notified C&L,89,H317:89
252308,"4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile",943-866-3,,Skin Sens. 1,Notified C&L,89,H317:89
252310,"4-((2S,5S)-13-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)-5-isopropyl-4,7-dioxo-2-(3-ureidopropyl)-8,11-dioxa-3,6-diazatridecanamido)benzyl (2-(((((S)-1-(chloromethyl)-3-(6-(4-hydroxybenzamido)imidazo[1,2-a]pyridine-2-carbonyl)-9-methyl-2,3-dihydro-1H-benzo[e]indol-5-yl)oxy)carbonyl)(2-(2-hydroxyethoxy)ethyl)amino)ethyl)(methyl)carbamate",813-138-9,1345681-58-4,Muta. 1B;Carc. 2;STOT RE 2,Notified C&L,1,H340:1;H373:1;H351:1
252311,"bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid, 1,4,5,6,7,7-hexachloro-, polymer with 1,3-isobenzofurandione, 4,4''-(1-methylethylidene)bis[cyclohexanol] and 2,2''-oxybis[ethanol]",943-867-9,,Eye Irrit. 2,Notified C&L,25,H319:25
252312,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with 1,1''-methylenebis[4-isocyanatocyclohexane] and 2-oxepanone",943-868-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,27,H319:27;H315:27
252313,"4-(3,4-dichlorophenyl)piperidine;hydrochloride",813-139-4,99329-54-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252314,"2-[3-ethylsulfonyl-5-(3-fluorophenyl)-2-pyridyl]-3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridine",943-870-5,,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H301:89;H410:89
252316,(3E)-non-3-en-2-one,813-141-5,18402-83-0,Not Classified,Notified C&L,1,Not classified:1
252317,"4,7-bis{5-[2-trifluoromethylphenyl](2-thienyl)}- 5-phenoxy-6-(4-carbomethoxyphenoxy)benzothiadiazole",943-872-6,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
252318,"4,7-bis{5-[2-trifluoromethylphenyl](2-thienyl)}- 5,6-di(4-trifluoromethylphenoxy)benzothiadiazole",943-873-1,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
252319,"4,7-bis{5-[2,6-dimethyl)phenyl](2-thienyl)}- 5,6-di(4-trifluoromethylphenoxy)benzothiadiazole",943-874-7,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
252320,"4,7-bis{5-[2-(trifluoromethyl)phenyl](2-thienyl)}- 5,6-diphenoxybenzothiadiazole",943-875-2,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
252321,Reaction mass of N-methylmethanamine and tetrahydrofuran,943-876-8,,Flam. Liq. 2;Skin Corr. 1A;Carc. 2,Notified C&L,1,H314:1;H351:1;H225:1
252322,Reaction mass of ammonia and methanol,943-877-3,,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 2,Notified C&L,1,H314:1;H301:1;H225:1;H330:1;H311:1
252323,"Reaction mass of chloride and 1,1'-oxydiethane",943-878-9,,Flam. Liq. 1;Skin Corr. 1B,Notified C&L,1,H224:1;H314:1
252326,1-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]ethanone,813-142-0,1417782-28-5,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,173,H400:173;H410:173;H317:173
252328,(2-methoxyethoxy)ethene,813-143-6,1663-35-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,2,H319:2;H335:2;H225:2;H315:2
252329,3-methoxymethylene-3H-benzofuran-2-one,813-144-1,40800-90-6,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,89,H318:89;H317:89;H315:89
252330,"1H-Pyrazole-4-carboxamide, N-[2-(2,4-dichlorophenyl)-2-methoxy-1-methylethyl]-3-(difluoromethyl)-1-methyl",813-145-7,1092400-95-7,Aquatic Chronic 2,Notified C&L,89,H411:89
252333,p-MSMC5,943-884-1,,Eye Irrit. 2,Notified C&L,1,H319:1
252335,Reaction mass of ethanol and sodium O-ethyl dithiocarbonate and sodium hydroxide,943-886-2,,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H228:1;H319:1;H302:1;H315:1;H312:1;H335:1
252337,"N-(3-(2-(2-chloropyriMidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide",813-146-2,1195768-20-7,Not Classified,Notified C&L,1,Not classified:1
252338,11-((tert-pentyloxy)methyl)tricosane,943-888-3,,Asp. Tox. 1,Notified C&L,1,H304:1
252339,"11-(((2,3-dimethylbutan-2-yl)oxy)methyl)tricosane",943-889-9,,Asp. Tox. 1,Notified C&L,1,H304:1
252340,"2-[(1R)-1-amino-2-(2,5-dibromophenyl)ethyl]-5-bromophenol",813-147-8,1585969-24-9,Not Classified,Notified C&L,1,Not classified:1
252341,"1-(4-bromo-2-hydroxyphenyl)-2-(2,5-dibromophenyl)ethanone",813-148-3,1403991-85-4,Not Classified,Notified C&L,1,Not classified:1
252342,"5-bromo-2-[2-(2,5-dibromophenyl)ethanimidoyl]phenol",813-149-9,1585969-22-7,Not Classified,Notified C&L,1,Not classified:1
252343,6-Nitronicotinic acid,813-150-4,33225-73-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252345,"Ethanol, 2,2'-[1,2-ethanediylbis(oxy)]bis-, reaction products with 3-(triethoxysilyl)-1-propanamine",813-152-5,152261-44-4,Flam. Liq. 3;Eye Dam. 1,REACH registration C&L,2,H318:2;H226:2
252346,"5-Bromo-2,3-difluorobenzonitrile",813-153-0,1105665-42-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
252347,"5-bromo-2-[(2R)-5-bromo-2,3-dihydro-1H-indol-2-yl]phenol",813-154-6,1585969-17-0,Not Classified,Notified C&L,1,Not classified:1
252348,"(6S,12aR)-3,10-dibromo-6-phenyl-12,12a-dihydroindolo[1,2-c][1,3]benzoxazine",813-155-1,1585969-16-9,Not Classified,Notified C&L,1,Not classified:1
252349,"(6S)-3,10-dibromo-6-phenylindolo[1,2-c][1,3]benzoxazine",813-156-7,1392102-38-3,Not Classified,Notified C&L,1,Not classified:1
252350,tert-butyl (2S)-2-(4-bromo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate,813-157-2,1007882-59-8,Not Classified,Notified C&L,1,Not classified:1
252351,3-tridecylphenol,943-892-5,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H317:1;H315:1;H412:1;H312:1;H318:1
252352,"Reaction mass of 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-5-(2-{[hydroxy(phosphonooxy)phosphoryl]oxy}ethyl)-4-methyl-1,3-thiazol-3-ium chloride and 3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-4-methyl-5-[2-(phosphonooxy)ethyl]-1,3-thiazol-3-ium chloride dihydrate",943-893-0,,Skin Sens. 1,REACH registration C&L,2,H317:2
252353,Pyrimidine-5-carbonyl chloride,813-158-8,40929-48-4,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1;Acute Tox. 4;STOT SE 3,Notified C&L,1,H302:1;H314:1;H312:1;H332:1;H335:1
252354,"7-HYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE HYDROBROMIDE",813-159-3,66393-01-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252355,"2,4-DICHLORO-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDINE",813-160-9,1012785-51-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252356,"Reaction mass of 2,5-Furandione, polymer with oxybis(propanol) and 2-ethylhexyl ester and bis(2-ethylhexyl) but-2-enedioate",943-894-6,,Aquatic Chronic 2,Notified C&L,1,H411:1
252359,"Poly(oxy-1,2-ethanediyl), α-undecyl-ω-hydroxy-, branched and linear, ethers with 1,2-decanediol (1:1)",943-897-2,,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,83,H319:83;H412:83
252360,"Melamine RPW formaldehyde, methanol, isobutanol, salicylic acid",943-898-8,,Aquatic Chronic 4,Notified C&L,25,H413:25
252361,N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide,813-161-4,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252365,[No public or meaningful name is available],,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252366,[No public or meaningful name is available],,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252367,[No public or meaningful name is available],,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252369,[No public or meaningful name is available],943-903-3,,Acute Tox. 4,REACH registration C&L,2,H302:2
252370,[No public or meaningful name is available],,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252371,"Reaction mass of 1-isopropyl-4-methylenebicyclo[3.1.0]hexane and 6,6-dimethyl-2-methylenebicyclo[3.1.1]heptane",943-905-4,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,1,H317:1;H315:1;H304:1;H226:1;H411:1
252372,"2,5-anhydro-4-{[4-(4-{4-[({1-[(2S,3S)-2-(benzyloxy)pentan-3-yl]hydrazino}carbonyl)amino]phenyl}piperazin1-yl)phenoxy]methyl}-1,3,4-trideoxy-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-",701-059-1,345217-03-0,Aquatic Chronic 4,REACH registration C&L,2,H413:2
252373,"tert-butyl (2S)-2-{4-[(6S)-10-{2-[(2S)-1-(tert-butoxycarbonyl)pyrrolidin-2-yl]-1H-imidazol-5-yl}-6-phenylindolo[1,2-c][1,3]benzoxazin-3-yl]-1H-imidazol-2-yl}pyrrolidine-1-carboxylate",813-165-6,1369595-05-0,Not Classified,Notified C&L,1,Not classified:1
252374,4-Fluoro-3-(methylcarbamoyl)benzeneboronic acid,813-166-1,874219-19-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252375,tert-butyl 4-(aminomethyl)phenyl(methyl)carbamate,813-167-7,191871-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252376,"4-Bromo-2,6-difluorobenzotrifluoride",813-168-2,156243-64-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H227:1
252377,Methyl 4-Bromo-3-(bromomethyl)benzoate,813-169-8,142031-67-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
252378,"N-(2-(tert-Butyl)-5-hydroxy-4-(1-hydroxy-2-methylpropan-2-yl)phenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide",813-170-3,1246213-23-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252379,(S)-2-Aminomethyl-1-Boc-azetidine,813-171-9,1007873-90-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252380,"Propanoic acid, 3-hydroxy-2-(hydroxymethyl)-2-methyl-, polymer with 1,6-diisocyanatohexane and alpha-hydro-omega-hydroxypoly [oxy(methyl-1,2-ethanediyl)] ether with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol (3:1) 2-propenoate, glycerol monoacrylate 1-neodecanoate- and propylene glycol monoacrylate-blocked",813-172-4,1052719-70-6,Aquatic Chronic 3,Notified C&L,1,H412:1
252388,Mixed metal oxide complex,,,Not Classified,Notified C&L,1,Not classified:1
252390,[3-(Trifluoromethoxy)phenyl]hydrazine hydrochloride,813-176-6,133115-55-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252391,"Fatty acids, linseed oil; compds. with triethylamine",943-909-6,,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H226:1;H319:1;H315:1
252392,"Poly(oxy-1,2-ethanediyl), a-methyl-w-[3-[1,3,3,3-tetramethyl-1-[(trimethylsilyl)oxy]disiloxanyl]propoxy]-",943-910-1,,Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H332:1;H319:1;H411:1
252393,"ethyl 2-(allyloxy)-2-chloro-3,3,3-trifluoropropanoate",813-177-1,168101-83-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,REACH registration C&L,4,H331:4;H319:4;H315:4;H301:4;H335:4;H311:4
252394,(2E)-3-[(tert-butoxycarbonyl)(propan-2-yl)amino]-2-(4-chlorophenyl)prop-2-enoic acid,813-178-7,1489004-27-4,Aquatic Chronic 3,REACH registration C&L,2,H412:2
252398,(10R)-10-hydroxyoctadecanoic acid,813-180-8,5856-32-6,Aquatic Chronic 3,REACH registration C&L,2,H412:2
252399,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252400,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252401,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252402,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252403,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252404,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252405,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252406,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252407,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252408,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252410,"4''-methyl-2'-fluoro-[1,1':4',1''-terphenyl]-4-methanol",813-182-9,1030826-33-5,Not Classified,REACH registration C&L,1,Not classified:1
252411,"3,3-dichloro-1-(4-nitrophenyl)piperidin-2-one",813-183-4,881386-01-2,Not Classified,REACH registration C&L,2,Not classified:2
252412,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252413,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252414,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252415,"Benzene, C20-24 (even numbered) sec-alkyl derivs.",701-016-7,,Asp. Tox. 1;Aquatic Chronic 4,REACH registration C&L,2,H304:2;H413:2
252416,"(cis-adamantane-2-spiro-3’-8’-[4’-[2’-(4’-morpholinyl)- ethoxy]phenyl-1’,2’,4’-troxaspiro[4.5]decane mesylate",813-185-5,1029939-87-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Repr. 2,Notified C&L,2,H312:1;H332:1;H361:2;H302:1;H317:1
252417,"Benzenesulfonic acid, 4-C20-24 (even numbered) sec-alkyl derivs.",701-015-1,,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,4,H413:4;H318:4;H314:4
252419,2-((2-ethoxy-2-oxoethyl)(methyl)amino)-2-oxoethyl 5-(tetradecyloxy))furan-2-carboxylate,943-927-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
252420,"N,N-dimethyl-[6-[4-(benzoylamino)-2-oxo-1(2H)-pyrimidinyl]-4-(triphenylmethyl)-2-morpholinyl]methyl ester phosphoramidochloridic acid",813-186-0,1155373-31-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
252421,N-(3-(aminomethyl)phenyl)acetamide hydrochloride,813-187-6,238428-27-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
252422,agelas stade 4,943-929-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
252423,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252424,[No public or meaningful name is available],,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252425,"Naphthalenesulphonic acid, dinonyl-, sodium salt",943-932-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252426,Mixed Cycloaliphatic amines,943-933-7,,Acute Tox. 4;Skin Corr. 1,Notified C&L,1,H302:1;H314:1
252427,Cycloaliphatic amine,943-934-2,,Skin Corr. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H314:1
252428,Cycloaliphatic Aromatic Amine,943-935-8,,Skin Corr. 1;Skin Sens. 1,Notified C&L,1,H314:1;H317:1
252429,"9-trimethylsilyl-1,2,3,4-tetrahydro-9H-fluorene",813-188-1,196213-23-7,Flam. Liq. 2;Aquatic Chronic 1,Notified C&L,1,H225:1;H410:1
252430,Polyamide,943-936-3,,Acute Tox. 4;Skin Corr. 1;Skin Sens. 1;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:1;H314:1;H317:1;H332:1;H335:1;H411:1
252431,"3,3-DIMETHYL-TETRAHYDRO-PYRAN-2-ONE",813-189-7,4830-05-1,Acute Tox. 4,Notified C&L,2,H302:1;Not classified:1
252432,"4,6-DICHLOROPYRIDINE-2-CARBONITRILE",813-190-2,40314-71-4,Acute Tox. 4,Notified C&L,1,H302:1
252433,"5-Bromo-4-fluoro-2,3-dihydro-1H-inden-1-one",813-191-8,127425-74-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
252435,"NAPHTHALENESULPHONIC ACID, DINONYL-, LITHIUM SALT",943-938-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252436,"1-[(benzyloxy)carbonyl]-4-ethyl-2,5-dihydro-1H-pyrrole-3-carboxylic acid",813-192-3,1869118-25-1,Acute Tox. 4,REACH registration C&L,4,H302:3;Not classified:1
252437,"2,3,3,3-Tetrafluoropropionitrile",813-193-9,431-32-3,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H315:1;H301:1;H335:1;H336:1
252438,"ethyl {5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl}carbamate",943-940-5,,Not Classified,REACH registration C&L,5,Not classified:5
252442,2-(benzyloxy)-5-methylpyridin-4-amine,813-194-4,1552820-82-2,Not Classified,REACH registration C&L,2,Not classified:2
252443,"3-BROMO-2,6-DIFLUOROPYRIDINE",813-196-5,80392-79-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252444,"hexanedioic acid, polymer with 2,2#-[1,2-ethanediylbis(oxy)] bis[ethanol], 2-ethyl-2-(hydroxymethyl)-1,2-propanediol and 1,3- isobenzofurandione, 2-propenoate)",943-942-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252447,tert-butyl 3-(2-oxoethyl)azetidine-1-carboxylate,813-197-0,152537-04-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
252448,3-(Benzyloxy)cyclobutanol,813-198-6,100058-61-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:1;H315:2;H312:1;H332:1;H335:2
252449,"1-Benzyl-1H-pyrazole-5-boronic acid, pinacol ester",813-199-1,1362243-50-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252450,"1-Ethylpyrazole-5-boronic acid, pinacol ester",813-200-5,1007110-53-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252451,2-chloro-5-methylpyridin-4-amine,813-201-0,79055-62-2,Not Classified,REACH registration C&L,1,Not classified:1
252452,"5-tert-butyl 3-ethyl 1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridine-3,5-dicarboxylate",813-202-6,518990-23-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:1;H315:2
252456,1-Ethoxycarbonylcyclopropanecarboxylic acid,813-203-1,13279-88-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H331:1;H319:1;H315:2;H301:1;H335:2;H311:1;H318:1
252460,"(5R)-5-[(7-Chloro-1H-indol-3-yl)methyl]-3-methylimidazolidine-2,4-dione",813-204-7,852391-19-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252461,"2,5-Dibromo-3-fluoropyridine",813-205-2,156772-60-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:2;H332:2;H335:2
252462,"2-Amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline",813-206-8,95896-78-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Muta. 2,Notified C&L,1,H341:1;H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252463,4-(4-Fluorophenoxy)benzenesulphonyl chloride,813-207-3,192329-91-2,Skin Corr. 1B,Notified C&L,2,H314:2
252464,"4,6-Dichloro-2,5-dimethylpyrimidine",813-208-9,1780-33-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252465,3-Bromo-4-fluorophenyl methyl sulphone,813-209-4,959961-65-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252466,1-Acetylpiperidine-3-carboxylic acid,813-211-5,2637-76-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
252471,Reaction mass of N-butylphthalimide and N-sec-butylphthalimide and N-propylphthalimide,943-947-3,,Acute Tox. 4;Skin Sens. 1,REACH registration C&L,1,H302:1;H317:1
252472,"N-((dimethylamino)methylene)3,5-bis(trifluoromethyl)benzamide",943-948-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
252473,ISOPROPYL 3 IODOACRYLATE,813-212-0,1333154-26-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
252475,"Benzamide, N-[1,2-dihydro-1-[6-(hydroxymethyl)-4-(triphenylmethyl)-2-morpholinyl]-2-oxo-4-pyrimidinyl]-, (2R-cis)- (9CI)",813-214-1,125515-31-3,Not Classified,REACH registration C&L,2,Not classified:1;H312:1;H332:1;H302:1
252479,ACETAL FMOC,813-218-3,1771804-77-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
252482,"4 amino N hydroxy 1,2,5 oxadiazole 3 carbimidoyl chloride",813-220-4,147085-13-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
252483,tert-Butyl 3-ethynylphenylcarbamate,813-222-5,185619-66-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252489,"trans-1,4-cyclohexyl diammonium acetate",943-951-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252492,4-(7-(Diethylamino)-2-oxo-2H-chromen-3-yl)-1-(3-(trimethylammonio)propyl)pyridinium dibromide,813-230-9,1622203-91-1,Acute Tox. 4,Notified C&L,1,H302:1
252493,"N-{3-[5-(2-chloro-4-pyrimidinyl)-2-(1,1-diethylethyl)-1,3-thiazol-4-yl]-2-fluoraphenyl}-2,6-difluorobenzenesulfonamide",813-231-4,1195768-23-0,Not Classified,Notified C&L,1,Not classified:1
252494,"2-(5-[1-[5-(2,5-Dioxo-pyrrolidin-1-yloxycarbonyl)-pentyl]-3,3-dimethyl-1,3-dihydro-indol-2-ylidene]-penta-1,3-dienyl)-1,3,3-trimethyl-3H-indolium bromide",813-233-5,1653991-59-3,Acute Tox. 4,Notified C&L,1,H302:1
252496,1-Dodecyl-2-(2-{3-[2-(1-dodecyl-1H-benzo[cd]indol-2-ylidene)-ethylidene]-2-phenyl-cyclohex-1-enyl}-vinyl)-benzo[cd]indolium tetrafluoroborate,943-952-0,,Acute Tox. 4,Notified C&L,1,H302:1
252499,"Reaction mass of 2,2-bis(chloromethyl)butan-1-ol and 1-Butanol, 2,2- bis(chloromethyl) -, 1-acetate",943-955-7,,Not Classified,REACH registration C&L,2,Not classified:2
252500,Methyl 2-chloro-2-methoxy-acetate,813-235-6,13157-96-5,Skin Corr. 1B,Notified C&L,2,H314:1;H318:1;H335:1;H227:1;H315:1
252502,"2-(2-[2-(4-tert-Butyl-phenylsulfanyl)-3-[2-(1,3,3-trimethyl-1,3-dihydro-indol-2-ylidene)-ethylidene]-cyclohex-1-enyl]-vinyl)-1,3,3-trimethyl-3H-indolium tetraphenylborate",813-239-8,1428324-56-4,Acute Tox. 4,Notified C&L,1,H302:1
252503,"1-(5-Carboxypentyl)-2-(5-[1-(5-carboxypentyl)-3,3-dimethyl-5-sulfo-1,3-dihydro-indol-2-ylidene]-penta-1,3-dienyl)-3,3-dimethyl-5-sulfo-3H-indolium hydroxide, inner salt",813-237-7,146368-10-7,Skin Irrit. 2,Notified C&L,1,H315:1
252505,"2-[2-[2-Chloro-3-[2-(1,3-dihydro-1,1,3-trimethyl-2H-benzo[e]-indol-2-ylidene)-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-1,1,3-trimethyl-1H-benzo[e]indolium tetraphenylborate",813-238-2,402475-23-4,Acute Tox. 4,Notified C&L,1,H302:1
252506,AGL-01332-93 Cl,943-954-1,,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Carc. 2,Notified C&L,1,H331:1;H351:1;H301:1;H311:1
252510,"2-Fluoro-N-methyl-4-[7-[(quinolin-6-yl)methyl]imidazo[1,2-b]-[1,2,4]triazin-2-yl]benzamide",813-241-9,1029712-80-8,Acute Tox. 3;Repr. 1B;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H360:1;H373:1;H301:1;H411:1
252515,Reaction mass of octyl dihydrogen phosphate and decyl dihydrogen phosphate and dioctyl hydrogen phosphate and didecyl hydrogen phosphate and decyl octyl hydrogen phosphate,943-963-0,,Skin Corr. 1B,Notified C&L,3,H314:3
252531,2-bromo-1-(4-octylphenyl)ethanone,813-242-4,64068-76-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252532,"2-[2-(2-Diphenylamino-3-[2-[3-(2-acetoxy-ethyl)-1,1-dimethyl-7-sulfo-1,3-dihydro-benzo[e]indol-2-ylidene]-ethylidene]-cyclopent-1-enyl)-vinyl]-3-(2-acetoxy-ethyl)-1,1-dimethyl-7-sulfo-1H-benzo[e]indolium hydroxide, inner salt",943-965-1,,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1,H319:1;H400:1
252536,"2-[5-[1-(5-Carboxypentyl)-3,3-dimethyl-5-sulfo-1,3-dihydro-indol-2-ylidene]-penta-1,3-dienyl]-3,3-dimethyl-5-sulfo-1-(4-sulfobutyl)-3H-indolium hydroxide, inner salt, disodium salt",943-968-8,,Skin Irrit. 2,Notified C&L,1,H315:1
252538,"3-(1,3-dioxopropan-2-yl)-2-nitrobenzoic acid",813-244-5,205680-83-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252539,CI-FIGM-11,813-269-1,51326-38-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252540,1-(4-Octylphenyl)ethanone,813-245-0,10541-56-7,Acute Tox. 4,Notified C&L,1,H302:1
252541,"Isoquinoline, 1,2,3,4-tetrahydro-1-phenyl-, (R)-",813-246-6,180272-45-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252542,Diethyl 2-acetamido-2-[2-(4-octylphenyl)-2-oxo-ethyl] propanedioate,813-247-1,268557-49-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252546,"2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)fenyl]-3-(2,2,2-trifluoroacetylamino) propanamid",813-250-8,260980-89-0,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1
252547,Reaction mass of hydrogen bis[2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxo-N-phenylbutyramidato(2-)]cobaltate(1-) and sodium bis[2-[(2-hydroxy-5-nitrophenyl)azo]-3-oxo-N-phenylbutyramidato(2-)]cobaltate(1-),943-971-4,,Not Classified,REACH registration C&L,1,Not classified:1
252548,"Reaction products of 6-hydroxy-5-nitrosonaphthalene-2-sulfonic acid, chelated with iron (3+), sodium salts.",943-973-5,,Eye Irrit. 2,REACH registration C&L,2,H319:2
252549,2-Amino-4-chloro-6-ethylpyrimidine,813-251-3,5734-67-8,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H302:1;H315:1
252556,"2H-1,4-Benzodiazepin-2-one, 3-(acetyloxy)-7-chloro-5-(2-chlorophenyl)-1,3-dihydro-1-methyl-",813-253-4,96576-92-0,Not Classified,Notified C&L,1,Not classified:1
252557,"Piperazinium, 4-(3-aminopyrazolo[1,5-a]pyridin-2-yl)-1,1-dimethyl-, chloride, hydrochloride (1:1:2)",813-255-5,1256553-33-9,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
252561,"N-[Trans-4[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-Ethyl-5,6,7,8-Tetrahydro-5-Methyl-8-(1-Methylethyl)-6-Oxo-2-Pteridinyl]Amino]-3-Methoxy-Benzamide",813-258-1,755038-65-4,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Repr. 2;STOT RE 2,Notified C&L,1,H319:1;H300:1;H315:1;H373:1;H361:1
252562,[No public or meaningful name is available],,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252563,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252564,Caesium hexafluorophosphate,813-259-7,16893-41-7,Skin Corr. 1B,Notified C&L,1,H314:1
252566,3-Chloro-1H-pyrazole,813-260-2,14339-33-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
252567,"4-BROMO-1H,2H,3H-PYRROLO[2,3-B]PYRIDIN-2-ONE",813-261-8,1086064-49-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1;H301:1
252568,1-Pentyl-1H-imidazole,813-262-3,19768-54-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
252569,"Esterification products of C10-14 (even numbered) alkyl oligomeric glycosides with citric acid, disodium salts",943-980-3,,Not Classified,Notified C&L,1,Not classified:1
252571,H-Asp-Tyr-Cys-Cys-Arg-Arg-Hyp-Thr-Cys-Ile-Pro-Ile-Cys-NH2(Disulfide bonds between Cys3 and Cys9/Cys4 and Cys13),943-981-9,,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1;H311:1
252572,"N-[(2S)-4-amino-1-[[(2S,3R)-1-[[(2S)-4-amino-1-oxo-1-[[(3S,6S,9S,12S,15R,18R,21S)-6,9,18-tris(2-aminoethyl)-15--(4-[(6-[1H-pyrrole-2,5-dione-1-yl]-1-oxohexyl)amino]butyl)-3-[(1R)-1-hydroxyethyl]-12-(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxobutan-2-yl]-6-methyloctanamide",943-982-4,,Acute Tox. 4,Notified C&L,1,H302:1
252573,"(Des-Gly10,D-Ala6,Pro-NHEt9)-LHRH (sea bream)",813-263-9,319429-24-8,Repr. 1A,Notified C&L,1,H360:1
252574,"9-(2-carboxy-3,4,5,6-tetrachlorophenyl)-3,6-bis(diethylamino)xanthylium perchlorate",943-984-5,,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H318:1;H412:1
252575,(1R)-1-isopropyl-4-methyl-cyclohex-3-en-1-ol,943-985-0,20126-76-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,8,H319:8;H302:8;H315:8
252576,"METHYL 4-(17-AMINO-28-NORLUPA-2,20(29)-DIEN-3-YL)BENZOATE",813-264-4,1392314-32-7,Acute Tox. 4,Notified C&L,1,H302:1
252577,6-chlorohexyl methacrylate,813-266-5,45101-66-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,2,H319:2;H317:2;H315:2;H412:2;H335:2
252578,(2-chloro-4-(trifluoromethyl)phenyl)hydrazine,813-267-0,86398-98-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252579,"1,3,5-Benzenetricarboxylic acid, copper(2+) salt (2:3)",813-272-8,309721-49-1,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H400:83;H302:83;H317:83;H315:83;H410:83
252580,6-Chloro-2-(trifluoromethoxy)nicotinic acid,813-268-6,1221171-91-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
252581,(Trans)-4-(4-(Cyclopropylmethyl)Piperazine-1-yl)Cyclohexan-1-Amine HCl,813-270-7,882660-42-6,Acute Tox. 4,Notified C&L,1,H302:1
252582,6-{4-[(1E)-3-methoxy-3-oxoprop-1-en-1-yl]phenoxy}hexyl methacrylate,813-271-2,439661-46-8,Not Classified,REACH registration C&L,4,Not classified:4
252583,"Reaction product of Ethylenglycol, Sodiumacetate and 3-oxo-alpha-Jonylacetate obtained by heating, extraction and distillation and subsequent saponification with Sodiumhydroxide.",943-986-6,,Skin Sens. 1;Repr. 2;Aquatic Chronic 3,REACH registration C&L,2,H361:2;H412:2;H317:2
252584,Butadiene Homopolymer,813-273-3,72102-33-1,Skin Irrit. 2;Skin Sens. 1,Notified C&L,1,H317:1;H315:1
252591,[R]-3-Pyrrolidinemethanol,813-275-4,110013-18-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252594,"2,3-Difluoro-6-(trifluoromethyl)benzonitrile",813-278-0,186517-05-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252595,"2,4-Dimethyl-1,3-oxazole-5-carboxylic acid",813-279-6,2510-37-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H302:1;H315:2;H312:1;H332:1;H335:2;H319:1
252596,"4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole",813-280-1,885618-33-7,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
252600,"Reaction mass of sulfonium, dodecylethyl[1-(2-methoxy-2-oxoethyl)-3-oxo-3-(pentyloxy)propyl]-, tetrafluoroborate(1-)(1:1) and sulfonium, dodecylethyl[3-methoxy-1-(2-methoxy-2-oxoethyl)-3-oxopropyl]-, tetrafluoroborate(1-)(1:1) and sulfonium, dodecylethyl[3-oxo-1-[2-oxo-2-(pentyloxy)ethyl]-3-(pentyloxy)propyl]-, tetrafluoroborate(1-)(1:1)",943-993-4,,Skin Irrit. 2;Skin Sens. 1A,Notified C&L,1,H317:1;H315:1
252601,"1-Bromobutane-2,3-dione",813-281-7,5308-51-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H315:2;H302:1;H227:1;H318:1
252603,"Reaction products of diazotised 2-amino-5-{[2-(sulfooxy)ethyl]sulfonyl}benzenesulfonic acid coupled with 2,4-diaminobenzensulfonic acid, subsequently coupled with diazotised 2-amino-5-(2-(sulfooxy)ethylsulfonyl)benzene, sodium salts",943-995-5,,Not Classified,REACH registration C&L,3,Not classified:3
252604,"5-Bromo-6-fluoro-2,3-dihydro-1H-inden-1-one",813-283-8,866862-25-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252605,3-BROMO-5-CYANOBENZYL ALCOHOL,813-284-3,1205515-06-5,Acute Tox. 4,Notified C&L,2,H302:2;H319:1;H315:1;H312:1;H332:1;H335:1
252606,(S)-3-(1-aminoethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one,813-285-9,1350643-72-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,2,H312:1;H319:1;Not classified:1
252608,"Fatty alcohol C8-10, ethoxylated, sulfated, mono-isopropanolamine salt",813-288-5,1812871-14-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
252609,6-[4-(tert-butyl)phenoxy]pyridin-3-amine,813-289-0,218457-67-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252610,"Reaction product of d-Limonene obtained by oxidation, UV-rays and rose bengale",943-996-0,,Flam. Liq. 2;Org. Perox. B;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H317:2;H241:2;H411:2;H225:2
252613,Perfluorohexanoyl chloride,813-291-1,335-53-5,Skin Corr. 1B,Notified C&L,1,H314:1
252616,"Reaction mass of pentasodium 2-[(8-{[4-chloro-6-(4-{[2-(sulfonatooxy)ethyl]sulfonyl}anilino)-1,3,5-triazin-2-yl]amino}-1-hydroxy-3,6-disulfonato-2-naphthyl)diazenyl]naphthalene-1,5-disulfonate and pentasodium 2-[(1-hydroxy-8-{[4-hydroxy-6-(4-{[2-(sulfonatooxy)ethyl]sulfonyl}anilino)-1,3,5-triazin-2-yl]amino}-3,6-disulfonato-2-naphthyl)diazenyl]naphthalene-1,5-disulfonate",943-998-1,,Not Classified,REACH registration C&L,3,Not classified:3
252619,"Fatty acids, C5-10 (linear and branched), mixed esters with pentaerythritol",,,Not Classified,REACH registration C&L,1,Not classified:1
252620,"Fatty acids, C16-18 (even numbered) and C18-unsatd., branched and linear, di- and triesters with trimethylolpropane",701-023-5,,Not Classified,REACH registration C&L,4,Not classified:4
252621,Reaction products of 4-alkylalkanol and diphosphorus pentaoxide with 2-ethylhexylamine,,,Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1,H318:1;H412:1;H317:1
252622,"Fatty acids, C18-unsatd., mono- and diesters with neopentylglycol and di-and triesters with trimethylolpropane",812-656-2,,Not Classified,REACH registration C&L,3,Not classified:3
252624,"Glycine, N-(phosphonomethyl)-, potassium salt",813-293-2,70901-12-1,Eye Irrit. 2,Notified C&L,1,H319:1
252625,poly[(2-ethylhexyl prop-2-enoate)-co-(2-hydroxyethyl prop-2-enoate)],813-294-8,36089-45-9,Skin Irrit. 2;Skin Sens. 1B;Aquatic Chronic 3,Notified C&L,33,H412:33;H317:33;H315:33
252626,"Fatty acids, reaction products with diethylenetriamine, maleic anhydride, tetraethylenepentamine and triethylenetetramine",813-295-3,1820591-71-6,Skin Sens. 1,Notified C&L,1,H317:1
252627,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252628,"Tetra-esterification products of C5-(branched and linear), C7, C8 and C10 fatty acids with pentaerythritol",,,Not Classified,REACH registration C&L,1,Not classified:1
252630,"Pentaerythritol tetraesters of decanoic acid, heptanoic acid, octanoic acid, and valeric acid",701-020-9,,Not Classified,REACH registration C&L,1,Not classified:1
252631,"Fatty acids, C8-16-(even numbered), tetraesters with pentaerythritol",812-655-7,,Not Classified,REACH registration C&L,1,Not classified:1
252633,"Fatty acids, coco, diesters and triesters with trimethylolpropane",812-688-7,,Not Classified,REACH registration C&L,5,Not classified:5
252634,"Fatty acids, C8-10-(even numbered), diesters and triesters with trimethylolpropane",812-652-0,,Not Classified,REACH registration C&L,28,Not classified:28
252635,"Heptanoic acid, mixed esters with pentaerythritol and valeric acid",812-653-6,,Not Classified,REACH registration C&L,7,Not classified:7
252637,"3-Chloro-4-methoxy-1,2,5-thiadiazole",944-002-8,,Acute Tox. 3;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H373:1;H412:1;H301:1;H317:1
252638,"Methanone, [6-methoxy-2-(4-methoxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride",813-297-4,84541-36-6,Not Classified,Notified C&L,1,Not classified:1
252640,"Imidazo[5,1-f][1,2,4]triazin-4(1H)-one, 2-[2-ethoxy-5-[(4-ethyl-4-oxido-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl-",813-300-9,448184-48-3,Acute Tox. 4,Notified C&L,1,H302:1
252641,"Reaction products of sodium sulphide, sulphur, carbon disulphide and potassium hydroxide",944-003-3,,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H318:1;H314:1
252645,5-Chloro-2-octylbenzimidazole,813-301-4,956013-39-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252646,"Reaction mass of 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl pivalate and 3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl pivalate",944-011-7,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H411:2;H315:2
252648,N-(4-(4-substituted-4-alkylpiperidine-1-carbonyl)phenyl)quinoxaline-5-sulfonamide,,,Acute Tox. 4,Notified C&L,1,H302:1
252649,1-(propan-2-yl)-1H-pyrazol-3-amine,813-304-0,857267-04-0,Skin Corr. 1B,Notified C&L,2,H314:1;H319:1;H335:1;H302:1;H315:1
252650,"1-(4-chlorophenyl)-4,4-dimethylpent-1-en-3-one",813-305-6,41564-62-9,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89;H317:89
252651,NONE 16 RESINE EPOXY,944-005-4,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H315:1
252652,"(2R)-2-(3-Benzoylphenyl)propanoic acid, 1-Deoxy-1-(octylamino)-D-glucitol salt",944-007-5,,Not Classified,REACH registration C&L,1,Not classified:1
252654,"4-methoxy-1,3-benzenediol",813-306-1,6100-60-3,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
252656,2-(methoxymethyl)-4-nitroaniline,813-308-2,337906-35-1,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,2,H302:2;H411:1;H319:1;H335:1;H315:1
252657,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2;Repr. 2,Notified C&L,1,H319:1;H315:1;H351:1;H361:1;H335:1
252658,"2-Propenoic acid, reaction products with polyethylene glycol ether with trimethylolpropane (3:1)",813-309-8,1687740-46-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
252659,"1-Octene, homopolymer, hydrogenated",813-310-3,70693-43-5,Asp. Tox. 1;Acute Tox. 4,Notified C&L,1,H304:1;H332:1
252662,"3-(4-Hydroxy-2-nitrophenyl)-1,3-oxazinane-2-one",944-012-2,,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,1,H302:1;H411:1
252663,Alkyl-(C2-C4)-1-hydroxyethyl-2-imidazoline,813-311-9,69980-75-2,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Eye Irrit. 2;STOT SE 3,Notified C&L,18,H319:18;H302:18;H314:18;H312:18;H335:18
252664,[No public or meaningful name is available],,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252665,2-(Hydroxymethyl)-4-{(E)-[2-(hydroxymethyl)phenyl]diazenyl}aniline,944-014-3,,Aquatic Chronic 2,Notified C&L,1,H411:1
252671,"Reaction mass of 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, (1R,4R)- and 2-Cyclohexen-1-ol, 1-methyl-4-(1-methylethenyl)-, (1S,4R)-",944-020-6,,Acute Tox. 4,REACH registration C&L,2,H302:2
252672,"3,5-bis(methylsulfonyl)benzoic acid",813-314-5,90536-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252673,5-(1H-pyrazol-5-yl)-2-(trifluoromethyl)pyridine,944-021-1,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252674,"3-(2-fluorophenyl)-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine",813-315-0,916423-12-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252675,ethyl 5-amino-1-benzyl-1H-imidazole-4-carboxylate,813-316-6,68462-61-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252677,"5-chloro-2-(trifluoromethyl)-1,6-naphthyridine",813-318-7,890301-88-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252680,"Ethanone, 1-[3,5-bis(acetyloxy)phenyl]-2-[(1,1-dimethylethyl)(phenylmethyl)amino]-, hydrobromide",813-321-3,28924-23-4,Not Classified,Notified C&L,1,Not classified:1
252681,"poly{(ethyl prop-2-enoate)-co-(methyl 2-methylprop-2-enoate)-co-[2-(prop-1-en-2-yl)-4,5-dihydro-1,3-oxazole]}",813-322-9,57460-65-8,Flam. Liq. 3,Notified C&L,32,H226:32
252682,Reaction mass of boron trichloride and dichloromethane,944-022-7,,Acute Tox. 3;Skin Corr. 1B;Carc. 2,Notified C&L,1,H351:1;H301:1;H314:1
252683,1-isopropyl-4-methyl-bicyclo[3.1.0]hex-2-en-4-ol,944-023-2,,Not Classified,REACH registration C&L,2,Not classified:2
252684,"Reaction mass of (iodomethyl)magnesium(1+) and 1,1'-oxydiethane",944-024-8,,Flam. Liq. 1;Water-react. 1;Acute Tox. 2;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H300:1;H314:1;H224:1;H260:1;H336:1
252685,1-(3-ethoxy-4-methoxy-phenyl)-2-(methylthio)ethan-1-one,944-025-3,2093007-28-2,Acute Tox. 4,REACH registration C&L,2,H302:2
252687,"(3S)-3-[6-[tert-butyl(dimethyl)silyl]oxy-1,3-benzodioxol-5-yl]-3-(hydroxymethyl)-1-[[5-(trifluoromethyl)-2-furyl]methyl]indolin-2-one",944-026-9,,Acute Tox. 4,Notified C&L,1,H302:1
252688,"(R,R)-(+/-)-N-(2-Benzyloxy-5-(1-hydroxy-2-(N'-benzyl-N'-(2-(4-methoxy-phenyl)-1-methylethyl)amino)ethyl)phenyl)formamide",813-325-5,43229-70-5,Aquatic Chronic 4,Notified C&L,3,H413:1;H372:1;H351:1;H370:1;H332:1;H361:1;Not classified:1
252689,[No public or meaningful name is available],,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252690,"3-Chloro-4,5-difluorophenol",813-326-0,1261472-63-2,Skin Corr. 1B,Notified C&L,1,H314:1
252691,"Sulfuric acid, di(butylamine) salt",813-327-6,39085-66-0,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1;Eye Dam. 1;Acute Tox. 3;STOT SE 3,Notified C&L,1,H331:1;H302:1;H314:1;H318:1;H335:1;H311:1
252692,trans-4-(11-Hydroxyundecyloxy)cyclohexanecarboxylic acid,944-029-5,2098249-48-8,Eye Irrit. 2,Notified C&L,1,H319:1
252693,"N,N'-bis{N-[N-(4-chlorophenyl)carbamimidoyl]carbamimidoyl}hexane-1,6-bis(aminium) diundec-10-enoate",813-944-0,1884575-91-0,Not Classified,REACH registration C&L,1,Not classified:1
252694,"N,N'-dibenzylethane-1,2-bis(aminium) bis{(6R,7S)-3-(hydroxymethyl)-7-methoxy-8-oxo-7-[2-(2-thienyl)acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate}",813-328-1,1022927-69-0,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1,H334:1;H317:1
252696,Tripro-amylin acetate,813-329-7,187887-46-3,Repr. 1B,Notified C&L,1,H360:1
252697,"3-(5-((1R,2S)-2-(2,2-difluoropropanamido)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)propoxy)-1H-indazol-1-yl)-N-((R)-tetrahydrofuran-3-yl)benzamide",813-330-2,1196509-60-0,Repr. 2;STOT RE 1;STOT RE 1,Notified C&L,2,H372:2;H361:2;H228:1;H252:1
252698,dec-1-en-4-yne,813-331-8,24948-66-1,Flam. Liq. 3;Acute Tox. 4;Skin Sens. 1B;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H400:2;H302:2;H317:2;H226:2;H410:2;H336:2
252699,"methyl 2,4-diacetoxy-6-pentyl-benzoate",944-031-6,,Repr. 2,Notified C&L,1,H361:1
252701,2-methyl-5-nitro-1H-indole-3-carbaldehyde,813-332-3,3558-17-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252703,[No public or meaningful name is available],944-033-7,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H302:2;H317:2
252709,"4,4'-[(6S)-6-phenylindolo[1,2-c][1,3]benzoxazine-3,10-diyl]bis{2-[(2S)-2-pyrrolidiniumyl]-1H-imidazol-3-ium} tetrachloride",944-036-3,,Not Classified,Notified C&L,1,Not classified:1
252714,"Reaction mass of 2-((((allyloxy)carbonyl)oxy)methyl)-2-ethylpropane-1,3-diyl bis(6-(((allyloxy)carbonyl)oxy)hexanoate) and 2-(((6-(((allyloxy)carbonyl)oxy)hexanoyl)oxy)methyl)-2-ethylpropane-1,3-diyl bis(6-(((allyloxy)carbonyl)oxy)hexanoate) and 2,2-bis((((allyloxy)carbonyl)oxy)methyl)butyl 6-(((allyloxy)carbonyl)oxy)hexanoate and 2,8-bis((((allyloxy)carbonyl)oxy)methyl)-2,8-diethyl-5,11-dioxo-4,6,10,12-tetraoxapentadec-14-en-1-yl 6-(((allyloxy)carbonyl)oxy)hexanoate",944-037-9,,Not Classified,REACH registration C&L,2,Not classified:2
252724,"(2E)-methyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl) but-2-en-1-ol",813-338-6,106155-02-6,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,11,H319:9;H411:11;H315:11;H320:2
252725,"Reaction products of diazotized 3-amino-4-hydroxybenzenesulfonic coupled with diazotized 4-nitro-1,3-benzenediamine and resorcinol, chelated with copper , sodium salts",944-040-5,,Not Classified,REACH registration C&L,8,Not classified:8
252726,"Reaction products of 4-amino-3-hydroxy-7-nitronaphthalene-1-sulfonic acid and 2′,4′-dihydroxyacetophenone chelated with iron, sodium salts",944-041-0,,Aquatic Chronic 3,REACH registration C&L,4,H412:4
252727,"Reaction product of diazotised 4-amino-5-hydroxy-2,7-naphthalenedisulfonic acid coupled with resorcinol, subsequently coupled with diazotised 2-amino-4,6-dinitrophenol and 4-nitrobenzenamine, chelated with iron (3+), sodium salts",944-042-6,,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H411:2
252731,"Reaction product of diazotised (Z)-2-amino-3-hydroxy-N-phenylbut-2-enamide coupled with 2-hydroxy-5- nitrobenzenesulfonic acid , chelated with chromium (3+), sodium salts",944-045-2,,Not Classified,REACH registration C&L,2,Not classified:2
252738,4-bromo-1-(bromomethyl)-2-(methylsulfonyl)benzene,813-344-9,254887-18-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252743,Chlorure de l’acide 2-bromohexadecanoïque,944-052-0,,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
252752,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252753,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252754,3-Bromo-2-nitrobenzoic acid,813-347-5,116529-61-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252755,3-Bromo-2-iodobenzoic acid,813-348-0,503821-94-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252759,"Reaction product of diazotized 3-aminobenzenesulfonic acid coupled with naphthalen-1-amine, subsequently diazotized and coupled with 3-((ethyl(phenyl)amino)methyl)benzenesulfonic acid or 4-((ethyl(phenyl)amino)methyl)benzenesulfonic acid, sodium salt",944-062-5,,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,8,H318:8;H411:8
252760,"Reaction mass of lithium acetylide, ethylenediamine complex and toluene",944-063-0,,Flam. Liq. 2;Water-react. 1;Asp. Tox. 1;Skin Corr. 1A;STOT SE 3;STOT RE 2,Notified C&L,1,H314:1;H304:1;H225:1;H260:1;H373:1;H336:1
252761,Reaction mass of potassium 2-methylpropan-2-olate and tetrahydrofuran,944-064-6,,Flam. Liq. 2;Skin Corr. 1B;STOT SE 3;Carc. 2,Notified C&L,1,H314:1;H335:1;H351:1;H225:1
252762,Reaction mass of ammonia and tetrahydrofuran,944-065-1,,Flam. Liq. 2;Skin Corr. 1B;STOT SE 3;Carc. 2,Notified C&L,1,H314:1;H335:1;H351:1;H225:1
252763,Reaction mass of boron trichloride and hexane,944-066-7,,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;STOT SE 3,Notified C&L,1,H314:1;H304:1;H301:1;H225:1;H336:1;H311:1
252766,"Reaction mass of 2,4-dimethyl-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-ol and 3,4-dimethyl-3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-ol",944-067-2,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1,H302:1;H317:1;H315:1;H411:1;H318:1
252767,"2-[(1S,2S,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]ethanol",701-063-3,133001-09-9,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,3,H319:3;H412:3
252768,prop-2-en-1-yl (2E)-3-phenylprop-2-enoate,813-349-6,56289-56-6,Acute Tox. 4;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H400:1;H302:1;H317:1
252771,Carbamic acid ester,,,Not Classified,Notified C&L,1,Not classified:1
252772,methyl 2-amino-4-(methoxymethyl)thiazole-5-carboxylate,813-351-7,733754-08-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252775,Reaction mass of Dimagnesium:pentane;dibromide and tetrahydrofuran,944-070-9,,Flam. Liq. 1;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H302:1;H314:1;H224:1;H312:1;H332:1
252776,"Synthetic amorphous magnesium silicate, with molar ratio (SiO2:MgO) range of 1.4-4",701-065-4,,Not Classified,REACH registration C&L,63,Not classified:63
252777,"Reaction mass of 2-Naphthaleneacetamide, N-[1-(hydroxymethyl)propyl]-6-methoxy-α-methyl-, [R-(R*,R*)]- (9CI) and 2-Naphthaleneacetamide, N-[1-(hydroxymethyl)propyl]-6-methoxy-α-methyl-, [R-(R*,S*)]- (9CI)",944-071-4,,Not Classified,Notified C&L,1,Not classified:1
252779,"1-(2,4-Difluorophenyl)ethane-1-sulfonyl chloride",813-353-8,1248002-37-0,Skin Corr. 1B,Notified C&L,1,H314:1
252780,Cyclopropylhydrazine dihydrochloride,813-354-3,1374652-23-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H331:1;H319:2;H315:2;H301:1;H335:2;H311:1;H302:1;H332:1
252781,"Reaction products of 1,3-dihydroxybenzene, 4-amino-5-hydroxynaphthalene-2,7-disulphonic acid, 4-methoxy-1-aminobenzene, 2-(4-aminoanilino)-5-nitrobenzenesulphonic acid, sodium salt",944-073-5,,Not Classified,REACH registration C&L,9,Not classified:9
252784,4-(2-aminopropan-2-yl)-2-fluorobenzoic acid,813-356-4,1314656-81-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252785,Reaction mass of Samarium II iodide and tetrahydrofuran,944-075-6,,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,1,H319:1;H315:1;H351:1;H225:1;H335:1
252786,N-phenyl-N'-[(phenylamino)sulfonyl]urea,813-358-5,4886-26-4,Not Classified,REACH registration C&L,2,Not classified:2
252789,"Reaction mass of (1S*, 2R*, 5S*)-2-Isopropenyl-5-methylcyclohexanol and (1S*, 2S*, 5R*)-2-Isopropenyl-5-methylcyclohexanol",946-911-5,,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,1,H302:1;H315:1
252790,"Amides, C18-unsatd., N-[2-[2-(C17-unsatd. alkyl)-4,5-dihydro-1H-imidazol-1-yl]ethyl]",944-076-1,,Skin Corr. 1C;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 1,REACH registration C&L,2,H318:2;H314:2;H317:2;H410:2
252791,"N-[2-(aminomethyl)phenyl]-N,N-dimethylamine",813-359-0,57678-45-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252795,"4,6-dimethoxy-2-(piperazin-1-ylmethyl)pyrimidine",813-362-7,387350-76-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252796,"3,3-dihydroxy-2-(quinolin-4-yl)propanal",813-363-2,386715-38-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252798,[No public or meaningful name is available],,,Eye Irrit. 2,REACH registration C&L,2,H319:2
252800,AL-P7,,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252802,CUZIN,,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252804,"1-[3,5-bis(benzyloxy)phenyl]-2-bromoethanone - 1,4-dioxane (2:1)",944-082-4,,Flam. Sol. 2;Carc. 2,Notified C&L,1,H228:1;H351:1
252805,2-(4-aminophenyl)propan-2-ol,813-367-4,23243-04-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
252806,3-AMINO-5-CHLOROBENZONITRILE,813-369-5,53312-78-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
252807,1-(4-BROMO-3-FLUOROPHENYL)CYCLOPROPANE-1-CARBOXYLIC,813-370-0,749269-74-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252808,6-BROMO-1-CHLOROPHTHALAZINE,813-371-6,470484-70-9,Acute Tox. 4,Notified C&L,1,H302:1
252809,"4,5,6,7-TETRAHYDRO-1H-INDOLE-2-CARBOXYLIC ACID",813-372-1,131172-64-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
252810,"2,4-Dichloro-5-cyanothiazole",813-373-7,82554-18-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
252811,N-(5-chloromonoheterocyc-2-yl)-2-[4-(substitutedcarbamimidoyl)arenamido]-5-methoxyarenamide,,,STOT SE 2,Notified C&L,1,H371:1
252812,3-Methyl-1H-pyrazole-5-carboxamide,944-085-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252813,4-Fluoro-2-(trifluoromethyl)aniline hydrochloride,813-374-2,139291-82-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252814,"2,2-dimethylpropane-1-sulfonyl chloride",813-375-8,53333-76-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H302:1;H315:1;H314:1
252816,Quinoxaline-5-carboxylic acid,813-377-9,6924-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
252817,Methyl 1-bromocyclopropanecarboxylate,813-378-4,96999-01-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H302:2;H315:2;H226:1;H318:1
252818,Methyl (E)-3-fluorocinnamate,813-380-5,74325-03-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252819,Methyl 3-aminobicyclo[1.1.1]pentane-1-carboxylatehydrochloride,813-381-0,676371-65-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
252821,(Isoquinolin-6-yl)methanamine hydrochloride,813-382-6,1396762-19-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H302:3;H315:3
252823,1-Benzyl-1H-imidazole-5-carboxaldehyde,813-383-1,85102-99-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252824,"Sulfonation products of (N-phenyl-4-[[4-(phenylamino)phenyl][4-(phenylimino)cyclohexa-2,5-dien-1-ylidene]methyl]aniline, monohydrochloride and 4,4'-[(4-iminocyclohexa-2,5-dien-1-ylidene)methylene]bis[N-phenylaniline], monohydrochloride), sodium salts",944-086-6,,Not Classified,Notified C&L,1,Not classified:1
252825,5-ACETYL-2H-PYRAZOLE-3-CARBOXYLIC ACID ETHYL ESTER,813-384-7,37622-89-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252826,tert-butyl 4-amino-3-methyl-1H-pyrazole-1-carboxylate,813-385-2,847139-23-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252843,"S-[2-hydroxy-4-(2,2,2-trifluoroacetamido)alicyclic] arenecarbothioate",,,STOT SE 2,Notified C&L,1,H371:1
252846,Cesium potassium fluoroaluminate,,,Eye Dam. 1;Acute Tox. 4;Lact.;STOT RE 1;Aquatic Chronic 2,Notified C&L,1,H362:1;H372:1;H411:1;H332:1;H318:1
252849,"[(E)-1-methyl-3-(2,6,6-trimethylcyclohex-2-en-1-yl)allyl] acetate",944-088-7,,Not Classified,REACH registration C&L,2,Not classified:2
252850,"Reaction product of [(E)-1-methyl-3-(2,6,6-trimethylcyclohex-2-en-1-yl) allyl] acetate isomer 1, [(E)-1-methyl-3-(2,6,6-trimethylcyclohex-2-en-1-yl) allyl] acetate isomer 2 and Cobalt(II)acetate/Sodiumbromide, obtained by oxidation.",944-089-2,,Not Classified,REACH registration C&L,2,Not classified:2
252852,"Reaction mass of morpholine and 6-[(p-tosyl)amino]hexanoic acid, compound with morpholine (1:1)",944-090-8,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H319:1;H412:1;H315:1
252853,"({[(2S,5R)-7-oxo-2-(piperidinium-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]oct-6-yl]oxy}sulfonyl)oxidanide hydrate (1:1)",813-387-3,1174020-13-3,STOT RE 2,Notified C&L,36,H373:36
252854,4-carbamimidamidobenzoic acid,813-388-9,16060-65-4,Acute Tox. 4,REACH registration C&L,2,H302:2
252856,"2-(1,3-Benzoxazol-2-yl)-1-[4-(trifluoromethyl)phenyl]ethanone",813-389-4,849021-35-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252859,4-(10-phenylanthracen-9-yl)benzeneboronic acid,813-393-6,952604-30-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252860,"2-(3,5-Di-tert-butylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",813-394-1,1071924-13-4,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
252861,"(3,5-di-tert-butylphenyl)boronic acid",813-395-7,197223-39-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252862,9-(3-bromophenyl)-10-(naphthalen-2-yl)anthracene,813-396-2,943861-20-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252863,"4,4,5,5-tetramethyl-2-(3-(9-phenyl-9H-fluoren-9-yl)phenyl)-1,3,2-dioxaborolane",813-397-8,1260032-45-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252864,Pyren-1-ylboronic acid,813-398-3,164461-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252865,"Magnesium 2,3,4,5,6,7-Hexahydroxyheptanoate",813-399-9,1821694-26-1,Not Classified,REACH registration C&L,4,Not classified:4
252866,Roxadustat,813-400-2,808118-40-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:1;H315:2;H332:1;H335:2
252867,"Reaction products of 7-amino-4-hydroxynaphthalene-2-sulfonic acid reacted with 2-((1,3,5-triazin-2-yl)amino)ethan-1-ol, coupled with diazotised 3-amino-4-hydroxybenzenesulfonic acid, subsequently coupled with diazotised 2-amino-5-methoxybenzenesulfonic acid, chelated with copper, sodium salt",944-092-9,,Aquatic Chronic 2,REACH registration C&L,7,H411:6;Not classified:1
252868,"tert-butyl (2S)-4-oxo-2-(1,3-thiazolidin-3-yl carbonyl)pyrrolidine-1-carboxylate",813-401-8,401564-36-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252870,Ethyl 1-thio-D-galactopyranoside,813-402-3,56245-60-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252871,2-(pyridin-3-yl)-5-(trifluoromethyl)benzenamine,813-403-9,158461-54-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252872,"PAMAM dendrimer, ethylenediamine core, generation 0.0 solution",813-404-4,155773-72-1,Flam. Liq. 3;Acute Tox. 3,Notified C&L,1,H226:1;H311:1
252873,"(3R,4R)-1-benzyl-4-fluoropyrrolidin-3-amine bis-hydrochloride",944-093-4,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252874,tert-butyl (S)-(3-oxopent-4-en-2-yl)carbamate; PF-06877893 ; synonym: SBAVEK,813-406-5,458531-57-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252875,3-Hydroxypyrazole-4-carboxylic acid ethyl ester,813-407-0,7251-53-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
252880,heterocyclic polyaromatic compound,,,Skin Sens. 1;STOT SE 3,Notified C&L,1,H335:1;H317:1
252881,aromatic P-compound,,,Aquatic Chronic 3,Notified C&L,1,H412:1
252882,heteropolycycle substituted tetraamine,,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H302:1;H317:1;H315:1;H335:1
252883,aromatic P-compound,,,Aquatic Chronic 3,Notified C&L,1,H412:1
252884,N-heterocyclic aromatic P-compound,,,Aquatic Chronic 3,Notified C&L,1,H412:1
252885,"2,3,4,5-tetrafluoro-6-(trifluoromethyl)pyridine",,,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Eye Dam. 1;Acute Tox. 4,Notified C&L,1,H302:1;H225:1;H312:1;H332:1;H318:1
252886,fluorinated cyclo[n]alkylidene compound,,,Acute Tox. 4,Notified C&L,1,H302:1
252887,aromatic nitrile compound,,,Acute Tox. 4,Notified C&L,1,H302:1
252888,(3-Bromophenyl)diphenylphosphine Oxide,813-412-8,10212-04-1,Aquatic Chronic 3,Notified C&L,2,H412:1;H319:1;H315:1
252889,"1,2-bis(substituted)ethane",,,Aquatic Chronic 3,Notified C&L,1,H412:1
252890,halogenated notrile compound,,,Acute Tox. 4,Notified C&L,1,H302:1
252891,N-heterocyclic aromatic compound,,,Aquatic Chronic 3,Notified C&L,1,H412:1
252892,aromatic P-compound,,,Aquatic Chronic 3,Notified C&L,1,H412:1
252893,aromatic P-compound,,,Aquatic Chronic 3,Notified C&L,1,H412:1
252894,aromatic P-compound,,,Aquatic Chronic 3,Notified C&L,1,H412:1
252895,2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate,813-418-0,59721-16-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2
252897,"[(3-methyl-1H-1,2,4-triazol-5-yl)thio]acetic acid",813-419-6,64679-65-8,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,3,H319:3;H315:3;H335:1
252898,"1,3-Dimethoxypropane",813-420-1,17081-21-9,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H226:2;H319:2;H335:2;H315:3;H360:1;H225:1
252900,2-((3-methoxyphenyl)amino)benzoic acid,813-421-7,27693-73-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252901,3-(1H-imidazol-1-yl)aniline,813-422-2,112677-67-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
252902,"4-[(4,6-dimethylpyrimidin-2-yl)oxy]aniline",813-423-8,55749-90-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252903,"Alkali metal [bis(4,4,5,5,6,6,7,7,8,8,9,9,9-tridecafluoro-2- substitutednonyl)amino]alkanesulfonate",,,Acute Tox. 4;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H302:2
252904,Flurobenzyl arboxamide derivative,,,Repr. 2;STOT SE 2;STOT RE 2,Notified C&L,1,H361:1;H373:1;H371:1
252924,Y-27632 (hydrochloride),813-428-5,129830-38-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H312:3;H332:3;H302:3
252925,Sulforhodamine 101 acid chloride,813-429-0,82354-19-6,Acute Tox. 3;Acute Tox. 4;Carc. 2,Notified C&L,1,H332:1;H351:1;H301:1
252927,"Thiophene-2,5-dicarboxylic acid mono tert butylester",944-106-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252928,Ethoxylated octylphenol,813-430-6,9081-83-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
252929,4-(4-chlorophenyl)-1H-pyrazole,813-431-1,111016-47-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252932,2-(2-chloro-4-methoxyphenyl)acetic acid,813-432-7,91367-09-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,91,H319:91;H302:91;H315:91;H312:90;H332:90;H335:91
252933,"(1,5-dimethyl-1H-pyrazol-3-yl)methanamine",813-433-2,423768-52-9,Skin Corr. 1B,Notified C&L,2,H314:2
252934,N-[1-(2-Fluorophenyl)ethyl]methylamine,813-434-8,926213-41-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252935,3-[(3-Fluorophenyl)carbamoyl]benzeneboronic acid,813-435-3,874288-34-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252936,3-[(2-Fluorophenyl)carbamoyl]benzeneboronic acid,813-436-9,874288-35-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252937,"2-Bromoimidazo[1,2-a]pyridine",813-437-4,112581-95-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
252938,4-[N-Benzyl-N-(methylaminocarbonyl)]benzeneboronic acid,813-439-5,874219-49-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252939,1-[phenyl-(4-phenylphenyl)methyl]imidazole; nitrate,814-266-8,60629-07-4,Acute Tox. 4;Repr. 2;Lact.;STOT RE 2,REACH registration C&L,2,H362:2;H361:2;H302:2;H373:2
252941,"Reaction products of diazotised 2-amino-5-{[2-(sulfooxy)ethyl]sulfonyl}benzenesulfonic acid coupled with 7-amino-4-hydroxynaphthalene-2-sulfonic acid, subsequently coupled with diazotized 2-[(4-aminophenyl)sulfonyl]ethyl hydrogen sulfate, sodium salts",944-110-5,,Eye Dam. 1,REACH registration C&L,3,H318:3
252942,Bifenazate Metabolite B,813-440-0,149878-40-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
252943,Octadec-9-ene,813-441-6,5557-31-3,Asp. Tox. 1,Notified C&L,2,H304:2
252944,"Reaction products of diazotized 4-aminobenzenesulfonic acid coupled with aniline, subsequently coupled with diazotized 2-aminobenzoic coupled with 7-amino-4-hydroxynaphthalene-2-sulfonic then reacted with (E)-6,6'(ethene-1,2-diyl)bis(3-nitrobenzenesulfonic acid), chelated with copper, sodium salt",944-111-0,,Not Classified,REACH registration C&L,2,Not classified:2
252946,"7-Aminoimidazo[1,2-a]pyridine",813-442-1,421595-81-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,90,H319:90;H302:90;H315:90;H312:90;H332:90;H335:90
252947,"1-(2,4-Difluorophenyl)ethanol",813-443-7,2267-47-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252948,"2-Formylbenzeneboronic acid, neopentyl glycol ester",813-444-2,95752-86-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252949,(5-methyl-1H-indazol-4-yl)boronic acid,813-445-8,1245816-10-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:2;H315:2
252950,"Bicyclo[2.2.2]octane-1,4-dicarboxylic Acid",813-446-3,711-02-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3
252951,3-(tert-Butyl)-5-methylbenzeneboronic acid,813-447-9,193905-93-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252952,2-(Piperidin-1-ylsulphonyl)benzeneboronic acid,813-448-4,957034-87-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252953,4-[Cyclohexyl(methyl)carbamoyl]benzeneboronic acid,813-450-5,913835-84-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252954,3-(Butylaminocarbonyl)benzeneboronic acid,813-451-0,397843-70-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252955,"4-(N,N-Diisopropylaminocarbonyl)benzeneboronic acid",813-452-6,850568-33-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252956,"4-(N,N-Dipropylaminocarbonyl)benzeneboronic acid",813-453-1,850568-32-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252957,3-[(4-Cyanophenyl)aminocarbonyl]benzeneboronic acid,813-454-7,850567-36-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252958,4-[(2-Methoxyethyl)carbamoyl]benzeneboronic acid,813-455-2,850589-34-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252959,3-Chloro-4-(N-isopropylcarbamoyl)benzeneboronic acid,813-456-8,850589-41-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252960,6-Iodoindoline,813-457-3,115666-46-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252961,"4-Bromo-2,6-dichloropyridine",813-458-9,98027-80-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:1;H302:2;H315:2;H312:1;H332:1;H335:2;H318:1
252962,"Methyl 5,6-dichloronicotinate",813-459-4,56055-54-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252963,Methyl 4-bromo-2-cyanobenzoate,813-461-5,1223434-15-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H302:3;H315:2;H312:1;H332:1
252964,(3.4)-cis-3-Fluoro-4-hydroxy-piperidine-1-carboxylic acid tert-butyl ester,813-462-0,955028-88-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252965,3-Methyl-2-(tributylstannyl)thiophene,813-463-6,166766-89-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,1,H331:1;H301:1;H411:1;H311:1
252966,2-(4-Methylphenoxy)benzoic acid,813-464-1,21905-69-1,Skin Irrit. 2,Notified C&L,1,H315:1
252967,5-Fluoro-6-methoxypyridin-3-amine,813-465-7,886372-63-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252968,3-Bromo-4-iodobenzoic acid,813-466-2,249647-25-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252972,[No public or meaningful name is available],944-113-1,,Flam. Liq. 2;Org. Perox. B;Eye Irrit. 2,REACH registration C&L,2,H319:2;H225:2;H241:2
252973,1-(dimethylamino)propan-2-yl carbamate,813-467-8,87037-84-1,Not Classified,REACH registration C&L,1,Not classified:1
252974,5-Fluoronaphthalen-1-ol,944-114-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252975,3-Amino-4-chlorobenzeneboronic acid hydrochloride,813-468-3,850568-45-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252976,8-Bromoisoquinolin-5-amine,813-469-9,90721-34-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252977,2-Bromo-2-(trifluoromethyl)hexafluoropropane,813-470-4,754-43-8,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H228:1;H319:1;H335:1;H315:1
252978,"2,3-Dibromo-6-(trifluoromethyl)pyridine",813-472-5,1159512-35-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252980,"2,5-Dimethyl-1,3-oxazole-4-carboxaldehyde",813-473-0,92901-88-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
252981,"1,3-Bis(trifluoromethyl)-2-bromobenzene",813-474-6,118527-30-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H412:1;H312:1;H332:1
252982,"4-Chloro-5,6-difluoropyridine-3-carboxylic acid",813-475-1,851386-32-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252983,"(2E)-3-(5-Oxo-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinolin-6-yl)acrylic acid",813-476-7,386715-44-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252990,Reaction mass of Magnesium; 3-methanidyl butane; chloride and tetrahydrofuran,944-121-5,,Flam. Liq. 2;Skin Corr. 1A;Carc. 2,Notified C&L,1,H314:1;H351:1;H225:1
252993,Perfluoro[(tert-butyl)cyclohexane],813-478-8,84808-64-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
252994,3-Iodo-4-methoxy-1H-indazole,813-479-3,944898-81-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
252995,1-(1-Methylazetidin-3-yl)methanamine,813-480-9,1359656-98-6,Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;STOT SE 3,Notified C&L,1,H331:1;H335:1;H301:1;H314:1
253004,"Amines, C12-18-(even numbered) and C18-(unsaturated) alkyl",701-068-0,2156592-58-2,Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1B;STOT SE 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,9,H302:9;H314:9;H400:9;H304:9;H373:9;H335:9;H410:9
253006,"n,n-diethyl-3.7-dimethyl-2.6-octadiene-1-amine",813-483-5,59117-55-4,Flam. Liq. 3;Skin Corr. 1B;Skin Sens. 1,Notified C&L,1,H226:1;H314:1;H317:1
253008,"Reaction mass of 6-butyl-3,6-dihydro-2,4-dimethyl-2H-pyran and 2-butyl-3,6-dihydro-4,6-dimethyl-2H-pyran and 2-butyltetrahydro-6-methyl-4-methylene-2H-pyran",944-251-2,,Aquatic Chronic 2,REACH registration C&L,2,H411:2
253011,"2-Phenyl-1,6-naphthyridine-3-carboxylic acid",813-484-0,849020-81-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253016,"1,2,3,4-Tetrahydro-2-carbomethoxy-1-oxonaphthalene",813-488-2,7442-52-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
253017,"2,2-Dimethyl-3,4-dihydronaphthalen-1-one",813-489-8,2977-45-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253020,"Reaction mass of (5E,7E)-8,12-dimethyltrideca-5,7,11-trien-4-one and (5E,7Z)-8,12-dimethyltrideca-5,7,11-trien-4-one",944-129-9,,Not Classified,REACH registration C&L,2,Not classified:2
253021,"2,5-Bis(trifluoromethyl)pyridine",813-490-3,20857-44-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253022,2-Methyltetrahydro-4H-pyran-4-one,813-491-9,1193-20-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2;H227:1
253023,5-Bromo-N-methylpyridine-2-carboxamide,813-492-4,845305-87-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253026,4-Hydroxy-1-methyl-1H-indazole,813-494-5,144528-23-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253027,4-Chloro-2-(methylsulphanyl)pyrimidine-5-carbonitrile,813-495-0,33089-15-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:2;H315:2;H312:2;H332:2;H335:2;H301:1
253028,"3,5-Dichloropyridine-2-carboxaldehyde",813-496-6,471909-65-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
253029,"2,3-Dibromo-5-fluoropyridine",813-497-1,878207-82-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H302:3;H315:3;H312:2;H332:2;H335:3
253030,"Dimethyl pyridine-2,4-dicarboxylate",813-498-7,25658-36-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253033,[No public or meaningful name is available],944-134-6,,Not Classified,REACH registration C&L,2,Not classified:2
253034,2-Amino-4-bromobenzotrifluoride,813-499-2,703-91-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253035,"2,2-Difluoroethyl chloroformate",813-500-6,111022-16-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B,Notified C&L,2,H226:2;H302:2;H314:2;H311:2;H335:1
253036,"2,2-Difluoroprop-1-yl toluene-4-sulphonate",813-501-1,1262400-01-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253037,"3,3,3-Trifluoro-1-phenylpropan-1-one",813-502-7,709-21-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253038,3-Iodo-1H-indazole-6-carbonitrile,813-503-2,906000-39-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253039,(2-amino-2-phenylethyl)dimethylamine,813-504-8,31788-88-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1;H318:1
253040,4-(Piperidin-2-ylcarbonyl)morpholine hydrochloride,813-505-3,690634-79-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253041,4-(Bromomethyl)-1-chloro-2-methoxybenzene,813-506-9,103347-14-4,Skin Corr. 1B,Notified C&L,1,H314:1
253042,"5-(Carboxymethyl)-5H-[1,2,4]triazino[5,6-b]indole-3-thiol",813-507-4,309283-89-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
253043,3-Ethylmorpholine,813-509-5,55265-24-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:1;H302:3;H315:1;H312:3;H332:1;H335:1;H314:2;H227:1
253044,Methyl 2-methoxyisonicotinate,813-510-0,26156-51-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253045,"trans-2,3-Dichlorocinnamic acid",813-511-6,20595-44-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253046,2-Fluoroacryloyl chloride,813-512-1,16522-55-7,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Acute Tox. 4,Notified C&L,1,H302:1;H314:1;H226:1;H312:1;H332:1
253047,2-(bromomethyl)-1-fluoro-4-nitrobenzene,813-513-7,454-15-9,Skin Corr. 1B,Notified C&L,2,H314:2;H302:1;H312:1;H332:1;H335:1
253048,Methyl 2-iodo-6-methylbenzoate,813-514-2,103440-55-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253049,3-Chloroisoquinoline-6-carbonitrile,813-515-8,1337880-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253050,2-(4-Hydroxycarbonyl-2-nitrophenyl)malondialdehyde,813-516-3,205985-96-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253051,2-(5-Hydroxycarbonyl-2-nitrophenyl)malondialdehyde monohydrate,813-517-9,205680-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253052,Reaction mass of Magnesium;but-2-ene;bromide and tetrahydrofuran,944-135-1,,Flam. Liq. 2;Water-react. 2;Acute Tox. 4;Acute Tox. 4;Skin Corr. 1C;Acute Tox. 4;Carc. 2,Notified C&L,1,H302:1;H261:1;H314:1;H351:1;H225:1;H312:1;H332:1
253053,"ethyl (2S)-2-[[6-fluoro-7-(2,4,6-trifluorophenyl)pyrido[2,3-b]pyrazin-8-yl]amino]-3-methyl-butanoate",944-136-7,,Aquatic Chronic 2,Notified C&L,89,H411:89
253054,[No public or meaningful name is available],,,Self-heat. 2,Notified C&L,1,H252:1
253055,"5-Bromo-2,3-Diphenyl-pyrazine",813-518-4,243472-70-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253057,"2-Chloro-4-oxo-4H-pyrido[1,2-a]pyrimidine-3-carbaldehyde",813-520-5,17481-62-8,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
253060,"3,5-dichloro-6-methyl-1,4-oxazin-2-one",813-522-6,125849-94-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H302:2;H315:2;H335:1
253061,2-pyridin-2-ylpropan-2-amine;dihydrochloride,813-523-1,1256633-17-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253062,2-(Methylsulfonyl)-1-pyridin-4-ylethanone,813-524-7,27302-95-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253064,Reaction mass of N-(2-hydroxyethyl)alkyl] alkylamide and glycerol,,,Not Classified,Notified C&L,1,Not classified:1
253065,2-(Trifluoromethyl)pyridine-3-boronic acid,813-525-2,947533-39-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253069,"2-azido-N-(β-oxo-2',5'-dimethoxyphenethyl)acetamide",813-529-4,59939-34-3,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1;H317:1
253073,"(1R,2R,4S,5S,7s)-7-[2-Hydroxy(di-2-thienyl)acetoxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide methanol (1:1:1)",813-534-1,913719-58-1,Acute Tox. 4;Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H332:1;H373:1;H412:1;H302:1
253074,Hexamethylen-bis-benzalamin,813-535-7,3009-40-3,Acute Tox. 4;Skin Sens. 1,Notified C&L,1,H302:1;H317:1
253075,LAVENDER SPECIAL,944-141-4,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,1,H319:1;H400:1;H317:1;H315:1;H411:1
253076,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253077,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253078,Chloro-Imid-Valine derivative,,,Skin Sens. 1B,Notified C&L,1,H317:1
253079,"2,6-dibromo-3-methoxy-5-nitropyridine",813-542-5,79491-46-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253080,"1,3,4-Thiadiazole-2(3H)-thione, 5-(tert-dodecyldithio)-",813-543-0,73984-93-7,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,35,H412:2;H317:2;Not classified:33
253082,"(2-chloro-4-pyridyl)-[5-fluoro-1'-[(E)-3-[4-(trifluoromethoxy)phenyl]allyl]spiro[indoline-3,4'-piperidine]-1-yl]methanone",944-143-5,,Aquatic Chronic 2,Notified C&L,89,H411:89
253085,2-[(3-bromo-8-chloro-6-quinolyl)oxy]-N-tert-butyl-2-methylsulfanyl-acetamide,944-145-6,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
253087,"(1S,4S)-1,4-bis(4-chloro-2-fluoro-5-nitrophenyl)butane-1,4-diyl dimethanesulfonate",813-546-7,1292836-21-5,Not Classified,REACH registration C&L,2,Not classified:2
253089,2-(2-Quinoxalinyl)malondialdehyde,813-548-8,205744-84-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253090,"Reaction mass of (6alpha,11beta)-11,17-dihydroxy-21-iodo-6-methylpregna-1,4-diene-3,20-dione and (6alpha,11beta)-11,17-dihydroxy-21,21-diiodo-6-methylpregna-1,4-diene-3,20-dione",944-146-1,,Repr. 2;STOT SE 2;STOT RE 2,Notified C&L,1,H361:1;H373:1;H371:1
253091,5-Acetamidonaphthalene-1-sulfonyl chloride,813-549-3,52218-37-8,Skin Corr. 1B,Notified C&L,1,H314:1
253094,"(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one hydrochloride",813-550-9,486459-71-6,Eye Irrit. 2,Notified C&L,2,H319:1;H411:1
253098,(2R)-2-{[(tert-butoxy)carbonyl]amino}-3-methylbutanoic acid,813-553-5,22838-58-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253100,3-Chloro-4-fluoropyridine,813-554-0,883107-69-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253104,"1,3,5-tris(3-mercaptopropyl)-1,3,5-triazinane-2,4,6-trione",813-556-1,78366-85-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,25,H400:2;H302:2;H317:2;H315:2;H410:2;Not classified:23
253105,(S)-1-[4-(trifluoromethoxy)phenyl]ethanamine hydrochloride,813-557-7,1391540-47-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253106,"1,4-Dimethoxytetrafluorobenzene",813-558-2,362-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253107,4-methylbenzo[b]thiophene-2-carboxylic acid,813-559-8,1735-13-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253109,Diphenylmethyl 7beta-Amino-3-cephem-4-carboxylate,813-561-9,36923-21-4,Skin Sens. 1;Resp. Sens. 1,Notified C&L,2,H334:1;H317:1;H319:1;H315:1
253111,"3,3-dihydroxy-2-(5-methoxy-2-nitrophenyl)propanal",813-564-5,205692-61-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253112,2-(4-chloro-2-nitrophenyl)malonaldehyde,813-565-0,205744-82-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253114,"Reaction mass of 3,7-dimethyloct-7-en-1-yl 3-methylbut-2-enoate and 3,7-dimethyloctyl 3-methyl-2-butenoate and citronellyl 3-methylcrotonate",946-248-1,,Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H400:1;H411:1
253116,"Siloxanes and Silicones, di-Me, 10-carboxydecyl group-terminated, polymers with bisphenol A diglycidyl ether",813-566-6,217448-17-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,13,H319:13;H317:13;H315:13
253118,"Poly (Isobornyl methacrylate, methyl methacrylate, dodecanethiol)",944-151-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
253120,Sodium (xylenes and 4-ethylbenzene)sulfonates,701-037-1,,Eye Irrit. 2,REACH registration C&L,22,H319:22
253124,2-(Bicyclo[1.1.1]pentan-1-yl)acetic acid,813-568-7,131515-31-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H315:2;H318:1
253125,Ethyl 5-methylhex-5-enoate,813-569-2,39495-82-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253126,1-(4-Fluorophenyl)cyclopropanecarboxylic acid,813-570-8,773100-29-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253127,4-Cyanophenylglyoxal hydrate,813-571-3,19010-28-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253128,1-(4-Fluorophenyl)cyclopropylmethanol,813-572-9,198976-40-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253129,1-bromo-4-(difluoromethyl)benzene,813-573-4,51776-71-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
253130,2-Bromo-2-fluoroacetamide,813-575-5,430-91-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H302:2;H315:3
253131,2-Bromoethyl trifluoromethanesulphonate,813-576-0,103935-47-3,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,2,H331:2;H301:2;H314:2;H311:2;H227:1;H335:1
253132,2-Fluorodiphenylamine,813-577-6,328-20-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253133,2-Chloro-4-iodo-pyridin-3-yl)-carbamic acid tert-butyl ester,813-578-1,855784-39-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253134,8-Bromo-5-nitroisoquinoline,813-579-7,252861-41-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253135,4-Bromo-1-(triisopropylsilyl)-7-azaindole,813-580-2,640735-24-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253136,2-Methyl-2-pyridin-2-ylpropanenitrile,813-581-8,81039-18-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253139,"1-(3,5-dichlorophenyl)propane-1,2-dione",813-584-4,386715-49-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253141,6-Aza-spiro[3.4]octane,813-586-5,765-64-0,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H226:2;H319:1;H335:2;H315:1;H318:1;H314:2
253142,2-Cyclobutylideneacetic acid,813-587-0,25021-04-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253143,"(R)-4-Benzyl-1,3-thiazolidine-2-thione",813-588-6,110199-17-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253144,(3-(methylsulfonyl)phenyl)methanamine,813-589-1,855267-50-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253145,9H-fluoren-9-yl 4-aminobenzylcarbamate,944-156-6,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253149,2-Cyclobutylacetic acid,813-590-7,6540-33-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:2;H302:2;H315:2;H318:1
253150,"2-Butenedioic acid (2Z)-, 1,4-diethyl ester, polymer with 5-amino-1,3,3-trimethylcyclohexanemethanamine",813-591-2,140921-94-4,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,16,H412:16;H317:16
253157,Overbased detergent,,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
253163,5-chloro-6-(3-chlorophenyl)-2-methylpyridazin-3(2H)-one,813-592-8,849021-00-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253164,5-chloro-6-(4-chlorophenyl)-2-methylpyridazin-3(2H)-one,813-593-3,849021-02-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253165,N-(3-(aminomethyl)phenyl)methanesulfonamide,813-594-9,114100-09-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1
253166,4-methylbenzenesulfonate (1:1),813-595-4,164650-61-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253169,"Reaction mass of [(1R*,5S*)-3,3,5-trimethylcyclohexyl] acetate and [(1S*,5S*)-3,3,5-trimethylcyclohexyl] acetate",946-282-7,,Aquatic Chronic 2,REACH registration C&L,4,H411:4
253171,"(2R,3R)-2-(2,4-Difluorophenyl)-3-(4-methylenepiperidin-1-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol",813-597-5,164650-44-6,Repr. 2,Notified C&L,2,H361:2
253172,4-(propanoylamino)benzoic acid,813-598-0,19313-85-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253173,Indolin-1-amine hydrochloride,813-599-6,92259-86-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253175,"Reaction mass of disodium 4,4'-bis(2-hydroxynaphthalen-1-ylazo)biphenyl-2,6'-disulphonate and potassium 4,4'-bis((E)-(2-hydroxynaphthalen-1-yl)diazenyl)-[1,1'-biphenyl]-2,2'-disulfonate",944-161-3,,Not Classified,REACH registration C&L,3,Not classified:3
253176,2-(Trifluoromethyl)-1H-benzimidazole-7-carbaldehyde,813-601-5,933741-41-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253177,"2,3-Dihydro-1H-indole-6-carboxamide",813-602-0,1158761-65-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253178,Organic acids and derivatives,,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
253179,"Reaction mass of Dec-1-ene, dimers, hydrogenated and 1-DECENE DIMER WITH DODECENE, HYDROGENATED; ALKANE 1",944-163-4,,Asp. Tox. 1;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H304:1;H332:1;H413:1
253180,"Amines, C12-14-tert-alkyl, compds. with 9-octadecen-1-ol-sulfur polymer dihydrogen phosphate",813-603-6,144468-70-2,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,33,H302:33;H411:33
253181,"1-Propanaminium, 3-amino-N-(carboxymethyl)-N,N-dimethyl-, N-C8-10 (even numbered) acyl derivs., hydroxides, inner salts",944-170-2,,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,2,H319:2;H412:2
253182,"1,1'-trans-cyclohexane-1,4-diyldiurea",813-604-1,68533-01-7,Not Classified,REACH registration C&L,84,Not classified:84
253183,1-Acetyl-N-cyclopropylpiperidin-4-amine,813-605-7,387358-46-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253184,"(1,4,8,11-Tetraazacyclotetradecane)diaquoiron (III) sulfate hydrate",944-165-5,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
253185,"(1,4,8,11-Tetraazacyclotetradecane)zinc (II) tetrafluoroborate hydrate",944-166-0,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
253186,"(1,4,8,11-Tetraazacyclotetradecane)diaquochromium (III) sulfate hydrate",944-167-6,,Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
253188,[No public or meaningful name is available],944-168-1,,Flam. Liq. 2,REACH registration C&L,2,H225:2
253189,Reaction mass of trimethylstannanylium chloride and tetrahydrofuran,944-169-7,,Flam. Liq. 2;Acute Tox. 2;Acute Tox. 2;Eye Irrit. 2;STOT SE 3;Carc. 2;STOT RE 1;Aquatic Chronic 2,Notified C&L,1,H372:1;H319:1;H300:1;H351:1;H411:1;H225:1;H335:1;H310:1
253191,Hexamethylen-bis-benzylamin-dihydrochlorid,813-607-8,671224-08-1,Acute Tox. 4,Notified C&L,1,H302:1
253192,"2-Chloro-N-(b-oxo-2,5-dimethoxy-phenylethyl)-acetamid",813-608-3,59908-77-9,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
253193,4-(Benzyloxy)-2-methylbenzeneboronic acid,813-609-9,847560-49-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253194,3-Oxo-3-(pyridin-4-yl)propanenitrile,813-610-4,23821-37-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:1;H332:1;H302:2;H318:1;H335:1;H315:1
253195,2-Amino-6-iodobenzoic acid,813-612-5,20776-52-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H302:2;H315:2;H312:1;H332:1;H335:2
253196,[No public or meaningful name is available],813-613-0,1084-45-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253199,"Reaction mass of (1R,4R,6S)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptane and (1S,4R,6R)-1-methyl-4-(prop-1-en-2-yl)-7-oxabicyclo[4.1.0]heptane",944-171-8,,Not Classified,REACH registration C&L,2,Not classified:2
253202,"Reaction Mass of (1S,3R,6R)-3-isopropyl-6-methyl-7-oxabicyclo[4.1.0]heptane and (1R,3R,6S)-3-isopropyl-6-methyl-7-oxabicyclo[4.1.0]heptane",944-172-3,,Not Classified,REACH registration C&L,2,Not classified:2
253203,4-Chloro-6-(trifluoromethyl)pyridin-3-amine,813-614-6,1196153-86-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
253204,2-Nitrophenylacetylene,813-615-1,16433-96-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253207,Reaction mass of sodium tetrahydroborate and 1-methoxy-2-(2-methoxyethoxy)ethane,944-174-4,,Skin Irrit. 2;Eye Irrit. 2;Repr. 1B,Notified C&L,1,H360:1;H319:1;H315:1
253209,Poly(pentaerythritol phosphate-co-ethyl phosphate-co-propyl phosphate),944-177-0,,Met. Corr. 1;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
253211,Quinuclidin-3-one oxime hydrochloride,813-616-7,76883-37-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H314:2;H315:2
253212,"N,N'-diisopropyl-(2 or 4)-methylcyclohexane-1,3-diamine",944-178-6,,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,83,H318:83;H412:83;H302:83;H314:83
253216,"Reaction product aqueous Phosphoric Acid, 2-Butoxyethanol and 4,4'-Isopropylidenediphenol-Epichlorohydrin",944-181-2,,Skin Corr. 1;Eye Dam. 1;STOT RE 2,REACH registration C&L,8,H318:8;H314:8;H373:8
253217,"N'-(2-cyano-5-methoxy-4-nitrophenyl)-N,N-dimethylformimidamide",813-618-8,1269400-04-5,Acute Tox. 3,Notified C&L,2,H301:1;Not classified:1
253223,"3,3,3-Trifluoropropylene carbonate",813-619-3,167951-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253224,"3,5-DICHLORO-2-PYRIDINECARBOXYLIC ACID",813-620-9,81719-53-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,65,H319:64;H335:64;H301:64;H315:64
253225,"3,3,4,4,5,5,6,6,7,7,7-Undecafluoroheptan-2-ol",813-621-4,914637-05-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
253226,3-Bromo-2-fluoroprop-1-ene,813-623-5,35386-83-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
253228,"Tetrasodium 5-[4-chloro-6-(N-methyl-anilino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(1,5-disulfonatonaphthalen-2-ylazo)-naphthalene-2,7-disulfonate",944-182-8,,Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H411:1;H317:1
253229,"Hydrocarbons, C7-C9, isoalkanes",826-025-4,1174921-67-5,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,13,H315:13;H304:13;H411:13;H225:13;H336:13
253230,"2-methyl-N-(1-oxothietan-3-yl)-4-[(5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]benzamide",944-183-3,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
253231,"4-[(3R)-3-(3,5-dichlorophenyl)-3-(trifluoromethyl)-2,4-dihydropyrrol-5-yl]-N-(1,1-dioxothietan-3-yl)-2-methyl-benzamide",944-184-9,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
253232,"2-[2-bromo-4-[(5S)-5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]phenyl]sulfanyl-N-cyclopropyl-acetamide",944-185-4,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
253233,"N-butyl-4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-benzamide",944-187-5,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
253234,"Feldspar minerals, magnetite and quartz, calcination products of copper mining residues.",944-188-0,,Skin Irrit. 2;Eye Irrit. 2;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,4,H360:4;H319:4;H400:4;H315:4;H412:4;H373:4
253235,"2-Iodo-1,1,1,3,3,3-hexafluoropropane",813-624-0,4141-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253236,(3-Bromophenoxy)(tert-butyl)diphenylsilane,813-625-6,133772-45-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253237,(S)-2-Cyclopentylglycine,813-626-1,2521-84-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253238,3-Bromoisoxazole-5-carboxylic acid,813-627-7,6567-35-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
253244,"Reaction mass of N-(4-((4-(dimethylamino)phenyl)(4-(methylamino)phenyl)methylene)cyclohexa-2,5-dienylidene)-N-methylmethanaminium acetate and N-(4-(bis(4-(dimethylamino)phenyl)methylene)cyclohexa-2,5-dienylidene)-N-methylmethanaminium",944-191-7,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H400:5;H302:5;H317:5;H315:5;H318:5;H410:5
253245,"2-Oxepanone, homopolymer, phosphate",813-628-2,103812-99-3,Skin Corr. 1B,Notified C&L,1,H314:1
253246,2-Chlorotrityl chloride resin,944-192-2,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253250,"2-Butenedioic acid (2Z)-, 1,4-diethyl ester, reaction products with 5-amino-1,3,3-trimethylcyclohexanemethanamine-5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane polymer",813-629-8,1809602-66-1,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,16,H412:16;H317:16
253252,"1-(4-Fluorobenzoyl)ethylene-2,2-dithiol",813-630-3,67259-61-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253255,"(2S,3S)-Butane-2,3-diol",813-634-5,19132-06-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253256,1-(tert-butoxycarbonyl)-2-methyl-L-proline,813-635-0,103336-06-7,Not Classified,REACH registration C&L,6,Not classified:5;H317:1;H315:1
253257,1-(tert-Butoxycarbonyl)-1H-indole-5-carboxylic acid,813-636-6,188751-54-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253258,2-Ethylhexoxytitanium trichloride,813-637-1,27438-41-1,Met. Corr. 1;Skin Corr. 1;Eye Dam. 1,Notified C&L,1,H318:1;H314:1;H290:1
253259,"(2,4-Difluorophenyl)(4-Fluorophenyl)methanone",813-638-7,80512-44-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H319:1;H302:1;H315:1;H411:1;H335:1
253260,3-Oxazolidinecarboxylic Acid,813-639-2,530441-39-5,Repr. 2,Notified C&L,1,H361:1
253261,3-CYANO-4-ISOPROPOXYBENZOIC ACID,813-640-8,258273-31-3,Acute Tox. 4,Notified C&L,1,H302:1
253262,"(2S,3S,4R)-3-ethyl-4-hydroxy-2-(methoxycarbonyl)pyrrolidinium 4-methylbenzenesulfonate",813-641-3,1799733-43-9,Not Classified,REACH registration C&L,5,Not classified:2;H319:2;H335:2;H315:2;H312:1;H332:1;H302:1
253263,"Benzene mono-C10-13-alkyl derivatives, distillation residues, sulfonated, sodium salts",944-207-2,,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,4,H317:4;H315:4
253264,"Fatty acids, vegetable-oil, polymd., esters with 1,2-hexadecanediol",813-642-9,68910-99-6,Not Classified,REACH registration C&L,2,Not classified:2
253267,"Reaction mass of (1R,5R)-5-isopropyl-2-methylenecyclohexanol and (1S,5R)-5-isopropyl-2-methylenecyclohexanol",944-198-5,339267-31-1,Not Classified,REACH registration C&L,2,Not classified:2
253270,"4,6-dichloro-2,3-dihydro-1H-pyrrolo[3,4-c]pyridin-1-one",813-643-4,1201676-03-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
253271,3-(ethanesulfonyl)pyridine-2-sulfonamide,813-645-5,117671-01-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253272,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253273,"(4R)-2,2-Dioxido-4-methyl-1,2,3-oxathiazolidine,N-BOC protected",813-646-0,454248-53-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:4;H315:4
253274,Alicyclediyldimethanol and [(hydroxymethyl)alicyclic]methyl (hydroxymethyl)alicyclecarboxylate and [oxybis(methylenealicyclediyl)]dimethanol,,,Not Classified,REACH registration C&L,4,Not classified:4
253275,"1-Oxo-2,3-Dihydro-1H-Indene-4-Carbonitrile",813-647-6,60899-34-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253276,"(4-([(2,4-Diaminopteridin-6-yl)methyl](methyl)amino)Benzoic Acid, hemihydrochloride",813-648-1,70844-48-3,Skin Sens. 1,Notified C&L,2,H317:2
253278,Reaction mass of (1Z)-prop-1-en-1-ylphosphonic acid and prop-2-en-1-ylphosphonic acid,944-204-6,,Skin Corr. 1A;STOT SE 3,REACH registration C&L,1,H335:1;H314:1
253279,Lithium Boron Thiophosphate Iodide,944-205-1,,Water-react. 2;Acute Tox. 3;Eye Dam. 1,Notified C&L,1,H318:1;H301:1;H261:1
253284,3-fluoro-4'-methylbiphenyl,813-650-2,72093-42-6,Not Classified,REACH registration C&L,2,Not classified:2
253285,"(4'-methyl-3-fluoro[1,1'-biphenyl]-4-yl)-boronic acid",813-651-8,1698890-39-9,Not Classified,REACH registration C&L,2,Not classified:2
253286,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253287,"2-[2-[4-(5-Oxidodibenzo[b,f][1,4]Thiazepin-11-yl]-1-Piperazinyl]Ethoxy]Ethanol",813-652-3,329216-63-9,Acute Tox. 4,Notified C&L,1,H302:1
253288,4-Bromo-2-methylisoindolin-1-one,813-654-4,435273-55-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253289,4-(Benzylcarbamoyl)benzeneboronic acid,813-656-5,252663-47-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253290,2-Cyanoisonicotinic Acid,813-657-0,161233-97-2,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,3,H318:1;H335:2;H301:1;H315:3;H319:2;H302:2;H312:2;H332:2
253291,Phenylalanin-isobutylboronsäure-ester,813-658-6,205393-21-1,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H301:1;H317:1;H315:1
253292,"Sulfamide, N-propyl-, potassium salt",813-659-1,1393813-41-6,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 1,Notified C&L,2,H319:2;H315:2;H301:1;H312:1;H373:1;H410:1;H335:1
253293,"Reaction mass of lithium bromide and lithium sulphide, anhydrous and diphosphorus pentasulphide",944-210-9,,Water-react. 1;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H301:1;H260:1;H315:1
253294,tert-butyl (3-{[2-(1H-imidazol-4-yl)ethyl]amino}-3-oxopropyl)carbamate,813-660-7,143885-59-0,Not Classified,Notified C&L,1,Not classified:1
253295,6-Chloro-4-methoxypyridine-3-carbaldehyde,813-661-2,1256823-05-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
253298,"Reaction mass of (E)-7-hydroperoxy-3,7-dimethyl-oct-5-en-1-ol and isomer 1 of 6-hydroperoxy-3,7-dimethyl-oct-7-en-1-ol and isomer 2 of 6-hydroperoxy-3,7-dimethyl-oct-7-en-1-ol",944-211-4,,Flam. Liq. 2;Org. Perox. B;Eye Irrit. 2,REACH registration C&L,2,H319:2;H225:2;H241:2
253300,Acetylated distarch phosphate,,68130-14-3,Not Classified,Notified C&L,52,Not classified:52
253301,3-amino-1-methyl-1H-pyrazole-4-carbonitrile,813-663-3,21230-50-2,Not Classified,Notified C&L,2,Not classified:1;H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253307,7-METHYL-5-NITRO-1H-INDAZOLE,813-668-0,75785-12-5,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,1,H335:1;H302:1;H315:1
253308,"2,5-Dichlorothiazole-4-carbonitrile",813-669-6,127426-26-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H332:1;H335:1
253309,2-(Bromomethyl)-6-methoxypyridine,813-670-1,156094-63-2,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H301:1;H315:1
253310,Amides and Derivatives,,,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
253311,4-Methylpiperidin-4-ol,813-671-7,3970-68-1,Skin Corr. 1B,Notified C&L,2,H314:2
253312,2-BROMO-4-FLUOROPHENYLACETIC ACID,813-672-2,61150-59-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
253316,"Reaction mass of 1,4-dimethyl bicyclo[3.3.0]oct-3-ene and 1,5-dimethyl-8-formoxy bicyclo[3.2.1]octane",944-217-7,,Not Classified,REACH registration C&L,2,Not classified:2
253317,"2,4-Dichloro-1-(trifluoromethoxy)benzene",813-674-3,451-85-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253318,"1,2-Propanediol, polymer with 1,2-ethanediol and 4,4'-(1-methylethylidene)bis[phenol] , 2-methyl-2-propenoate",813-675-9,146478-33-3,Eye Irrit. 2,Notified C&L,1,H319:1
253320,"1,2,3-Tris(trifluoromethyl)benzene",813-678-5,42175-48-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H226:1;H319:1;H335:1;H315:1
253321,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H317:1;H315:1
253323,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253328,(4R)-2-(1-butoxyethoxy)-4-isopropyl-1-methylenecyclohexane,944-221-9,1429469-15-7,Not Classified,REACH registration C&L,2,Not classified:2
253329,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253330,2-[2-(1-Cyano-1-methyl-ethyl)hydrazino]-2-methyl-propanenitrile,813-680-6,6869-07-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H331:1;H319:1;H315:1;H301:1;H335:1;H311:1
253332,Reaction mass of titanium dioxide and silver chloride,944-224-5,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,32,H400:31;H410:31;Not classified:1
253333,Ethyl-methyl-2-[ethyl-(3-chloro-propyl)]-malonate,813-687-4,83103-73-5,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H317:2;H315:2;H411:2;H401:2;H373:2
253335,5-bromo-4-fluoro-1h-indazole,813-682-7,1082041-85-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253336,Methyl 4-bromo-2-fluoro-6-methylbenzoate,813-683-2,1427409-40-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253337,DNA Plasmid,944-225-0,,Repr. 2,Notified C&L,1,H361:1
253339,"(1,4,8,11-Tetraazacyclotetradecane)zinc (II) iodide",944-227-1,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
253340,"(1,4,8,11-Tetramethyl-1,4,8,11-tetraazacyclotetradecane)zinc (II) tetrafluoborate",944-228-7,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1;H315:1
253341,"(1,4,8,11-Tetraazacyclotetradecane)zinc (II) bromide",944-229-2,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1,H319:1;H400:1;H302:1;H315:1
253342,"(1,4,8,11-Tetraazacyclotetradecane)zinc (II) chloride",944-230-8,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,1,H319:1;H400:1;H302:1;H315:1
253343,"Reaction product of 3,9-dibromobenzanthrone condensed with 2 equivalents of 1-aminoanthraquinone, subsequently further condensed under oxidative conditions",944-232-9,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,7,H411:7;H317:7
253346,diethyl (2Z)-2-methylbut-2-enedioate,813-684-8,691-83-8,Skin Irrit. 2;Eye Irrit. 2;Muta. 1B;Carc. 1B,REACH registration C&L,2,H340:2;H319:2;H350:2;H315:2
253347,"2,2-Dilfuoropropionitrile",813-685-3,49781-49-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H331:2;H319:2;H315:2;H301:2;H335:2;H311:2;H225:1
253348,3-Chloro-4-fluorophenethyl alcohol,813-686-9,340825-21-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253354,"N-[4-(5-methyl-3-phenylisoxazol-4-yl)phenylsulfonyl]propionamide, sodium salt",813-689-5,198470-85-8,Repr. 2,Notified C&L,3,H361:2;H360:1;H373:1
253355,"Reaction product of vanilline, obtained by hydrogenation",944-235-5,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;STOT SE 3,REACH registration C&L,2,H302:2;H317:2;H315:2;H226:2;H318:2;H335:2;H336:2
253356,"(2',2''-(propane-1,3-diylbis(oxy))bis(3-(3,6-di-tert-butyl-9H-carbazol-9-yl)-5'-fluoro-5-(2,4,4-trimethylpentan-2-yl)biphenyl-2-ol)dimethyl-hafnium",813-690-0,1253105-77-9,Aquatic Chronic 4,Notified C&L,1,H413:1
253357,[No public or meaningful name is available],,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253364,"4-[(5S)-5-(3,5-dichloro-4-fluoro-phenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-N-(1,1-dioxothietan-3-yl)-2-methyl-benzamide",944-240-2,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
253365,"[1-(2-Hydroxy-ethyl)-2,2-dimethyl-propyl]-carbamic acid tert-butyl ester",813-692-1,892874-24-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253366,2-Azaspiro[3.3]heptan-6-ol hydrochloride,813-693-7,1630907-10-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H302:1;H315:2;H303:1
253367,"5-(Hydroxyimino)1,3-dimethylpyrimidine-2,4,6-(1H,3H,5H)-trione",813-694-2,5417-13-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
253368,3-(allyloxy)-2-hydroxypropyl methacrylate,813-695-8,13438-19-2,STOT SE 3,REACH registration C&L,6,H319:6;H335:6;H317:6;H315:6
253369,dichlorocadmium;hydrate,813-696-3,34330-64-8,Acute Tox. 3;Acute Tox. 2;STOT RE 1;Aquatic Chronic 1,Notified C&L,1,H372:1;H301:1;H410:1;H330:1
253370,(S)-N-2-(9-Fluorenylmethyloxycarbonyl)amino-octanoic acid,944-241-8,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253371,"Sulfuric acid, mono-C9-12-alkyl esters, sodium salts",944-243-9,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,4,H318:4;H302:4;H315:4;H228:2;H332:2;H335:2
253372,(S)-tert-butyl (1-(2-fluoro-6-nitro-N-phenylbenzamido)-1-oxobutan-2-yl)carbamate,944-242-3,,Muta. 2;Carc. 2,Notified C&L,1,H341:1;H351:1
253383,8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1(2H)-one,813-697-9,1201438-56-3,Repr. 1B,Notified C&L,1,H360:1
253384,"9,10-Di-(methoxy-d3)-1,3,4,6,7,11b-hexahydro-3-isobutyl-2H- benzo[a]quinolizin-2-one",813-698-4,1392826-25-3,Repr. 2,Notified C&L,1,H361:1
253385,"6,6'-Di-(o-toluyl)-[1,1'-binaphthalene-2,2'-diylbis(oxy)]diethanol",944-244-4,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253386,DNBHBNA,,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253387,"Polyoxirane-2,3-dicarboxylic acid",813-700-3,51274-37-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
253388,"Reaction products of condensation between 2,2'-(1,2-ethenediyl)bis(5-nitrobenzenesulfonic acid) and 4-[(4-aminophenyl)diazenyl]benzenesulfonic acid, sodium salts",944-247-0,,Not Classified,REACH registration C&L,8,Not classified:8
253389,"1-Tetradecene homopolymer, hydrogenated",813-701-9,1857296-89-9,Asp. Tox. 1,Notified C&L,1,H304:1
253390,"Nonadecane, 9-methylene-, mixed with 1-decene, dimers and trimers, hydrogenated",813-702-4,1000172-32-6,Asp. Tox. 1,Notified C&L,1,H304:1
253391,"(10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile",813-704-5,1454846-35-5,Muta. 2;STOT RE 2,Notified C&L,4,H341:3;H373:3;H361:2;H400:1;H410:1;Not classified:1
253394,"(1,3-Dichloro-isopropyl)-nonylphthalat",813-707-1,2043320-76-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
253395,"(1,3-Dichloro-isopropyl)-butylphthalat",813-708-7,2043341-06-4,Repr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H360:1;H400:1;H410:1
253396,Ertugliflozin,813-709-2,1431329-06-4,Eye Dam. 1,Notified C&L,1,H318:1
253397,"Reaction product of acid red 143 (free acid) or the respective sodium salt (e.g Lansyn red F-5B) (UVCB) with Tetrabutylammonium bromide (CAS nr.: 1643-19-2) resulting in a mixture of AR143-(TBN)2 (Main component), AR143-(TBN), AR143-(TBN)3, AR143-(TBN) without alkyl tail, AR143-(TBN)2 without alkyl tail.Chemical name main component AR143-(TBN)2:di-(tetra-n-butylammonium) salt of 1-benzoyl-4-[4'-(1'',1''-dimethylpropyl)-phenoxy]-6-phenylamino-2,7-dioxo-2,7-dihydro-3H-naphtho(1,2,3-de)quinolin, disulfonic acid",944-248-6,,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H319:1;H302:1;H411:1
253398,"(2S,4R)-methyl 4-((methylsulfonyl)oxy)-1-(1-(trifluoromethyl)cyclopropanecarbonyl)pyrrolidine-2-carboxylate",813-710-8,1434816-61-1,Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H301:1;H314:1
253399,"tert-butyl 2-chloro-4-((3-cyanobenzyl)amino)-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate",944-249-1,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253400,N-alpha-(9-Fluorenylmethyloxycarbonyl)-S-Phenylacetylaminomethyl)-L-cysteine,813-711-3,159680-21-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253401,Formyl-methyl-amino-benzoic acid,813-712-9,51865-84-0,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,1,H319:1;H335:1;H225:1;H315:1
253402,[No public or meaningful name is available],813-713-4,261627-68-3,Eye Dam. 1,Notified C&L,1,H318:1
253403,"2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid",813-715-5,594839-88-0,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,4,H319:2;H335:2;H315:2;H360:1;Not classified:1
253404,methyl 2-((3-(((tert-butoxycarbonyl)amino)methyl)benzyl)amino)-6-chloro-4-methylnicotinate,944-250-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253405,"(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol 2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylate",813-716-0,951395-08-7,Repr. 1B,Notified C&L,2,H360:2
253406,"methyl 2,6-dichloro-4-iodonicotinate",813-717-6,1309866-40-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253407,Methyl 3-oxocyclobutanecarboxylate,813-718-1,695-95-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253408,"N,1-Dimethylazetidin-3-amine",813-719-7,321890-38-4,Skin Corr. 1;STOT SE 3,Notified C&L,1,H335:1;H314:1
253409,"4,4'-methylenediphenyl diisocyanate and its oligomeric reaction products with oxydipropanol and [(methylethylene)bis(oxy)]dipropanol",701-072-2,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,REACH registration C&L,2,H319:2;H317:2;H315:2;H351:2;H334:2;H332:2;H373:2;H335:2
253410,"2,5-Diazapyrrole",813-720-2,288-35-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253411,Reaction product of sulfuric acid with Cedrenepoxide.,944-252-8,,Skin Irrit. 2,REACH registration C&L,2,H315:2
253412,11a-chloro-6-methylene-5-oxytetracycline-p-toluene sulphonate,813-721-8,88274-98-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3;Repr. 2;Lact.,Notified C&L,1,H362:1;H319:1;H302:1;H317:1;H315:1;H361:1;H335:1
253414,"Reaction mass of 1,5,5-trimethylcyclohexene and 1,3,3-trimethylcyclohexene",944-253-3,,Flam. Liq. 3,REACH registration C&L,2,H226:2
253418,Reaction mass of bromoethene and tetrahydrofuran,944-254-9,,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;Carc. 2,Notified C&L,1,H319:1;H315:1;H351:1;H225:1;H335:1;H336:1
253419,"[(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6S)-3,4-dihydroxy-6-methyl-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl] (4aR,5R,6aR,6aS,6bR,8aR,10R,11S,12aR,14bS)-5,11-dihydroxy-9,9-bis(hydroxymethyl)-2,2,6a,6b,12a-pentamethyl-10-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylat",813-722-3,78763-58-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253420,"(2R)-2-[(1R,4R,4aS,8aS)-4,7-dimethyl-1,2,3,4,4a,5,6,8a-octahydronaphthalen-1-yl]propanoic acid",813-723-9,85031-59-0,Eye Irrit. 2,Notified C&L,1,H319:1
253421,"2-Propenoic acid, 2-methyl-, 2-ethylhexyl ester, polymer with hexadecyl 2-methyl-2-propenoate, α-(2-methyl-1-oxo-2-propen-1-yl)-ω-hydroxypoly(oxy-1,2-ethanediyl), octadecyl 2-methyl-2-propenoate and 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl 2-methyl-2-propenoate",813-724-4,1793073-25-2,Skin Irrit. 2,Notified C&L,1,H315:1
253422,Pentafluoroprop-1-en-2-yl benzoate,813-726-5,53841-60-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253423,1-(Nonafluorobutyl)trifluoroethanesultone,813-727-0,85211-95-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H302:1;H315:1
253424,"2,2-Difluorobutane",813-728-6,353-81-1,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H225:1;H315:1
253425,"3-Chloro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline",813-729-1,1100832-66-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253426,Perfluorotetrahydro-2-furancarboxylic acid,813-730-7,65578-62-3,Skin Corr. 1B;STOT SE 3,Notified C&L,1,H335:1;H314:1
253427,"3,5-Bis(trifluoromethyl)-alpha,N-dimethylbenzylamine",813-731-2,290297-43-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H302:1;H315:1;H312:1;H332:1;H335:1
253428,"Reaction product of (+)-pin-2(3)-ene CAS 7785-70-8 and Formic Acid CAS 64-18-6, obtained by phase separation and distillation.",944-255-4,,Asp. Tox. 1;Skin Sens. 1;Repr. 2;Aquatic Chronic 2,REACH registration C&L,2,H304:2;H361:2;H411:2;H317:2
253429,n-Butyldi(tert-butyl)phosphonium tetrafluoroborate,813-732-8,1816254-91-7,Acute Tox. 4;Aquatic Acute 1,Notified C&L,1,H302:1;H401:1
253430,RD 14156,,,Not Classified,REACH registration C&L,2,Not classified:2
253432,(25S)-1beta-(6-Deoxy-beta-D-galactopyranosyloxy)-3beta-(alpha-L-rhamnopyranosyloxy)spirost-5-ene,813-733-3,87425-34-1,Skin Sens. 1,Notified C&L,1,H317:1
253433,Perfluoroalkylethyl methacrylate copolymer,944-259-6,,Eye Irrit. 2,Notified C&L,1,H319:1
253434,N-t-BOC-trans-4-Fluoro-L-Prolinonitrile,813-734-9,1330286-47-9,Acute Tox. 4;Skin Sens. 1A,Notified C&L,1,H302:1;H317:1
253435,N-(Methoxycarbonyl)-L-phenylalanine,813-735-4,41844-91-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253436,"(1R,2S)-Cyclohexanediamine(1,2-ethanedionato)platinum(II)",813-737-5,61913-68-6,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Muta. 1B;Carc. 1B;Repr. 1B,Notified C&L,1,H360:1;H319:1;H302:1;H317:1;H340:1;H334:1;H350:1
253437,"2,2,3,3,4,4,5,5-Octafluoropentyl difluoromethylether",813-738-0,742063-29-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
253439,"(3R)-5,7-dihydroxy-3-[(4-methoxyphenyl)methyl]-6,8-dimethyl-2,3-dihydrochromen-4-one",813-739-6,74805-91-7,Skin Sens. 1,Notified C&L,1,H317:1
253440,Dihydrogen bisoxalatopalladate(II),813-740-1,120678-27-5,Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H312:1;H332:1;H302:1;H290:1
253441,bis(tert-butyldicylcohexylphosphine)dichloropalladium(II),813-741-7,104889-13-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3;H413:1;H228:1;H302:1;H312:1;H332:1
253442,"Trimethyl-[(1,2,3,4,5- η)-1-[3-(dimethoxymethylsilyl)propyl]-2,4-cyclopentadien-1-yl]platinum(IV)",813-742-2,1097896-98-4,Acute Tox. 3;Skin Sens. 1A;Aquatic Acute 1,Notified C&L,1,H400:1;H301:1;H317:1
253443,"cis-Dichloro[(2-quinoline-methanamine)-1,4-bis(diphenylphosphino)butane] ruthenium(II)",813-743-8,1631124-86-1,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,91,H413:91;H228:91;H319:91;H302:91;H315:91;H312:91;H332:91
